id,TARGET_NAME,TARGET_CLASS,SWISSPROT,ACTION_TYPE
Q12809,Potassium voltage-gated channel subfamily H member 2,Ion channel,KCNH2_HUMAN,
P35498,Sodium channel protein type 1 subunit alpha,Ion channel,SCN1A_HUMAN,
P35499,Sodium channel protein type 4 subunit alpha,Ion channel,SCN4A_HUMAN,BLOCKER
P34995,Prostaglandin E2 receptor EP1 subtype,GPCR,PE2R1_HUMAN,
P10635,Cytochrome P450 2D6,Enzyme,CP2D6_HUMAN,
P46098,5-hydroxytryptamine receptor 3A,Ion channel,5HT3A_HUMAN,
Q9UK17,Potassium voltage-gated channel subfamily D member 3,Ion channel,KCND3_HUMAN,
P22460,Potassium voltage-gated channel subfamily A member 5,Ion channel,KCNA5_HUMAN,
Q01668|Q13936,Voltage-gated L-type calcium channel,Ion channel,CAC1D_HUMAN|CAC1C_HUMAN,BLOCKER
O15554,Intermediate conductance calcium-activated potassium channel protein 4,Ion channel,KCNN4_HUMAN,BLOCKER
Q01668,Voltage-dependent L-type calcium channel subunit alpha-1D,Ion channel,CAC1D_HUMAN,GATING INHIBITOR
O60840,Voltage-dependent L-type calcium channel subunit alpha-1F,Ion channel,CAC1F_HUMAN,GATING INHIBITOR
P22002,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,CAC1C_RAT,GATING INHIBITOR
Q02485,Voltage-dependent L-type calcium channel subunit alpha-1S,Ion channel,CAC1S_RAT,GATING INHIBITOR
Q13936,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,CAC1C_HUMAN,BLOCKER
P08588,Beta-1 adrenergic receptor,GPCR,ADRB1_HUMAN,AGONIST
P00375,Dihydrofolate reductase,Enzyme,DYR_MOUSE,
P00381,Dihydrofolate reductase,Enzyme,DYR_LACCA,
B0BL08,Dihydrofolate reductase,Enzyme,B0BL08_ECOLX,
P48760,Folylpoly-gamma-glutamate synthetase,Enzyme,FOLC_MOUSE,
P00374,Dihydrofolate reductase,Enzyme,DYR_HUMAN,INHIBITOR
P15121,Aldose reductase,Enzyme,ALDR_HUMAN,
Q92769,Histone deacetylase 2,Enzyme,HDAC2_HUMAN,
Q13547,Histone deacetylase 1,Enzyme,HDAC1_HUMAN,
Q9BY41,Histone deacetylase 8,Enzyme,HDAC8_HUMAN,
P26358,DNA (cytosine-5)-methyltransferase 1,Enzyme,DNMT1_HUMAN,INHIBITOR
Q9Y6K1,DNA (cytosine-5)-methyltransferase 3A,Enzyme,DNM3A_HUMAN,INHIBITOR
P04818,Thymidylate synthase,Enzyme,TYSY_HUMAN,INHIBITOR
O15440,Multidrug resistance-associated protein 5,Transporter,MRP5_HUMAN,
Q96J66,ATP-binding cassette sub-family C member 11,Transporter,ABCCB_HUMAN,
P07607,Thymidylate synthase,Enzyme,TYSY_MOUSE,
P0A8F0,Uracil phosphoribosyltransferase,Enzyme,UPP_ECOLI,
O26232,Orotidine 5'-phosphate decarboxylase,Enzyme,PYRF_METTH,
P03962,Orotidine 5'-phosphate decarboxylase,Enzyme,PYRF_YEAST,
P22303,Acetylcholinesterase,Enzyme,ACES_HUMAN,
P05177,Cytochrome P450 1A2,Enzyme,CP1A2_HUMAN,
P21397,Amine oxidase [flavin-containing] A,Enzyme,AOFA_HUMAN,
O42713,Polyphenol oxidase 2,Enzyme,PPO2_AGABI,
P03369,Gag-Pol polyprotein,Polyprotein,POL_HV1A2,
Q72547,Reverse transcriptase/RNaseH,Enzyme,Q72547_9HIV1,INHIBITOR
Q9WKE8,Reverse transcriptase,Enzyme,Q9WKE8_9HIV1,
P30968,Gonadotropin-releasing hormone receptor,GPCR,GNRHR_HUMAN,ANTAGONIST
P14867|P18507|P28472,GABA-A receptor alpha-1/beta-3/gamma-2,Ion channel,GBRA1_HUMAN|GBRG2_HUMAN|GBRB3_HUMAN,POSITIVE MODULATOR
O15399|O60391|Q05586|Q12879|Q13224|Q14957|Q8TCU5,Glutamate [NMDA] receptor,Ion channel,NMDE4_HUMAN|NMD3B_HUMAN|NMDZ1_HUMAN|NMDE1_HUMAN|NMDE2_HUMAN|NMDE3_HUMAN|NMD3A_HUMAN,ANTAGONIST
O43451,"Maltase-glucoamylase, intestinal",Enzyme,MGA_HUMAN,INHIBITOR
P04746,Pancreatic alpha-amylase,Enzyme,AMYP_HUMAN,INHIBITOR
P04745,Alpha-amylase 1,Enzyme,AMY1_HUMAN,
P10253,Lysosomal alpha-glucosidase,Enzyme,LYAG_HUMAN,
P23739,"Sucrase-isomaltase, intestinal",Enzyme,SUIS_RAT,
Q6P7A9,Lysosomal alpha-glucosidase,Enzyme,LYAG_RAT,
P94451,Alpha-amylase,Enzyme,P94451_GEOSE,
P53051,"Oligo-1,6-glucosidase",Enzyme,MALX3_YEAST,
P00690,Pancreatic alpha-amylase,Enzyme,AMYP_PIG,
P14410,"Sucrase-isomaltase, intestinal",Enzyme,SUIS_HUMAN,
P08588,Beta-1 adrenergic receptor,GPCR,ADRB1_HUMAN,ANTAGONIST
P07550,Beta-2 adrenergic receptor,GPCR,ADRB2_HUMAN,
P19327,5-hydroxytryptamine receptor 1A,GPCR,5HT1A_RAT,
P02766,Transthyretin,Secreted,TTHY_HUMAN,
P07943,Aldose reductase,Enzyme,ALDR_RAT,
P28482,Mitogen-activated protein kinase 1,Kinase,MK01_HUMAN,
P35354,Prostaglandin G/H synthase 2,Enzyme,PGH2_HUMAN,INHIBITOR
P16116,Aldose reductase,Enzyme,ALDR_BOVIN,
Q4Z710,"Dihydropteroate synthetase, putative",Unclassified,Q4Z710_PLABA,
A0A113T0T6,"6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase",Unclassified,A0A113T0T6_PLABE,
P23219,Prostaglandin G/H synthase 1,Enzyme,PGH1_HUMAN,INHIBITOR
Q04760,Lactoylglutathione lyase,Enzyme,LGUL_HUMAN,
Q6TEK4,Vitamin K epoxide reductase complex subunit 1,Unclassified,VKOR1_RAT,INHIBITOR
Q9BQB6,Vitamin K epoxide reductase complex subunit 1,Enzyme,VKOR1_HUMAN,INHIBITOR
P29275,Adenosine receptor A2b,GPCR,AA2BR_HUMAN,
P35367,Histamine H1 receptor,GPCR,HRH1_HUMAN,ANTAGONIST
Q8NER1,Transient receptor potential cation channel subfamily V member 1,Ion channel,TRPV1_HUMAN,OPENER
Q14994,Nuclear receptor subfamily 1 group I member 3,Nuclear hormone receptor,NR1I3_HUMAN,
P00918,Carbonic anhydrase 2,Enzyme,CAH2_HUMAN,
P00915,Carbonic anhydrase 1,Enzyme,CAH1_HUMAN,
P22748,Carbonic anhydrase 4,Enzyme,CAH4_HUMAN,
Q16790,Carbonic anhydrase 9,Enzyme,CAH9_HUMAN,
O43570,Carbonic anhydrase 12,Enzyme,CAH12_HUMAN,
P43166,Carbonic anhydrase 7,Enzyme,CAH7_HUMAN,
P07451,Carbonic anhydrase 3,Enzyme,CAH3_HUMAN,
Q9ULX7,Carbonic anhydrase 14,Enzyme,CAH14_HUMAN,
P20292,Arachidonate 5-lipoxygenase-activating protein,Cytosolic other,AL5AP_HUMAN,
P12530,Arachidonate 15-lipoxygenase,Enzyme,LOX15_RABIT,
Q9D6N1,Carbonic anhydrase 13,Enzyme,CAH13_MOUSE,
Q99N23,Carbonic anhydrase 15,Enzyme,CAH15_MOUSE,
P02144,Myoglobin,Unclassified,MYG_HUMAN,
P21554,Cannabinoid receptor 1,GPCR,CNR1_HUMAN,AGONIST
Q6XQN6,Nicotinate phosphoribosyltransferase,Enzyme,PNCB_HUMAN,
Q9VTU8,"Carbonic anhydrase 2, isoform A; LD26647p",Enzyme,Q9VTU8_DROME,
Q9V396,Carbonic anhydrase 1; GH09688p,Enzyme,Q9V396_DROME,
P00918,Carbonic anhydrase 2,Enzyme,CAH2_HUMAN,INHIBITOR
P00915,Carbonic anhydrase 1,Enzyme,CAH1_HUMAN,INHIBITOR
P22748,Carbonic anhydrase 4,Enzyme,CAH4_HUMAN,INHIBITOR
O43570,Carbonic anhydrase 12,Enzyme,CAH12_HUMAN,INHIBITOR
P29972,Aquaporin-1,Transporter,AQP1_HUMAN,
P35218,"Carbonic anhydrase 5A, mitochondrial",Enzyme,CAH5A_HUMAN,
Q9Y2D0,"Carbonic anhydrase 5B, mitochondrial",Enzyme,CAH5B_HUMAN,
O24855,Carbonic anhydrase,Enzyme,CYNT_HELPY,
P23280,Carbonic anhydrase 6,Enzyme,CAH6_HUMAN,
Q95323,Carbonic anhydrase 4,Enzyme,CAH4_BOVIN,
Q9ERQ8,Carbonic anhydrase 7,Enzyme,CAH7_MOUSE,
P40881,Carbonic anhydrase,Enzyme,CAH_METTE,
Q50565,Carbonic anhydrase,Enzyme,Q50565_METTH,
Q8N1Q1,Carbonic anhydrase 13,Enzyme,CAH13_HUMAN,
P53615,Carbonic anhydrase,Enzyme,CAN_YEAST,
Q5AJ71,Carbonic anhydrase,Enzyme,CAN_CANAL,
P96878,Probable transmembrane carbonic anhydrase (Carbonate dehydratase) (Carbonic dehydratase); Transmembrane carbonic anhydrase,Enzyme,P96878_MYCTU,
Q6FTL6,Carbonic anhydrase,Enzyme,Q6FTL6_CANGA,
B5SU02,Alpha carbonic anhydrase,Enzyme,B5SU02_9CNID,
P29029,Endochitinase,Enzyme,CHIT_YEAST,
C0IX24,Carbonic anhydrase,Enzyme,C0IX24_9CNID,
Q3I4V7,Carbonic anhydrase 2,Enzyme,Q3I4V7_CRYNV,
Q2PCB5,Carbonic anhydrase,Enzyme,Q2PCB5_DICLA,
A6YCJ1,Astrosclerin-3,Enzyme,A6YCJ1_9METZ,
P9WPJ7,Beta-carbonic anhydrase 1,Enzyme,MTCA1_MYCTU,
Q5U9J1,Delta carbonic anhydrase,Unclassified,Q5U9J1_THAWE,
P9WPJ9,Carbonic anhydrase 2,Enzyme,MTCA2_MYCTU,
P00921,Carbonic anhydrase 2,Enzyme,CAH2_BOVIN,
O43570|P00915|P00918|P07451|P22748|P23280|P35218|P43166|Q16790|Q8N1Q1|Q9ULX7|Q9Y2D0,Carbonic anhydrase,Enzyme,CAH12_HUMAN|CAH1_HUMAN|CAH2_HUMAN|CAH3_HUMAN|CAH4_HUMAN|CAH6_HUMAN|CAH5A_HUMAN|CAH7_HUMAN|CAH9_HUMAN|CAH13_HUMAN|CAH14_HUMAN|CAH5B_HUMAN,
P00921|P18915|Q3SZX4|Q95323,Carbonic anhydrase,Enzyme,CAH2_BOVIN|CAH6_BOVIN|CAH3_BOVIN|CAH4_BOVIN,
P35218|Q9Y2D0,Carbonic anhydrase V,Enzyme,CAH5A_HUMAN|CAH5B_HUMAN,
P46510,Carbonic anhydrase,Enzyme,CAHX_FLABI,
Q3SZX4,Carbonic anhydrase 3,Enzyme,CAH3_BOVIN,
Q5TU56,Carbonic anhydrase,Enzyme,Q5TU56_ANOGA,
Q9HVB9,Carbonic anhydrase,Enzyme,Q9HVB9_PSEAE,
Q31FD6,"Carbonic anhydrase, alpha family",Unclassified,Q31FD6_HYDCU,
B2V8E3,Carbonate dehydratase,Enzyme,B2V8E3_SULSY,
O75493,Carbonic anhydrase-related protein 11,Enzyme,CAH11_HUMAN,
Q09428|Q14654,"Sulfonylurea receptor 1, Kir6.2",Ion channel,ABCC8_HUMAN|KCJ11_HUMAN,BLOCKER
Q03282|Q03283|Q03284,Bacterial urease,Enzyme,URE3_ECOLX|URE2_ECOLX|URE1_ECOLX,INHIBITOR
P07374,Urease,Enzyme,UREA_CANEN,
Q0PXQ5,Urease subunit beta,Enzyme,Q0PXQ5_HELPX,
P14416,D(2) dopamine receptor,GPCR,DRD2_HUMAN,ANTAGONIST
P15207,Androgen receptor,Transcription factor,ANDR_RAT,
P12821,Angiotensin-converting enzyme,Enzyme,ACE_HUMAN,
P08473,Neprilysin,Enzyme,NEP_HUMAN,INHIBITOR
P12822,Angiotensin-converting enzyme,Enzyme,ACE_RABIT,
P07861,Neprilysin,Enzyme,NEP_RAT,
P08049,Neprilysin,Enzyme,NEP_RABIT,
P19621,Neprilysin,Enzyme,NEP_PIG,
P42892,Endothelin-converting enzyme 1,Enzyme,ECE1_HUMAN,
P00800,Thermolysin,Enzyme,THER_BACTH,
P23141,Liver carboxylesterase 1,Enzyme,EST1_HUMAN,
P14061,Estradiol 17-beta-dehydrogenase 1,Enzyme,DHB1_HUMAN,
P37059,Estradiol 17-beta-dehydrogenase 2,Enzyme,DHB2_HUMAN,
P80365,Corticosteroid 11-beta-dehydrogenase isozyme 2,Enzyme,DHI2_HUMAN,
P28845,Corticosteroid 11-beta-dehydrogenase isozyme 1,Enzyme,DHI1_HUMAN,
O00748,Cocaine esterase,Enzyme,EST2_HUMAN,
P11229,Muscarinic acetylcholine receptor M1,GPCR,ACM1_HUMAN,
P08172,Muscarinic acetylcholine receptor M2,GPCR,ACM2_HUMAN,AGONIST
P20309,Muscarinic acetylcholine receptor M3,GPCR,ACM3_HUMAN,AGONIST
P08173,Muscarinic acetylcholine receptor M4,GPCR,ACM4_HUMAN,AGONIST
P08912,Muscarinic acetylcholine receptor M5,GPCR,ACM5_HUMAN,
P36544,Neuronal acetylcholine receptor subunit alpha-7,Ion channel,ACHA7_HUMAN,
P58154,Acetylcholine-binding protein,Unclassified,ACHP_LYMST,
P02718,Acetylcholine receptor subunit delta,Ion channel,ACHD_TORCA,
Q05941,Neuronal acetylcholine receptor subunit alpha-7,Ion channel,ACHA7_RAT,
P12389|P12390,Neuronal acetylcholine receptor; alpha2/beta2,Ion channel,ACHA2_RAT|ACHB2_RAT,
P04757|P12390,Neuronal acetylcholine receptor; alpha3/beta2,Ion channel,ACHA3_RAT|ACHB2_RAT,
P04757|P12392,Neuronal acetylcholine receptor; alpha3/beta4,Ion channel,ACHA3_RAT|ACHB4_RAT,
P09483|P12390,Neuronal acetylcholine receptor; alpha4/beta2,Ion channel,ACHA4_RAT|ACHB2_RAT,
P09483|P12392,Neuronal acetylcholine receptor; alpha4/beta4,Ion channel,ACHA4_RAT|ACHB4_RAT,
P17787|P43681,Neuronal acetylcholine receptor; alpha4/beta2,Ion channel,ACHB2_HUMAN|ACHA4_HUMAN,
P08482|P08483|P08485|P08911|P10980,Muscarinic acetylcholine receptor,GPCR,ACM1_RAT|ACM3_RAT|ACM4_RAT|ACM5_RAT|ACM2_RAT,
H6TY12,Nicotinic acetylcholine receptor alpha8 subunit,Ion channel,H6TY12_PERAM,
P99999,Cytochrome c,Enzyme,CYC_HUMAN,
P15692,Vascular endothelial growth factor A,Secreted,VEGFA_HUMAN,
P04179,"Superoxide dismutase [Mn], mitochondrial",Enzyme,SODM_HUMAN,
P48637,Glutathione synthetase,Enzyme,GSHB_HUMAN,MODULATOR
Q9UPY5,Cystine/glutamate transporter,Transporter,XCT_HUMAN,MODULATOR
P05023|P05026|P13637|P14415|P50993|P54709|P54710|Q13733,Sodium/potassium-transporting ATPase,Transporter,AT1A1_HUMAN|AT1B1_HUMAN|AT1A3_HUMAN|AT1B2_HUMAN|AT1A2_HUMAN|AT1B3_HUMAN|ATNG_HUMAN|AT1A4_HUMAN,INHIBITOR
P21728,D(1A) dopamine receptor,GPCR,DRD1_HUMAN,ANTAGONIST
P04156,Major prion protein,Surface antigen,PRIO_HUMAN,
P60045,Acidic phospholipase A2 3,Enzyme,PA2A3_NAJSG,
P19440,Gamma-glutamyltranspeptidase 1,Enzyme,GGT1_HUMAN,
P05979,Prostaglandin G/H synthase 1,Enzyme,PGH1_SHEEP,
P79208,Prostaglandin G/H synthase 2,Enzyme,PGH2_SHEEP,
O62664,Prostaglandin G/H synthase 1,Enzyme,PGH1_BOVIN,
Q9UHC3,Acid-sensing ion channel 3,Ion channel,ASIC3_HUMAN,BLOCKER
Q8TDS4,Hydroxycarboxylic acid receptor 2,GPCR,HCAR2_HUMAN,AGONIST
P10276,Retinoic acid receptor alpha,Nuclear hormone receptor,RARA_HUMAN,AGONIST
O95342,Bile salt export pump,Transporter,ABCBB_HUMAN,
P13631,Retinoic acid receptor gamma,Nuclear hormone receptor,RARG_HUMAN,AGONIST
O70127,Bile salt export pump,Transporter,ABCBB_RAT,
P41595,5-hydroxytryptamine receptor 2B,GPCR,5HT2B_HUMAN,
P08253,72 kDa type IV collagenase,Enzyme,MMP2_HUMAN,
P11387,DNA topoisomerase 1,Enzyme,TOP1_HUMAN,INHIBITOR
P11388|Q02880,DNA topoisomerase II,Enzyme,TOP2A_HUMAN|TOP2B_HUMAN,INHIBITOR
P08172|P08173|P08912|P11229|P20309,Muscarinic acetylcholine receptor,GPCR,ACM2_HUMAN|ACM4_HUMAN|ACM5_HUMAN|ACM1_HUMAN|ACM3_HUMAN,AGONIST
P08183,Multidrug resistance protein 1,Transporter,MDR1_HUMAN,
P31389,Histamine H1 receptor,GPCR,HRH1_CAVPO,
P00491,Purine nucleoside phosphorylase,Enzyme,PNPH_HUMAN,
P09250,Thymidine kinase,Kinase,KITH_VZVD,
P9WP01,Purine nucleoside phosphorylase,Enzyme,PUNA_MYCTU,
P04293,DNA polymerase catalytic subunit,Enzyme,DPOL_HHV11,INHIBITOR
P09252,DNA polymerase catalytic subunit,Enzyme,DPOL_VZVD,INHIBITOR
Q9QNF7,Thymidine kinase,Kinase,KITH_HHV1,INHIBITOR
P04407,Thymidine kinase,Kinase,KITH_HHV23,INHIBITOR
P23415,Glycine receptor subunit alpha-1,Ion channel,GLRA1_HUMAN,
P10276,Retinoic acid receptor alpha,Nuclear hormone receptor,RARA_HUMAN,
P10826,Retinoic acid receptor beta,Nuclear hormone receptor,RARB_HUMAN,AGONIST
Q9IF40,Protein P,Polyprotein,Q9IF40_HBV,INHIBITOR
P54098,DNA polymerase subunit gamma-1,Enzyme,DPOG1_HUMAN,
Q03732,Capsid protein,Unclassified,Q03732_HBV,
P47989,Xanthine dehydrogenase/oxidase,Enzyme,XDH_HUMAN,
P42356|Q8TCG2|Q9BTU6|Q9UBF8,"Phosphatidylinositol 4-kinase, PI4K",Kinase,PI4KA_HUMAN|P4K2B_HUMAN|P4K2A_HUMAN|PI4KB_HUMAN,
P29274,Adenosine receptor A2a,GPCR,AA2AR_HUMAN,AGONIST
P30542,Adenosine receptor A1,GPCR,AA1R_HUMAN,AGONIST
P29275,Adenosine receptor A2b,GPCR,AA2BR_HUMAN,AGONIST
P0DMS8,Adenosine receptor A3,GPCR,AA3R_HUMAN,AGONIST
P55263,Adenosine kinase,Kinase,ADK_HUMAN,
P00813,Adenosine deaminase,Enzyme,ADA_HUMAN,
P25099,Adenosine receptor A1,GPCR,AA1R_RAT,
P30543,Adenosine receptor A2a,GPCR,AA2AR_RAT,
P28647,Adenosine receptor A3,GPCR,AA3R_RAT,
Q9TVW2,Adenosine kinase,Kinase,ADK_TOXGO,
O43318,Mitogen-activated protein kinase kinase kinase 7,Kinase,M3K7_HUMAN,
P23526,Adenosylhomocysteinase,Enzyme,SAHH_HUMAN,
P29276|P30543,Adenosine A2 receptor,GPCR,AA2BR_RAT|AA2AR_RAT,
Q9BTU6,Phosphatidylinositol 4-kinase type 2-alpha,Kinase,P4K2A_HUMAN,INHIBITOR
Q8TCG2,Phosphatidylinositol 4-kinase type 2-beta,Kinase,P4K2B_HUMAN,INHIBITOR
P04406,Glyceraldehyde-3-phosphate dehydrogenase liver,Enzyme,G3P_HUMAN,
P00515|P00517|P05131|P31322,cAMP-dependent protein kinase A,Kinase,KAP2_BOVIN|KAPCA_BOVIN|KAPCB_BOVIN|KAP3_BOVIN,
Q8TEK3,"Histone-lysine N-methyltransferase, H3 lysine-79 specific",Enzyme,DOT1L_HUMAN,
P49652,P2Y purinoceptor 1,GPCR,P2RY1_MELGA,
P51575,P2X purinoceptor 1,Ion channel,P2RX1_HUMAN,AGONIST
P51582,P2Y purinoceptor 4,GPCR,P2RY4_HUMAN,
O60674,Tyrosine-protein kinase JAK2,Kinase,JAK2_HUMAN,
P47900,P2Y purinoceptor 1,GPCR,P2RY1_HUMAN,
P41231,P2Y purinoceptor 2,GPCR,P2RY2_HUMAN,AGONIST
Q96G91,P2Y purinoceptor 11,GPCR,P2Y11_HUMAN,
Q8TD43,Transient receptor potential cation channel subfamily M member 4,Ion channel,TRPM4_HUMAN,BLOCKER
Q9BPV8,P2Y purinoceptor 13,GPCR,P2Y13_HUMAN,AGONIST
P41148,Endoplasmin,Membrane other,ENPL_CANFA,
P49137,MAP kinase-activated protein kinase 2,Kinase,MAPK2_HUMAN,
Q99571,P2X purinoceptor 4,Ion channel,P2RX4_HUMAN,AGONIST
Q13304,Uracil nucleotide/cysteinyl leukotriene receptor,GPCR,GPR17_HUMAN,AGONIST
P56373,P2X purinoceptor 3,Ion channel,P2RX3_HUMAN,
Q12931,"Heat shock protein 75 kDa, mitochondrial",Unclassified,TRAP1_HUMAN,
P29410,Adenylate kinase 2,Kinase,KAD2_RAT,
P11142,Heat shock cognate 71 kDa protein,Unclassified,HSP7C_HUMAN,
P0DMV8,Heat shock 70 kDa protein 1A,Unclassified,HS71A_HUMAN,
Q7TN37,Transient receptor potential cation channel subfamily M member 4,Ion channel,TRPM4_MOUSE,BLOCKER
P49653,P2X purinoceptor 2,Unclassified,P2RX2_RAT,AGONIST
Q9JJX6,P2X purinoceptor 4,Unclassified,P2RX4_MOUSE,AGONIST
O35811,P2Y purinoceptor 4,GPCR,P2RY4_RAT,AGONIST
P51577,P2X purinoceptor 4,Unclassified,P2RX4_RAT,AGONIST
P51579,P2X purinoceptor 6,Unclassified,P2RX6_RAT,AGONIST
P51578,P2X purinoceptor 5,Unclassified,P2RX5_RAT,AGONIST
P09467,"Fructose-1,6-bisphosphatase 1",Enzyme,F16P1_HUMAN,
P00636,"Fructose-1,6-bisphosphatase 1",Enzyme,F16P1_PIG,
P12931,Proto-oncogene tyrosine-protein kinase Src,Kinase,SRC_HUMAN,
O94759,Transient receptor potential cation channel subfamily M member 2,Ion channel,TRPM2_HUMAN,
Q8TD43,Transient receptor potential cation channel subfamily M member 4,Ion channel,TRPM4_HUMAN,GATING INHIBITOR
Q72874,Pol polyprotein,Enzyme,Q72874_9HIV1,
P00327|P00328,Alcohol dehydrogenase,Enzyme,ADH1E_HORSE|ADH1S_HORSE,
P00338,L-lactate dehydrogenase A chain,Enzyme,LDHA_HUMAN,
P0A9J4,Ketopantoate reductase,Enzyme,PANE_ECOLI,
O43598,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,Enzyme,DNPH1_HUMAN,
O35820,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,Enzyme,DNPH1_RAT,
P30536,Translocator protein,Transporter,TSPO_HUMAN,
O14764|P14867|P18505|P18507|P28472|P31644|P34903|P47869|P47870|P48169|Q16445|Q8N1C3|Q99928,GABA-A receptor,Ion channel,GBRD_HUMAN|GBRA1_HUMAN|GBRB1_HUMAN|GBRG2_HUMAN|GBRB3_HUMAN|GBRA5_HUMAN|GBRA3_HUMAN|GBRA2_HUMAN|GBRB2_HUMAN|GBRA4_HUMAN|GBRA6_HUMAN|GBRG1_HUMAN|GBRG3_HUMAN,POSITIVE ALLOSTERIC MODULATOR
P31390,Histamine H1 receptor,GPCR,HRH1_RAT,
P28223,5-hydroxytryptamine receptor 2A,GPCR,5HT2A_HUMAN,ANTAGONIST
P41595,5-hydroxytryptamine receptor 2B,GPCR,5HT2B_HUMAN,ANTAGONIST
P48039|P49286,Melatonin receptor,GPCR,MTR1A_HUMAN|MTR1B_HUMAN,
P49285|P49288|P51050,Melatonin receptor,GPCR,MTR1A_CHICK|MTR1C_CHICK|MTR1B_CHICK,
P28335,5-hydroxytryptamine receptor 2C,GPCR,5HT2C_HUMAN,ANTAGONIST
P48039,Melatonin receptor type 1A,GPCR,MTR1A_HUMAN,AGONIST
P49286,Melatonin receptor type 1B,GPCR,MTR1B_HUMAN,AGONIST
Q14524,Sodium channel protein type 5 subunit alpha,Ion channel,SCN5A_HUMAN,INHIBITOR
Q9UK17,Potassium voltage-gated channel subfamily D member 3,Ion channel,KCND3_HUMAN,INHIBITOR
P22460,Potassium voltage-gated channel subfamily A member 5,Ion channel,KCNA5_HUMAN,INHIBITOR
P12821,Angiotensin-converting enzyme,Enzyme,ACE_HUMAN,INHIBITOR
P0AFI2|P20083,Topoisomerase IV,Enzyme,PARC_ECOLI|PARE_ECOLI,INHIBITOR
P0AES4|P0AES6,DNA gyrase,Enzyme,GYRA_ECOLI|GYRB_ECOLI,INHIBITOR
P50719,Tubulin alpha chain,Structural,TBA_HAECO,
C4PKY4|C4PKZ2|C4PKZ6,Tubulin,Structural,C4PKY4_ECHGR|C4PKZ2_ECHGR|C4PKZ6_ECHGR,INHIBITOR
F1L005|F1L4P8|F1L5G6|F1L7U3|F1L7Y0|F1L8A5|F1LCS0,Tubulin,Structural,F1L005_ASCSU|F1L4P8_ASCSU|F1L5G6_ASCSU|F1L7U3_ASCSU|F1L7Y0_ASCSU|F1L8A5_ASCSU|F1LCS0_ASCSU,INHIBITOR
P08588,Beta-1 adrenergic receptor,GPCR,ADRB1_HUMAN,
P07550,Beta-2 adrenergic receptor,GPCR,ADRB2_HUMAN,AGONIST
Q8K4Z4,Beta-2 adrenergic receptor,GPCR,ADRB2_CAVPO,
Q28044,Beta-2 adrenergic receptor,GPCR,ADRB2_BOVIN,
P23219,Prostaglandin G/H synthase 1,Enzyme,PGH1_HUMAN,
P11229,Muscarinic acetylcholine receptor M1,GPCR,ACM1_HUMAN,ALLOSTERIC MODULATOR
P08172,Muscarinic acetylcholine receptor M2,GPCR,ACM2_HUMAN,ALLOSTERIC MODULATOR
P20309,Muscarinic acetylcholine receptor M3,GPCR,ACM3_HUMAN,ALLOSTERIC MODULATOR
P08173,Muscarinic acetylcholine receptor M4,GPCR,ACM4_HUMAN,
Q15822,Neuronal acetylcholine receptor subunit alpha-2,Ion channel,ACHA2_HUMAN,
P06199,Muscarinic acetylcholine receptor M2,GPCR,ACM2_PIG,
P02708|P11230|Q07001,Acetylcholine receptor,Ion channel,ACHA_HUMAN|ACHB_HUMAN|ACHD_HUMAN,
P30926|P43681,Neuronal acetylcholine receptor; alpha4/beta4,Ion channel,ACHB4_HUMAN|ACHA4_HUMAN,
P08235,Mineralocorticoid receptor,Nuclear hormone receptor,MCR_HUMAN,
P08185,Corticosteroid-binding globulin,Secreted,CBG_HUMAN,
P04278,Sex hormone-binding globulin,Secreted,SHBG_HUMAN,
P22199,Mineralocorticoid receptor,Transcription factor,MCR_RAT,
P14324,Farnesyl pyrophosphate synthase,Enzyme,FPPS_HUMAN,INHIBITOR
Q0GKD7,Farnesyl pyrophosphate synthase,Enzyme,Q0GKD7_LEIDO,
P49356,Protein farnesyltransferase subunit beta,Enzyme,FNTB_HUMAN,
P05369,Farnesyl pyrophosphate synthase,Enzyme,FPPS_RAT,
Q9NR96,Toll-like receptor 9,Membrane receptor,TLR9_HUMAN,
P0C6X7,Replicase polyprotein 1ab,Enzyme,R1AB_CVHSA,
Q932Y6,Beta-lactamase,Enzyme,Q932Y6_PSEAI,
Q8WUK0,Phosphatidylglycerophosphatase and protein-tyrosine phosphatase 1,Enzyme,PTPM1_HUMAN,INHIBITOR
P35372,Mu-type opioid receptor,GPCR,OPRM_HUMAN,AGONIST
P33535,Mu-type opioid receptor,GPCR,OPRM_RAT,
P97266,Mu-type opioid receptor,GPCR,OPRM_CAVPO,
P33533|P33535|P34975|Q9R0C9,Opioid receptor,GPCR,OPRD_RAT|OPRM_RAT|OPRK_RAT|SGMR1_RAT,
P35348,Alpha-1A adrenergic receptor,GPCR,ADA1A_HUMAN,ANTAGONIST
P25100,Alpha-1D adrenergic receptor,GPCR,ADA1D_HUMAN,ANTAGONIST
P35368,Alpha-1B adrenergic receptor,GPCR,ADA1B_HUMAN,ANTAGONIST
O15245,Solute carrier family 22 member 1,Transporter,S22A1_HUMAN,
P23944,Alpha-1D adrenergic receptor,GPCR,ADA1D_RAT,
P18130,Alpha-1A adrenergic receptor,GPCR,ADA1A_BOVIN,
P08684,Cytochrome P450 3A4,Enzyme,CP3A4_HUMAN,
P00797,Renin,Enzyme,RENI_HUMAN,INHIBITOR
Q9TSZ1,Renin,Enzyme,RENI_CALJA,
Q6DLS0,Renin,Enzyme,RENI_MACFA,
P08424,Renin,Enzyme,RENI_RAT,
P06281,Renin-1,Enzyme,RENI1_MOUSE,
Q7M3D2,Renin,Enzyme,Q7M3D2_RABIT,
Q9YQ12,Protease,Enzyme,Q9YQ12_9HIV1,
Q6DLW5,Renin,Enzyme,RENI_MACMU,
P18825,Alpha-2C adrenergic receptor,GPCR,ADA2C_HUMAN,
P61169,D(2) dopamine receptor,GPCR,DRD2_RAT,
P47989,Xanthine dehydrogenase/oxidase,Enzyme,XDH_HUMAN,INHIBITOR
P00492,Hypoxanthine-guanine phosphoribosyltransferase,Enzyme,HPRT_HUMAN,
P80457,Xanthine dehydrogenase/oxidase,Enzyme,XDH_BOVIN,
P22985,Xanthine dehydrogenase/oxidase,Enzyme,XDH_RAT,
Q9FBI2,Shiga toxin subunit A,Unclassified,STXA_SHIDY,
P28222,5-hydroxytryptamine receptor 1B,GPCR,5HT1B_HUMAN,AGONIST
P28221,5-hydroxytryptamine receptor 1D,GPCR,5HT1D_HUMAN,AGONIST
P30939,5-hydroxytryptamine receptor 1F,GPCR,5HT1F_HUMAN,AGONIST
P46098,5-hydroxytryptamine receptor 3A,Ion channel,5HT3A_HUMAN,ANTAGONIST
P23975,Sodium-dependent noradrenaline transporter,Transporter,SC6A2_HUMAN,
P11473,Vitamin D3 receptor,Nuclear hormone receptor,VDR_HUMAN,AGONIST
P30531,Sodium- and chloride-dependent GABA transporter 1,Transporter,SC6A1_HUMAN,
P14867|P18507|P47870,GABA-A receptor alpha-1/beta-2/gamma-2,Ion channel,GBRA1_HUMAN|GBRG2_HUMAN|GBRB2_HUMAN,
O09028|P15431|P18506|P18508|P19969|P20236|P23574|P23576|P28471|P28473|P30191|P62813|P63079|P63138|Q91ZM7|Q9ES14,GABA-A receptor; anion channel,Ion channel,GBRP_RAT|GBRB1_RAT|GBRD_RAT|GBRG2_RAT|GBRA5_RAT|GBRA3_RAT|GBRG1_RAT|GBRA2_RAT|GBRA4_RAT|GBRG3_RAT|GBRA6_RAT|GBRA1_RAT|GBRB3_RAT|GBRB2_RAT|Q91ZM7_RAT|GBRE_RAT,
P18507|P47869|P47870,GABA A receptor alpha-2/beta-2/gamma-2,Ion channel,GBRG2_HUMAN|GBRA2_HUMAN|GBRB2_HUMAN,
P16257,Translocator protein,Membrane receptor,TSPO_RAT,
P30536,Translocator protein,Unclassified,TSPO_HUMAN,
P14867,Gamma-aminobutyric acid receptor subunit alpha-1,Ion channel,GBRA1_HUMAN,PARTIAL AGONIST
P25105,Platelet-activating factor receptor,GPCR,PTAFR_HUMAN,
P30551,Cholecystokinin receptor type A,GPCR,CCKAR_RAT,
O60885,Bromodomain-containing protein 4,Unclassified,BRD4_HUMAN,
P14867|P18507|P47870,GABA-A receptor alpha-1/beta-2/gamma-2,Ion channel,GBRA1_HUMAN|GBRG2_HUMAN|GBRB2_HUMAN,POSITIVE ALLOSTERIC MODULATOR
P18507|P28472|P47869,GABA-A receptor alpha-2/beta-3/gamma-2,Ion channel,GBRG2_HUMAN|GBRB3_HUMAN|GBRA2_HUMAN,POSITIVE ALLOSTERIC MODULATOR
P18507|P28472|P34903,GABA-A receptor alpha-3/beta-3/gamma-2,Ion channel,GBRG2_HUMAN|GBRB3_HUMAN|GBRA3_HUMAN,POSITIVE ALLOSTERIC MODULATOR
P18507|P28472|P31644,GABA-A receptor alpha-5/beta-3/gamma-2,Ion channel,GBRG2_HUMAN|GBRB3_HUMAN|GBRA5_HUMAN,POSITIVE ALLOSTERIC MODULATOR
P08908,5-hydroxytryptamine receptor 1A,GPCR,5HT1A_HUMAN,
P28223,5-hydroxytryptamine receptor 2A,GPCR,5HT2A_HUMAN,
P13945,Beta-3 adrenergic receptor,GPCR,ADRB3_HUMAN,
Q02769,Squalene synthase,Enzyme,FDFT_RAT,
P07550,Beta-2 adrenergic receptor,GPCR,ADRB2_HUMAN,ANTAGONIST
P34995,Prostaglandin E2 receptor EP1 subtype,GPCR,PE2R1_HUMAN,AGONIST
P43115,Prostaglandin E2 receptor EP3 subtype,GPCR,PE2R3_HUMAN,AGONIST
P43119,Prostacyclin receptor,GPCR,PI2R_HUMAN,
P43116,Prostaglandin E2 receptor EP2 subtype,GPCR,PE2R2_HUMAN,AGONIST
P35408,Prostaglandin E2 receptor EP4 subtype,GPCR,PE2R4_HUMAN,AGONIST
Q13258,Prostaglandin D2 receptor,GPCR,PD2R_HUMAN,
P35375,Prostaglandin E2 receptor EP1 subtype,GPCR,PE2R1_MOUSE,
Q62053,Prostaglandin E2 receptor EP2 subtype,GPCR,PE2R2_MOUSE,
P30557,Prostaglandin E2 receptor EP3 subtype,GPCR,PE2R3_MOUSE,
P32240,Prostaglandin E2 receptor EP4 subtype,GPCR,PE2R4_MOUSE,
Q62928,Prostaglandin E2 receptor EP2 subtype,GPCR,PE2R2_RAT,AGONIST
P43114,Prostaglandin E2 receptor EP4 subtype,GPCR,PE2R4_RAT,AGONIST
Q8NEC5,Cation channel sperm-associated protein 1,Ion channel,CTSR1_HUMAN,ACTIVATOR
Q96P56,Cation channel sperm-associated protein 2,Ion channel,CTSR2_HUMAN,ACTIVATOR
Q86XQ3,Cation channel sperm-associated protein 3,Ion channel,CTSR3_HUMAN,ACTIVATOR
Q7RTX7,Cation channel sperm-associated protein 4,Ion channel,CTSR4_HUMAN,ACTIVATOR
P43252,Prostacyclin receptor,GPCR,PI2R_MOUSE,AGONIST
P34980,Prostaglandin E2 receptor EP3 subtype,GPCR,PE2R3_RAT,AGONIST
P70597,Prostaglandin E2 receptor EP1 subtype,GPCR,PE2R1_RAT,AGONIST
P35372,Mu-type opioid receptor,GPCR,OPRM_HUMAN,ANTAGONIST
P41145,Kappa-type opioid receptor,GPCR,OPRK_HUMAN,
P41143,Delta-type opioid receptor,GPCR,OPRD_HUMAN,
P41144,Kappa-type opioid receptor,GPCR,OPRK_CAVPO,
Q99720,Sigma non-opioid intracellular receptor 1,Membrane receptor,SGMR1_HUMAN,
Q96FL8,Multidrug and toxin extrusion protein 1,Transporter,S47A1_HUMAN,
P63231,Matrix protein 2,Ion channel,M2_I72A2,INHIBITOR
O15399|O60391|Q05586|Q12879|Q13224|Q14957|Q8TCU5,Glutamate [NMDA] receptor,Ion channel,NMDE4_HUMAN|NMD3B_HUMAN|NMDZ1_HUMAN|NMDE1_HUMAN|NMDE2_HUMAN|NMDE3_HUMAN|NMD3A_HUMAN,BLOCKER
Q20MD5,Matrix protein 2,Unclassified,Q20MD5_9INFA,
P05778,Matrix protein 2,Unclassified,M2_I000F,
P0DOF8,Matrix protein 2,Unclassified,M2_I72A8,
P22303,Acetylcholinesterase,Enzyme,ACES_HUMAN,INHIBITOR
P21836,Acetylcholinesterase,Enzyme,ACES_MOUSE,
P23795,Acetylcholinesterase,Enzyme,ACES_BOVIN,
P31645,Sodium-dependent serotonin transporter,Transporter,SC6A4_HUMAN,
Q9Y5Y9,Sodium channel protein type 10 subunit alpha,Ion channel,SCNAA_HUMAN,
P04062,Glucosylceramidase,Enzyme,GLCM_HUMAN,
P04150,Glucocorticoid receptor,Nuclear hormone receptor,GCR_HUMAN,AGONIST
P19328|P22086|P22909,Adrenergic receptor alpha-2,GPCR,ADA2B_RAT|ADA2C_RAT|ADA2A_RAT,
P15823|P23944|P43140,Adrenergic receptor alpha-1,GPCR,ADA1B_RAT|ADA1D_RAT|ADA1A_RAT,
P35462,D(3) dopamine receptor,GPCR,DRD3_HUMAN,
P05186,"Alkaline phosphatase, tissue-nonspecific isozyme",Enzyme,PPBT_HUMAN,
O32553,"Macrolide 2'-phosphotransferase II; Macrolide 2'-phosphotransferase II protein MphB; Macrolide 2-phosphotransferase, mph(B)",Enzyme,O32553_ECOLX,
P37088,Amiloride-sensitive sodium channel subunit alpha,Ion channel,SCNNA_HUMAN,
P00749,Urokinase-type plasminogen activator,Enzyme,UROK_HUMAN,
P29274,Adenosine receptor A2a,GPCR,AA2AR_HUMAN,
P19634,Sodium/hydrogen exchanger 1,Transporter,SL9A1_HUMAN,
Q16515,Acid-sensing ion channel 2,Ion channel,ASIC2_HUMAN,BLOCKER
P78348,Acid-sensing ion channel 1,Ion channel,ASIC1_HUMAN,
O08590,Membrane primary amine oxidase,Enzyme,AOC3_RAT,
Q9UHC3,Acid-sensing ion channel 3,Ion channel,ASIC3_HUMAN,
P37088|P51168|P51170,"Amiloride-sensitive sodium channel, ENaC",Ion channel,SCNNA_HUMAN|SCNNB_HUMAN|SCNNG_HUMAN,BLOCKER
Q9W6Q1,Sodium/hydrogen exchanger,Transporter,Q9W6Q1_9SALA,
Q14940,Sodium/hydrogen exchanger 5,Transporter,SL9A5_HUMAN,INHIBITOR
P26431,Sodium/hydrogen exchanger 1,Transporter,SL9A1_RAT,INHIBITOR
P50482,Sodium/hydrogen exchanger 2,Transporter,SL9A2_RABIT,
P06869,Urokinase-type plasminogen activator,Enzyme,UROK_MOUSE,
P55926,Acid-sensing ion channel 1,Ion channel,ASIC1_RAT,
P16083,Ribosyldihydronicotinamide dehydrogenase [quinone],Enzyme,NQO2_HUMAN,
P28593,Trypanothione reductase,Enzyme,TYTR_TRYCR,
P23977,Sodium-dependent dopamine transporter,Transporter,SC6A3_RAT,
P00747,Plasminogen,Enzyme,PLMN_HUMAN,INHIBITOR
P00750,Tissue-type plasminogen activator,Enzyme,TPA_HUMAN,INHIBITOR
P11511,Aromatase,Enzyme,CP19A_HUMAN,INHIBITOR
P24557,Thromboxane-A synthase,Enzyme,THAS_HUMAN,
P05108,"Cholesterol side-chain cleavage enzyme, mitochondrial",Enzyme,CP11A_HUMAN,INHIBITOR
P22443,Aromatase,Enzyme,CP19A_RAT,
P00189,Cytochrome P450 11A1,Enzyme,CP11A_BOVIN,
Q4U2R8,Solute carrier family 22 member 6,Transporter,S22A6_HUMAN,
Q8VC69,Solute carrier family 22 member 6,Transporter,S22A6_MOUSE,
P35354,Prostaglandin G/H synthase 2,Enzyme,PGH2_HUMAN,
P35228,"Nitric oxide synthase, inducible",Enzyme,NOS2_HUMAN,INHIBITOR
P14780,Matrix metalloproteinase-9,Enzyme,MMP9_HUMAN,
P03956,Interstitial collagenase,Enzyme,MMP1_HUMAN,
P15917,Lethal factor,Enzyme,LEF_BACAN,
P10845,Botulinum neurotoxin type A,Enzyme,BXA1_CLOBO,
Q14524,Sodium channel protein type 5 subunit alpha,Ion channel,SCN5A_HUMAN,BLOCKER
P35372,Mu-type opioid receptor,GPCR,OPRM_HUMAN,
P21728,D(1A) dopamine receptor,GPCR,DRD1_HUMAN,
P14416,D(2) dopamine receptor,GPCR,DRD2_HUMAN,
P08913,Alpha-2A adrenergic receptor,GPCR,ADA2A_HUMAN,
P10827,Thyroid hormone receptor alpha,Nuclear hormone receptor,THA_HUMAN,
P10828,Thyroid hormone receptor beta,Nuclear hormone receptor,THB_HUMAN,
Q12809,Potassium voltage-gated channel subfamily H member 2,Ion channel,KCNH2_HUMAN,BLOCKER
Q15125,"3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase",Enzyme,EBP_HUMAN,
P28335,5-hydroxytryptamine receptor 2C,GPCR,5HT2C_HUMAN,
P50406,5-hydroxytryptamine receptor 6,GPCR,5HT6R_HUMAN,
P18089,Alpha-2B adrenergic receptor,GPCR,ADA2B_HUMAN,
P25021,Histamine H2 receptor,GPCR,HRH2_HUMAN,
P08172,Muscarinic acetylcholine receptor M2,GPCR,ACM2_HUMAN,
P20309,Muscarinic acetylcholine receptor M3,GPCR,ACM3_HUMAN,
Q01959,Sodium-dependent dopamine transporter,Transporter,SC6A3_HUMAN,
P0DMS8,Adenosine receptor A3,GPCR,AA3R_HUMAN,
P21917,D(4) dopamine receptor,GPCR,DRD4_HUMAN,
P11712,Cytochrome P450 2C9,Enzyme,CP2C9_HUMAN,
O95180,Voltage-dependent T-type calcium channel subunit alpha-1H,Ion channel,CAC1H_HUMAN,
P25101,Endothelin-1 receptor,GPCR,EDNRA_HUMAN,
Q14534,Squalene monooxygenase,Enzyme,ERG1_HUMAN,
P06241,Tyrosine-protein kinase Fyn,Kinase,FYN_HUMAN,
P04626,Receptor tyrosine-protein kinase erbB-2,Kinase,ERBB2_HUMAN,
P37268,Squalene synthase,Enzyme,FDFT_HUMAN,
P41597,C-C chemokine receptor type 2,GPCR,CCR2_HUMAN,
P21452,Substance-K receptor,GPCR,NK2R_HUMAN,
Q9Y3Q4,Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4,Ion channel,HCN4_HUMAN,
Q96RP8,Potassium voltage-gated channel subfamily A member 7,Ion channel,KCNA7_HUMAN,
P28564,5-hydroxytryptamine receptor 1B,GPCR,5HT1B_RAT,
P30411,B2 bradykinin receptor,GPCR,BKRB2_HUMAN,
P32245,Melanocortin receptor 4,GPCR,MC4R_HUMAN,
P33032,Melanocortin receptor 5,GPCR,MC5R_HUMAN,
P41968,Melanocortin receptor 3,GPCR,MC3R_HUMAN,
P51679,C-C chemokine receptor type 4,GPCR,CCR4_HUMAN,
P70580,Membrane-associated progesterone receptor component 1,Membrane receptor,PGRC1_RAT,
P32352,C-8 sterol isomerase,Enzyme,ERG2_YEAST,
P25779,Cruzipain,Enzyme,CYSP_TRYCR,
Q9NVV9,THAP domain-containing protein 1,Unclassified,THAP1_HUMAN,
P15389,Sodium channel protein type 5 subunit alpha,Ion channel,SCN5A_RAT,BLOCKER
O75151,Lysine-specific demethylase PHF2,Enzyme,PHF2_HUMAN,
P29375,Lysine-specific demethylase 5A,Enzyme,KDM5A_HUMAN,
Q6ZMT4,Lysine-specific demethylase 7A,Enzyme,KDM7A_HUMAN,
P34969,5-hydroxytryptamine receptor 7,GPCR,5HT7R_HUMAN,
P28222,5-hydroxytryptamine receptor 1B,GPCR,5HT1B_HUMAN,
P28221,5-hydroxytryptamine receptor 1D,GPCR,5HT1D_HUMAN,
P19020,D(3) dopamine receptor,GPCR,DRD3_RAT,ANTAGONIST
P35462,D(3) dopamine receptor,GPCR,DRD3_HUMAN,ANTAGONIST
Q14524,Sodium channel protein type 5 subunit alpha,Ion channel,SCN5A_HUMAN,
P31645,Sodium-dependent serotonin transporter,Transporter,SC6A4_HUMAN,INHIBITOR
P23975,Sodium-dependent noradrenaline transporter,Transporter,SC6A2_HUMAN,INHIBITOR
P35348,Alpha-1A adrenergic receptor,GPCR,ADA1A_HUMAN,
P21918,D(1B) dopamine receptor,GPCR,DRD5_HUMAN,
Q9H3N8,Histamine H4 receptor,GPCR,HRH4_HUMAN,
P11229,Muscarinic acetylcholine receptor M1,GPCR,ACM1_HUMAN,ANTAGONIST
Q06278,Aldehyde oxidase,Enzyme,AOXA_HUMAN,
Q99250,Sodium channel protein type 2 subunit alpha,Ion channel,SCN2A_HUMAN,
Q15858,Sodium channel protein type 9 subunit alpha,Ion channel,SCN9A_HUMAN,
P25100,Alpha-1D adrenergic receptor,GPCR,ADA1D_HUMAN,
P07949,Proto-oncogene tyrosine-protein kinase receptor Ret,Kinase,RET_HUMAN,
P04629,High affinity nerve growth factor receptor,Kinase,NTRK1_HUMAN,
P15823,Alpha-1B adrenergic receptor,GPCR,ADA1B_RAT,
P43140,Alpha-1A adrenergic receptor,GPCR,ADA1A_RAT,
P31652,Sodium-dependent serotonin transporter,Transporter,SC6A4_RAT,
P14842,5-hydroxytryptamine receptor 2A,GPCR,5HT2A_RAT,ANTAGONIST
Q9WTR4,Transporter,Transporter,Q9WTR4_RAT,
P32305,5-hydroxytryptamine receptor 7,GPCR,5HT7R_RAT,ANTAGONIST
P32304,5-hydroxytryptamine receptor 7,GPCR,5HT7R_MOUSE,ANTAGONIST
P08909,5-hydroxytryptamine receptor 2C,GPCR,5HT2C_RAT,ANTAGONIST
P31388,5-hydroxytryptamine receptor 6,GPCR,5HT6R_RAT,ANTAGONIST
O15244,Solute carrier family 22 member 2,Transporter,S22A2_HUMAN,
P48542,G protein-activated inward rectifier potassium channel 2,Ion channel,KCNJ6_MOUSE,BLOCKER
Q14164,Inhibitor of nuclear factor kappa-B kinase subunit epsilon,Kinase,IKKE_HUMAN,INHIBITOR
Q9UHD2,Serine/threonine-protein kinase TBK1,Kinase,TBK1_HUMAN,INHIBITOR
Q9HC97,G-protein coupled receptor 35,GPCR,GPR35_HUMAN,
P27815|Q07343|Q08493|Q08499,Phosphodiesterase 4,Enzyme,PDE4A_HUMAN|PDE4B_HUMAN|PDE4C_HUMAN|PDE4D_HUMAN,INHIBITOR
P35368,Alpha-1B adrenergic receptor,GPCR,ADA1B_HUMAN,
Q06432,Voltage-dependent calcium channel gamma-1 subunit,Ion channel,CCG1_HUMAN,
P54289,Voltage-dependent calcium channel subunit alpha-2/delta-1,Ion channel,CA2D1_HUMAN,
Q01668,Voltage-dependent L-type calcium channel subunit alpha-1D,Ion channel,CAC1D_HUMAN,BLOCKER
O95069,Potassium channel subfamily K member 2,Ion channel,KCNK2_HUMAN,
P22002,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,CAC1C_RAT,
Q8HY88,Potassium channel subfamily K member 2,Ion channel,Q8HY88_BOVIN,
P50135,Histamine N-methyltransferase,Enzyme,HNMT_HUMAN,
Q9Y251,Heparanase,Enzyme,HPSE_HUMAN,
P05067,Amyloid beta A4 protein,Unclassified,A4_HUMAN,
P50406,5-hydroxytryptamine receptor 6,GPCR,5HT6R_HUMAN,ANTAGONIST
P35367,Histamine H1 receptor,GPCR,HRH1_HUMAN,
P21917,D(4) dopamine receptor,GPCR,DRD4_HUMAN,ANTAGONIST
Q9Y345,Sodium- and chloride-dependent glycine transporter 2,Transporter,SC6A5_HUMAN,
Q8XJ01,Penicillin-binding protein 1A,Enzyme,PBPA_CLOPE,
P02918|P02919|P08506|P0AD65|P0AD68|P0AEB2|P24228,Bacterial penicillin-binding protein,Enzyme,PBPA_ECOLI|PBPB_ECOLI|DACC_ECOLI|PBP2_ECOLI|FTSI_ECOLI|DACA_ECOLI|DACB_ECOLI,INHIBITOR
O00519,Fatty-acid amide hydrolase 1,Enzyme,FAAH1_HUMAN,
P23975,Sodium-dependent noradrenaline transporter,Transporter,SC6A2_HUMAN,RELEASING AGENT
Q01959,Sodium-dependent dopamine transporter,Transporter,SC6A3_HUMAN,RELEASING AGENT
Q16568,Cocaine- and amphetamine-regulated transcript protein,Transcription factor,CART_HUMAN,
P21396,Amine oxidase [flavin-containing] A,Enzyme,AOFA_RAT,
O55192,Sodium-dependent noradrenaline transporter,Transporter,SC6A2_MOUSE,
P30994,5-hydroxytryptamine receptor 2B,GPCR,5HT2B_RAT,
Q60857,Sodium-dependent serotonin transporter,Transporter,SC6A4_MOUSE,
Q63380,Transporter,Transporter,Q63380_RAT,
P08909|P14842|P19327|P28564|P28565|P30940|P30994|P31388|P32305|P35364|P35365|P35563|Q62758|Q9JJ16,Serotonin (5-HT) receptor,GPCR,5HT2C_RAT|5HT2A_RAT|5HT1A_RAT|5HT1B_RAT|5HT1D_RAT|5HT1F_RAT|5HT2B_RAT|5HT6R_RAT|5HT7R_RAT|5HT5A_RAT|5HT5B_RAT|5HT3A_RAT|5HT4R_RAT|5HT3B_RAT,
P19327|P28564|P28565|P30940,Serotonin 1 (5-HT1) receptor,GPCR,5HT1A_RAT|5HT1B_RAT|5HT1D_RAT|5HT1F_RAT,
P08909|P14842|P30994,Serotonin 2 (5-HT2) receptor,GPCR,5HT2C_RAT|5HT2A_RAT|5HT2B_RAT,
Q96RJ0,Trace amine-associated receptor 1,GPCR,TAAR1_HUMAN,AGONIST
Q02763,Angiopoietin-1 receptor,Kinase,TIE2_HUMAN,
Q8TD43,Transient receptor potential cation channel subfamily M member 4,Ion channel,TRPM4_HUMAN,
P03367,Gag-Pol polyprotein,Polyprotein,POL_HV1BR,
P07339,Cathepsin D,Enzyme,CATD_HUMAN,
Q72874,Pol polyprotein,Enzyme,Q72874_9HIV1,INHIBITOR
O90781,Protease,Unclassified,O90781_9PLVG,
Q9YQ30,Protease,Unclassified,Q9YQ30_9PLVG,
Q14432,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A",Enzyme,PDE3A_HUMAN,INHIBITOR
P33981,Dual specificity protein kinase TTK,Kinase,TTK_HUMAN,
Q13370,"cGMP-inhibited 3',5'-cyclic phosphodiesterase B",Enzyme,PDE3B_HUMAN,INHIBITOR
P27815|Q07343|Q08493|Q08499,Phosphodiesterase 4,Enzyme,PDE4A_HUMAN|PDE4B_HUMAN|PDE4C_HUMAN|PDE4D_HUMAN,
P11388,DNA topoisomerase 2-alpha,Enzyme,TOP2A_HUMAN,
Q969P6,"DNA topoisomerase I, mitochondrial",Enzyme,TOP1M_HUMAN,
P11387,DNA topoisomerase 1,Enzyme,TOP1_HUMAN,
Q02880,DNA topoisomerase 2-beta,Enzyme,TOP2B_HUMAN,
P11388|Q02880,DNA topoisomerase II,Enzyme,TOP2A_HUMAN|TOP2B_HUMAN,
O00408,"cGMP-dependent 3',5'-cyclic phosphodiesterase",Enzyme,PDE2A_HUMAN,
P10275,Androgen receptor,Nuclear hormone receptor,ANDR_HUMAN,
P03372,Estrogen receptor,Nuclear hormone receptor,ESR1_HUMAN,
Q92731,Estrogen receptor beta,Nuclear hormone receptor,ESR2_HUMAN,
P11511,Aromatase,Enzyme,CP19A_HUMAN,
P37058,Testosterone 17-beta-dehydrogenase 3,Enzyme,DHB3_HUMAN,
O54939,Testosterone 17-beta-dehydrogenase 3,Enzyme,DHB3_RAT,
P05121,Plasminogen activator inhibitor 1,Secreted,PAI1_HUMAN,
Q92887,Canalicular multispecific organic anion transporter 1,Transporter,MRP2_HUMAN,
P33527,Multidrug resistance-associated protein 1,Transporter,MRP1_HUMAN,
Q5T3U5,Multidrug resistance-associated protein 7,Transporter,MRP7_HUMAN,
P68371,Tubulin beta-4B chain,Structural,TBB4B_HUMAN,
P38435,Vitamin K-dependent gamma-carboxylase,Enzyme,VKGC_HUMAN,INHIBITOR
P12527,Arachidonate 5-lipoxygenase,Enzyme,LOX5_RAT,
P20309,Muscarinic acetylcholine receptor M3,GPCR,ACM3_HUMAN,ANTAGONIST
O75342,"Arachidonate 12-lipoxygenase, 12R-type",Enzyme,LX12B_HUMAN,
Q9BEG3,5-lipoxygenase,Enzyme,Q9BEG3_BOVIN,
Q9NXA8,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",Enzyme,SIR5_HUMAN,
P05981,Serine protease hepsin,Enzyme,HEPS_HUMAN,
P00761,Trypsin,Enzyme,TRYP_PIG,
P14416,D(2) dopamine receptor,GPCR,DRD2_HUMAN,AGONIST
P08913,Alpha-2A adrenergic receptor,GPCR,ADA2A_HUMAN,AGONIST
P18089,Alpha-2B adrenergic receptor,GPCR,ADA2B_HUMAN,ANTAGONIST
P35462,D(3) dopamine receptor,GPCR,DRD3_HUMAN,AGONIST
P21918,D(1B) dopamine receptor,GPCR,DRD5_HUMAN,AGONIST
P18825,Alpha-2C adrenergic receptor,GPCR,ADA2C_HUMAN,ANTAGONIST
P21917,D(4) dopamine receptor,GPCR,DRD4_HUMAN,AGONIST
O75762,Transient receptor potential cation channel subfamily A member 1,Ion channel,TRPA1_HUMAN,ACTIVATOR
P32305,5-hydroxytryptamine receptor 7,GPCR,5HT7R_RAT,
P18901,D(1A) dopamine receptor,GPCR,DRD1_RAT,
P20288,D(2) dopamine receptor,GPCR,DRD2_BOVIN,
P19020,D(3) dopamine receptor,GPCR,DRD3_RAT,
P30729,D(4) dopamine receptor,GPCR,DRD4_RAT,
Q61616,D(1A) dopamine receptor,GPCR,DRD1_MOUSE,
Q9XUB2,Zinc finger protein mex-5,Cytosolic other,MEX5_CAEEL,
P20288|Q95136,Dopamine receptor,GPCR,DRD2_BOVIN|DRD1_BOVIN,
P18901|P19020|P25115|P30729|P61169,Dopamine receptor,GPCR,DRD1_RAT|DRD3_RAT|DRD5_RAT|DRD4_RAT|DRD2_RAT,
P34949,Mannose-6-phosphate isomerase,Enzyme,MPI_HUMAN,
G5EF15,Cytoplasmic zinc-finger protein,Unclassified,G5EF15_CAEEL,
Q00987,E3 ubiquitin-protein ligase Mdm2,Nuclear other,MDM2_HUMAN,
P18089,Alpha-2B adrenergic receptor,GPCR,ADA2B_HUMAN,AGONIST
P18825,Alpha-2C adrenergic receptor,GPCR,ADA2C_HUMAN,AGONIST
P19328,Alpha-2B adrenergic receptor,GPCR,ADA2B_RAT,
P25100|P35348|P35368,Adrenergic receptor alpha-1,GPCR,ADA1D_HUMAN|ADA1A_HUMAN|ADA1B_HUMAN,
P25103,Substance-P receptor,GPCR,NK1R_HUMAN,ANTAGONIST
P29371,Neuromedin-K receptor,GPCR,NK3R_HUMAN,
Q5DUB1,Substance-P receptor,GPCR,NK1R_MERUN,
P25786,Proteasome subunit alpha type-1,Enzyme,PSA1_HUMAN,
P32418,Sodium/calcium exchanger 1,Transporter,NAC1_HUMAN,
P0DP23|P0DP24|P0DP25,Calmodulin,Cytosolic other,CALM1_HUMAN|CALM2_HUMAN|CALM3_HUMAN,INHIBITOR
P00734,Prothrombin,Enzyme,THRB_HUMAN,INHIBITOR
P00742,Coagulation factor X,Enzyme,FA10_HUMAN,
P00750,Tissue-type plasminogen activator,Enzyme,TPA_HUMAN,
P00760,Cationic trypsin,Enzyme,TRY1_BOVIN,
P00735,Prothrombin,Enzyme,THRB_BOVIN,
P14416,D(2) dopamine receptor,GPCR,DRD2_HUMAN,PARTIAL AGONIST
P47898,5-hydroxytryptamine receptor 5A,GPCR,5HT5A_HUMAN,
P28566,5-hydroxytryptamine receptor 1E,GPCR,5HT1E_HUMAN,
P14842,5-hydroxytryptamine receptor 2A,GPCR,5HT2A_RAT,
P32305,5-hydroxytryptamine receptor 7,GPCR,5HT7R_RAT,AGONIST
P08909,5-hydroxytryptamine receptor 2C,GPCR,5HT2C_RAT,
P30729,D(4) dopamine receptor,GPCR,DRD4_RAT,ANTAGONIST
P31388,5-hydroxytryptamine receptor 6,GPCR,5HT6R_RAT,AGONIST
P07305,Histone H1.0,Nuclear other,H10_HUMAN,
P08908,5-hydroxytryptamine receptor 1A,GPCR,5HT1A_HUMAN,PARTIAL AGONIST
Q16881,"Thioredoxin reductase 1, cytoplasmic",Enzyme,TRXR1_HUMAN,INHIBITOR
O00337,Sodium/nucleoside cotransporter 1,Transporter,S28A1_HUMAN,
Q9UNQ0,ATP-binding cassette sub-family G member 2,Transporter,ABCG2_HUMAN,
P0DP23|P0DP24|P0DP25,Calmodulin,Cytosolic other,CALM1_HUMAN|CALM2_HUMAN|CALM3_HUMAN,
P35346,Somatostatin receptor type 5,GPCR,SSR5_HUMAN,
P00533,Epidermal growth factor receptor,Kinase,EGFR_HUMAN,
P25103,Substance-P receptor,GPCR,NK1R_HUMAN,
P06239,Tyrosine-protein kinase Lck,Kinase,LCK_HUMAN,
O95259,Potassium voltage-gated channel subfamily H member 1,Ion channel,KCNH1_HUMAN,BLOCKER
P29702|P49355,Protein farnesyltransferase,Enzyme,FNTA_BOVIN|FNTB_BOVIN,
O75530,Polycomb protein EED,Unclassified,EED_HUMAN,
P04439,"HLA class I histocompatibility antigen, A-3 alpha chain",Unclassified,1A03_HUMAN,
Q5BJF2,Transmembrane protein 97,Enzyme,TMM97_HUMAN,
Q72547,Reverse transcriptase/RNaseH,Enzyme,Q72547_9HIV1,
P22309,UDP-glucuronosyltransferase 1-1,Enzyme,UD11_HUMAN,
B0FL73,Beta-1 adrenergic receptor,GPCR,B0FL73_CAVPO,
P48051,G protein-activated inward rectifier potassium channel 2,Ion channel,KCNJ6_HUMAN,
P48051|P48549,Kir3.1/Kir3.2,Ion channel,KCNJ6_HUMAN|KCNJ3_HUMAN,
P48544|P48549,Kir3.1/Kir3.4,Ion channel,KCNJ5_HUMAN|KCNJ3_HUMAN,
Q13118,Krueppel-like factor 10,Nuclear other,KLF10_HUMAN,
P04035,3-hydroxy-3-methylglutaryl-coenzyme A reductase,Enzyme,HMDH_HUMAN,INHIBITOR
Q9UBN7,Histone deacetylase 6,Enzyme,HDAC6_HUMAN,
P51639,3-hydroxy-3-methylglutaryl-coenzyme A reductase,Enzyme,HMDH_RAT,
Q1W675,3-hydroxy-3-methylglutaryl-coenzyme A reductase,Enzyme,HMDH_PIG,
Q02127,"Dihydroorotate dehydrogenase (quinone), mitochondrial",Enzyme,PYRD_HUMAN,
P43264,"Ubiquinol-cytochrome-c reductase complex core protein I, mitochondrial",Enzyme,QCR1_EUGGR,
Q02768,Cytochrome b,Enzyme,CYB_PLAFA,INHIBITOR
Q63707,"Dihydroorotate dehydrogenase (quinone), mitochondrial",Enzyme,PYRD_RAT,
Q54A96,Dihydroorotate dehydrogenase,Enzyme,Q54A96_PLAFA,
P36544,Neuronal acetylcholine receptor subunit alpha-7,Ion channel,ACHA7_HUMAN,ANTAGONIST
P70605,Small conductance calcium-activated potassium channel protein 3,Ion channel,KCNN3_RAT,
P02708|P11230|Q07001,Acetylcholine receptor,Ion channel,ACHA_HUMAN|ACHB_HUMAN|ACHD_HUMAN,ANTAGONIST
P32297,Neuronal acetylcholine receptor subunit alpha-3,Ion channel,ACHA3_HUMAN,ANTAGONIST
P43681,Neuronal acetylcholine receptor subunit alpha-4,Ion channel,ACHA4_HUMAN,ANTAGONIST
P08913,Alpha-2A adrenergic receptor,GPCR,ADA2A_HUMAN,ANTAGONIST
P08172,Muscarinic acetylcholine receptor M2,GPCR,ACM2_HUMAN,ANTAGONIST
P10980,Muscarinic acetylcholine receptor M2,GPCR,ACM2_RAT,
P08482,Muscarinic acetylcholine receptor M1,GPCR,ACM1_RAT,
Q9ERZ4,Muscarinic acetylcholine receptor M2,GPCR,ACM2_MOUSE,
P08483,Muscarinic acetylcholine receptor M3,GPCR,ACM3_RAT,
Q8WMX0,Muscarinic receptor M1,GPCR,Q8WMX0_BOVIN,
P08911,Muscarinic acetylcholine receptor M5,GPCR,ACM5_RAT,
P08485,Muscarinic acetylcholine receptor M4,GPCR,ACM4_RAT,
Q8VH26,Muscarinic acetylcholine receptor,GPCR,Q8VH26_CAVPO,
A9XFY4,Nicotinic acetylcholine receptor alpha 5 subunit,Ion channel,A9XFY4_MUSDO,
O15439,Multidrug resistance-associated protein 4,Transporter,MRP4_HUMAN,
P63000,Ras-related C3 botulinum toxin substrate 1,Enzyme,RAC1_HUMAN,
P51580,Thiopurine S-methyltransferase,Enzyme,TPMT_HUMAN,
P31213,3-oxo-5-alpha-steroid 4-dehydrogenase 2,Enzyme,S5A2_HUMAN,
Q9Y5N1,Histamine H3 receptor,GPCR,HRH3_HUMAN,
O08703,Potassium voltage-gated channel subfamily H member 2,Ion channel,KCNH2_CAVPO,
O70344,Potassium voltage-gated channel subfamily KQT member 1,Ion channel,KCNQ1_CAVPO,
P97414,Potassium voltage-gated channel subfamily KQT member 1,Ion channel,KCNQ1_MOUSE,BLOCKER
O43193,Motilin receptor,GPCR,MTLR_HUMAN,AGONIST
Q07806|Q51504|Q51505|Q9X6V3|Q9X6V7|Q9X6W0,Penicillin-binding protein,Enzyme,PBPA_PSEAE|Q51504_PSEAI|Q51505_PSEAI|Q9X6V3_PSEAI|Q9X6V7_PSEAI|Q9X6W0_PSEAI,INHIBITOR
P0AD68,Peptidoglycan synthase FtsI,Enzyme,FTSI_ECOLI,INHIBITOR
Q07806,Penicillin-binding protein 1A,Enzyme,PBPA_PSEAE,
P02918,Penicillin-binding protein 1A,Enzyme,PBPA_ECOLI,INHIBITOR
P02919,Penicillin-binding protein 1B,Enzyme,PBPB_ECOLI,INHIBITOR
A2RP81,Beta-lactamase,Enzyme,A2RP81_CITFR,
A4ZYU9,Beta-lactamase,Enzyme,A4ZYU9_ECOLX,
Q83TT7,AmpC,Unclassified,Q83TT7_ECOLX,
Q3S5C3,Efflux transporter; SugE,Transporter,Q3S5C3_SALNE,
Q48435,Beta-lactamase,Enzyme,Q48435_KLEPN,
B2ZTR6,Beta-lactamase,Enzyme,B2ZTR6_ACIBA,
D6NSM8,Beta-lactamase,Enzyme,D6NSM8_ACIBA,
P60932,Undecaprenyl-diphosphatase,Unclassified,UPPP_ECOLI,
O88871|Q9Z0U4,GABA B receptor,GPCR,GABR2_RAT|GABR1_RAT,
O75899|Q9UBS5,GABA-B receptor,GPCR,GABR2_HUMAN|GABR1_HUMAN,AGONIST
P09917,Arachidonate 5-lipoxygenase,Enzyme,LOX5_HUMAN,INHIBITOR
P37231,Peroxisome proliferator-activated receptor gamma,Nuclear hormone receptor,PPARG_HUMAN,AGONIST
P06276,Cholinesterase,Enzyme,CHLE_HUMAN,INHIBITOR
P81908,Cholinesterase,Enzyme,CHLE_HORSE,
P05113,Interleukin-5,Cytokine,IL5_HUMAN,
P06401,Progesterone receptor,Nuclear hormone receptor,PRGR_HUMAN,
Q690N0,Progesterone receptor,Transcription factor,Q690N0_BOVIN,
P06536,Glucocorticoid receptor,Transcription factor,GCR_RAT,
Q86Y34,Probable G-protein coupled receptor 97,GPCR,AGRG3_HUMAN,AGONIST
P04401,Interleukin-5,Unclassified,IL5_MOUSE,
P47820,Angiotensin-converting enzyme,Enzyme,ACE_RAT,
O15379,Histone deacetylase 3,Enzyme,HDAC3_HUMAN,
Q969S8,Histone deacetylase 10,Enzyme,HDA10_HUMAN,
P55017,Solute carrier family 12 member 3,Transporter,S12A3_HUMAN,INHIBITOR
Q12791,Calcium-activated potassium channel subunit alpha-1,Ion channel,KCMA1_HUMAN,
P35498|Q99250|Q9NY46,"Sodium channel alpha subunits; brain (Types I, II, III)",Ion channel,SCN1A_HUMAN|SCN2A_HUMAN|SCN3A_HUMAN,
P20711,Aromatic-L-amino-acid decarboxylase,Enzyme,DDC_HUMAN,
Q9UBE0|Q9UBT2,SUMO-activating enzyme,Enzyme,SAE1_HUMAN|SAE2_HUMAN,
P03313,Genome polyprotein [Cleaved into: P1; Capsid protein VP0,Unclassified,POLG_CXB3N,
P52789,Hexokinase-2,Kinase,HXK2_HUMAN,
Q96S37,Solute carrier family 22 member 12,Transporter,S22AC_HUMAN,
Q99504,Eyes absent homolog 3,Enzyme,EYA3_HUMAN,
Q04828,Aldo-keto reductase family 1 member C1,Enzyme,AK1C1_HUMAN,
P18031,Tyrosine-protein phosphatase non-receptor type 1,Enzyme,PTN1_HUMAN,
P27815,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",Enzyme,PDE4A_HUMAN,
Q16539,Mitogen-activated protein kinase 14,Kinase,MK14_HUMAN,
Q8IEK1,M1-family alanyl aminopeptidase,Enzyme,Q8IEK1_PLAF7,
Q75760,Envelope glycoprotein gp160,Viral envelope protein,Q75760_9HIV1,
P03433,Polymerase acidic protein,Enzyme,PA_I34A1,
O00167,Eyes absent homolog 2,Enzyme,EYA2_HUMAN,
Q96S37,Solute carrier family 22 member 12,Transporter,S22AC_HUMAN,INHIBITOR
O15392,Baculoviral IAP repeat-containing protein 5,Unclassified,BIRC5_HUMAN,
P35498,Sodium channel protein type 1 subunit alpha,Ion channel,SCN1A_HUMAN,BLOCKER
Q99250,Sodium channel protein type 2 subunit alpha,Ion channel,SCN2A_HUMAN,BLOCKER
Q9NY46,Sodium channel protein type 3 subunit alpha,Ion channel,SCN3A_HUMAN,BLOCKER
Q9UQD0,Sodium channel protein type 8 subunit alpha,Ion channel,SCN8A_HUMAN,BLOCKER
Q15858,Sodium channel protein type 9 subunit alpha,Ion channel,SCN9A_HUMAN,BLOCKER
Q9UI33,Sodium channel protein type 11 subunit alpha,Ion channel,SCNBA_HUMAN,BLOCKER
Q9Y5Y9,Sodium channel protein type 10 subunit alpha,Ion channel,SCNAA_HUMAN,BLOCKER
Q01118,Sodium channel protein type 7 subunit alpha,Ion channel,SCN7A_HUMAN,BLOCKER
Q05940,Synaptic vesicular amine transporter,Transporter,VMAT2_HUMAN,INHIBITOR
P08173,Muscarinic acetylcholine receptor M4,GPCR,ACM4_HUMAN,ANTAGONIST
P08912,Muscarinic acetylcholine receptor M5,GPCR,ACM5_HUMAN,ANTAGONIST
Q695T7,Sodium-dependent neutral amino acid transporter B(0)AT1,Transporter,S6A19_HUMAN,INHIBITOR
P00811,Beta-lactamase,Enzyme,AMPC_ECOLI,
P15304,Hormone-sensitive lipase,Enzyme,LIPS_RAT,
O00555,Voltage-dependent P/Q-type calcium channel subunit alpha-1A,Ion channel,CAC1A_HUMAN,BLOCKER
O95180,Voltage-dependent T-type calcium channel subunit alpha-1H,Ion channel,CAC1H_HUMAN,BLOCKER
P56696,Potassium voltage-gated channel subfamily KQT member 4,Ion channel,KCNQ4_HUMAN,BLOCKER
P15381,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,CAC1C_RABIT,
Q9Z258,Potassium channel subfamily T member 1,Ion channel,KCNT1_RAT,GATING INHIBITOR
P43253,Prostacyclin receptor,GPCR,PI2R_RAT,AGONIST
P43119,Prostacyclin receptor,GPCR,PI2R_HUMAN,AGONIST
Q2Q167,Core protein,Unclassified,Q2Q167_9HEPC,
Q9QYN8,Histamine H3 receptor,GPCR,HRH3_RAT,
Q9Y5N1,Histamine H3 receptor,GPCR,HRH3_HUMAN,INVERSE AGONIST
P04083,Annexin A1,Cytosolic other,ANXA1_HUMAN,
Q8TCC7,Solute carrier family 22 member 8,Transporter,S22A8_HUMAN,
P18090,Beta-1 adrenergic receptor,GPCR,ADRB1_RAT,
P25021,Histamine H2 receptor,GPCR,HRH2_HUMAN,AGONIST
P11229,Muscarinic acetylcholine receptor M1,GPCR,ACM1_HUMAN,AGONIST
Q8VH27,Muscarinic receptor 2,GPCR,Q8VH27_CAVPO,
P23975,Sodium-dependent noradrenaline transporter,Transporter,SC6A2_HUMAN,SUBSTRATE
P37231,Peroxisome proliferator-activated receptor gamma,Nuclear hormone receptor,PPARG_HUMAN,ANTAGONIST
P19793,Retinoic acid receptor RXR-alpha,Nuclear hormone receptor,RXRA_HUMAN,AGONIST
P28702,Retinoic acid receptor RXR-beta,Nuclear hormone receptor,RXRB_HUMAN,AGONIST
P48443,Retinoic acid receptor RXR-gamma,Nuclear hormone receptor,RXRG_HUMAN,AGONIST
P10826,Retinoic acid receptor beta,Nuclear hormone receptor,RARB_HUMAN,
P13631,Retinoic acid receptor gamma,Nuclear hormone receptor,RARG_HUMAN,
P28704,Retinoic acid receptor RXR-beta,Transcription factor,RXRB_MOUSE,
P28705,Retinoic acid receptor RXR-gamma,Transcription factor,RXRG_MOUSE,
P28700,Retinoic acid receptor RXR-alpha,Transcription factor,RXRA_MOUSE,
Q05343,Retinoic acid receptor RXR-alpha,Nuclear hormone receptor,RXRA_RAT,
O43174,Cytochrome P450 26A1,Enzyme,CP26A_HUMAN,
Q9NR63,Cytochrome P450 26B1,Enzyme,CP26B_HUMAN,
P55055,Oxysterols receptor LXR-beta,Nuclear other,NR1H2_HUMAN,
Q13133,Oxysterols receptor LXR-alpha,Nuclear other,NR1H3_HUMAN,
P06858,Lipoprotein lipase,Enzyme,LIPL_HUMAN,
Q07869,Peroxisome proliferator-activated receptor alpha,Nuclear hormone receptor,PPARA_HUMAN,AGONIST
P37231,Peroxisome proliferator-activated receptor gamma,Nuclear hormone receptor,PPARG_HUMAN,
Q03181,Peroxisome proliferator-activated receptor delta,Nuclear hormone receptor,PPARD_HUMAN,
P12104,"Fatty acid-binding protein, intestinal",Cytosolic other,FABPI_HUMAN,
P02692,"Fatty acid-binding protein, liver",Unclassified,FABPL_RAT,
Q9X6V3,Penicillin-binding protein 2,Enzyme,Q9X6V3_PSEAI,
Q5D1E9,Penicillin-binding protein 4,Enzyme,Q5D1E9_STAAU,
Q9X6V7,D-ala-D-ala-carboxypeptidase; D-alanyl-D-alanine carboxypeptidase; D-alanyl-D-alanine carboxypeptidase family protein; Penicillin-binding protein 5,Enzyme,Q9X6V7_PSEAI,
A1KS91,Penicillin-binding protein 1,Enzyme,A1KS91_NEIMF,
Q7CHG0,D-alanyl-D-alanine carboxypeptidase; D-alanyl-D-alanine carboxypeptidase penicillin-binding protein 6,Enzyme,Q7CHG0_YERPE,
P10275,Androgen receptor,Nuclear hormone receptor,ANDR_HUMAN,ANTAGONIST
P33261,Cytochrome P450 2C19,Enzyme,CP2CJ_HUMAN,
P19091,Androgen receptor,Transcription factor,ANDR_MOUSE,
P06186,Progesterone receptor,Transcription factor,PRGR_RABIT,
Q63449,Progesterone receptor,Transcription factor,PRGR_RAT,
Q9Y468,Lethal(3)malignant brain tumor-like protein 1,Unclassified,LMBL1_HUMAN,
P05093,"Steroid 17-alpha-hydroxylase/17,20 lyase",Enzyme,CP17A_HUMAN,
Q16850,Lanosterol 14-alpha demethylase,Enzyme,CP51A_HUMAN,
P14902,"Indoleamine 2,3-dioxygenase 1",Enzyme,I23O1_HUMAN,
P42330,Aldo-keto reductase family 1 member C3,Enzyme,AK1C3_HUMAN,
P43088,Prostaglandin F2-alpha receptor,GPCR,PF2R_HUMAN,AGONIST
P14735,Insulin-degrading enzyme,Enzyme,IDE_HUMAN,
P15559,NAD(P)H dehydrogenase [quinone] 1,Enzyme,NQO1_HUMAN,
P34971,Beta-1 adrenergic receptor,GPCR,ADRB1_MOUSE,
P00734,Prothrombin,Enzyme,THRB_HUMAN,
Q99460,26S proteasome non-ATPase regulatory subunit 1,Cytosolic other,PSMD1_HUMAN,
P25786,Proteasome subunit alpha type-1,Enzyme,PSA1_HUMAN,INHIBITOR
P08246,Neutrophil elastase,Enzyme,ELNE_HUMAN,
P08311,Cathepsin G,Enzyme,CATG_HUMAN,
P23946,Chymase,Enzyme,CMA1_HUMAN,
P17538,Chymotrypsinogen B,Enzyme,CTRB1_HUMAN,
P28062,Proteasome subunit beta type-8,Enzyme,PSB8_HUMAN,INHIBITOR
P10619,Lysosomal protective protein,Enzyme,PPGB_HUMAN,
P20618,Proteasome subunit beta type-1,Enzyme,PSB1_HUMAN,INHIBITOR
P49721,Proteasome subunit beta type-2,Enzyme,PSB2_HUMAN,INHIBITOR
P28074,Proteasome subunit beta type-5,Enzyme,PSB5_HUMAN,INHIBITOR
A5PKW4,PH and SEC7 domain-containing protein 1,Unclassified,PSD1_HUMAN,
P19838|Q00653|Q04206,Nuclear factor NF-kappa-B complex,Transcription factor,NFKB1_HUMAN|NFKB2_HUMAN|TF65_HUMAN,
P00766,Alpha-chymotrypsin,Enzyme,CTRA_BOVIN,
Q8IJT1,Proteasome subunit beta,Enzyme,Q8IJT1_PLAF7,
P28063,Proteasome subunit beta type-8,Enzyme,PSB8_MOUSE,
P28065,Proteasome subunit beta type-9,Enzyme,PSB9_HUMAN,
P40306,Proteasome subunit beta type-10,Enzyme,PSB10_HUMAN,
O75469,Nuclear receptor subfamily 1 group I member 2,Nuclear hormone receptor,NR1I2_HUMAN,
P25101,Endothelin-1 receptor,GPCR,EDNRA_HUMAN,ANTAGONIST
P24530,Endothelin B receptor,GPCR,EDNRB_HUMAN,ANTAGONIST
P26684,Endothelin-1 receptor,GPCR,EDNRA_RAT,
Q29010,Endothelin-1 receptor,GPCR,EDNRA_PIG,
P21451,Endothelin B receptor,GPCR,EDNRB_RAT,
G3HDX1,Alpha-1B adrenergic receptor,GPCR,G3HDX1_CRIGR,
Q9QNF7,Thymidine kinase,Kinase,KITH_HHV1,
P04183,"Thymidine kinase, cytosolic",Kinase,KITH_HUMAN,
P06479,Thymidine kinase,Kinase,KITH_HHV1S,
A3RLP8,Thymidine kinase,Kinase,A3RLP8_CHV1,
Q07422,Bifunctional dihydrofolate reductase-thymidylate synthase,Enzyme,DRTS_TOXGO,
P16184,Dihydrofolate reductase,Enzyme,DYR_PNECA,
Q920D2,Dihydrofolate reductase,Enzyme,DYR_RAT,
P0ABQ4,Dihydrofolate reductase,Enzyme,DYR_ECOLI,
P00378,Dihydrofolate reductase,Enzyme,DYR_CHICK,
Q8Z9J9,Dihydrofolate reductase,Enzyme,Q8Z9J9_SALTI,
O62664|O62698,Cyclooxygenase,Enzyme,PGH1_BOVIN|PGH2_BOVIN,
P21728,D(1A) dopamine receptor,GPCR,DRD1_HUMAN,AGONIST
P50406,5-hydroxytryptamine receptor 6,GPCR,5HT6R_HUMAN,AGONIST
Q7TSF2,Vesicular glutamate transporter 3,Transporter,VGLU3_RAT,
P18130|Q28838,Cerebral cortex alpha adrenergic receptor,GPCR,ADA1A_BOVIN|ADA2A_BOVIN,
P22734,Catechol O-methyltransferase,Enzyme,COMT_RAT,
P01579,Interferon gamma,Cytokine,IFNG_HUMAN,
P08235,Mineralocorticoid receptor,Nuclear hormone receptor,MCR_HUMAN,AGONIST
P06401,Progesterone receptor,Nuclear hormone receptor,PRGR_HUMAN,AGONIST
O15399|O60391|Q05586|Q12879|Q13224|Q14957|Q8TCU5,Glutamate [NMDA] receptor,Ion channel,NMDE4_HUMAN|NMD3B_HUMAN|NMDZ1_HUMAN|NMDE1_HUMAN|NMDE2_HUMAN|NMDE3_HUMAN|NMD3A_HUMAN,
Q13621,Solute carrier family 12 member 1,Transporter,S12A1_HUMAN,INHIBITOR
P05023,Sodium/potassium-transporting ATPase subunit alpha-1,Transporter,AT1A1_HUMAN,
P55011,Solute carrier family 12 member 2,Transporter,S12A2_HUMAN,INHIBITOR
Q9HC97,G-protein coupled receptor 35,GPCR,GPR35_HUMAN,AGONIST
P13945,Beta-3 adrenergic receptor,GPCR,ADRB3_HUMAN,ANTAGONIST
P25962,Beta-3 adrenergic receptor,GPCR,ADRB3_MOUSE,ANTAGONIST
P26255,Beta-3 adrenergic receptor,GPCR,ADRB3_RAT,ANTAGONIST
P22460,Potassium voltage-gated channel subfamily A member 5,Ion channel,KCNA5_HUMAN,BLOCKER
O14649,Potassium channel subfamily K member 3,Ion channel,KCNK3_HUMAN,
Q9Z0V1,Potassium voltage-gated channel subfamily D member 3,Ion channel,KCND3_MOUSE,BLOCKER
P35372,Mu-type opioid receptor,GPCR,OPRM_HUMAN,PARTIAL AGONIST
P41145,Kappa-type opioid receptor,GPCR,OPRK_HUMAN,ANTAGONIST
P41143,Delta-type opioid receptor,GPCR,OPRD_HUMAN,ANTAGONIST
P41146,Nociceptin receptor,GPCR,OPRX_HUMAN,
P33533,Delta-type opioid receptor,GPCR,OPRD_RAT,
Q01959,Sodium-dependent dopamine transporter,Transporter,SC6A3_HUMAN,INHIBITOR
P30926|P32297,Neuronal acetylcholine receptor; alpha3/beta4,Ion channel,ACHB4_HUMAN|ACHA3_HUMAN,
P17787|P32297,Neuronal acetylcholine receptor; alpha3/beta2,Ion channel,ACHB2_HUMAN|ACHA3_HUMAN,
P22888,Lutropin-choriogonadotropic hormone receptor,GPCR,LSHR_HUMAN,
P30968,Gonadotropin-releasing hormone receptor,GPCR,GNRHR_HUMAN,AGONIST
Q01776,Gonadotropin-releasing hormone receptor,GPCR,GNRHR_MOUSE,AGONIST
Q9R0C9,Sigma non-opioid intracellular receptor 1,Membrane receptor,SGMR1_RAT,
Q95136,D(1A) dopamine receptor,GPCR,DRD1_BOVIN,
Q28838,Alpha-2A adrenergic receptor,GPCR,ADA2A_BOVIN,
Q75Z89,5-hydroxytryptamine receptor 2A,GPCR,5HT2A_BOVIN,
Q86VL8,Multidrug and toxin extrusion protein 2,Transporter,S47A2_HUMAN,
P14867|P18507|P28472,GABA-A receptor alpha-1/beta-3/gamma-2,Ion channel,GBRA1_HUMAN|GBRG2_HUMAN|GBRB3_HUMAN,POSITIVE ALLOSTERIC MODULATOR
Q4JEY0,Squalene epoxidase,Enzyme,Q4JEY0_TRIRU,INHIBITOR
Q5NGQ3,Enoyl-[acyl-carrier-protein] reductase [NADH],Enzyme,Q5NGQ3_FRATT,
Q92206,Squalene monooxygenase,Enzyme,ERG1_CANAL,
P10613,Lanosterol 14-alpha demethylase,Enzyme,CP51_CANAL,INHIBITOR
P41145,Kappa-type opioid receptor,GPCR,OPRK_HUMAN,PARTIAL AGONIST
P08908,5-hydroxytryptamine receptor 1A,GPCR,5HT1A_HUMAN,AGONIST
P28223,5-hydroxytryptamine receptor 2A,GPCR,5HT2A_HUMAN,AGONIST
P28335,5-hydroxytryptamine receptor 2C,GPCR,5HT2C_HUMAN,AGONIST
Q13936,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,CAC1C_HUMAN,
P05164,Myeloperoxidase,Enzyme,PERM_HUMAN,
P29274,Adenosine receptor A2a,GPCR,AA2AR_HUMAN,ANTAGONIST
P30542,Adenosine receptor A1,GPCR,AA1R_HUMAN,ANTAGONIST
P29275,Adenosine receptor A2b,GPCR,AA2BR_HUMAN,ANTAGONIST
P0DMS8,Adenosine receptor A3,GPCR,AA3R_HUMAN,ANTAGONIST
O00329,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform",Kinase,PK3CD_HUMAN,
P00489,"Glycogen phosphorylase, muscle form",Enzyme,PYGM_RABIT,
P28190,Adenosine receptor A1,GPCR,AA1R_BOVIN,
P47745,Adenosine receptor A1,GPCR,AA1R_CAVPO,
P25099|P28647|P29276|P30543,Adenosine receptor,GPCR,AA1R_RAT|AA3R_RAT|AA2BR_RAT|AA2AR_RAT,
Q9Y2T3,Guanine deaminase,Enzyme,GUAD_HUMAN,
P46616,Adenosine A2a receptor,GPCR,AA2AR_CAVPO,
Q60614,Adenosine receptor A2b,GPCR,AA2BR_MOUSE,ANTAGONIST
O15528,"25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial",Enzyme,CP27B_HUMAN,
Q6VVX0,Vitamin D 25-hydroxylase,Enzyme,CP2R1_HUMAN,
P02774,Vitamin D-binding protein,Secreted,VTDB_HUMAN,
P13053,Vitamin D3 receptor,Transcription factor,VDR_RAT,
O42392,Vitamin D3 receptor,Transcription factor,VDR_CHICK,
Q28037,Vitamin D3 receptor,Transcription factor,VDR_BOVIN,
A3RGC1,Vitamin D3 receptor,Nuclear hormone receptor,VDR_PIG,
Q9PTN2,Vitamin D3 receptor A,Nuclear hormone receptor,VDRA_DANRE,
O42275,Acetylcholinesterase,Enzyme,ACES_ELEEL,
Q8BLA8,Transient receptor potential cation channel subfamily A member 1,Ion channel,TRPA1_MOUSE,GATING INHIBITOR
P07477,Trypsin-1,Enzyme,TRY1_HUMAN,INHIBITOR
P06870,Kallikrein-1,Enzyme,KLK1_HUMAN,
Q01177,Plasminogen,Enzyme,PLMN_RAT,
Q04756,Hepatocyte growth factor activator,Enzyme,HGFA_HUMAN,
O15393,Transmembrane protease serine 2,Enzyme,TMPS2_HUMAN,INHIBITOR
P25104,Type-1 angiotensin II receptor,GPCR,AGTR1_BOVIN,
P34976,Type-1 angiotensin II receptor,GPCR,AGTR1_RABIT,
Q9UBT6,DNULL polymerase kappa,Enzyme,POLK_HUMAN,
Q9UNA4,DNULL polymerase iota,Enzyme,POLI_HUMAN,
Q9Y253,DNULL polymerase eta,Enzyme,POLH_HUMAN,
P30556,Type-1 angiotensin II receptor,GPCR,AGTR1_HUMAN,ANTAGONIST
P08235,Mineralocorticoid receptor,Nuclear hormone receptor,MCR_HUMAN,ANTAGONIST
P00797,Renin,Enzyme,RENI_HUMAN,
P09960,Leukotriene A-4 hydrolase,Enzyme,LKHA4_HUMAN,
P44514,Succinyl-diaminopimelate desuccinylase,Enzyme,DAPE_HAEIN,
Q79MP6,Beta-lactamase,Enzyme,Q79MP6_PSEAI,
Q93T40,Beta-lactamase II,Enzyme,Q93T40_BACAN,
Q9K2N0,Beta-lactamase class B VIM-2,Unclassified,Q9K2N0_PSEAI,
C7C422,Beta-lactamase NDM-1,Enzyme,BLAN1_KLEPN,
P42785,Lysosomal Pro-X carboxypeptidase,Enzyme,PCP_HUMAN,
P13945,Beta-3 adrenergic receptor,GPCR,ADRB3_HUMAN,AGONIST
P25962,Beta-3 adrenergic receptor,GPCR,ADRB3_MOUSE,AGONIST
P26255,Beta-3 adrenergic receptor,GPCR,ADRB3_RAT,AGONIST
P12657,Muscarinic acetylcholine receptor M1,GPCR,ACM1_MOUSE,
P02710,Acetylcholine receptor subunit alpha,Ion channel,ACHA_TORCA,
P30926|Q15822,Neuronal acetylcholine receptor; alpha2/beta4,Ion channel,ACHB4_HUMAN|ACHA2_HUMAN,
Q9H461,Frizzled-8,GPCR,FZD8_HUMAN,ALLOSTERIC MODULATOR
P28845,Corticosteroid 11-beta-dehydrogenase isozyme 1,Enzyme,DHI1_HUMAN,INHIBITOR
P50172,Corticosteroid 11-beta-dehydrogenase isozyme 1,Enzyme,DHI1_MOUSE,
P51661,Corticosteroid 11-beta-dehydrogenase isozyme 2,Enzyme,DHI2_MOUSE,
P37288,Vasopressin V1a receptor,GPCR,V1AR_HUMAN,
P30518,Vasopressin V2 receptor,GPCR,V2R_HUMAN,
P30559,Oxytocin receptor,GPCR,OXYR_HUMAN,AGONIST
P20711,Aromatic-L-amino-acid decarboxylase,Enzyme,DDC_HUMAN,INHIBITOR
B2RXH2,Lysine-specific demethylase 4E,Enzyme,KDM4E_HUMAN,
P22079,Lactoperoxidase,Enzyme,PERL_HUMAN,
P07202,Thyroid peroxidase,Enzyme,PERT_HUMAN,INHIBITOR
P27361,Mitogen-activated protein kinase 3,Kinase,MK03_HUMAN,
Q6P7S1,Acid ceramidase,Enzyme,ASAH1_RAT,
Q13510,Acid ceramidase,Enzyme,ASAH1_HUMAN,
Q9Y6N5,"Sulfide:quinone oxidoreductase, mitochondrial",Unclassified,SQRD_HUMAN,
P00390,"Glutathione reductase, mitochondrial",Enzyme,GSHR_HUMAN,INHIBITOR
P50416,"Carnitine O-palmitoyltransferase 1, liver isoform",Enzyme,CPT1A_HUMAN,
Q63704,"Carnitine O-palmitoyltransferase 1, muscle isoform",Enzyme,CPT1B_RAT,
P18886,Carnitine palmitoyltransferase 2,Enzyme,CPT2_RAT,
P16066,Atrial natriuretic peptide receptor 1,Enzyme,ANPRA_HUMAN,
P18910,Atrial natriuretic peptide receptor 1,Enzyme,ANPRA_RAT,
P97612,Fatty-acid amide hydrolase 1,Enzyme,FAAH1_RAT,
P01031,Complement C5,Secreted,CO5_HUMAN,
P01031,Complement C5,Unclassified,CO5_HUMAN,
P0AD68,Peptidoglycan synthase FtsI,Enzyme,FTSI_ECOLI,
Q92736,Ryanodine receptor 2,Ion channel,RYR2_HUMAN,INHIBITOR
O70528,5-hydroxytryptamine receptor 4,GPCR,5HT4R_CAVPO,
P57789,Potassium channel subfamily K member 10,Ion channel,KCNKA_HUMAN,
O00206,Toll-like receptor 4,Membrane receptor,TLR4_HUMAN,
P10520,Streptokinase A,Enzyme,STRP_STRP1,
P46059,Solute carrier family 15 member 1,Transporter,S15A1_HUMAN,
O54286,"Pencillin binding protein 2a; Penicillin binding protein 2'; Penicillin binding protein, PBP2; Penicillin-binding protein 2; Penicillin-binding protein 2'; Peptidase",Enzyme,O54286_STAAU,
Q14TG6,Penicillin-binding protein 3,Enzyme,Q14TG6_HAEIF,
Q54906,Penicillin-binding protein,Enzyme,Q54906_STRPY,
P42971,Penicillin-binding protein 3,Enzyme,PBPC_BACSU,
P19174,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1",Enzyme,PLCG1_HUMAN,
P31391,Somatostatin receptor type 4,GPCR,SSR4_HUMAN,
P0AD65,Penicillin-binding protein 2,Enzyme,PBP2_ECOLI,INHIBITOR
P21964,Catechol O-methyltransferase,Enzyme,COMT_HUMAN,
P32241,Vasoactive intestinal polypeptide receptor 1,GPCR,VIPR1_HUMAN,
P00808,Beta-lactamase,Enzyme,BLAC_BACLI,
P25098,Beta-adrenergic receptor kinase 1,Kinase,ARBK1_HUMAN,
P02918,Penicillin-binding protein 1A,Enzyme,PBPA_ECOLI,
P02919,Penicillin-binding protein 1B,Enzyme,PBPB_ECOLI,
Q06124,Tyrosine-protein phosphatase non-receptor type 11,Enzyme,PTN11_HUMAN,
P29350,Protein-tyrosine phosphatase 1C,Enzyme,PTN6_HUMAN,
Q5A7N4,tRNA 2'-phosphotransferase,Unclassified,Q5A7N4_CANAL,
Q1J5W5,Penicillin-binding protein,Enzyme,Q1J5W5_STRPF,
Q60FU1,Penicillin-binding protein 3,Enzyme,Q60FU1_HAEIF,
P14920,D-amino-acid oxidase,Enzyme,OXDA_HUMAN,
O76074,"cGMP-specific 3',5'-cyclic phosphodiesterase",Enzyme,PDE5A_HUMAN,
P00403,Cytochrome c oxidase subunit 2,Enzyme,COX2_HUMAN,
O15530,3-phosphoinositide-dependent protein kinase 1,Kinase,PDPK1_HUMAN,
Q05769,Prostaglandin G/H synthase 2,Enzyme,PGH2_MOUSE,
P22437,Prostaglandin G/H synthase 1,Enzyme,PGH1_MOUSE,
Q8SPQ9,Cyclooxygenase 2; Prostaglandin G/H synthase-2; Uncharacterized protein,Enzyme,Q8SPQ9_CANFA,
O62698,Prostaglandin G/H synthase 2,Enzyme,PGH2_BOVIN,
P35355,Prostaglandin G/H synthase 2,Enzyme,PGH2_RAT,
Q63921,Prostaglandin G/H synthase 1,Enzyme,PGH1_RAT,
Q8HZR1,Prostaglandin G/H synthase 1,Enzyme,PGH1_CANFA,
O78750,Cytochrome c oxidase subunit 2,Enzyme,COX2_SHEEP,
O14684,Prostaglandin E synthase,Enzyme,PTGES_HUMAN,
O78749,Cytochrome c oxidase subunit 1,Enzyme,COX1_SHEEP,
Q16348,Solute carrier family 15 member 2,Transporter,S15A2_HUMAN,
Q8TCC7,Solute carrier family 22 member 8,Transporter,S22A8_HUMAN,INHIBITOR
Q9NSA0,Solute carrier family 22 member 11,Transporter,S22AB_HUMAN,INHIBITOR
P35236,Tyrosine-protein phosphatase non-receptor type 7,Enzyme,PTN7_HUMAN,
P21554,Cannabinoid receptor 1,GPCR,CNR1_HUMAN,
Q9Y2I1,Nischarin,Membrane receptor,NISCH_HUMAN,
P20815,Cytochrome P450 3A5,Enzyme,CP3A5_HUMAN,
P49327,Fatty acid synthase,Enzyme,FAS_HUMAN,
P00488,Coagulation factor XIII A chain,Enzyme,F13A_HUMAN,
P32238,Cholecystokinin receptor type A,GPCR,CCKAR_HUMAN,AGONIST
P14091,Cathepsin E,Enzyme,CATE_HUMAN,
Q13443,Disintegrin and metalloproteinase domain-containing protein 9,Enzyme,ADAM9_HUMAN,
P62580,Chloramphenicol acetyltransferase,Enzyme,CAT_SALTI,
Q88N29,Probable HTH-type transcriptional regulator TtgR,Unclassified,TTGR_PSEPK,
P10415,Apoptosis regulator Bcl-2,Cytosolic other,BCL2_HUMAN,
P34981,Thyrotropin-releasing hormone receptor,GPCR,TRFR_HUMAN,
Q01717,Thyrotropin-releasing hormone receptor,GPCR,TRFR_RAT,ANTAGONIST
P21761,Thyrotropin-releasing hormone receptor,GPCR,TRFR_MOUSE,ANTAGONIST
P14867|P18507|P28472,GABA-A receptor alpha-1/beta-3/gamma-2,Ion channel,GBRA1_HUMAN|GBRG2_HUMAN|GBRB3_HUMAN,
P08219|P08220|P10063|P10064|P20237|P22300,GABA-A receptor; anion channel,Ion channel,GBRA1_BOVIN|GBRB1_BOVIN|GBRA2_BOVIN|GBRA3_BOVIN|GBRA4_BOVIN|GBRG2_BOVIN,
P32238|P32239,Cholecystokinin receptor,GPCR,CCKAR_HUMAN|GASR_HUMAN,
P30551|P30553,Cholecystokinin receptor,GPCR,CCKAR_RAT|GASR_RAT,
O75751,Solute carrier family 22 member 3,Transporter,S22A3_HUMAN,
Q03530,CAAX prenyl protease 2,Enzyme,RCE1_YEAST,
O15056,Synaptojanin-2,Enzyme,SYNJ2_HUMAN,
D2WKD8,Sodium/potassium-transporting ATPase subunit alpha-2,Ion channel,AT1A2_PIG,
P04150,Glucocorticoid receptor,Nuclear hormone receptor,GCR_HUMAN,
Q05397,Focal adhesion kinase 1,Kinase,FAK1_HUMAN,
P56817,Beta-secretase 1,Enzyme,BACE1_HUMAN,
P05227,Histidine-rich protein PFHRP-II,Cytosolic other,HRP1_PLAFA,
P02752,Riboflavin-binding protein,Unclassified,RBP_CHICK,
P00376,Dihydrofolate reductase,Enzyme,DYR_BOVIN,
Q9N6S8,Cysteine proteinase falcipain 2a,Enzyme,Q9N6S8_PLAFA,
Q92731,Estrogen receptor beta,Nuclear hormone receptor,ESR2_HUMAN,MODULATOR
P09917,Arachidonate 5-lipoxygenase,Enzyme,LOX5_HUMAN,
P16050,Arachidonate 15-lipoxygenase,Enzyme,LOX15_HUMAN,
P18054,"Arachidonate 12-lipoxygenase, 12S-type",Enzyme,LOX12_HUMAN,
O15296,"Arachidonate 15-lipoxygenase, type II",Enzyme,LX15B_HUMAN,
Q96JM7,Lethal(3)malignant brain tumor-like protein 3,Unclassified,LMBL3_HUMAN,
Q05BQ5,MBT domain-containing protein 1,Unclassified,MBTD1_HUMAN,
Q9N623,Chloroquine resistance transporter,Transporter,CRT_PLAFA,
P31645,Sodium-dependent serotonin transporter,Transporter,SC6A4_HUMAN,SUBSTRATE
P21817,Ryanodine receptor 1,Ion channel,RYR1_HUMAN,
O35433,Transient receptor potential cation channel subfamily V member 1,Ion channel,TRPV1_RAT,
P33302,Pleiotropic ABC efflux transporter of multiple drugs,Transporter,PDR5_YEAST,
P35439|Q00959|Q00960|Q00961|Q62645|Q8VHN2|Q9R1M7,Glutamate NMDA receptor,Ion channel,NMDZ1_RAT|NMDE1_RAT|NMDE2_RAT|NMDE3_RAT|NMDE4_RAT|NMD3B_RAT|NMD3A_RAT,
D4A3N4|P21932|P26769|P26770|P40146|Q03343|Q04400|Q8CFM9,Adenylate cyclase,Enzyme,D4A3N4_RAT|ADCY3_RAT|ADCY2_RAT|ADCY4_RAT|ADCY8_RAT|ADCY6_RAT|ADCY5_RAT|Q8CFM9_RAT,
P55789,FAD-linked sulfhydryl oxidase ALR,Enzyme,ALR_HUMAN,
P62157,Calmodulin,Cytosolic other,CALM_BOVIN,
P04925,Major prion protein,Unclassified,PRIO_MOUSE,
P17405,Sphingomyelin phosphodiesterase,Enzyme,ASM_HUMAN,
O35956,Solute carrier family 22 member 6,Transporter,S22A6_RAT,
Q9UM07,Protein-arginine deiminase type-4,Enzyme,PADI4_HUMAN,
O15554,Intermediate conductance calcium-activated potassium channel protein 4,Ion channel,KCNN4_HUMAN,ACTIVATOR
P35228,"Nitric oxide synthase, inducible",Enzyme,NOS2_HUMAN,
P29475,"Nitric oxide synthase, brain",Enzyme,NOS1_HUMAN,
P29474,"Nitric oxide synthase, endothelial",Enzyme,NOS3_HUMAN,
P29476,"Nitric oxide synthase, brain",Enzyme,NOS1_RAT,
P70604,Small conductance calcium-activated potassium channel protein 2,Ion channel,KCNN2_RAT,ACTIVATOR
Q12791,Calcium-activated potassium channel subunit alpha-1,Ion channel,KCMA1_HUMAN,OPENER
P10721,Mast/stem cell growth factor receptor Kit,Kinase,KIT_HUMAN,
O96394,Arginase,Enzyme,O96394_LEIAM,
Q4QEW7,Dihydroorotate dehydrogenase,Enzyme,Q4QEW7_LEIMA,
Q14654,ATP-sensitive inward rectifier potassium channel 11,Ion channel,KCJ11_HUMAN,
P43115,Prostaglandin E2 receptor EP3 subtype,GPCR,PE2R3_HUMAN,
P35408,Prostaglandin E2 receptor EP4 subtype,GPCR,PE2R4_HUMAN,
P43088,Prostaglandin F2-alpha receptor,GPCR,PF2R_HUMAN,
Q62053,Prostaglandin E2 receptor EP2 subtype,GPCR,PE2R2_MOUSE,AGONIST
P30557,Prostaglandin E2 receptor EP3 subtype,GPCR,PE2R3_MOUSE,AGONIST
P09874,Poly [ADP-ribose] polymerase 1,Enzyme,PARP1_HUMAN,INHIBITOR
P09874,Poly [ADP-ribose] polymerase 1,Unclassified,PARP1_HUMAN,INHIBITOR
Q9BU89,Deoxyhypusine hydroxylase,Enzyme,DOHH_HUMAN,
P16444,Dipeptidase 1,Enzyme,DPEP1_HUMAN,INHIBITOR
P22412,Dipeptidase 1,Enzyme,DPEP1_PIG,
Q02294,Voltage-dependent N-type calcium channel subunit alpha-1B,Ion channel,CAC1B_RAT,BLOCKER
P25021,Histamine H2 receptor,GPCR,HRH2_HUMAN,ANTAGONIST
P47747,Histamine H2 receptor,GPCR,HRH2_CAVPO,
Q86VL8,Multidrug and toxin extrusion protein 2,Transporter,S47A2_HUMAN,INHIBITOR
P25102,Histamine H2 receptor,GPCR,HRH2_RAT,ANTAGONIST
P41180,Extracellular calcium-sensing receptor,GPCR,CASR_HUMAN,POSITIVE ALLOSTERIC MODULATOR
P31424,Metabotropic glutamate receptor 5,GPCR,GRM5_RAT,ALLOSTERIC MODULATOR
Q2NNR5,Cysteinyl leukotriene receptor 1,GPCR,CLTR1_CAVPO,
Q9Y271,Cysteinyl leukotriene receptor 1,GPCR,CLTR1_HUMAN,ANTAGONIST
P0AFI2,DNA topoisomerase 4 subunit A,Enzyme,PARC_ECOLI,
Q45066,DNA topoisomerase 4 subunit A,Enzyme,PARC_BACSU,
P0C1U9,DNA topoisomerase 4 subunit A,Enzyme,PARC_STAAU,INHIBITOR
P9WG47,DNA gyrase subunit A,Enzyme,GYRA_MYCTU,
P0AES4,DNA gyrase subunit A,Enzyme,GYRA_ECOLI,INHIBITOR
P37340,Multidrug resistance protein mdtK,Unclassified,MDTK_ECOLI,
P04035,3-hydroxy-3-methylglutaryl-coenzyme A reductase,Enzyme,HMDH_HUMAN,
Q13639,5-hydroxytryptamine receptor 4,GPCR,5HT4R_HUMAN,AGONIST
P32304,5-hydroxytryptamine receptor 7,GPCR,5HT7R_MOUSE,AGONIST
P22909,Alpha-2A adrenergic receptor,GPCR,ADA2A_RAT,
Q62758,5-hydroxytryptamine receptor 4,GPCR,5HT4R_RAT,AGONIST
P35563|Q9JJ16,Serotonin 3 (5-HT3) receptor,Ion channel,5HT3A_RAT|5HT3B_RAT,
A5X5Y0|O95264|P46098|Q70Z44|Q8WXA8,Serotonin 3 (5-HT3) receptor,Ion channel,5HT3E_HUMAN|5HT3B_HUMAN|5HT3A_HUMAN|5HT3D_HUMAN|5HT3C_HUMAN,
P97288,5-hydroxytryptamine receptor 4,GPCR,5HT4R_MOUSE,AGONIST
Q61327,Sodium-dependent dopamine transporter,Transporter,SC6A3_MOUSE,
Q48255,3-dehydroquinate dehydratase,Enzyme,AROQ_HELPY,
P15474,3-dehydroquinate dehydratase,Enzyme,AROQ_STRCO,
Q9EPK8,Transient receptor potential cation channel subfamily V member 4,Ion channel,TRPV4_MOUSE,ACTIVATOR
P27707,Deoxycytidine kinase,Kinase,DCK_HUMAN,
P00807,Beta-lactamase,Enzyme,BLAC_STAAU,
P62593,Beta-lactamase TEM,Enzyme,BLAT_ECOLX,INHIBITOR
Q59401,Beta-lactamase,Enzyme,Q59401_ENTCL,
P0AD63,Beta-lactamase SHV-1,Enzyme,BLA1_ECOLX,
P05364,Beta-lactamase,Enzyme,AMPC_ENTCL,
P13661,Beta-lactamase OXA-1,Enzyme,BLO1_ECOLX,
P24735,Beta-lactamase,Enzyme,AMPC_PSEAE,
A4KCT8,Beta-lactamase,Enzyme,A4KCT8_9ENTR,
A1E3K9,Beta-lactamase,Enzyme,A1E3K9_ECOLX,
A8RR46,Beta-lactamase,Enzyme,A8RR46_BACCS,
Q6JP75,Carbapenem-hydrolizing beta-lactamase SFC-1,Enzyme,Q6JP75_SERFO,
Q9F663,Carbepenem-hydrolyzing beta-lactamase KPC,Enzyme,BLKPC_KLEPN,
Q9EXV5,Beta-lactamase,Enzyme,Q9EXV5_ECOLX,
P0AD64,Beta-lactamase SHV-1,Enzyme,BLA1_KLEPN,
Q6GWS8,Beta-lactamase,Enzyme,Q6GWS8_ECOLX,
D1MIX9,Beta-lactamase GES-13,Enzyme,D1MIX9_PSEAI,
A0ZX81,Beta-lactamase,Enzyme,A0ZX81_KLEPN,
Q4TVR4,Beta-lactamase,Enzyme,Q4TVR4_KLEPN,
Q50H31,Class D beta-lactamase,Unclassified,Q50H31_BRAPL,
Q2XPY6,Beta-lactamase,Enzyme,Q2XPY6_SALET,
P0A3M1,Beta-lactamase SHV-5,Enzyme,BLA5_KLEPN,
D2SSQ3,Beta-lactamase,Enzyme,D2SSQ3_PSEAI,
Q3SAW3,Beta-lactamase,Enzyme,Q3SAW3_PSEAI,
Q670S6,Beta-lactamase,Enzyme,Q670S6_PSELU,
Q62758,5-hydroxytryptamine receptor 4,GPCR,5HT4R_RAT,
P23711,Heme oxygenase 2,Enzyme,HMOX2_RAT,
Q9UBN4,Short transient receptor potential channel 4,Ion channel,TRPC4_HUMAN,BLOCKER
Q9UL62,Short transient receptor potential channel 5,Ion channel,TRPC5_HUMAN,BLOCKER
Q13507,Short transient receptor potential channel 3,Ion channel,TRPC3_HUMAN,BLOCKER
Q9Y210,Short transient receptor potential channel 6,Ion channel,TRPC6_HUMAN,BLOCKER
P15825,50S ribosomal protein L10,Ribosomal protein,RL10_HALMA,
P05141,ADP/ATP translocase 2,Enzyme,ADT2_HUMAN,
P12235,ADP/ATP translocase 1,Transporter,ADT1_HUMAN,
P12236,ADP/ATP translocase 3,Enzyme,ADT3_HUMAN,
Q9BYT1,Solute carrier family 17 member 9,Transporter,S17A9_HUMAN,INHIBITOR
B1LRJ1,Type IV secretion-like conjugative transfer relaxase protein TraI,Unclassified,B1LRJ1_ECOSM,
P09884,DNA polymerase alpha catalytic subunit,Enzyme,DPOLA_HUMAN,INHIBITOR
P23921,Ribonucleoside-diphosphate reductase large subunit,Enzyme,RIR1_HUMAN,INHIBITOR
P31350,Ribonucleoside-diphosphate reductase subunit M2,Enzyme,RIR2_HUMAN,INHIBITOR
P60891,Ribose-phosphate pyrophosphokinase 1,Kinase,PRPS1_HUMAN,
Q9HA47,Uridine-cytidine kinase 1,Kinase,UCK1_HUMAN,
Q9BZX2,Uridine-cytidine kinase 2,Kinase,UCK2_HUMAN,
Q5L2G3,Uncharacterized oxidoreductase CzcO-like,Enzyme,CZCO_GEOKA,
Q07869,Peroxisome proliferator-activated receptor alpha,Nuclear hormone receptor,PPARA_HUMAN,
P23204,Peroxisome proliferator-activated receptor alpha,Transcription factor,PPARA_MOUSE,
O09114,Prostaglandin-H2 D-isomerase,Enzyme,PTGDS_MOUSE,
P03372,Estrogen receptor,Nuclear hormone receptor,ESR1_HUMAN,MODULATOR
P09211,Glutathione S-transferase P,Enzyme,GSTP1_HUMAN,
P39051,Trypanothione reductase,Enzyme,TYTR_TRYBB,
O00591|O14764|P14867|P18505|P18507|P28472|P31644|P34903|P47869|P47870|P48169|P78334|Q16445|Q8N1C3|Q99928|Q9UN88,GABA-A receptor; anion channel,Ion channel,GBRP_HUMAN|GBRD_HUMAN|GBRA1_HUMAN|GBRB1_HUMAN|GBRG2_HUMAN|GBRB3_HUMAN|GBRA5_HUMAN|GBRA3_HUMAN|GBRA2_HUMAN|GBRB2_HUMAN|GBRA4_HUMAN|GBRE_HUMAN|GBRA6_HUMAN|GBRG1_HUMAN|GBRG3_HUMAN|GBRT_HUMAN,
P23944,Alpha-1D adrenergic receptor,GPCR,ADA1D_RAT,AGONIST
Q4G017,Nischarin,Unclassified,NISCH_RAT,
O88704,Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1,Ion channel,HCN1_MOUSE,BLOCKER
O88703,Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2,Ion channel,HCN2_MOUSE,BLOCKER
O70507,Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4,Ion channel,HCN4_MOUSE,BLOCKER
Q9H244,P2Y purinoceptor 12,GPCR,P2Y12_HUMAN,ANTAGONIST
P20813,Cytochrome P450 2B6,Enzyme,CP2B6_HUMAN,
Q14994,Nuclear receptor subfamily 1 group I member 3,Nuclear hormone receptor,NR1I3_HUMAN,ANTAGONIST
P30542,Adenosine receptor A1,GPCR,AA1R_HUMAN,
O15554,Intermediate conductance calcium-activated potassium channel protein 4,Ion channel,KCNN4_HUMAN,
Q9Y271,Cysteinyl leukotriene receptor 1,GPCR,CLTR1_HUMAN,
P22001,Potassium voltage-gated channel subfamily A member 3,Ion channel,KCNA3_HUMAN,
Q96RI1,Bile acid receptor,Nuclear hormone receptor,NR1H4_HUMAN,
P9WPP9,Lanosterol 14-alpha demethylase,Enzyme,CP51_MYCTU,
P25024,C-X-C chemokine receptor type 1,GPCR,CXCR1_HUMAN,
Q4WNT5,14-alpha sterol demethylase Cyp51A,Enzyme,Q4WNT5_ASPFU,
Q96W81,14-alpha sterol demethylase,Enzyme,Q96W81_ASPFM,
Q8R0V5,"Indoleamine 2,3-dioxygenase 2",Enzyme,I23O2_MOUSE,
P9WPP7,Mycocyclosin synthase,Enzyme,CP121_MYCTU,
P55072,Transitional endoplasmic reticulum ATPase,Enzyme,TERA_HUMAN,
P40925,Malate dehydrogenase cytoplasmic ,Enzyme,MDHC_HUMAN,
P9WPN5,Putative cytochrome P450 130,Enzyme,CP130_MYCTU,
P28776,"Indoleamine 2,3-dioxygenase 1",Enzyme,I23O1_MOUSE,
Q9UNU6,7-alpha-hydroxycholest-4-en-3-one 12-alpha-hydroxylase,Enzyme,CP8B1_HUMAN,
P62593,Beta-lactamase TEM,Enzyme,BLAT_ECOLX,
P62594,Beta-lactamase TEM,Enzyme,BLAT_SALTI,
P72355|Q53707|Q53725|Q53729|Q9XDB3,Penicillin-binding protein,Enzyme,P72355_STAAU|Q53707_STAAU|Q53725_STAAU|Q53729_STAAU|Q9XDB3_STAAU,INHIBITOR
P22310,UDP-glucuronosyltransferase 1-4,Enzyme,UD14_HUMAN,
P28566,5-hydroxytryptamine receptor 1E,GPCR,5HT1E_HUMAN,AGONIST
P61168,D(2) dopamine receptor,GPCR,DRD2_MOUSE,
Q64264,5-hydroxytryptamine receptor 1A,GPCR,5HT1A_MOUSE,
P52702,D(2) dopamine receptor,GPCR,DRD2_CHLAE,
Q9QYN8,Histamine H3 receptor,GPCR,HRH3_RAT,ANTAGONIST
P23979,5-hydroxytryptamine receptor 3A,Ion channel,5HT3A_MOUSE,
P50130,D(1A) dopamine receptor,GPCR,DRD1_PIG,
P52703,D(3) dopamine receptor,GPCR,DRD3_CHLAE,
Q91ZY2,Histamine H4 receptor,GPCR,HRH4_MOUSE,ANTAGONIST
Q91ZY1,Histamine H4 receptor,GPCR,HRH4_RAT,ANTAGONIST
P34968|P35363|Q02152,Serotonin 2 (5-HT2) receptor,GPCR,5HT2C_MOUSE|5HT2A_MOUSE|5HT2B_MOUSE,
P30966,5-hydroxytryptamine receptor 5A,GPCR,5HT5A_MOUSE,ANTAGONIST
P0DP23,Calmodulin-1,Cytosolic other,CALM1_HUMAN,
Q9UI33,Sodium channel protein type 11 subunit alpha,Ion channel,SCNBA_HUMAN,
O95264|P46098,Serotonin 3 receptor (5HT3),Ion channel,5HT3B_HUMAN|5HT3A_HUMAN,ANTAGONIST
P27922,Dopamine transporter,Transporter,SC6A3_BOVIN,
Q9GJT6,Dopamine transporter,Transporter,SC6A3_MACFA,
P41145,Kappa-type opioid receptor,GPCR,OPRK_HUMAN,AGONIST
P41143,Delta-type opioid receptor,GPCR,OPRD_HUMAN,AGONIST
P23416,Glycine receptor subunit alpha-2,Ion channel,GLRA2_HUMAN,
P07437,Tubulin beta chain,Structural,TBB5_HUMAN,INHIBITOR
P11309,Serine/threonine-protein kinase pim-1,Kinase,PIM1_HUMAN,
P02550,Tubulin alpha-1A chain,Structural,TBA1A_PIG,
Q6B856,Tubulin beta-2B chain,Structural,TBB2B_BOVIN,
O60885,Bromodomain-containing protein 4,Unclassified,BRD4_HUMAN,INHIBITOR
Q27957,Tubulin polymerization-promoting protein,Unclassified,TPPP_BOVIN,
Q6B856|Q862F3|Q862L2,Tubulin,Structural,TBB2B_BOVIN|Q862F3_BOVIN|Q862L2_BOVIN,
P02550|P02554,Tubulin,Structural,TBA1A_PIG|TBB_PIG,
Q08828,Adenylate cyclase type 1,Enzyme,ADCY1_HUMAN,
P11166,"Solute carrier family 2, facilitated glucose transporter member 1",Transporter,GTR1_HUMAN,
P19754,Adenylate cyclase type 1,Enzyme,ADCY1_BOVIN,
P37288,Vasopressin V1a receptor,GPCR,V1AR_HUMAN,ANTAGONIST
P30518,Vasopressin V2 receptor,GPCR,V2R_HUMAN,ANTAGONIST
P70536,Oxytocin receptor,GPCR,OXYR_RAT,
Q00788,Vasopressin V2 receptor,GPCR,V2R_RAT,
P30560,Vasopressin V1a receptor,GPCR,V1AR_RAT,
Q09470,Potassium voltage-gated channel subfamily A member 1,Ion channel,KCNA1_HUMAN,
P49354|P49356,Protein farnesyltransferase,Enzyme,FNTA_HUMAN|FNTB_HUMAN,
P19643,Amine oxidase [flavin-containing] B,Enzyme,AOFB_RAT,
Q33BM1,G protein-coupled receptor GPR35,GPCR,Q33BM1_RAT,
Q9ES90,G-protein coupled receptor 35,GPCR,GPR35_MOUSE,
P25815,Protein S100-P,Cytosolic other,S100P_HUMAN,
P08908,5-hydroxytryptamine receptor 1A,GPCR,5HT1A_HUMAN,ANTAGONIST
P34969,5-hydroxytryptamine receptor 7,GPCR,5HT7R_HUMAN,ANTAGONIST
P27338,Amine oxidase [flavin-containing] B,Enzyme,AOFB_HUMAN,
P03372,Estrogen receptor,Nuclear other,ESR1_HUMAN,
P00374,Dihydrofolate reductase,Enzyme,DYR_HUMAN,
P13922,Bifunctional dihydrofolate reductase-thymidylate synthase,Enzyme,DRTS_PLAFK,INHIBITOR
Q12879,"Glutamate receptor ionotropic, NMDA 2A",Ion channel,NMDE1_HUMAN,
Q8TCU5,"Glutamate receptor ionotropic, NMDA 3A",Ion channel,NMD3A_HUMAN,
Q13224,"Glutamate receptor ionotropic, NMDA 2B",Ion channel,NMDE2_HUMAN,
Q14957,"Glutamate receptor ionotropic, NMDA 2C",Ion channel,NMDE3_HUMAN,
O15399,"Glutamate receptor ionotropic, NMDA 2D",Ion channel,NMDE4_HUMAN,
P9WQA8,Alanine racemase,Enzyme,ALR_MYCTO,
Q05586,"Glutamate receptor ionotropic, NMDA 1",Ion channel,NMDZ1_HUMAN,
O60391,"Glutamate receptor ionotropic, NMDA 3B",Ion channel,NMD3B_HUMAN,
P9WP31,D-alanine--D-alanine ligase,Enzyme,DDL_MYCTU,INHIBITOR
P9WQA9,Alanine racemase,Enzyme,ALR_MYCTU,INHIBITOR
P35439,"Glutamate receptor ionotropic, NMDA 1",Ion channel,NMDZ1_RAT,
Q00961,"Glutamate receptor ionotropic, NMDA 2C",Ion channel,NMDE3_RAT,
P62942,Peptidyl-prolyl cis-trans isomerase FKBP1A,Enzyme,FKB1A_HUMAN,
P62937,Peptidyl-prolyl cis-trans isomerase A,Enzyme,PPIA_HUMAN,MODULATOR
P21462,fMet-Leu-Phe receptor,GPCR,FPR1_HUMAN,ANTAGONIST
Q9Y6L6,Solute carrier organic anion transporter family member 1B1,Transporter,SO1B1_HUMAN,INHIBITOR
Q02790,Peptidyl-prolyl cis-trans isomerase FKBP4,Enzyme,FKBP4_HUMAN,
P23284,Peptidyl-prolyl cis-trans isomerase B,Enzyme,PPIB_HUMAN,
Q08209,Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform,Enzyme,PP2BA_HUMAN,
P68106,Peptidyl-prolyl cis-trans isomerase FKBP1B,Enzyme,FKB1B_HUMAN,
Q08752,Peptidyl-prolyl cis-trans isomerase D,Enzyme,PPID_HUMAN,
Q9NPD5,Solute carrier organic anion transporter family member 1B3,Transporter,SO1B3_HUMAN,INHIBITOR
Q14973,Sodium/bile acid cotransporter,Transporter,NTCP_HUMAN,INHIBITOR
Q9JHG7,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",Kinase,PK3CG_MOUSE,
P42261,Glutamate receptor 1,Ion channel,GRIA1_HUMAN,
P42262,Glutamate receptor 2,Ion channel,GRIA2_HUMAN,
P48058,Glutamate receptor 4,Ion channel,GRIA4_HUMAN,ALLOSTERIC MODULATOR
P42263,Glutamate receptor 3,Ion channel,GRIA3_HUMAN,ALLOSTERIC MODULATOR
P19490|P19491|P19492|P19493,"Glutamate receptor ionotropic, AMPA",Ion channel,GRIA1_RAT|GRIA2_RAT|GRIA3_RAT|GRIA4_RAT,
P19838,Nuclear factor NF-kappa-B p105 subunit,Cytosolic other,NFKB1_HUMAN,
Q7ZJM1,Integrase,Enzyme,Q7ZJM1_9HIV1,
P05412,Transcription factor AP-1,Transcription factor,JUN_HUMAN,
P34968,5-hydroxytryptamine receptor 2C,GPCR,5HT2C_MOUSE,
Q8WTS6,Histone-lysine N-methyltransferase SETD7,Enzyme,SETD7_HUMAN,
Q9UPY5,Cystine/glutamate transporter,Transporter,XCT_HUMAN,
P15309,Prostatic acid phosphatase,Enzyme,PPAP_HUMAN,
P06746,DNA polymerase beta,Enzyme,DPOLB_HUMAN,
P09884|P28340|Q07864,DNA polymerase (alpha/delta/epsilon),Enzyme,DPOLA_HUMAN|DPOD1_HUMAN|DPOE1_HUMAN,INHIBITOR
Q14181,DNA polymerase alpha subunit B,Enzyme,DPOA2_HUMAN,
P62993,Growth factor receptor-bound protein 2,Cytosolic other,GRB2_HUMAN,
Q16832,Discoidin domain-containing receptor 2,Kinase,DDR2_HUMAN,
Q60631,Growth factor receptor-bound protein 2,Cytosolic other,GRB2_MOUSE,
Q96IV0,Peptide-N(4)-(N-acetyl-beta-glucosaminyl)asparagine amidase,Enzyme,NGLY1_HUMAN,
P00747,Plasminogen,Enzyme,PLMN_HUMAN,
P04070,Vitamin K-dependent protein C,Enzyme,PROC_HUMAN,
P07477|P07478|P35030,Trypsin,Enzyme,TRY1_HUMAN|TRY2_HUMAN|TRY3_HUMAN,
Q28731,Thrombin,Unclassified,Q28731_RABIT,
P10275,Androgen receptor,Nuclear hormone receptor,ANDR_HUMAN,AGONIST
P08842,Steryl-sulfatase,Enzyme,STS_HUMAN,
P21817,Ryanodine receptor 1,Ion channel,RYR1_HUMAN,ANTAGONIST
Q15413,Ryanodine receptor 3,Ion channel,RYR3_HUMAN,ANTAGONIST
Q9NZ45,CDGSH iron-sulfur domain-containing protein 1,Unclassified,CISD1_HUMAN,
P0C0X1,Dihydropteroate synthase 1,Enzyme,DHPS1_MYCLE,INHIBITOR
P11413,Glucose-6-phosphate 1-dehydrogenase,Enzyme,G6PD_HUMAN,
Q57P83,Outer membrane porin protein OmpD,Transporter,OMPD_SALCH,
P52333,Tyrosine-protein kinase JAK3,Kinase,JAK3_HUMAN,
P09619,Platelet-derived growth factor receptor beta,Kinase,PGFRB_HUMAN,INHIBITOR
P00519,Tyrosine-protein kinase ABL1,Kinase,ABL1_HUMAN,INHIBITOR
P10721,Mast/stem cell growth factor receptor Kit,Kinase,KIT_HUMAN,INHIBITOR
P42345,Serine/threonine-protein kinase mTOR,Kinase,MTOR_HUMAN,
P11274,Breakpoint cluster region protein,Kinase,BCR_HUMAN,
P12931,Proto-oncogene tyrosine-protein kinase Src,Kinase,SRC_HUMAN,INHIBITOR
P06239,Tyrosine-protein kinase Lck,Kinase,LCK_HUMAN,INHIBITOR
P07947,Tyrosine-protein kinase Yes,Kinase,YES_HUMAN,INHIBITOR
P06241,Tyrosine-protein kinase Fyn,Kinase,FYN_HUMAN,INHIBITOR
P29317,Ephrin type-A receptor 2,Kinase,EPHA2_HUMAN,INHIBITOR
P04049,RAF proto-oncogene serine/threonine-protein kinase,Kinase,RAF1_HUMAN,
P15056,Serine/threonine-protein kinase B-raf,Kinase,BRAF_HUMAN,
P36888,Receptor-type tyrosine-protein kinase FLT3,Kinase,FLT3_HUMAN,
P17948,Vascular endothelial growth factor receptor 1,Kinase,VGFR1_HUMAN,
P35968,Vascular endothelial growth factor receptor 2,Kinase,VGFR2_HUMAN,
P07333,Macrophage colony-stimulating factor 1 receptor,Kinase,CSF1R_HUMAN,
P16234,Platelet-derived growth factor receptor alpha,Kinase,PGFRA_HUMAN,
P22607,Fibroblast growth factor receptor 3,Kinase,FGFR3_HUMAN,
P08631,Tyrosine-protein kinase HCK,Kinase,HCK_HUMAN,INHIBITOR
Q15303,Receptor tyrosine-protein kinase erbB-4,Kinase,ERBB4_HUMAN,
P43405,Tyrosine-protein kinase SYK,Kinase,KSYK_HUMAN,
Q9H1R3,"Myosin light chain kinase 2, skeletal/cardiac muscle",Kinase,MYLK2_HUMAN,
P41240,Tyrosine-protein kinase CSK,Kinase,CSK_HUMAN,
P29322,Ephrin type-A receptor 8,Kinase,EPHA8_HUMAN,
P07948,Tyrosine-protein kinase Lyn,Kinase,LYN_HUMAN,INHIBITOR
P51813,Cytoplasmic tyrosine-protein kinase BMX,Kinase,BMX_HUMAN,
P51955,Serine/threonine-protein kinase Nek2,Kinase,NEK2_HUMAN,
P53667,LIM domain kinase 1,Kinase,LIMK1_HUMAN,
P11362,Fibroblast growth factor receptor 1,Kinase,FGFR1_HUMAN,
O94804,Serine/threonine-protein kinase 10,Kinase,STK10_HUMAN,
P42684,Abelson tyrosine-protein kinase 2,Kinase,ABL2_HUMAN,
Q15759,Mitogen-activated protein kinase 11,Kinase,MK11_HUMAN,
P54756,Ephrin type-A receptor 5,Kinase,EPHA5_HUMAN,
P54764,Ephrin type-A receptor 4,Kinase,EPHA4_HUMAN,
P21802,Fibroblast growth factor receptor 2,Kinase,FGFR2_HUMAN,
Q9UF33,Ephrin type-A receptor 6,Kinase,EPHA6_HUMAN,
Q9UKE5,TRAF2 and NCK-interacting protein kinase,Kinase,TNIK_HUMAN,
P49674,Casein kinase I isoform epsilon,Kinase,KC1E_HUMAN,
P09769,Tyrosine-protein kinase Fgr,Kinase,FGR_HUMAN,INHIBITOR
O14965,Aurora kinase A,Kinase,AURKA_HUMAN,
Q9NRP7,Serine/threonine-protein kinase 36,Kinase,STK36_HUMAN,
P29320,Ephrin type-A receptor 3,Kinase,EPHA3_HUMAN,
P42685,Tyrosine-protein kinase FRK,Kinase,FRK_HUMAN,INHIBITOR
Q9Y4K4,Mitogen-activated protein kinase kinase kinase kinase 5,Kinase,M4K5_HUMAN,
Q9Y6R4,Mitogen-activated protein kinase kinase kinase 4,Kinase,M3K4_HUMAN,
O14976,Cyclin-G-associated kinase,Kinase,GAK_HUMAN,
O43353,Receptor-interacting serine/threonine-protein kinase 2,Kinase,RIPK2_HUMAN,
P54762,Ephrin type-B receptor 1,Kinase,EPHB1_HUMAN,
Q13043,Serine/threonine-protein kinase 4,Kinase,STK4_HUMAN,
Q07912,Activated CDC42 kinase 1,Kinase,ACK1_HUMAN,
Q9H2G2,STE20-like serine/threonine-protein kinase,Kinase,SLK_HUMAN,
Q08345,Epithelial discoidin domain-containing receptor 1,Kinase,DDR1_HUMAN,
P54760,Ephrin type-B receptor 4,Kinase,EPHB4_HUMAN,
P36896,Activin receptor type-1B,Kinase,ACV1B_HUMAN,
P37023,Serine/threonine-protein kinase receptor R3,Kinase,ACVL1_HUMAN,
Q04771,Activin receptor type-1,Kinase,ACVR1_HUMAN,
P37173,TGF-beta receptor type-2,Kinase,TGFR2_HUMAN,
Q02750,Dual specificity mitogen-activated protein kinase kinase 1,Kinase,MP2K1_HUMAN,
P36507,Dual specificity mitogen-activated protein kinase kinase 2,Kinase,MP2K2_HUMAN,
Q08881,Tyrosine-protein kinase ITK/TSK,Kinase,ITK_HUMAN,
Q13882,Protein-tyrosine kinase 6,Kinase,PTK6_HUMAN,
P06240,Proto-oncogene tyrosine-protein kinase LCK,Kinase,LCK_MOUSE,
Q06187,Tyrosine-protein kinase BTK,Kinase,BTK_HUMAN,
P42680,Tyrosine-protein kinase Tec,Kinase,TEC_HUMAN,
P29323,Ephrin type-B receptor 2,Kinase,EPHB2_HUMAN,
P29597,Non-receptor tyrosine-protein kinase TYK2,Kinase,TYK2_HUMAN,
P42336,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform",Kinase,PK3CA_HUMAN,
P00523,Proto-oncogene tyrosine-protein kinase Src,Kinase,SRC_CHICK,
P30291,Wee1-like protein kinase,Kinase,WEE1_HUMAN,
O00506,Serine/threonine-protein kinase 25,Kinase,STK25_HUMAN,
Q9NYL2,Mitogen-activated protein kinase kinase kinase MLT,Kinase,MLTK_HUMAN,
P42681,Tyrosine-protein kinase TXK,Kinase,TXK_HUMAN,
P53671,LIM domain kinase 2,Kinase,LIMK2_HUMAN,
Q9P289,Serine/threonine-protein kinase 26,Kinase,STK26_HUMAN,
Q9UBE8,Serine/threonine-protein kinase NLK,Kinase,NLK_HUMAN,
Q9P2K8,Eukaryotic translation initiation factor 2-alpha kinase 4,Kinase,E2AK4_HUMAN,
Q9H0K1,Serine/threonine-protein kinase SIK2,Kinase,SIK2_HUMAN,
P27037,Activin receptor type-2A,Kinase,AVR2A_HUMAN,
Q13705,Activin receptor type-2B,Kinase,AVR2B_HUMAN,
Q59H18,Serine/threonine-protein kinase TNNI3K,Kinase,TNI3K_HUMAN,
Q09013,Myotonin-protein kinase,Kinase,DMPK_HUMAN,
Q8NI60,"Chaperone activity of bc1 complex-like, mitochondrial",Kinase,COQ8A_HUMAN,
Q6DT37,Serine/threonine-protein kinase MRCK gamma,Kinase,MRCKG_HUMAN,
Q92918,Mitogen-activated protein kinase kinase kinase kinase 1,Kinase,M4K1_HUMAN,
Q99640,Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase,Kinase,PMYT1_HUMAN,
Q8IVH8,Mitogen-activated protein kinase kinase kinase kinase 3,Kinase,M4K3_HUMAN,
Q96GD4,Aurora kinase B,Kinase,AURKB_HUMAN,
P51451,Tyrosine-protein kinase Blk,Kinase,BLK_HUMAN,INHIBITOR
P36894,Bone morphogenetic protein receptor type-1A,Kinase,BMR1A_HUMAN,
O95819,Mitogen-activated protein kinase kinase kinase kinase 4,Kinase,M4K4_HUMAN,
Q5VT25,Serine/threonine-protein kinase MRCK alpha,Kinase,MRCKA_HUMAN,
Q9Y5S2,Serine/threonine-protein kinase MRCK beta,Kinase,MRCKB_HUMAN,
P57059,Serine/threonine-protein kinase SIK1,Kinase,SIK1_HUMAN,
Q9H3Y6,Tyrosine-protein kinase Srms,Kinase,SRMS_HUMAN,INHIBITOR
Q15569,Dual specificity testis-specific protein kinase 1,Kinase,TESK1_HUMAN,
P36897,TGF-beta receptor type-1,Kinase,TGFR1_HUMAN,
P21709,Ephrin type-A receptor 1,Kinase,EPHA1_HUMAN,
P54753,Ephrin type-B receptor 3,Kinase,EPHB3_HUMAN,
P68370,Tubulin alpha-1A chain,Structural,TBA1A_RAT,
Q12851,Mitogen-activated protein kinase kinase kinase kinase 2,Kinase,M4K2_HUMAN,
Q8N4C8,Misshapen-like kinase 1,Kinase,MINK1_HUMAN,
P16277,Tyrosine-protein kinase Blk,Kinase,BLK_MOUSE,
O15197,Ephrin type-B receptor 6,Kinase,EPHB6_HUMAN,
O43283,Mitogen-activated protein kinase kinase kinase 13,Kinase,M3K13_HUMAN,
Q9Y2U5,Mitogen-activated protein kinase kinase kinase 2,Kinase,M3K2_HUMAN,
Q99759,Mitogen-activated protein kinase kinase kinase 3,Kinase,M3K3_HUMAN,
Q9H2K8,Serine/threonine-protein kinase TAO3,Kinase,TAOK3_HUMAN,
Q6PHR2,Serine/threonine-protein kinase ULK3,Kinase,ULK3_HUMAN,
Q56UN5,Mitogen-activated protein kinase kinase kinase 19,Kinase,M3K19_HUMAN,
Q8TDR2,Serine/threonine-protein kinase 35,Kinase,STK35_HUMAN,
P21860,Receptor tyrosine-protein kinase erbB-3,Kinase,ERBB3_HUMAN,
Q9Y2K2,Serine/threonine-protein kinase SIK3,Kinase,SIK3_HUMAN,
P0C1S8,Wee1-like protein kinase 2,Kinase,WEE2_HUMAN,
O00238,Bone morphogenetic protein receptor type-1B,Kinase,BMR1B_HUMAN,
P0A0J7,Quinolone resistance protein NorA,Transporter,NORA_STAAU,
Q52WX2,Serine/threonine-protein kinase SBK1,Kinase,SBK1_HUMAN,
Q86Y07,Serine/threonine-protein kinase VRK2,Kinase,VRK2_HUMAN,
Q9UL54,Serine/threonine-protein kinase TAO2,Kinase,TAOK2_HUMAN,
Q13163,Dual specificity mitogen-activated protein kinase kinase 5,Kinase,MP2K5_HUMAN,
Q8NG66,Serine/threonine-protein kinase Nek11,Kinase,NEK11_HUMAN,
P62344,Calcium-dependent protein kinase 1,Kinase,CDPK1_PLAF7,
O15264|P53778|Q15759|Q16539,MAP kinase p38,Kinase,MK13_HUMAN|MK12_HUMAN|MK11_HUMAN|MK14_HUMAN,
P36507|Q02750,Dual specificity mitogen-activated protein kinase kinase; MEK1/2,Kinase,MP2K2_HUMAN|MP2K1_HUMAN,
P00519|P11274,Bcr/Abl fusion protein,Kinase,ABL1_HUMAN|BCR_HUMAN,
Q01538,Myelin transcription factor 1,Transcription factor,MYT1_HUMAN,
P11388,DNA topoisomerase 2-alpha,Enzyme,TOP2A_HUMAN,INHIBITOR
O95255,Multidrug resistance-associated protein 6,Transporter,MRP6_HUMAN,
O40947,ORF 73,Unclassified,O40947_HHV8,
Q8BGY9,High affinity choline transporter 1,Transporter,SC5A7_MOUSE,
P28570,Creatine transporter,Transporter,SC6A8_RAT,
P02708|P07510|P11230|Q04844|Q07001,Muscle-type nicotinic acetylcholine receptor,Ion channel,ACHA_HUMAN|ACHG_HUMAN|ACHB_HUMAN|ACHE_HUMAN|ACHD_HUMAN,PARTIAL AGONIST
Q16665,Hypoxia-inducible factor 1-alpha,Transcription factor,HIF1A_HUMAN,
Q9GRG7,Glucose-6-phosphate 1-dehydrogenase,Enzyme,Q9GRG7_9TRYP,
P0A7V8,30S ribosomal protein S4,Ribosomal protein,RS4_ECOLI,
P0A7X3,30S ribosomal protein S9,Ribosomal protein,RS9_ECOLI,
Q8WSF8,Soluble acetylcholine receptor,Unclassified,Q8WSF8_APLCA,
O95069,Potassium channel subfamily K member 2,Ion channel,KCNK2_HUMAN,OPENER
O14649,Potassium channel subfamily K member 3,Ion channel,KCNK3_HUMAN,OPENER
Q9NPC2,Potassium channel subfamily K member 9,Ion channel,KCNK9_HUMAN,OPENER
P57789,Potassium channel subfamily K member 10,Ion channel,KCNKA_HUMAN,OPENER
Q7Z418,Potassium channel subfamily K member 18,Ion channel,KCNKI_HUMAN,OPENER
P23415|P48167,Glycine receptor (alpha-1/beta),Ion channel,GLRA1_HUMAN|GLRB_HUMAN,POSITIVE MODULATOR
O00591|O14764|P14867|P18505|P18507|P28472|P31644|P34903|P47869|P47870|P48169|P78334|Q16445|Q8N1C3|Q99928|Q9UN88,GABA-A receptor; anion channel,Ion channel,GBRP_HUMAN|GBRD_HUMAN|GBRA1_HUMAN|GBRB1_HUMAN|GBRG2_HUMAN|GBRB3_HUMAN|GBRA5_HUMAN|GBRA3_HUMAN|GBRA2_HUMAN|GBRB2_HUMAN|GBRA4_HUMAN|GBRE_HUMAN|GBRA6_HUMAN|GBRG1_HUMAN|GBRG3_HUMAN|GBRT_HUMAN,POSITIVE ALLOSTERIC MODULATOR
Q7RTT9,Equilibrative nucleoside transporter 4,Transporter,S29A4_HUMAN,INHIBITOR
P48545,G protein-activated inward rectifier potassium channel 4,Ion channel,KCNJ5_MOUSE,BLOCKER
O75899,Gamma-aminobutyric acid type B receptor subunit 2,GPCR,GABR2_HUMAN,
P28476,Gamma-aminobutyric acid receptor subunit rho-2,Ion channel,GBRR2_HUMAN,
A2AMW3|P16305|P22723|P22933|P26048|P26049|P27681|P50571|P62812|P63080|Q8BHJ7|Q8QZW7|Q9D6F4|Q9JLF1|Q9R0Y8,GABA-A receptor; anion channel,Ion channel,A2AMW3_MOUSE|GBRA6_MOUSE|GBRG2_MOUSE|GBRD_MOUSE|GBRA2_MOUSE|GBRA3_MOUSE|GBRG3_MOUSE|GBRB1_MOUSE|GBRA1_MOUSE|GBRB3_MOUSE|GBRA5_MOUSE|GBRP_MOUSE|GBRA4_MOUSE|GBRT_MOUSE|GBRG1_MOUSE,
P47901,Vasopressin V1b receptor,GPCR,V1BR_HUMAN,
P48974,Vasopressin V1b receptor,GPCR,V1BR_RAT,
P30518,Vasopressin V2 receptor,GPCR,V2R_HUMAN,AGONIST
P05112,Interleukin-4,Cytokine,IL4_HUMAN,
O54915,Nuclear receptor subfamily 1 group I member 2,Nuclear hormone receptor,NR1I2_MOUSE,AGONIST
P10980,Muscarinic acetylcholine receptor M2,GPCR,ACM2_RAT,ANTAGONIST
P12657|P32211|Q920H4|Q9ERZ3|Q9ERZ4,Muscarinic acetylcholine receptor,GPCR,ACM1_MOUSE|ACM4_MOUSE|ACM5_MOUSE|ACM3_MOUSE|ACM2_MOUSE,
P32238,Cholecystokinin receptor type A,GPCR,CCKAR_HUMAN,
P22002|P27732|Q02485,Voltage-gated L-type calcium channel,Ion channel,CAC1C_RAT|CAC1D_RAT|CAC1S_RAT,
Q96RJ0,Trace amine-associated receptor 1,GPCR,TAAR1_HUMAN,
Q8HZ64,Trace amine-associated receptor 1,GPCR,TAAR1_MACMU,
Q923Y9,Trace amine-associated receptor 1,GPCR,TAAR1_RAT,
Q923Y8,Trace amine-associated receptor 1,GPCR,TAAR1_MOUSE,
Q99720,Sigma non-opioid intracellular receptor 1,Membrane receptor,SGMR1_HUMAN,AGONIST
Q8TCU5,"Glutamate receptor ionotropic, NMDA 3A",Ion channel,NMD3A_HUMAN,ANTAGONIST
Q14957,"Glutamate receptor ionotropic, NMDA 2C",Ion channel,NMDE3_HUMAN,BLOCKER
Q60492,Sigma non-opioid intracellular receptor 1,Membrane other,SGMR1_CAVPO,
P04774|P04775|P08104,"Sodium channel alpha subunits; brain (Types I, II, III)",Ion channel,SCN1A_RAT|SCN2A_RAT|SCN3A_RAT,
P59540,Taste receptor type 2 member 46,GPCR,T2R46_HUMAN,
P18113,Thyroid hormone receptor beta,Transcription factor,THB_RAT,
P10827|P10828,Thyroid hormone receptor,Nuclear hormone receptor,THA_HUMAN|THB_HUMAN,AGONIST
P42574,Caspase-3,Enzyme,CASP3_HUMAN,
P55210,Caspase-7,Enzyme,CASP7_HUMAN,
Q17339,Female germline-specific tumor suppressor gld-1,Unclassified,GLD1_CAEEL,
Q02083,N-acylethanolamine-hydrolyzing acid amidase,Enzyme,NAAA_HUMAN,
P31644|P47870|Q99928,GABA A receptor alpha-5/beta-2/gamma-3,Ion channel,GBRA5_HUMAN|GBRB2_HUMAN|GBRG3_HUMAN,POSITIVE ALLOSTERIC MODULATOR
P31644,Gamma-aminobutyric acid receptor subunit alpha-5,Ion channel,GBRA5_HUMAN,
P35348,Alpha-1A adrenergic receptor,GPCR,ADA1A_HUMAN,ALLOSTERIC MODULATOR
P52895,Aldo-keto reductase family 1 member C2,Enzyme,AK1C2_HUMAN,
P62813,Gamma-aminobutyric acid receptor subunit alpha-1,Ion channel,GBRA1_RAT,
P23576,Gamma-aminobutyric acid receptor subunit alpha-2,Ion channel,GBRA2_RAT,
P19969,Gamma-aminobutyric acid receptor subunit alpha-5,Ion channel,GBRA5_RAT,
P14867|P47870|Q99928,GABA-A receptor alpha-1/beta-2/gamma-3,Ion channel,GBRA1_HUMAN|GBRB2_HUMAN|GBRG3_HUMAN,POSITIVE ALLOSTERIC MODULATOR
P18508|P20236|P63138,GABA A receptor alpha-3/beta-2/gamma-2,Ion channel,GBRG2_RAT|GBRA3_RAT|GBRB2_RAT,
P18508|P30191|P63138,GABA A receptor alpha-6/beta-2/gamma-2,Ion channel,GBRG2_RAT|GBRA6_RAT|GBRB2_RAT,
P18508|P62813|P63138,GABA-A receptor; alpha-1/beta-2/gamma-2,Ion channel,GBRG2_RAT|GBRA1_RAT|GBRB2_RAT,
P18508|P23576|P63138,GABA A receptor alpha-2/beta-2/gamma-2,Ion channel,GBRG2_RAT|GBRA2_RAT|GBRB2_RAT,
P18508|P19969|P63079,GABA A receptor alpha-5/beta-3/gamma-2,Ion channel,GBRG2_RAT|GBRA5_RAT|GBRB3_RAT,
P18507|P34903|P47870,GABA A receptor alpha-3/beta-2/gamma-2,Ion channel,GBRG2_HUMAN|GBRA3_HUMAN|GBRB2_HUMAN,POSITIVE ALLOSTERIC MODULATOR
P34903|P47870|Q99928,GABA A receptor alpha-3/beta-2/gamma-3,Ion channel,GBRA3_HUMAN|GBRB2_HUMAN|GBRG3_HUMAN,POSITIVE ALLOSTERIC MODULATOR
P28472|P31644|Q99928,GABA A receptor alpha-5/beta-3/gamma-3,Ion channel,GBRB3_HUMAN|GBRA5_HUMAN|GBRG3_HUMAN,POSITIVE ALLOSTERIC MODULATOR
P18507|P31644|P47870,GABA A receptor alpha-5/beta-2/gamma-2,Ion channel,GBRG2_HUMAN|GBRA5_HUMAN|GBRB2_HUMAN,POSITIVE ALLOSTERIC MODULATOR
P43490,Nicotinamide phosphoribosyltransferase,Enzyme,NAMPT_HUMAN,
Q09428|Q14654,"Sulfonylurea receptor 1, Kir6.2",Ion channel,ABCC8_HUMAN|KCJ11_HUMAN,OPENER
Q61743,ATP-sensitive inward rectifier potassium channel 11,Ion channel,KCJ11_MOUSE,ACTIVATOR
O75762,Transient receptor potential cation channel subfamily A member 1,Ion channel,TRPA1_HUMAN,BLOCKER
Q15118,"[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial",Kinase,PDK1_HUMAN,INHIBITOR
Q15119,"[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial",Kinase,PDK2_HUMAN,INHIBITOR
Q15120,"[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 3, mitochondrial",Kinase,PDK3_HUMAN,INHIBITOR
Q16654,"[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrial",Kinase,PDK4_HUMAN,INHIBITOR
P11021,78 kDa glucose-regulated protein,Unclassified,GRP78_HUMAN,
Q16790,Carbonic anhydrase 9,Enzyme,CAH9_HUMAN,INHIBITOR
Q9Y2D0,"Carbonic anhydrase 5B, mitochondrial",Enzyme,CAH5B_HUMAN,INHIBITOR
P43166,Carbonic anhydrase 7,Enzyme,CAH7_HUMAN,INHIBITOR
P10145,Interleukin-8,Cytokine,IL8_HUMAN,
O75762,Transient receptor potential cation channel subfamily A member 1,Ion channel,TRPA1_HUMAN,
O60218,Aldo-keto reductase family 1 member B10,Enzyme,AK1BA_HUMAN,
Q9HAW7,UDP-glucuronosyltransferase 1-7,Enzyme,UD17_HUMAN,
P19224,UDP-glucuronosyltransferase 1-6,Enzyme,UD16_HUMAN,
O60656,UDP-glucuronosyltransferase 1-9,Enzyme,UD19_HUMAN,
Q9HAW8,UDP-glucuronosyltransferase 1-10,Enzyme,UD110_HUMAN,
Q9HCF6,Transient receptor potential cation channel subfamily M member 3,Ion channel,TRPM3_HUMAN,BLOCKER
Q16549,Proprotein convertase subtilisin/kexin type 7,Enzyme,PCSK7_HUMAN,
P9WMN1,ATP phosphoribosyltransferase,Enzyme,HIS1_MYCTU,
P05982,NULLD(P)H dehydrogenase [quinone] 1,Enzyme,NQO1_RAT,
P70676,SMR1-alpha2,Unclassified,P70676_RAT,
Q72549,Reverse transcriptase/RNaseH,Enzyme,Q72549_9HIV1,INHIBITOR
P03372,Estrogen receptor,Nuclear hormone receptor,ESR1_HUMAN,AGONIST
E1FVX6|E1G1C3,Nematode GABA-A receptor,Ion channel,E1FVX6_LOALO|E1G1C3_LOALO,POSITIVE MODULATOR
P62508,Estrogen-related receptor gamma,Nuclear hormone receptor,ERR3_HUMAN,ANTAGONIST
O95718,Steroid hormone receptor ERR2,Nuclear hormone receptor,ERR2_HUMAN,ANTAGONIST
Q14376,UDP-glucose 4-epimerase,Enzyme,GALE_HUMAN,
O08580,Steroid hormone receptor ERR1,Nuclear hormone receptor,ERR1_MOUSE,ANTAGONIST
P05023,Sodium/potassium-transporting ATPase subunit alpha-1,Transporter,AT1A1_HUMAN,INHIBITOR
P50997,Sodium/potassium-transporting ATPase subunit alpha-1,Transporter,AT1A1_CANFA,
P40763,Signal transducer and activator of transcription 3,Transcription factor,STAT3_HUMAN,
P05023|P05026|P13637|P14415|P50993|P54709|P54710|Q13733,Sodium/potassium-transporting ATPase,Transporter,AT1A1_HUMAN|AT1B1_HUMAN|AT1A3_HUMAN|AT1B2_HUMAN|AT1A2_HUMAN|AT1B3_HUMAN|ATNG_HUMAN|AT1A4_HUMAN,
P51449,Nuclear receptor ROR-gamma,Nuclear hormone receptor,RORG_HUMAN,
P51450,Nuclear receptor ROR-gamma,Nuclear hormone receptor,RORG_MOUSE,
P56481,Gastrin/cholecystokinin type B receptor,GPCR,GASR_MOUSE,
Q07699,Sodium channel subunit beta-1,Ion channel,SCN1B_HUMAN,
O60939,Sodium channel subunit beta-2,Ion channel,SCN2B_HUMAN,
Q9NY72,Sodium channel subunit beta-3,Ion channel,SCN3B_HUMAN,
Q8IWT1,Sodium channel subunit beta-4,Ion channel,SCN4B_HUMAN,
Q99808,Equilibrative nucleoside transporter 1,Transporter,S29A1_HUMAN,
O54699,Equilibrative nucleoside transporter 2,Transporter,S29A2_RAT,
P46098,5-hydroxytryptamine receptor 3A,Ion channel,5HT3A_HUMAN,BLOCKER
Q13698,Voltage-dependent L-type calcium channel subunit alpha-1S,Ion channel,CAC1S_HUMAN,
P27732,Voltage-dependent L-type calcium channel subunit alpha-1D,Ion channel,CAC1D_RAT,
P23979,5-hydroxytryptamine receptor 3A,Ion channel,5HT3A_MOUSE,BLOCKER
P15388,Potassium voltage-gated channel subfamily C member 1,Ion channel,KCNC1_MOUSE,BLOCKER
Q17ST2,Potassium voltage-gated channel subfamily A member 7,Ion channel,KCNA7_MOUSE,BLOCKER
Q9JIS7,Voltage-dependent L-type calcium channel subunit alpha-1F,Ion channel,CAC1F_MOUSE,BLOCKER
Q9R0C9,Sigma non-opioid intracellular receptor 1,Membrane receptor,SGMR1_RAT,INHIBITOR
Q7KQK5,Apical membrane antigen 1,Unclassified,Q7KQK5_PLAF7,
P17787|Q15822,Neuronal acetylcholine receptor; alpha2/beta2,Ion channel,ACHB2_HUMAN|ACHA2_HUMAN,
P50579,Methionine aminopeptidase 2,Enzyme,MAP2_HUMAN,
P53582,Methionine aminopeptidase 1,Enzyme,MAP11_HUMAN,
Q9Y5Y4,Prostaglandin D2 receptor 2,GPCR,PD2R2_HUMAN,AGONIST
P21731,Thromboxane A2 receptor,GPCR,TA2R_HUMAN,AGONIST
P37289,Prostaglandin F2-alpha receptor,GPCR,PF2R_BOVIN,
P35375,Prostaglandin E2 receptor EP1 subtype,GPCR,PE2R1_MOUSE,AGONIST
P43117,Prostaglandin F2-alpha receptor,GPCR,PF2R_MOUSE,
Q9Z2J6,Prostaglandin D2 receptor 2,GPCR,PD2R2_MOUSE,AGONIST
Q13258,Prostaglandin D2 receptor,GPCR,PD2R_HUMAN,AGONIST
Q80UJ1,Solute carrier family 22 member 20,Transporter,S22AK_MOUSE,
P43117,Prostaglandin F2-alpha receptor,GPCR,PF2R_MOUSE,AGONIST
Q62928,Prostaglandin E2 receptor EP2 subtype,GPCR,PE2R2_RAT,
P43114,Prostaglandin E2 receptor EP4 subtype,GPCR,PE2R4_RAT,
O00337,Sodium/nucleoside cotransporter 1,Transporter,S28A1_HUMAN,INHIBITOR
O76074,"cGMP-specific 3',5'-cyclic phosphodiesterase",Enzyme,PDE5A_HUMAN,INHIBITOR
Q9HCR9,"Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A",Enzyme,PDE11_HUMAN,
Q9Y233,"cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A",Enzyme,PDE10_HUMAN,INHIBITOR
P27815,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",Enzyme,PDE4A_HUMAN,INHIBITOR
Q99808,Equilibrative nucleoside transporter 1,Transporter,S29A1_HUMAN,INHIBITOR
O95263,"High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8B",Enzyme,PDE8B_HUMAN,INHIBITOR
O00408,"cGMP-dependent 3',5'-cyclic phosphodiesterase",Enzyme,PDE2A_HUMAN,INHIBITOR
Q9NP56,"cAMP-specific 3',5'-cyclic phosphodiesterase 7B",Enzyme,PDE7B_HUMAN,INHIBITOR
O60658,"High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A",Enzyme,PDE8A_HUMAN,INHIBITOR
Q9XSW7,Cyclic nucleotide phosphodiesterase PDE3A,Enzyme,Q9XSW7_PIG,
O77823,Cyclic AMP-specific phosphodiesterase SSPDE4A1A,Enzyme,O77823_PIG,
Q13370|Q14432,Phosphodiesterase 3,Enzyme,PDE3B_HUMAN|PDE3A_HUMAN,INHIBITOR
Q13946|Q9NP56,Phosphodiesterase 7,Enzyme,PDE7A_HUMAN|PDE7B_HUMAN,INHIBITOR
O43924|P16499|P18545|P35913|P51160|Q13956,Phosphodiesterase 6,Enzyme,PDE6D_HUMAN|PDE6A_HUMAN|CNRG_HUMAN|PDE6B_HUMAN|PDE6C_HUMAN|CNCG_HUMAN,INHIBITOR
P54750|Q01064|Q14123,Phosphodiesterase 1,Enzyme,PDE1A_HUMAN|PDE1B_HUMAN|PDE1C_HUMAN,INHIBITOR
Q86TP1,Protein prune homolog,Enzyme,PRUNE_HUMAN,
P0DTD1,Replicase polyprotein 1ab,Enzyme,R1AB_SARS2,INHIBITOR
P48544,G protein-activated inward rectifier potassium channel 4,Ion channel,KCNJ5_HUMAN,
P05091,"Aldehyde dehydrogenase, mitochondrial",Enzyme,ALDH2_HUMAN,INHIBITOR
P51681,C-C chemokine receptor type 5,GPCR,CCR5_HUMAN,
P25025,C-X-C chemokine receptor type 2,GPCR,CXCR2_HUMAN,
P11884,"Aldehyde dehydrogenase, mitochondrial",Enzyme,ALDH2_RAT,
Q99685,Monoglyceride lipase,Enzyme,MGLL_HUMAN,
P9WMN3,Bifunctional protein GlmU,Enzyme,GLMU_MYCTU,
P28300,Protein-lysine 6-oxidase,Enzyme,LYOX_HUMAN,
P58215,Lysyl oxidase homolog 3,Enzyme,LOXL3_HUMAN,
Q96JB6,Lysyl oxidase homolog 4,Enzyme,LOXL4_HUMAN,
Q96KQ7,Histone-lysine N-methyltransferase EHMT2,Enzyme,EHMT2_HUMAN,
Q9H9B1,Histone-lysine N-methyltransferase EHMT1,Enzyme,EHMT1_HUMAN,
Q9Y4K0,Lysyl oxidase homolog 2,Enzyme,LOXL2_HUMAN,
P57764,Gasdermin-D,Unclassified,GSDMD_HUMAN,
P05181,Cytochrome P450 2E1,Enzyme,CP2E1_HUMAN,
Q8R4D5,Transient receptor potential cation channel subfamily M member 8,Ion channel,TRPM8_MOUSE,ACTIVATOR
Q8R455,Transient receptor potential cation channel subfamily M member 8,Ion channel,TRPM8_RAT,ACTIVATOR
Q7Z2W7,Transient receptor potential cation channel subfamily M member 8,Ion channel,TRPM8_HUMAN,ACTIVATOR
P00533,Epidermal growth factor receptor,Kinase,EGFR_HUMAN,INHIBITOR
Q02643,Growth hormone-releasing hormone receptor,GPCR,GHRHR_HUMAN,
P07437|Q9H4B7|Q13885|Q9BVA1|Q13509|P04350|P68371|Q9BUF5|Q3ZCM7,Tubulin beta,Tumour-associated antigen,TBB5_HUMAN|TBB1_HUMAN|TBB2A_HUMAN|TBB2B_HUMAN|TBB3_HUMAN|TBB4A_HUMAN|TBB4B_HUMAN|TBB6_HUMAN|TBB8_HUMAN,INHIBITOR
Q9HC29,Nucleotide-binding oligomerization domain-containing protein 2,Cytosolic other,NOD2_HUMAN,
O09800|P04288|P04488|P06477|P06480|P06484|P06487|P10185|P10211|P10228|P68331|Q69091,Envelope glycoprotein,Membrane other,GN_HHV11|GM_HHV11|GE_HHV11|GH_HHV11|GJ_HHV11|GG_HHV11|GI_HHV11|GL_HHV11|GB_HHV11|GC_HHV11|GK_HHV11|GD_HHV11,INHIBITOR
P19793,Retinoic acid receptor RXR-alpha,Nuclear hormone receptor,RXRA_HUMAN,
P06276,Cholinesterase,Enzyme,CHLE_HUMAN,
P04058,Acetylcholinesterase,Enzyme,ACES_TORCA,
Q9JKC1,Butyrylcholinesterase; Protein Bche,Enzyme,Q9JKC1_RAT,
P37136,Acetylcholinesterase,Enzyme,ACES_RAT,
P32738,Choline O-acetyltransferase,Enzyme,CLAT_RAT,
Q03311,Cholinesterase,Enzyme,CHLE_MOUSE,
Q9N1N9,Butyrylcholinesterase,Enzyme,Q9N1N9_HORSE,
P48039,Melatonin receptor type 1A,GPCR,MTR1A_HUMAN,
P49286,Melatonin receptor type 1B,GPCR,MTR1B_HUMAN,
P54833,Beta-2 adrenergic receptor,GPCR,ADRB2_CANFA,
P09172,Dopamine beta-hydroxylase,Enzyme,DOPO_HUMAN,
P29276,Adenosine A2b receptor,GPCR,AA2BR_RAT,
Q8I2J3,M18 aspartyl aminopeptidase,Enzyme,Q8I2J3_PLAF7,
O14649,Potassium channel subfamily K member 3,Ion channel,KCNK3_HUMAN,BLOCKER
Q9NPC2,Potassium channel subfamily K member 9,Ion channel,KCNK9_HUMAN,BLOCKER
P04818,Thymidylate synthase,Enzyme,TYSY_HUMAN,
P29466,Caspase-1,Enzyme,CASP1_HUMAN,
O14746,Telomerase reverse transcriptase,Enzyme,TERT_HUMAN,
P61823,Ribonuclease pancreatic,Enzyme,RNAS1_BOVIN,
P43870,Type-2 restriction enzyme HindIII,Unclassified,T2D3_HAEIN,
O52691,Type-2 restriction enzyme ScaI,Unclassified,T2S1_STRCS,
P9WIQ1,UDP-galactopyranose mutase,Enzyme,GLF_MYCTU,
P08254,Stromelysin-1,Enzyme,MMP3_HUMAN,
P22894,Neutrophil collagenase,Enzyme,MMP8_HUMAN,INHIBITOR
P45452,Collagenase 3,Enzyme,MMP13_HUMAN,INHIBITOR
P02980,"Tetracycline resistance protein, class B",Transporter,TCR2_ECOLX,
P09237,Matrilysin,Enzyme,MMP7_HUMAN,INHIBITOR
Q07343,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",Enzyme,PDE4B_HUMAN,
P07550|P08588|P08913|P13945|P18089|P18825|P25100|P35348|P35368,Adrenergic receptor,GPCR,ADRB2_HUMAN|ADRB1_HUMAN|ADA2A_HUMAN|ADRB3_HUMAN|ADA2B_HUMAN|ADA2C_HUMAN|ADA1D_HUMAN|ADA1A_HUMAN|ADA1B_HUMAN,AGONIST
P30939,5-hydroxytryptamine receptor 1F,GPCR,5HT1F_HUMAN,
P34897,"Serine hydroxymethyltransferase, mitochondrial",Enzyme,GLYM_HUMAN,
P31213,3-oxo-5-alpha-steroid 4-dehydrogenase 2,Enzyme,S5A2_HUMAN,INHIBITOR
P18405,3-oxo-5-alpha-steroid 4-dehydrogenase 1,Enzyme,S5A1_HUMAN,INHIBITOR
Q9Y466,Nuclear receptor subfamily 2 group E member 1,Nuclear hormone receptor,NR2E1_HUMAN,
Q07343,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",Enzyme,PDE4B_HUMAN,INHIBITOR
P49146,Neuropeptide Y receptor type 2,GPCR,NPY2R_HUMAN,
Q96D31,Calcium release-activated calcium channel protein 1,Ion channel,CRCM1_HUMAN,
Q05932,"Folylpolyglutamate synthase, mitochondrial",Enzyme,FOLC_HUMAN,
Q16739,Ceramide glucosyltransferase,Enzyme,CEGT_HUMAN,
Q9XAY4,Beta-lactamase VIM-1; Class B carbapenemase VIM-1; Metallo-beta-lactamase; Metallo-beta-lactamase VIM-1; Metallobeta-lactamase; VIM-1; VIM-1 metallo-beta lactamase; VIM-1 metallo-beta-lactamase; VIM-1,Unclassified,Q9XAY4_PSEAI,
J3SE37,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",Enzyme,J3SE37_CROAD,
P08684,Cytochrome P450 3A4,Enzyme,CP3A4_HUMAN,INHIBITOR
P03369,Gag-Pol polyprotein,Polyprotein,POL_HV1A2,INHIBITOR
Q9WJQ2,Reverse transcriptase protein,Unclassified,Q9WJQ2_9HIV1,
P11926,Ornithine decarboxylase,Enzyme,DCOR_HUMAN,INHIBITOR
P09057,Ornithine decarboxylase,Enzyme,DCOR_RAT,
Q9TZZ6,Ornithine decarboxylase,Enzyme,Q9TZZ6_TRYBG,INHIBITOR
O54898,Voltage-dependent T-type calcium channel subunit alpha-1G,Ion channel,CAC1G_RAT,BLOCKER
O75884,Putative hydrolase RBBP9,Enzyme,RBBP9_HUMAN,
Q5EGZ1,Angiotensin-converting enzyme 2,Enzyme,ACE2_RAT,
P09470,Angiotensin-converting enzyme,Enzyme,ACE_MOUSE,
P23415,Glycine receptor subunit alpha-1,Ion channel,GLRA1_HUMAN,POSITIVE MODULATOR
Q53I07,Envelope glycoprotein,Viral envelope protein,Q53I07_9HIV1,
O40239,Transmembrane glycoprotein gp41,Membrane other,O40239_9PLVG,INHIBITOR
Q76270,GP41,Unclassified,Q76270_9HIV1,
P43700,DNA gyrase subunit A,Enzyme,GYRA_HAEIN,
P21281,"V-type proton ATPase subunit B, brain isoform",Enzyme,VATB2_HUMAN,
P48374|Q5EP76,Topoisomerase IV,Enzyme,PARC_NEIGO|Q5EP76_NEIGO,INHIBITOR
P22118|P48371,DNA gyrase,Enzyme,GYRB_NEIGO|GYRA_NEIGO,INHIBITOR
Q14432,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A",Enzyme,PDE3A_HUMAN,
Q9C0B1,Alpha-ketoglutarate-dependent dioxygenase FTO,Unclassified,FTO_HUMAN,
P21964,Catechol O-methyltransferase,Enzyme,COMT_HUMAN,INHIBITOR
P17394,Protein P,Polyprotein,DPOL_HBVB1,
P14550,Alcohol dehydrogenase [NADP(+)],Enzyme,AK1A1_HUMAN,
P50578,Alcohol dehydrogenase [NADP(+)],Enzyme,AK1A1_PIG,
P51635,Alcohol dehydrogenase [NADP(+)],Enzyme,AK1A1_RAT,
Q00796,Sorbitol dehydrogenase,Enzyme,DHSO_HUMAN,
Q02928,Cytochrome P450 4A11,Enzyme,CP4AB_HUMAN,INHIBITOR
P15121,Aldose reductase,Enzyme,ALDR_HUMAN,INHIBITOR
P35348,Alpha-1A adrenergic receptor,GPCR,ADA1A_HUMAN,AGONIST
P25100,Alpha-1D adrenergic receptor,GPCR,ADA1D_HUMAN,AGONIST
P35368,Alpha-1B adrenergic receptor,GPCR,ADA1B_HUMAN,AGONIST
P10608,Beta-2 adrenergic receptor,GPCR,ADRB2_RAT,
P10608|P18090|P26255,Adrenergic receptor beta,GPCR,ADRB2_RAT|ADRB1_RAT|ADRB3_RAT,
A3EZI9,NS3,Enzyme,A3EZI9_9HEPC,
P06401,Progesterone receptor,Nuclear other,PRGR_HUMAN,
P22199,Mineralocorticoid receptor,Nuclear hormone receptor,MCR_RAT,
Q9H244,P2Y purinoceptor 12,GPCR,P2Y12_HUMAN,
P29089,Type-1B angiotensin II receptor,GPCR,AGTRB_RAT,
P35351,Type-2 angiotensin II receptor,GPCR,AGTR2_RAT,
P25095|P29089,Angiotensin II receptor (AT-1) type-1,GPCR,AGTRA_RAT|AGTRB_RAT,
P25095|P29089|P35351,Angiotensin II receptor,GPCR,AGTRA_RAT|AGTRB_RAT|AGTR2_RAT,
P05106|P08514,Integrin alpha-IIb/beta-3,Adhesion,ITB3_HUMAN|ITA2B_HUMAN,INHIBITOR
P14842,5-hydroxytryptamine receptor 2A,GPCR,5HT2A_RAT,AGONIST
P41595,5-hydroxytryptamine receptor 2B,GPCR,5HT2B_HUMAN,AGONIST
P08909,5-hydroxytryptamine receptor 2C,GPCR,5HT2C_RAT,AGONIST
O08786,Cholecystokinin A receptor,GPCR,CCKAR_MOUSE,
O32393,Adenylate cyclase,Unclassified,O32393_ARTPT,
P35364,5-hydroxytryptamine receptor 5A,GPCR,5HT5A_RAT,ANTAGONIST
P30940,5-hydroxytryptamine receptor 1F,GPCR,5HT1F_RAT,AGONIST
P09619,Platelet-derived growth factor receptor beta,Kinase,PGFRB_HUMAN,
P00519,Tyrosine-protein kinase ABL1,Kinase,ABL1_HUMAN,
P07947,Tyrosine-protein kinase Yes,Kinase,YES_HUMAN,
P35916,Vascular endothelial growth factor receptor 3,Kinase,VGFR3_HUMAN,
O43293,Death-associated protein kinase 3,Kinase,DAPK3_HUMAN,
P08631,Tyrosine-protein kinase HCK,Kinase,HCK_HUMAN,
P53779,Mitogen-activated protein kinase 10,Kinase,MK10_HUMAN,
Q13557,Calcium/calmodulin-dependent protein kinase type II subunit delta,Kinase,KCC2D_HUMAN,
Q2M2I8,AP2-associated protein kinase 1,Kinase,AAK1_HUMAN,
P08581,Hepatocyte growth factor receptor,Kinase,MET_HUMAN,
P07948,Tyrosine-protein kinase Lyn,Kinase,LYN_HUMAN,
O94768,Serine/threonine-protein kinase 17B,Kinase,ST17B_HUMAN,
O00444,Serine/threonine-protein kinase PLK4,Kinase,PLK4_HUMAN,
Q9UQB9,Aurora kinase C,Kinase,AURKC_HUMAN,
Q9UEE5,Serine/threonine-protein kinase 17A,Kinase,ST17A_HUMAN,
P09769,Tyrosine-protein kinase Fgr,Kinase,FGR_HUMAN,
Q9UM73,ALK tyrosine kinase receptor,Kinase,ALK_HUMAN,
Q9NSY1,BMP-2-inducible protein kinase,Kinase,BMP2K_HUMAN,
P42685,Tyrosine-protein kinase FRK,Kinase,FRK_HUMAN,
Q15375,Ephrin type-A receptor 7,Kinase,EPHA7_HUMAN,
Q9HBH9,MAP kinase-interacting serine/threonine-protein kinase 2,Kinase,MKNK2_HUMAN,
P45984,Mitogen-activated protein kinase 9,Kinase,MK09_HUMAN,
Q3U3Q1,Serine/threonine-protein kinase ULK3,Kinase,ULK3_MOUSE,
P30530,Tyrosine-protein kinase receptor UFO,Kinase,UFO_HUMAN,
Q06418,Tyrosine-protein kinase receptor TYRO3,Kinase,TYRO3_HUMAN,
Q13470,Non-receptor tyrosine-protein kinase TNK1,Kinase,TNK1_HUMAN,
P48730,Casein kinase I isoform delta,Kinase,KC1D_HUMAN,
P35590,Tyrosine-protein kinase receptor Tie-1,Kinase,TIE1_HUMAN,
Q9BUB5,MAP kinase-interacting serine/threonine-protein kinase 1,Kinase,MKNK1_HUMAN,
P29376,Leukocyte tyrosine kinase receptor,Kinase,LTK_HUMAN,
P51451,Tyrosine-protein kinase Blk,Kinase,BLK_HUMAN,
Q12866,Tyrosine-protein kinase Mer,Kinase,MERTK_HUMAN,
O14578,Citron Rho-interacting kinase,Kinase,CTRO_HUMAN,
Q96D53,AarF domain-containing protein kinase 4,Kinase,COQ8B_HUMAN,
P31152,Mitogen-activated protein kinase 4,Kinase,MK04_HUMAN,
P19525,"Interferon-induced, double-stranded RNA-activated protein kinase",Kinase,E2AK2_HUMAN,
O75676,Ribosomal protein S6 kinase alpha-4,Kinase,KS6A4_HUMAN,
Q9UHD2,Serine/threonine-protein kinase TBK1,Kinase,TBK1_HUMAN,
Q92630,Dual specificity tyrosine-phosphorylation-regulated kinase 2,Kinase,DYRK2_HUMAN,
P32298,G protein-coupled receptor kinase 4,Kinase,GRK4_HUMAN,
Q8NE63,Homeodomain-interacting protein kinase 4,Kinase,HIPK4_HUMAN,
Q9UPE1,SRSF protein kinase 3,Kinase,SRPK3_HUMAN,
P57078,Receptor-interacting serine/threonine-protein kinase 4,Kinase,RIPK4_HUMAN,
Q8TBX8,Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma,Kinase,PI42C_HUMAN,
Q5S007,Leucine-rich repeat serine/threonine-protein kinase 2,Kinase,LRRK2_HUMAN,
O94956,Solute carrier organic anion transporter family member 2B1,Transporter,SO2B1_HUMAN,INHIBITOR
P28028,Serine/threonine-protein kinase B-raf,Kinase,BRAF_MOUSE,
P24228,D-alanyl-D-alanine carboxypeptidase DacB,Enzyme,DACB_ECOLI,INHIBITOR
O43193,Motilin receptor,GPCR,MTLR_HUMAN,
Q16678,Cytochrome P450 1B1,Enzyme,CP1B1_HUMAN,
P20648|P51164,Potassium-transporting ATPase,Transporter,ATP4A_HUMAN|ATP4B_HUMAN,INHIBITOR
Q12791,Calcium-activated potassium channel subunit alpha-1,Ion channel,KCMA1_HUMAN,ACTIVATOR
Q99527,G-protein coupled estrogen receptor 1,GPCR,GPER1_HUMAN,
P11474,Steroid hormone receptor ERR1,Nuclear hormone receptor,ERR1_HUMAN,
O95718,Steroid hormone receptor ERR2,Nuclear hormone receptor,ERR2_HUMAN,
P06211,Estrogen receptor,Transcription factor,ESR1_RAT,
Q62986,Estrogen receptor beta,Transcription factor,ESR2_RAT,
O08537,Estrogen receptor beta,Transcription factor,ESR2_MOUSE,
P19785,Estrogen receptor,Transcription factor,ESR1_MOUSE,
P06211|Q62986,Estrogen receptor,Transcription factor,ESR1_RAT|ESR2_RAT,
Q9H255,Olfactory receptor 51E2,GPCR,O51E2_HUMAN,
P14867,Gamma-aminobutyric acid receptor subunit alpha-1,Ion channel,GBRA1_HUMAN,
P47869,Gamma-aminobutyric acid receptor subunit alpha-2,Ion channel,GBRA2_HUMAN,POSITIVE ALLOSTERIC MODULATOR
P34903,Gamma-aminobutyric acid receptor subunit alpha-3,Ion channel,GBRA3_HUMAN,
P48169,Gamma-aminobutyric acid receptor subunit alpha-4,Ion channel,GBRA4_HUMAN,POSITIVE ALLOSTERIC MODULATOR
P08263,Glutathione S-transferase A1,Enzyme,GSTA1_HUMAN,
P78417,Glutathione S-transferase omega-1,Unclassified,GSTO1_HUMAN,
P9WNL8,Probable arabinosyltransferase A,Enzyme,EMBA_MYCTO,
P9WNL6,Probable arabinosyltransferase B,Enzyme,EMBB_MYCTO,
P9WNL5,Probable arabinosyltransferase C,Enzyme,EMBC_MYCTU,
P9WNL9,Probable arabinosyltransferase A,Enzyme,EMBA_MYCTU,INHIBITOR
O14764|P47870|P48169,GABA A receptor alpha-4/beta-2/delta,Ion channel,GBRD_HUMAN|GBRB2_HUMAN|GBRA4_HUMAN,
P9WIE4,Catalase-peroxidase,Enzyme,KATG_MYCTO,
P9WGR1,Enoyl-[acyl-carrier-protein] reductase [NADH],Enzyme,INHA_MYCTU,INHIBITOR
P08482,Muscarinic acetylcholine receptor M1,GPCR,ACM1_RAT,ANTAGONIST
O43497,Voltage-dependent T-type calcium channel subunit alpha-1G,Ion channel,CAC1G_HUMAN,BLOCKER
P35498|P35499|Q01118|Q14524|Q15858|Q99250|Q9NY46|Q9UI33|Q9UQD0|Q9Y5Y9,Sodium channel alpha subunit,Ion channel,SCN1A_HUMAN|SCN4A_HUMAN|SCN7A_HUMAN|SCN5A_HUMAN|SCN9A_HUMAN|SCN2A_HUMAN|SCN3A_HUMAN|SCNBA_HUMAN|SCN8A_HUMAN|SCNAA_HUMAN,BLOCKER
P35218,"Carbonic anhydrase 5A, mitochondrial",Enzyme,CAH5A_HUMAN,INHIBITOR
P07451,Carbonic anhydrase 3,Enzyme,CAH3_HUMAN,INHIBITOR
P23280,Carbonic anhydrase 6,Enzyme,CAH6_HUMAN,INHIBITOR
Q9ULX7,Carbonic anhydrase 14,Enzyme,CAH14_HUMAN,INHIBITOR
Q8N1Q1,Carbonic anhydrase 13,Enzyme,CAH13_HUMAN,INHIBITOR
P35218|Q9Y2D0,Carbonic anhydrase V,Enzyme,CAH5A_HUMAN|CAH5B_HUMAN,INHIBITOR
Q9BQB6,Vitamin K epoxide reductase complex subunit 1,Enzyme,VKOR1_HUMAN,
P04775,Sodium channel protein type 2 subunit alpha,Ion channel,SCN2A_RAT,BLOCKER
P18507|P28472|P47869,GABA-A receptor alpha-2/beta-3/gamma-2,Ion channel,GBRG2_HUMAN|GBRB3_HUMAN|GBRA2_HUMAN,
P18507|P28472|P34903,GABA-A receptor alpha-3/beta-3/gamma-2,Ion channel,GBRG2_HUMAN|GBRB3_HUMAN|GBRA3_HUMAN,
P18507|P28472|P31644,GABA-A receptor alpha-5/beta-3/gamma-2,Ion channel,GBRG2_HUMAN|GBRB3_HUMAN|GBRA5_HUMAN,
P15538,"Cytochrome P450 11B1, mitochondrial",Enzyme,C11B1_HUMAN,
P19099,"Cytochrome P450 11B2, mitochondrial",Enzyme,C11B2_HUMAN,
P14867|P18507|P47870,GABA-A receptor alpha-1/beta-2/gamma-2,Ion channel,GBRA1_HUMAN|GBRG2_HUMAN|GBRB2_HUMAN,POSITIVE MODULATOR
O15438,Canalicular multispecific organic anion transporter 2,Transporter,MRP3_HUMAN,
P43116,Prostaglandin E2 receptor EP2 subtype,GPCR,PE2R2_HUMAN,
P62942,Peptidyl-prolyl cis-trans isomerase FKBP1A,Enzyme,FKB1A_HUMAN,INHIBITOR
P42345,Serine/threonine-protein kinase mTOR,Kinase,MTOR_HUMAN,INHIBITOR
P43220,Glucagon-like peptide 1 receptor,GPCR,GLP1R_HUMAN,AGONIST
P32301,Glucagon-like peptide 1 receptor,GPCR,GLP1R_RAT,
Q9UHC9,Niemann-Pick C1-like protein 1,Membrane other,NPCL1_HUMAN,ANTAGONIST
Q6T3U3,Niemann-Pick C1-like protein 1,Unclassified,NPCL1_RAT,
P15538,"Cytochrome P450 11B1, mitochondrial",Enzyme,C11B1_HUMAN,INHIBITOR
P19099,"Cytochrome P450 11B2, mitochondrial",Enzyme,C11B2_HUMAN,INHIBITOR
P15539,"Cytochrome P450 11B2, mitochondrial",Enzyme,C11B2_MOUSE,
P09252,DNA polymerase catalytic subunit,Enzyme,DPOL_VZVD,
P07900,Heat shock protein HSP 90-alpha,Cytosolic other,HS90A_HUMAN,
Q15746,"Myosin light chain kinase, smooth muscle",Kinase,MYLK_HUMAN,
Q02156,Protein kinase C epsilon type,Kinase,KPCE_HUMAN,
Q16512,Serine/threonine-protein kinase N1,Kinase,PKN1_HUMAN,
O75582,Ribosomal protein S6 kinase alpha-5,Kinase,KS6A5_HUMAN,
P13500,C-C motif chemokine 2,Cytokine,CCL2_HUMAN,
Q16513,Serine/threonine-protein kinase N2,Kinase,PKN2_HUMAN,
P17612,cAMP-dependent protein kinase catalytic subunit alpha,Kinase,KAPCA_HUMAN,
Q62868,Rho-associated protein kinase 2,Kinase,ROCK2_RAT,
Q13464,Rho-associated protein kinase 1,Kinase,ROCK1_HUMAN,INHIBITOR
O75116,Rho-associated protein kinase 2,Kinase,ROCK2_HUMAN,INHIBITOR
Q12879,"Glutamate receptor ionotropic, NMDA 2A",Ion channel,NMDE1_HUMAN,ANTAGONIST
Q13224,"Glutamate receptor ionotropic, NMDA 2B",Ion channel,NMDE2_HUMAN,ANTAGONIST
P13569,Cystic fibrosis transmembrane conductance regulator,Ion channel,CFTR_HUMAN,ACTIVATOR
P41180,Extracellular calcium-sensing receptor,GPCR,CASR_HUMAN,
P12746,Transcriptional activator protein luxR,Unclassified,LUXR_ALIFS,
P35384,Extracellular calcium-sensing receptor,GPCR,CASR_BOVIN,POSITIVE ALLOSTERIC MODULATOR
Q8N695,Sodium-coupled monocarboxylate transporter 1,Transporter,SC5A8_HUMAN,INHIBITOR
P42866,Mu-type opioid receptor,GPCR,OPRM_MOUSE,
P32300,Delta-type opioid receptor,GPCR,OPRD_MOUSE,
P21397|P27338,Monoamine oxidase,Enzyme,AOFA_HUMAN|AOFB_HUMAN,
Q60492,Sigma non-opioid intracellular receptor 1,Unclassified,SGMR1_CAVPO,
Q99720,Sigma non-opioid intracellular receptor 1,Unclassified,SGMR1_HUMAN,
Q9Y5Y4,Prostaglandin D2 receptor 2,GPCR,PD2R2_HUMAN,
P46721,Solute carrier organic anion transporter family member 1A2,Transporter,SO1A2_HUMAN,
P14060,3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1,Enzyme,3BHS1_HUMAN,
P24008,3-oxo-5-alpha-steroid 4-dehydrogenase 1,Enzyme,S5A1_RAT,
P31214,3-oxo-5-alpha-steroid 4-dehydrogenase 2,Enzyme,S5A2_RAT,
P24008|P31214,Steroid 5-alpha-reductase,Enzyme,S5A1_RAT|S5A2_RAT,
O60658|O95263,Phosphodiesterase 8,Enzyme,PDE8A_HUMAN|PDE8B_HUMAN,INHIBITOR
P35499,Sodium channel protein type 4 subunit alpha,Ion channel,SCN4A_HUMAN,
Q96RP8,Potassium voltage-gated channel subfamily A member 7,Ion channel,KCNA7_HUMAN,BLOCKER
Q63881,Potassium voltage-gated channel subfamily D member 2,Ion channel,KCND2_RAT,
P0AES4,DNA gyrase subunit A,Enzyme,GYRA_ECOLI,
Q7Z1V1,Sterol 14-alpha demethylase,Enzyme,CP51_TRYCC,
P0CS13,Thymidylate synthase,Enzyme,TYSY_CRYNB,INHIBITOR
P12461,Thymidylate synthase,Enzyme,TYSY_CANAL,INHIBITOR
P02829,ATP-dependent molecular chaperone HSP82,Cytosolic other,HSP82_YEAST,
Q6UVM3,Potassium channel subfamily T member 2,Ion channel,KCNT2_HUMAN,ACTIVATOR
Q9NZQ8,Transient receptor potential cation channel subfamily M member 5,Ion channel,TRPM5_HUMAN,
Q7TN37,Transient receptor potential cation channel subfamily M member 4,Ion channel,TRPM4_MOUSE,GATING INHIBITOR
Q15561,Transcriptional enhancer factor TEF-3,Transcription factor,TEAD4_HUMAN,
Q9NYV8,Taste receptor type 2 member 14,GPCR,T2R14_HUMAN,AGONIST
P47869,Gamma-aminobutyric acid receptor subunit alpha-2,Ion channel,GBRA2_HUMAN,
P48169,Gamma-aminobutyric acid receptor subunit alpha-4,Ion channel,GBRA4_HUMAN,ALLOSTERIC ANTAGONIST
P18507|P28472|P47869,GABA-A receptor alpha-2/beta-3/gamma-2,Ion channel,GBRG2_HUMAN|GBRB3_HUMAN|GBRA2_HUMAN,ALLOSTERIC ANTAGONIST
P18507|P28472|P34903,GABA-A receptor alpha-3/beta-3/gamma-2,Ion channel,GBRG2_HUMAN|GBRB3_HUMAN|GBRA3_HUMAN,ALLOSTERIC ANTAGONIST
P18507|P28472|P31644,GABA-A receptor alpha-5/beta-3/gamma-2,Ion channel,GBRG2_HUMAN|GBRB3_HUMAN|GBRA5_HUMAN,ALLOSTERIC ANTAGONIST
P14867|P18507|P28472,GABA-A receptor alpha-1/beta-3/gamma-2,Ion channel,GBRA1_HUMAN|GBRG2_HUMAN|GBRB3_HUMAN,ALLOSTERIC ANTAGONIST
P18507|P28472|Q16445,GABA-A receptor alpha-6/beta-3/gamma-2,Ion channel,GBRG2_HUMAN|GBRB3_HUMAN|GBRA6_HUMAN,ALLOSTERIC ANTAGONIST
Q00975,Voltage-dependent N-type calcium channel subunit alpha-1B,Ion channel,CAC1B_HUMAN,
P04775,Sodium channel protein type 2 subunit alpha,Ion channel,SCN2A_RAT,
Q9Y256,CAAX prenyl protease 2,Enzyme,FACE2_HUMAN,
Q9P0X4,Voltage-dependent T-type calcium channel subunit alpha-1I,Ion channel,CAC1I_HUMAN,BLOCKER
P14867,Gamma-aminobutyric acid receptor subunit alpha-1,Ion channel,GBRA1_HUMAN,ALLOSTERIC MODULATOR
P47869,Gamma-aminobutyric acid receptor subunit alpha-2,Ion channel,GBRA2_HUMAN,ALLOSTERIC MODULATOR
P34903,Gamma-aminobutyric acid receptor subunit alpha-3,Ion channel,GBRA3_HUMAN,ALLOSTERIC MODULATOR
P31644,Gamma-aminobutyric acid receptor subunit alpha-5,Ion channel,GBRA5_HUMAN,ALLOSTERIC MODULATOR
P14867|P47870|Q99928,GABA-A receptor alpha-1/beta-2/gamma-3,Ion channel,GBRA1_HUMAN|GBRB2_HUMAN|GBRG3_HUMAN,
P18507|P34903|P47870,GABA A receptor alpha-3/beta-2/gamma-2,Ion channel,GBRG2_HUMAN|GBRA3_HUMAN|GBRB2_HUMAN,
P34903|P47870|Q99928,GABA A receptor alpha-3/beta-2/gamma-3,Ion channel,GBRA3_HUMAN|GBRB2_HUMAN|GBRG3_HUMAN,
P28472|P31644|Q99928,GABA A receptor alpha-5/beta-3/gamma-3,Ion channel,GBRB3_HUMAN|GBRA5_HUMAN|GBRG3_HUMAN,
P18507|P31644|P47870,GABA A receptor alpha-5/beta-2/gamma-2,Ion channel,GBRG2_HUMAN|GBRA5_HUMAN|GBRB2_HUMAN,
P31644|P47870|Q99928,GABA A receptor alpha-5/beta-2/gamma-3,Ion channel,GBRA5_HUMAN|GBRB2_HUMAN|GBRG3_HUMAN,
Q99873,Protein arginine N-methyltransferase 1,Enzyme,ANM1_HUMAN,
P25122,Potassium voltage-gated channel subfamily C member 1,Ion channel,KCNC1_RAT,
P48542,G protein-activated inward rectifier potassium channel 2,Ion channel,KCNJ6_MOUSE,GATING INHIBITOR
P21918,D(1B) dopamine receptor,GPCR,DRD5_HUMAN,ANTAGONIST
O43526,Potassium voltage-gated channel subfamily KQT member 2,Ion channel,KCNQ2_HUMAN,ACTIVATOR
O43525,Potassium voltage-gated channel subfamily KQT member 3,Ion channel,KCNQ3_HUMAN,
P28221,5-hydroxytryptamine receptor 1D,GPCR,5HT1D_HUMAN,ANTAGONIST
P28566,5-hydroxytryptamine receptor 1E,GPCR,5HT1E_HUMAN,ANTAGONIST
P47712,Cytosolic phospholipase A2,Enzyme,PA24A_HUMAN,
Q14973,Sodium/bile acid cotransporter,Transporter,NTCP_HUMAN,
P31652,Sodium-dependent serotonin transporter,Transporter,SC6A4_RAT,INHIBITOR
P00325|P00326|P07327,Alcohol dehydrogenase,Enzyme,ADH1B_HUMAN|ADH1G_HUMAN|ADH1A_HUMAN,INHIBITOR
P01008,Antithrombin-III,Secreted,ANT3_HUMAN,ACTIVATOR
P08546,DNA polymerase catalytic subunit,Enzyme,DPOL_HCMVA,
P10613,Lanosterol 14-alpha demethylase,Enzyme,CP51_CANAL,
Q836E5,UDP-N-acetylglucosamine 1-carboxyvinyltransferase 1,Enzyme,MURA1_ENTFA,
Q831A8,UDP-N-acetylglucosamine 1-carboxyvinyltransferase 2,Enzyme,MURA2_ENTFA,
P0A749,UDP-N-acetylglucosamine 1-carboxyvinyltransferase,Enzyme,MURA_ECOLI,INHIBITOR
Q9HVW7,UDP-N-acetylglucosamine 1-carboxyvinyltransferase,Enzyme,MURA_PSEAE,
P03372,Estrogen receptor,Nuclear hormone receptor,ESR1_HUMAN,ANTAGONIST
Q92731,Estrogen receptor beta,Nuclear hormone receptor,ESR2_HUMAN,ANTAGONIST
P34913,Bifunctional epoxide hydrolase 2,Enzyme,HYES_HUMAN,
P96618,Holo-[acyl-carrieir-protein] synthase,Enzyme,ACPS_BACSU,
P23978,Sodium- and chloride-dependent GABA transporter 1,Transporter,SC6A1_RAT,
P31648,Sodium- and chloride-dependent GABA transporter 1,Transporter,SC6A1_MOUSE,
P24046,Gamma-aminobutyric acid receptor subunit rho-1,Ion channel,GBRR1_HUMAN,
P48066,Sodium- and chloride-dependent GABA transporter 3,Transporter,S6A11_HUMAN,
P48065,Sodium- and chloride-dependent betaine transporter,Transporter,S6A12_HUMAN,
P31650,Sodium- and chloride-dependent GABA transporter 3,Transporter,S6A11_MOUSE,
P31646,Sodium- and chloride-dependent GABA transporter 2,Transporter,S6A13_RAT,
P31649,Sodium- and chloride-dependent GABA transporter 2,Transporter,S6A13_MOUSE,
P23574,Gamma-aminobutyric acid receptor subunit gamma-1,Ion channel,GBRG1_RAT,
Q9Z0U4,Gamma-aminobutyric acid type B receptor subunit 1,GPCR,GABR1_RAT,AGONIST
Q9NSD5,Sodium- and chloride-dependent GABA transporter 2,Transporter,S6A13_HUMAN,
Q01650,Large neutral amino acids transporter small subunit 1,Transporter,LAT1_HUMAN,
P54289,Voltage-dependent calcium channel subunit alpha-2/delta-1,Ion channel,CA2D1_HUMAN,MODULATOR
O43525,Potassium voltage-gated channel subfamily KQT member 3,Ion channel,KCNQ3_HUMAN,ACTIVATOR
Q9NR82,Potassium voltage-gated channel subfamily KQT member 5,Ion channel,KCNQ5_HUMAN,ACTIVATOR
O08532,Voltage-dependent calcium channel subunit alpha-2/delta-1,Ion channel,CA2D1_MOUSE,
O77773,Uncharacterized protein; Voltage-dependent calcium channel alpha-2 delta subunit,Ion channel,O77773_PIG,
Q9NY47,Voltage-dependent calcium channel subunit alpha-2/delta-2,Ion channel,CA2D2_HUMAN,MODULATOR
P10980,Muscarinic acetylcholine receptor M2,GPCR,ACM2_RAT,ALLOSTERIC MODULATOR
P02708,Acetylcholine receptor subunit alpha,Ion channel,ACHA_HUMAN,BLOCKER
P08172,Muscarinic acetylcholine receptor M2,GPCR,ACM2_HUMAN,NEGATIVE ALLOSTERIC MODULATOR
O14842,Free fatty acid receptor 1,GPCR,FFAR1_HUMAN,
P13726,Tissue factor,Membrane receptor,TF_HUMAN,
Q13255,Metabotropic glutamate receptor 1,GPCR,GRM1_HUMAN,
P41594,Metabotropic glutamate receptor 5,GPCR,GRM5_HUMAN,
P10210,Capsid scaffolding protein,Enzyme,SCAF_HHV11,
P0C1U9,DNA topoisomerase 4 subunit A,Enzyme,PARC_STAAU,
P72525|Q59961,DNA topoisomerase 4,Enzyme,PARC_STRPN|PARE_STRPN,INHIBITOR
P0A4L9|P72524,DNA gyrase,Enzyme,GYRB_STRPN|GYRA_STRPN,INHIBITOR
P0AES4|P0AES6,DNA gyrase,Enzyme,GYRA_ECOLI|GYRB_ECOLI,
P15735,"Phosphorylase b kinase gamma catalytic chain, liver/testis isoform",Kinase,PHKG2_HUMAN,
Q16816,"Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform",Kinase,PHKG1_HUMAN,
P50613,Cyclin-dependent kinase 7,Kinase,CDK7_HUMAN,
Q15139,Serine/threonine-protein kinase D1,Kinase,KPCD1_HUMAN,
Q9C098,Serine/threonine-protein kinase DCLK3,Kinase,DCLK3_HUMAN,
Q9H093,NUAK family SNF1-like kinase 2,Kinase,NUAK2_HUMAN,
Q9Y616,Interleukin-1 receptor-associated kinase 3,Kinase,IRAK3_HUMAN,
Q86V86,Serine/threonine-protein kinase pim-3,Kinase,PIM3_HUMAN,
Q16659,Mitogen-activated protein kinase 6,Kinase,MK06_HUMAN,
Q9NWZ3,Interleukin-1 receptor-associated kinase 4,Kinase,IRAK4_HUMAN,
O96017,Serine/threonine-protein kinase Chk2,Kinase,CHK2_HUMAN,
P51617,Interleukin-1 receptor-associated kinase 1,Kinase,IRAK1_HUMAN,
P30085,UMP-CMP kinase,Kinase,KCY_HUMAN,
P10632,Cytochrome P450 2C8,Enzyme,CP2C8_HUMAN,
P0AES7,DNA gyrase subunit B,Enzyme,GYRB_ECO57,
P72525,DNA topoisomerase 4 subunit A,Enzyme,PARC_STRPN,INHIBITOR
Q12882,Dihydropyrimidine dehydrogenase [NADP(+)],Enzyme,DPYD_HUMAN,INHIBITOR
O60706|Q14654,"Sulfonylurea receptor 2, Kir6.2",Ion channel,ABCC9_HUMAN|KCJ11_HUMAN,BLOCKER
P00390,"Glutathione reductase, mitochondrial",Enzyme,GSHR_HUMAN,
P39086,"Glutamate receptor ionotropic, kainate 1",Ion channel,GRIK1_HUMAN,
P00367,"Glutamate dehydrogenase 1, mitochondrial",Enzyme,DHE3_HUMAN,
P49448,"Glutamate dehydrogenase 2, mitochondrial",Enzyme,DHE4_HUMAN,
Q16478,"Glutamate receptor ionotropic, kainate 5",Ion channel,GRIK5_HUMAN,
Q14833,Metabotropic glutamate receptor 4,GPCR,GRM4_HUMAN,
P48058,Glutamate receptor 4,Ion channel,GRIA4_HUMAN,
Q13002,"Glutamate receptor ionotropic, kainate 2",Ion channel,GRIK2_HUMAN,
Q13003,"Glutamate receptor ionotropic, kainate 3",Ion channel,GRIK3_HUMAN,
Q14831,Metabotropic glutamate receptor 7,GPCR,GRM7_HUMAN,
O15303,Metabotropic glutamate receptor 6,GPCR,GRM6_HUMAN,
Q14416,Metabotropic glutamate receptor 2,GPCR,GRM2_HUMAN,
P43003,Excitatory amino acid transporter 1,Transporter,EAA1_HUMAN,
P43004,Excitatory amino acid transporter 2,Transporter,EAA2_HUMAN,
P43005,Excitatory amino acid transporter 3,Transporter,EAA3_HUMAN,
P19491,Glutamate receptor 2,Ion channel,GRIA2_RAT,
P42263,Glutamate receptor 3,Ion channel,GRIA3_HUMAN,
Q16099,"Glutamate receptor ionotropic, kainate 4",Ion channel,GRIK4_HUMAN,
Q14832,Metabotropic glutamate receptor 3,GPCR,GRM3_HUMAN,AGONIST
O00222,Metabotropic glutamate receptor 8,GPCR,GRM8_HUMAN,AGONIST
P42260,"Glutamate receptor ionotropic, kainate 2",Ion channel,GRIK2_RAT,
P22756,"Glutamate receptor ionotropic, kainate 1",Ion channel,GRIK1_RAT,
P31423,Metabotropic glutamate receptor 4,GPCR,GRM4_RAT,
P35349,Metabotropic glutamate receptor 6,GPCR,GRM6_RAT,
P19490,Glutamate receptor 1,Ion channel,GRIA1_RAT,
P19492,Glutamate receptor 3,Ion channel,GRIA3_RAT,
P19493,Glutamate receptor 4,Ion channel,GRIA4_RAT,
P42264,"Glutamate receptor ionotropic, kainate 3",Ion channel,GRIK3_RAT,
Q03469,Glutamate racemase,Enzyme,MURI_LACFE,
P70579,Metabotropic glutamate receptor 8,GPCR,GRM8_RAT,
P47743,Metabotropic glutamate receptor 8,GPCR,GRM8_MOUSE,
P31424,Metabotropic glutamate receptor 5,GPCR,GRM5_RAT,
P23385,Metabotropic glutamate receptor 1,GPCR,GRM1_RAT,
P31421,Metabotropic glutamate receptor 2,GPCR,GRM2_RAT,
P31422,Metabotropic glutamate receptor 3,GPCR,GRM3_RAT,
P56068,Glutamate racemase,Enzyme,MURI_HELPY,
O35921,Excitatory amino acid transporter 4,Transporter,EAA4_RAT,
Q9Z1J7,Amino acid transporter,Transporter,Q9Z1J7_RAT,
Q9Y2Q3,Glutathione S-transferase kappa 1,Enzyme,GSTK1_HUMAN,
P11712,Cytochrome P450 2C9,Enzyme,CP2C9_HUMAN,INHIBITOR
P13569,Cystic fibrosis transmembrane conductance regulator,Ion channel,CFTR_HUMAN,BLOCKER
Q61743,ATP-sensitive inward rectifier potassium channel 11,Ion channel,KCJ11_MOUSE,BLOCKER
Q96P20,"NACHT, LRR and PYD domains-containing protein 3",Unclassified,NLRP3_HUMAN,
P37231,Peroxisome proliferator-activated receptor gamma,Nuclear other,PPARG_HUMAN,
Q09429|Q9ESQ5,Sur1-Trpm4; Sulfonylurea receptor 1 - Transient receptor potential melastatin 4,Ion channel,ABCC8_RAT|TRPM4_RAT,INHIBITOR
P48067,Sodium- and chloride-dependent glycine transporter 1,Transporter,SC6A9_HUMAN,
P09429,High mobility group protein B1,Nuclear other,HMGB1_HUMAN,
Q07820,Induced myeloid leukemia cell differentiation protein Mcl-1,Cytosolic other,MCL1_HUMAN,
Q07817,Bcl-2-like protein 1,Cytosolic other,B2CL1_HUMAN,
P00346,"Malate dehydrogenase, mitochondrial",Enzyme,MDHM_PIG,
Q0PJ46,Lactate dehydrogenase,Enzyme,Q0PJ46_PLAFA,
Q6VVP7,Malate dehydrogenase,Enzyme,Q6VVP7_PLAFA,
P11708,"Malate dehydrogenase, cytoplasmic",Enzyme,MDHC_PIG,
Q92843,Apoptosis regulator Bcl-W,Cytosolic other,B2CL2_HUMAN,
P52732,Kinesin-like protein 1,Enzyme,KIF11_HUMAN,
P29372,DNA-3-methyladenine glycosylase,Enzyme,3MG_HUMAN,
P07195,L-lactate dehydrogenase B chain,Enzyme,LDHB_HUMAN,
O95264,5-hydroxytryptamine receptor 3B,Ion channel,5HT3B_HUMAN,
P32297,Neuronal acetylcholine receptor subunit alpha-3,Ion channel,ACHA3_HUMAN,
P10875,Tubulin beta chain,Structural,TBB_CANAX,
F2SG63|F2SZ02|F2SZD3,Tubulin,Structural,F2SG63_TRIRC|F2SZ02_TRIRC|F2SZD3_TRIRC,INHIBITOR
O43525|O43526|O95259|P16389|P17658|P22001|P22459|P22460|P48547|P51787|P56696|Q03721|Q09470|Q12809|Q14003|Q14721|Q16322|Q6PIU1|Q8NCM2|Q8TAE7|Q8TDN1|Q8TDN2|Q92953|Q96KK3|Q96L42|Q96PR1|Q96RP8|Q9BQ31|Q9H252|Q9H3M0|Q9NR82|Q9NS40|Q9NSA2|Q9NZV8|Q9UIX4|Q9UJ96|Q9UK17|Q9ULD8|Q9ULS6|Q9UQ05,Voltage-gated potassium channel,Ion channel,KCNQ3_HUMAN|KCNQ2_HUMAN|KCNH1_HUMAN|KCNA2_HUMAN|KCNA6_HUMAN|KCNA3_HUMAN|KCNA4_HUMAN|KCNA5_HUMAN|KCNC1_HUMAN|KCNQ1_HUMAN|KCNQ4_HUMAN|KCNC4_HUMAN|KCNA1_HUMAN|KCNH2_HUMAN|KCNC3_HUMAN|KCNB1_HUMAN|KCA10_HUMAN|KCNV1_HUMAN|KCNH5_HUMAN|KCNG3_HUMAN|KCNG4_HUMAN|KCNV2_HUMAN|KCNB2_HUMAN|KCNS1_HUMAN|KCNH8_HUMAN|KCNC2_HUMAN|KCNA7_HUMAN|KCNS3_HUMAN|KCNH6_HUMAN|KCNF1_HUMAN|KCNQ5_HUMAN|KCNH7_HUMAN|KCND1_HUMAN|KCND2_HUMAN|KCNG1_HUMAN|KCNG2_HUMAN|KCND3_HUMAN|KCNH3_HUMAN|KCNS2_HUMAN|KCNH4_HUMAN,BLOCKER
P14416,D(2) dopamine receptor,GPCR,DRD2_HUMAN,INVERSE AGONIST
P35462,D(3) dopamine receptor,GPCR,DRD3_HUMAN,INVERSE AGONIST
Q4U254,Protease,Enzyme,Q4U254_9ENTO,
P50129,5-hydroxytryptamine receptor 2A,GPCR,5HT2A_PIG,
Q62666,Vesicular acetylcholine transporter,Transporter,VACHT_RAT,
P62744,AP-2 complex subunit sigma,Unclassified,AP2S1_RAT,
Q5U3Y7,Sigma intracellular receptor 2,Unclassified,SGMR2_RAT,
Q60493,Zinc finger protein 664,Unclassified,ZN664_CAVPO,
P21917,D(4) dopamine receptor,GPCR,DRD4_HUMAN,INVERSE AGONIST
P0DTC2,Spike glycoprotein,Glycoprotein,SPIKE_SARS2,
P0DTC2,Spike glycoprotein,Unclassified,SPIKE_SARS2,
P27487,Dipeptidyl peptidase 4,Enzyme,DPP4_HUMAN,
P49841,Glycogen synthase kinase-3 beta,Kinase,GSK3B_HUMAN,
O60341,Lysine-specific histone demethylase 1A,Enzyme,KDM1A_HUMAN,
Q54618|Q75Y37|Q75Y54|Q75YD8|Q75YK0|Q9RET4,Penicillin-binding protein,Enzyme,Q54618_STREE|Q75Y37_STREE|Q75Y54_STREE|Q75YD8_STREE|Q75YK0_STREE|Q9RET4_STREE,INHIBITOR
P06149,D-lactate dehydrogenase,Enzyme,DLD_ECOLI,
P0AEK4,Enoyl-[acyl-carrier-protein] reductase [NADH] FabI,Enzyme,FABI_ECOLI,INHIBITOR
P14174,Macrophage migration inhibitory factor,Unclassified,MIF_HUMAN,
Q6IQ20,N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D,Unclassified,NAPEP_HUMAN,INHIBITOR
P02710|P02712|P02714|P02718,Acetylcholine receptor,Ion channel,ACHA_TORCA|ACHB_TORCA|ACHG_TORCA|ACHD_TORCA,
P43681,Neuronal acetylcholine receptor subunit alpha-4,Ion channel,ACHA4_HUMAN,BLOCKER
Q15825,Neuronal acetylcholine receptor subunit alpha-6,Ion channel,ACHA6_HUMAN,BLOCKER
P35498|Q99250|Q9NY46,"Sodium channel alpha subunits; brain (Types I, II, III)",Ion channel,SCN1A_HUMAN|SCN2A_HUMAN|SCN3A_HUMAN,BLOCKER
P14679,Tyrosinase,Enzyme,TYRO_HUMAN,
P35367,Histamine H1 receptor,GPCR,HRH1_HUMAN,AGONIST
P58406,Histamine H3 receptor,GPCR,HRH3_MOUSE,
Q91ZY2,Histamine H4 receptor,GPCR,HRH4_MOUSE,
Q91ZY1,Histamine H4 receptor,GPCR,HRH4_RAT,
Q9JI35,Histamine H3 receptor,GPCR,HRH3_CAVPO,
Q91ZY3,Histamine H4 receptor,GPCR,Q91ZY3_CAVPO,
P27695,DNA-(apurinic or apyrimidinic site) lyase,Enzyme,APEX1_HUMAN,
P26358,DNA (cytosine-5)-methyltransferase 1,Enzyme,DNMT1_HUMAN,
Q9Y6K1,DNA (cytosine-5)-methyltransferase 3A,Enzyme,DNM3A_HUMAN,
Q9UBC3,DNA (cytosine-5)-methyltransferase 3B,Enzyme,DNM3B_HUMAN,
P80025,Lactoperoxidase,Enzyme,PERL_BOVIN,
B0LPN4,Ryanodine receptor 2,Ion channel,RYR2_RAT,
Q92736,Ryanodine receptor 2,Ion channel,RYR2_HUMAN,BLOCKER
P06537,Glucocorticoid receptor,Transcription factor,GCR_MOUSE,
P69905,Hemoglobin subunit alpha,Secreted,HBA_HUMAN,
Q9NYK1,Toll-like receptor 7,Membrane receptor,TLR7_HUMAN,ANTAGONIST
Q9NR96,Toll-like receptor 9,Membrane receptor,TLR9_HUMAN,ANTAGONIST
O95749,Geranylgeranyl pyrophosphate synthase,Enzyme,GGPPS_HUMAN,
P05369,Farnesyl pyrophosphate synthase,Enzyme,FPPS_RAT,INHIBITOR
Q08499,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",Enzyme,PDE4D_HUMAN,
Q08493,"cAMP-specific 3',5'-cyclic phosphodiesterase 4C",Enzyme,PDE4C_HUMAN,
P02769,Serum albumin,Secreted,ALBU_BOVIN,
P35355|Q63921,Cyclooxygenase,Enzyme,PGH2_RAT|PGH1_RAT,
Q8VD48,Dehydrogenase/reductase SDR family member 9,Enzyme,DHRS9_RAT,
P78348,Acid-sensing ion channel 1,Ion channel,ASIC1_HUMAN,BLOCKER
O75907,Diacylglycerol O-acyltransferase 1,Enzyme,DGAT1_HUMAN,INHIBITOR
Q05586|Q13224,Glutamate NMDA receptor; GRIN1/GRIN2B,Ion channel,NMDZ1_HUMAN|NMDE2_HUMAN,
Q00960,Glutamate [NMDA] receptor subunit epsilon 2,Ion channel,NMDE2_RAT,
Q60490,"3-beta-hydroxysteroid-delta(8),delta(7)-isomerase",Unclassified,EBP_CAVPO,
P32240,Prostaglandin E2 receptor EP4 subtype,GPCR,PE2R4_MOUSE,AGONIST
P43253,Prostacyclin receptor,GPCR,PI2R_RAT,
P06213,Insulin receptor,Kinase,INSR_HUMAN,AGONIST
P45983,Mitogen-activated protein kinase 8,Kinase,MK08_HUMAN,
P49759,Dual specificity protein kinase CLK1,Kinase,CLK1_HUMAN,
Q9HAZ1,Dual specificity protein kinase CLK4,Kinase,CLK4_HUMAN,
Q15046,Lysine--tRNA ligase,Enzyme,SYK_HUMAN,
Q14680,Maternal embryonic leucine zipper kinase,Kinase,MELK_HUMAN,
Q9BWU1,Cyclin-dependent kinase 19,Kinase,CDK19_HUMAN,
P00520,Tyrosine-protein kinase ABL1,Kinase,ABL1_MOUSE,
P09619|P16234,Platelet-derived growth factor receptor,Kinase,PGFRB_HUMAN|PGFRA_HUMAN,
P00519|P42684,Tyrosine-protein kinase ABL,Kinase,ABL1_HUMAN|ABL2_HUMAN,
Q05030,Platelet-derived growth factor receptor beta,Kinase,PGFRB_RAT,
Q9NYK1,Toll-like receptor 7,Membrane receptor,TLR7_HUMAN,AGONIST
Q8MTZ4,Vacuolar-type proton translocating pyrophosphatase 1,Unclassified,Q8MTZ4_9TRYP,
P51787,Potassium voltage-gated channel subfamily KQT member 1,Ion channel,KCNQ1_HUMAN,
Q9BPW9,Dehydrogenase/reductase SDR family member 9,Enzyme,DHRS9_HUMAN,
P05979|P79208,Prostaglandin G/H synthase (cyclooxygenase),Enzyme,PGH1_SHEEP|PGH2_SHEEP,
P29477,"Nitric oxide synthase, inducible",Enzyme,NOS2_MOUSE,
P17516,Aldo-keto reductase family 1 member C4,Enzyme,AK1C4_HUMAN,
P08659,Luciferin 4-monooxygenase,Unclassified,LUCI_PHOPY,
P27338,Amine oxidase [flavin-containing] B,Enzyme,AOFB_HUMAN,INHIBITOR
P21397,Amine oxidase [flavin-containing] A,Enzyme,AOFA_HUMAN,INHIBITOR
Q29550,Liver carboxylesterase,Enzyme,EST1_PIG,
P9WNX1,Dihydrofolate reductase,Enzyme,DYR_MYCTU,
Q9NYV8,Taste receptor type 2 member 14,GPCR,T2R14_HUMAN,
P04274,Beta-2 adrenergic receptor,GPCR,ADRB2_MESAU,
P59533,Taste receptor type 2 member 38,GPCR,T2R38_HUMAN,
P59534,Taste receptor type 2 member 39,GPCR,T2R39_HUMAN,
P59535,Taste receptor type 2 member 40,GPCR,T2R40_HUMAN,
P59536,Taste receptor type 2 member 41,GPCR,T2R41_HUMAN,
P59537,Taste receptor type 2 member 43,GPCR,T2R43_HUMAN,
P59538,Taste receptor type 2 member 31,GPCR,T2R31_HUMAN,
P59539,Taste receptor type 2 member 45,GPCR,T2R45_HUMAN,
P59541,Taste receptor type 2 member 30,GPCR,T2R30_HUMAN,
P59542,Taste receptor type 2 member 19,GPCR,T2R19_HUMAN,
P59543,Taste receptor type 2 member 20,GPCR,T2R20_HUMAN,
P59544,Taste receptor type 2 member 50,GPCR,T2R50_HUMAN,
P59551,Taste receptor type 2 member 60,GPCR,T2R60_HUMAN,
Q7RTR8,Taste receptor type 2 member 42,GPCR,T2R42_HUMAN,
Q9NYV7,Taste receptor type 2 member 16,GPCR,T2R16_HUMAN,
Q9NYV9,Taste receptor type 2 member 13,GPCR,T2R13_HUMAN,
Q9NYW0,Taste receptor type 2 member 10,GPCR,T2R10_HUMAN,
Q9NYW1,Taste receptor type 2 member 9,GPCR,TA2R9_HUMAN,
Q9NYW2,Taste receptor type 2 member 8,GPCR,TA2R8_HUMAN,
Q9NYW3,Taste receptor type 2 member 7,GPCR,TA2R7_HUMAN,
Q9NYW4,Taste receptor type 2 member 5,GPCR,TA2R5_HUMAN,
Q9NYW5,Taste receptor type 2 member 4,GPCR,TA2R4_HUMAN,
Q9NYW6,Taste receptor type 2 member 3,GPCR,TA2R3_HUMAN,
Q9NYW7,Taste receptor type 2 member 1,GPCR,TA2R1_HUMAN,
O75343|P33402|Q02108|Q02153,Soluble guanylate cyclase,Enzyme,GCYB2_HUMAN|GCYA2_HUMAN|GCYA3_HUMAN|GCYB1_HUMAN,ACTIVATOR
P08319,Alcohol dehydrogenase 4,Enzyme,ADH4_HUMAN,
Q92781,11-cis retinol dehydrogenase,Enzyme,RDH1_HUMAN,
O14756,17-beta-hydroxysteroid dehydrogenase type 6,Enzyme,H17B6_HUMAN,
P10826,Retinoic acid receptor beta,Nuclear hormone receptor,RARB_HUMAN,INHIBITOR
P40220,Cellular retinoic acid-binding protein 1,Cytosolic other,RABP1_CHICK,
Q13936,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,CAC1C_HUMAN,GATING INHIBITOR
Q9JIS7,Voltage-dependent L-type calcium channel subunit alpha-1F,Ion channel,CAC1F_MOUSE,GATING INHIBITOR
Q01815,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,CAC1C_MOUSE,GATING INHIBITOR
P0A6R0,3-oxoacyl-[acyl-carrier-protein] synthase 3,Unclassified,FABH_ECOLI,
P29033,Gap junction beta-2 protein,Unclassified,CXB2_HUMAN,
C3TDZ2,3-oxoacyl-[acyl-carrier-protein] synthase 3,Enzyme,C3TDZ2_ECOLX,
P42261|P42262|P42263|P48058,Glutamate receptor ionotropic AMPA,Ion channel,GRIA1_HUMAN|GRIA2_HUMAN|GRIA3_HUMAN|GRIA4_HUMAN,OPENER
P47898,5-hydroxytryptamine receptor 5A,GPCR,5HT5A_HUMAN,ANTAGONIST
Q05940,Synaptic vesicular amine transporter,Transporter,VMAT2_HUMAN,
P54219,Chromaffin granule amine transporter,Transporter,VMAT1_HUMAN,INHIBITOR
P28334,5-hydroxytryptamine receptor 1B,GPCR,5HT1B_MOUSE,ANTAGONIST
Q8BRU6,Synaptic vesicular amine transporter,Transporter,VMAT2_MOUSE,
O55242|P32300|P33534|P42866,Opioid receptor,GPCR,SGMR1_MOUSE|OPRD_MOUSE|OPRK_MOUSE|OPRM_MOUSE,
Q16322,Potassium voltage-gated channel subfamily A member 10,Ion channel,KCA10_HUMAN,BLOCKER
P30969,Gonadotropin-releasing hormone receptor,GPCR,GNRHR_RAT,
Q07973,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",Enzyme,CP24A_HUMAN,
P08686,Cytochrome P450 21,Enzyme,CP21A_HUMAN,
P15150,Cytochrome P450 11B1,Enzyme,C11B1_BOVIN,
P14137,Cytochrome P450 11A1,Enzyme,CP11A_RAT,
Q09128,Cytochrome P450 24A1,Enzyme,CP24A_RAT,
P18125,Cytochrome P450 7A1,Enzyme,CP7A1_RAT,
Q64654,Cytochrome P450 51,Enzyme,CP51A_RAT,
P11715,Cytochrome P450 17A1,Enzyme,CP17A_RAT,
O35084,"25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial",Enzyme,CP27B_MOUSE,
P05093,"Steroid 17-alpha-hydroxylase/17,20 lyase",Enzyme,CP17A_HUMAN,INHIBITOR
Q13153,Serine/threonine-protein kinase PAK 1,Kinase,PAK1_HUMAN,
P47154,CAAX prenyl protease 1,Enzyme,STE24_YEAST,
O00214,Galectin-8,Unclassified,LEG8_HUMAN,
O00182,Galectin-9,Unclassified,LEG9_HUMAN,
P17931,Galectin-3,Unclassified,LEG3_HUMAN,
Q62968,Sodium channel protein type X alpha subunit,Ion channel,SCNAA_RAT,
P30874,Somatostatin receptor type 2,GPCR,SSR2_HUMAN,AGONIST
P32745,Somatostatin receptor type 3,GPCR,SSR3_HUMAN,AGONIST
P35346,Somatostatin receptor type 5,GPCR,SSR5_HUMAN,AGONIST
P30875,Somatostatin receptor type 2,GPCR,SSR2_MOUSE,AGONIST
P30935,Somatostatin receptor type 3,GPCR,SSR3_MOUSE,AGONIST
P30938,Somatostatin receptor type 5,GPCR,SSR5_RAT,AGONIST
P30872,Somatostatin receptor type 1,GPCR,SSR1_HUMAN,
P30680,Somatostatin receptor type 2,GPCR,SSR2_RAT,AGONIST
P30936,Somatostatin receptor type 3,GPCR,SSR3_RAT,AGONIST
Q8TCT1,Phosphoethanolamine/phosphocholine phosphatase,Enzyme,PHOP1_HUMAN,
P10636,Microtubule-associated protein tau,Structural,TAU_HUMAN,
O94760,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",Enzyme,DDAH1_HUMAN,
Q8NFI3,Cytosolic endo-beta-N-acetylglucosaminidase,Enzyme,ENASE_HUMAN,
P04626,Receptor tyrosine-protein kinase erbB-2,Kinase,ERBB2_HUMAN,INHIBITOR
Q9Y6L6,Solute carrier organic anion transporter family member 1B1,Transporter,SO1B1_HUMAN,
P24941,Cyclin-dependent kinase 2,Kinase,CDK2_HUMAN,
O14733,Dual specificity mitogen-activated protein kinase kinase 7,Kinase,MP2K7_HUMAN,
O00750,Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta,Kinase,P3C2B_HUMAN,
O75747,Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit gamma,Kinase,P3C2G_HUMAN,
Q9UBF8,Phosphatidylinositol 4-kinase beta,Kinase,PI4KB_HUMAN,
Q5T6X5,G-protein coupled receptor family C group 6 member A,GPCR,GPC6A_HUMAN,AGONIST
O75746,Calcium-binding mitochondrial carrier protein Aralar1,Transporter,CMC1_HUMAN,
P17174,"Aspartate aminotransferase, cytoplasmic",Enzyme,AATC_HUMAN,
P45381,Aspartoacylase,Enzyme,ACY2_HUMAN,
P08243,Asparagine synthetase [glutamine-hydrolyzing],Enzyme,ASNS_HUMAN,
P00966,Argininosuccinate synthase,Enzyme,ASSY_HUMAN,
Q03154,Aminoacylase-1,Enzyme,ACY1_HUMAN,
P00505,"Aspartate aminotransferase, mitochondrial",Enzyme,AATM_HUMAN,
P14868,"Aspartate--tRNA ligase, cytoplasmic",Enzyme,SYDC_HUMAN,
Q12797,Aspartyl/asparaginyl beta-hydroxylase,Enzyme,ASPH_HUMAN,
Q9UJS0,Calcium-binding mitochondrial carrier protein Aralar2,Transporter,CMC2_HUMAN,
O59010,Glutamate transporter homolog,Transporter,GLT_PYRHO,
Q02127,"Dihydroorotate dehydrogenase (quinone), mitochondrial",Enzyme,PYRD_HUMAN,INHIBITOR
O35435,"Dihydroorotate dehydrogenase (quinone), mitochondrial",Enzyme,PYRD_MOUSE,
Q9N587,Acetylcholine receptor subunit alpha-type unc-63,Ion channel,ACH6_CAEEL,
O96760,Nicotinic acetylcholine receptor alpha subunit,Ion channel,O96760_ASCSU,AGONIST
P09487,"Alkaline phosphatase, tissue-nonspecific isozyme",Enzyme,PPBT_BOVIN,
P09923,Intestinal-type alkaline phosphatase,Enzyme,PPBI_HUMAN,
O43497,Voltage-dependent T-type calcium channel subunit alpha-1G,Ion channel,CAC1G_HUMAN,
Q02563,Synaptic vesicle glycoprotein 2A,Unclassified,SV2A_RAT,INHIBITOR
Q7L0J3,Synaptic vesicle glycoprotein 2A,Transporter,SV2A_HUMAN,MODULATOR
O95665,Neurotensin receptor type 2,GPCR,NTR2_HUMAN,AGONIST
Q63384,Neurotensin receptor 2,GPCR,NTR2_RAT,
P70310,Neurotensin receptor type 2,GPCR,NTR2_MOUSE,AGONIST
P33534,Kappa-type opioid receptor,GPCR,OPRK_MOUSE,
O55242,Sigma non-opioid intracellular receptor 1,Membrane receptor,SGMR1_MOUSE,
Q15842,ATP-sensitive inward rectifier potassium channel 8,Ion channel,KCNJ8_HUMAN,
P63316,"Troponin C, slow skeletal and cardiac muscles",Cytosolic other,TNNC1_HUMAN,OPENER
Q62968,Sodium channel protein type X alpha subunit,Ion channel,SCNAA_RAT,BLOCKER
P28472,Gamma-aminobutyric acid receptor subunit beta-3,Ion channel,GBRB3_HUMAN,
Q75NA5,Gamma-aminobutyric acid receptor subunit beta,Ion channel,GBRB_MUSDO,
H9U2V9|H9U2W0|H9U2W1,GABA-A receptor,Ion channel,H9U2V9_TETUR|H9U2W0_TETUR|H9U2W1_TETUR,NEGATIVE ALLOSTERIC MODULATOR
E0V9W2|E0VY07|E0W492,GABA-A receptor,Ion channel,E0V9W2_PEDHC|E0VY07_PEDHC|E0W492_PEDHC,NEGATIVE ALLOSTERIC MODULATOR
P18507|P28472|Q16445,GABA-A receptor alpha-6/beta-3/gamma-2,Ion channel,GBRG2_HUMAN|GBRB3_HUMAN|GBRA6_HUMAN,
P14867|P18505|P18507,GABA A receptor alpha-1/beta-1/gamma-2,Ion channel,GBRA1_HUMAN|GBRB1_HUMAN|GBRG2_HUMAN,
P31040,"Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial",Enzyme,SDHA_HUMAN,
P10827,Thyroid hormone receptor alpha,Nuclear hormone receptor,THA_HUMAN,AGONIST
P10828,Thyroid hormone receptor beta,Nuclear hormone receptor,THB_HUMAN,AGONIST
P12004,Proliferating cell nuclear antigen,Nuclear other,PCNA_HUMAN,
O00555,Voltage-dependent P/Q-type calcium channel subunit alpha-1A,Ion channel,CAC1A_HUMAN,
O00255,Menin,Unclassified,MEN1_HUMAN,
Q80W54,CAAX prenyl protease 1 homolog,Enzyme,FACE1_MOUSE,
Q9NPC2,Potassium channel subfamily K member 9,Ion channel,KCNK9_HUMAN,
Q9H2J7,Sodium-dependent neutral amino acid transporter B(0)AT2,Transporter,S6A15_HUMAN,
P50052,Type-2 angiotensin II receptor,GPCR,AGTR2_HUMAN,
P25095,Type-1A angiotensin II receptor,GPCR,AGTRA_RAT,
Q9WV26,Type-1 angiotensin II receptor,GPCR,AGTR1_CAVPO,
Q13370|Q14432,Phosphodiesterase 3,Enzyme,PDE3B_HUMAN|PDE3A_HUMAN,
P30556|P50052,Angiotensin II receptor,GPCR,AGTR1_HUMAN|AGTR2_HUMAN,
Q9HCN6,Platelet glycoprotein VI,Unclassified,GPVI_HUMAN,
O75469,Nuclear receptor subfamily 1 group I member 2,Nuclear hormone receptor,NR1I2_HUMAN,AGONIST
Q8TDS4,Hydroxycarboxylic acid receptor 2,GPCR,HCAR2_HUMAN,
P49019,Hydroxycarboxylic acid receptor 3,GPCR,HCAR3_HUMAN,
Q01237,3-hydroxy-3-methylglutaryl-coenzyme A reductase,Enzyme,HMDH_MOUSE,
P20701,Leukocyte adhesion glycoprotein LFA-1 alpha,Adhesion,ITAL_HUMAN,
Q95214,Acyl-CoA:cholesterol acyltransferase,Enzyme,Q95214_RABIT,
Q5JUK3,Potassium channel subfamily T member 1,Ion channel,KCNT1_HUMAN,ACTIVATOR
P30551,Cholecystokinin receptor type A,GPCR,CCKAR_RAT,ANTAGONIST
P0AC13,Dihydropteroate synthase,Enzyme,DHPS_ECOLI,INHIBITOR
A2PZ98,Acetylcholinesterase,Enzyme,A2PZ98_9NEOP,INHIBITOR
P51681,C-C chemokine receptor type 5,GPCR,CCR5_HUMAN,ANTAGONIST
P51682,C-C chemokine receptor type 5,GPCR,CCR5_MOUSE,
P61813,C-C chemokine receptor type 5,GPCR,CCR5_MACMU,
P08069,Insulin-like growth factor 1 receptor,Kinase,IGF1R_HUMAN,
Q15722,Leukotriene B4 receptor 1,GPCR,LT4R1_HUMAN,
P08170,Seed linoleate 13S-lipoxygenase-1,Enzyme,LOX1_SOYBN,
P48999,Arachidonate 5-lipoxygenase,Enzyme,LOX5_MOUSE,
Q39829,Lipoxygenase,Unclassified,Q39829_SOYBN,
K4CF70,"Fatty acid hydroperoxide lyase, chloroplastic",Enzyme,HPL_SOLLC,
P11473,Vitamin D3 receptor,Nuclear hormone receptor,VDR_HUMAN,
P13053,Vitamin D3 receptor,Transcription factor,VDR_RAT,AGONIST
Q9BJF5,Calmodulin-domain protein kinase 1,Kinase,Q9BJF5_TOXGO,
P30926|P32297,Neuronal acetylcholine receptor; alpha3/beta4,Ion channel,ACHB4_HUMAN|ACHA3_HUMAN,NEGATIVE ALLOSTERIC MODULATOR
P30926|P43681,Neuronal acetylcholine receptor; alpha4/beta4,Ion channel,ACHB4_HUMAN|ACHA4_HUMAN,BLOCKER
P17787|P32297|Q05901|Q15825,Neuronal acetylcholine receptor; alpha3/alpha6/beta2/beta3,Ion channel,ACHB2_HUMAN|ACHA3_HUMAN|ACHB3_HUMAN|ACHA6_HUMAN,
P32297,Neuronal acetylcholine receptor subunit alpha-3,Ion channel,ACHA3_HUMAN,BLOCKER
O35627,Constitutive androstane receptor,Nuclear hormone receptor,NR1I3_MOUSE,AGONIST
P08913|P18089|P18825,Adrenergic receptor alpha-2,GPCR,ADA2A_HUMAN|ADA2B_HUMAN|ADA2C_HUMAN,
P03372|Q92731,Estrogen receptor,Nuclear hormone receptor,ESR1_HUMAN|ESR2_HUMAN,
P90584,Protein kinase Pfmrk,Unclassified,P90584_PLAFA,
P35398,Nuclear receptor ROR-alpha,Nuclear hormone receptor,RORA_HUMAN,
P51050,Melatonin receptor type 1B,GPCR,MTR1B_CHICK,
Q63016,L-type amino acid transporter 1,Transporter,LAT1_RAT,
Q8TCU5,"Glutamate receptor ionotropic, NMDA 3A",Ion channel,NMD3A_HUMAN,NEGATIVE ALLOSTERIC MODULATOR
Q05586,"Glutamate receptor ionotropic, NMDA 1",Ion channel,NMDZ1_HUMAN,NEGATIVE ALLOSTERIC MODULATOR
Q05586|Q13224,Glutamate NMDA receptor; GRIN1/GRIN2B,Ion channel,NMDZ1_HUMAN|NMDE2_HUMAN,NEGATIVE ALLOSTERIC MODULATOR
Q05586|Q12879,Glutamate NMDA receptor; GRIN1/GRIN2A,Ion channel,NMDZ1_HUMAN|NMDE1_HUMAN,NEGATIVE ALLOSTERIC MODULATOR
P30305,M-phase inducer phosphatase 2,Enzyme,MPIP2_HUMAN,
P30307,Dual specificity phosphatase Cdc25C,Enzyme,MPIP3_HUMAN,
P15374,Ubiquitin carboxyl-terminal hydrolase isozyme L3,Enzyme,UCHL3_HUMAN,
P30304,Dual specificity phosphatase Cdc25A,Enzyme,MPIP1_HUMAN,
Q64346,Dual specificity protein phosphatase 6,Enzyme,DUS6_RAT,
P28563,Dual specificity protein phosphatase 1,Enzyme,DUS1_MOUSE,
P30304,M-phase inducer phosphatase 1,Enzyme,MPIP1_HUMAN,
Q9UDY8,Mucosa-associated lymphoid tissue lymphoma translocation protein 1,Enzyme,MALT1_HUMAN,
P18507|P28472|P47869,GABA-A receptor alpha-2/beta-3/gamma-2,Ion channel,GBRG2_HUMAN|GBRB3_HUMAN|GBRA2_HUMAN,AGONIST
P18507|P28472|P34903,GABA-A receptor alpha-3/beta-3/gamma-2,Ion channel,GBRG2_HUMAN|GBRB3_HUMAN|GBRA3_HUMAN,AGONIST
P18507|P28472|P31644,GABA-A receptor alpha-5/beta-3/gamma-2,Ion channel,GBRG2_HUMAN|GBRB3_HUMAN|GBRA5_HUMAN,AGONIST
P14867|P18507|P28472,GABA-A receptor alpha-1/beta-3/gamma-2,Ion channel,GBRA1_HUMAN|GBRG2_HUMAN|GBRB3_HUMAN,AGONIST
Q389T8,Trypanothione reductase,Enzyme,Q389T8_TRYB2,
Q06203,Amidophosphoribosyltransferase,Enzyme,PUR1_HUMAN,INHIBITOR
Q6XEC0,Beta-lactamase,Enzyme,Q6XEC0_KLEPN,
P01375,Tumor necrosis factor,Cytokine,TNFA_HUMAN,
Q9WU19,Hydroxyacid oxidase 1,Enzyme,HAOX1_MOUSE,
P28222,5-hydroxytryptamine receptor 1B,GPCR,5HT1B_HUMAN,ANTAGONIST
P30939,5-hydroxytryptamine receptor 1F,GPCR,5HT1F_HUMAN,ANTAGONIST
Q9Y478,5'-AMP-activated protein kinase subunit beta-1,Kinase,AAKB1_HUMAN,
O00217|O00483|O14561|O15239|O43181|O43674|O43676|O43677|O43678|O43920|O75251|O75306|O75380|O75438|O75489|O95139|O95167|O95168|O95169|O95178|O95182|O95298|O95299|O96000|P03886|P03891|P03897|P03901|P03905|P03915|P03923|P17568|P19404|P28331|P49821|P51970|P56181|P56556|Q16718|Q16795|Q86Y39|Q8N183|Q9BU61|Q9NRX3|Q9NX14|Q9P032|Q9P0J0|Q9UI09|Q9Y375|Q9Y6M9,Mitochondrial complex I (NADH dehydrogenase),Enzyme,NDUS8_HUMAN|NDUA4_HUMAN|ACPM_HUMAN|NDUA1_HUMAN|NDUS4_HUMAN|NDUB5_HUMAN|NDUB3_HUMAN|NDUC1_HUMAN|NDUA2_HUMAN|NDUS5_HUMAN|NDUS7_HUMAN|NDUS2_HUMAN|NDUS6_HUMAN|NDUB1_HUMAN|NDUS3_HUMAN|NDUB6_HUMAN|NDUA3_HUMAN|NDUB4_HUMAN|NDUB8_HUMAN|NDUB2_HUMAN|NDUA7_HUMAN|NDUC2_HUMAN|NDUAA_HUMAN|NDUBA_HUMAN|NU1M_HUMAN|NU2M_HUMAN|NU3M_HUMAN|NU4LM_HUMAN|NU4M_HUMAN|NU5M_HUMAN|NU6M_HUMAN|NDUB7_HUMAN|NDUV2_HUMAN|NDUS1_HUMAN|NDUV1_HUMAN|NDUA8_HUMAN|NDUV3_HUMAN|NDUA6_HUMAN|NDUA5_HUMAN|NDUA9_HUMAN|NDUAB_HUMAN|MIMIT_HUMAN|NDUF3_HUMAN|NUA4L_HUMAN|NDUBB_HUMAN|NDUF4_HUMAN|NDUAD_HUMAN|NDUAC_HUMAN|CIA30_HUMAN|NDUB9_HUMAN,INHIBITOR
P08482,Muscarinic acetylcholine receptor M1,GPCR,ACM1_RAT,AGONIST
P08483,Muscarinic acetylcholine receptor M3,GPCR,ACM3_RAT,AGONIST
P43351,DNA repair protein RAD52 homolog,Nuclear other,RAD52_HUMAN,
Q9GZZ6,Neuronal acetylcholine receptor subunit alpha-10,Ion channel,ACH10_HUMAN,
Q01827,Synaptic vesicular amine transporter,Transporter,VMAT2_RAT,
P08172|P08173|P08912|P11229|P20309,Muscarinic acetylcholine receptor,GPCR,ACM2_HUMAN|ACM4_HUMAN|ACM5_HUMAN|ACM1_HUMAN|ACM3_HUMAN,ANTAGONIST
P18507|P47869|P47870,GABA A receptor alpha-2/beta-2/gamma-2,Ion channel,GBRG2_HUMAN|GBRA2_HUMAN|GBRB2_HUMAN,POSITIVE ALLOSTERIC MODULATOR
O14764|P47870|P48169,GABA A receptor alpha-4/beta-2/delta,Ion channel,GBRD_HUMAN|GBRB2_HUMAN|GBRA4_HUMAN,POSITIVE ALLOSTERIC MODULATOR
P48169|P28472|O14764,GABA A receptor alpha-4/beta-3/delta,Ion channel,GBRA4_HUMAN|GBRB3_HUMAN|GBRD_HUMAN,AGONIST
Q16445|P47870,GABA-A receptor alpha-6/beta-2,Ion channel,GBRA6_HUMAN|GBRB2_HUMAN,POSITIVE ALLOSTERIC MODULATOR
P47870|Q16445|O14764,GABA-A receptor alpha-6/beta-2/delta,Ion channel,GBRB2_HUMAN|GBRA6_HUMAN|GBRD_HUMAN,POSITIVE ALLOSTERIC MODULATOR
O14764|P28472|Q16445,GABA-A receptor alpha-6/beta-3/delta,Ion channel,GBRD_HUMAN|GBRB3_HUMAN|GBRA6_HUMAN,POSITIVE ALLOSTERIC MODULATOR
P07944,Beta-lactam-inducible penicillin-binding protein,Enzyme,PBP_STAAU,
P18843,NH(3)-dependent NAD(+) synthetase,Enzyme,NADE_ECOLI,
P15101,Dopamine beta-hydroxylase,Enzyme,DOPO_BOVIN,
P14207,Folate receptor beta,Membrane receptor,FOLR2_HUMAN,
P13922,Bifunctional dihydrofolate reductase-thymidylate synthase,Enzyme,DRTS_PLAFK,
Q96NT5,Proton-coupled folate transporter,Transporter,PCFT_HUMAN,
P07382,Bifunctional dihydrofolate reductase-thymidylate synthase,Enzyme,DRTS_LEIMA,
P00469,Thymidylate synthase,Enzyme,TYSY_LACCA,
C3SWJ7,Thymidylate synthase,Enzyme,C3SWJ7_ECOLX,
Q01782,Pteridine reductase 1,Enzyme,PTR1_LEIMA,
P0A017,Dihydrofolate reductase,Enzyme,DYR_STAAU,
Q81R22,Dihydrofolate reductase,Enzyme,Q81R22_BACAN,
P00380,Dihydrofolate reductase,Enzyme,DYR_ENTFC,
P41440,Folate transporter 1,Transporter,S19A1_HUMAN,
P15328,Folate receptor alpha,Membrane receptor,FOLR1_HUMAN,
P23415,Glycine receptor subunit alpha-1,Ion channel,GLRA1_HUMAN,AGONIST
O00591|O14764|P14867|P18505|P18507|P28472|P31644|P34903|P47869|P47870|P48169|P78334|Q16445|Q8N1C3|Q99928|Q9UN88,GABA-A receptor; anion channel,Ion channel,GBRP_HUMAN|GBRD_HUMAN|GBRA1_HUMAN|GBRB1_HUMAN|GBRG2_HUMAN|GBRB3_HUMAN|GBRA5_HUMAN|GBRA3_HUMAN|GBRA2_HUMAN|GBRB2_HUMAN|GBRA4_HUMAN|GBRE_HUMAN|GBRA6_HUMAN|GBRG1_HUMAN|GBRG3_HUMAN|GBRT_HUMAN,POSITIVE MODULATOR
O43497|O95180|Q9P0X4,Voltage-gated T-type calcium channel,Ion channel,CAC1G_HUMAN|CAC1H_HUMAN|CAC1I_HUMAN,BLOCKER
Q16881,"Thioredoxin reductase 1, cytoplasmic",Enzyme,TRXR1_HUMAN,
O15770,Glutathione reductase,Enzyme,GSHR_PLAF7,
P41595,5-hydroxytryptamine receptor 2B,GPCR,5HT2B_HUMAN,PARTIAL AGONIST
P09483,Neuronal acetylcholine receptor subunit alpha-4,Ion channel,ACHA4_RAT,
P34975,Kappa-type opioid receptor,GPCR,OPRK_RAT,
P32300|P42866,Opioid receptors; mu and delta,GPCR,OPRD_MOUSE|OPRM_MOUSE,
Q9UL62,Short transient receptor potential channel 5,Ion channel,TRPC5_HUMAN,ACTIVATOR
P30940,5-hydroxytryptamine receptor 1F,GPCR,5HT1F_RAT,ANTAGONIST
P61168,D(2) dopamine receptor,GPCR,DRD2_MOUSE,ANTAGONIST
P23979|Q9JHJ5,Serotonin 3 receptor (5HT3),Ion channel,5HT3A_MOUSE|5HT3B_MOUSE,
Q13621,Solute carrier family 12 member 1,Transporter,S12A1_HUMAN,
C4LW95,Thioredoxin reductase,Enzyme,C4LW95_ENTHI,
P15393,"Cytochrome P450 11B1, mitochondrial",Enzyme,C11B1_RAT,
P07101,Tyrosine 3-monooxygenase,Enzyme,TY3H_HUMAN,INHIBITOR
Q62205,Sodium channel protein type 9 subunit alpha,Ion channel,SCN9A_MOUSE,
A2APX8,Sodium channel protein type 1 subunit alpha,Ion channel,SCN1A_MOUSE,
P34972,Cannabinoid receptor 2,GPCR,CNR2_HUMAN,
P02768,Serum albumin,Secreted,ALBU_HUMAN,
P14778,Interleukin-1 receptor type 1,Membrane receptor,IL1R1_HUMAN,
P41222,Prostaglandin-H2 D-isomerase,Enzyme,PTGDS_HUMAN,
Q9NG02,G-protein coupled receptor,GPCR,Q9NG02_APIME,
Q9P0X4,Voltage-dependent T-type calcium channel subunit alpha-1I,Ion channel,CAC1I_HUMAN,
Q8NEC5,Cation channel sperm-associated protein 1,Ion channel,CTSR1_HUMAN,BLOCKER
Q96P56,Cation channel sperm-associated protein 2,Ion channel,CTSR2_HUMAN,BLOCKER
Q86XQ3,Cation channel sperm-associated protein 3,Ion channel,CTSR3_HUMAN,BLOCKER
Q7RTX7,Cation channel sperm-associated protein 4,Ion channel,CTSR4_HUMAN,BLOCKER
Q07652,Voltage-dependent R-type calcium channel subunit alpha-1E,Ion channel,CAC1E_RAT,GATING INHIBITOR
P54282,Voltage-dependent P/Q-type calcium channel subunit alpha-1A,Ion channel,CAC1A_RAT,GATING INHIBITOR
P15390,Sodium channel protein type 4 subunit alpha,Ion channel,SCN4A_RAT,
Q5AIC4,"Beta-1,3-glucan synthase",Unclassified,Q5AIC4_CANAL,
O13428,"Beta-1,3-glucan synthase catalytic subunit 1",Enzyme,O13428_CANAX,INHIBITOR
P04150,Glucocorticoid receptor,Nuclear hormone receptor,GCR_HUMAN,ANTAGONIST
P06401,Progesterone receptor,Nuclear hormone receptor,PRGR_HUMAN,ANTAGONIST
P21447,P-glycoprotein 3,Transporter,MDR1A_MOUSE,
F1Q298,Glucocorticoid receptor,Nuclear hormone receptor,F1Q298_CANLF,
Q9N1U3,Glucocorticoid receptor,Nuclear hormone receptor,GCR_PIG,
P04746,Pancreatic alpha-amylase,Enzyme,AMYP_HUMAN,
P10253,Lysosomal alpha-glucosidase,Enzyme,LYAG_HUMAN,INHIBITOR
P35574,Glycogen debranching enzyme,Enzyme,GDE_RABIT,
P09848,Lactase-phlorizin hydrolase,Enzyme,LPH_HUMAN,
Q58D55,Beta-galactosidase,Enzyme,BGAL_BOVIN,
C0HJB3,Alpha-mannosidase,Enzyme,MANULL_CANEN,
P56526,Alpha-glucosidase,Enzyme,AGLU_ASPNG,
O43451,"Maltase-glucoamylase, intestinal",Enzyme,MGA_HUMAN,
Q16739,Ceramide glucosyltransferase,Enzyme,CEGT_HUMAN,INHIBITOR
Q69ZF3,Non-lysosomal glucosylceramidase,Enzyme,GBA2_MOUSE,
Q9HCG7,Non-lysosomal glucosylceramidase,Enzyme,GBA2_HUMAN,
P35573,Glycogen debranching enzyme,Enzyme,GDE_HUMAN,
P70699,Lysosomal alpha-glucosidase,Enzyme,LYAG_MOUSE,
B5THE3,Sucrase-isomaltase,Enzyme,B5THE3_MOUSE,
Q9LGC6,Putative alpha-glucosidase,Enzyme,Q9LGC6_ORYSJ,
O70282,Trehalase,Enzyme,O70282_RAT,
I3LIR5,Uncharacterized protein,Enzyme,I3LIR5_PIG,
O88693,Ceramide glucosyltransferase,Enzyme,CEGT_MOUSE,
Q13370,"cGMP-inhibited 3',5'-cyclic phosphodiesterase B",Enzyme,PDE3B_HUMAN,
E1BN64,Uncharacterized protein,Enzyme,E1BN64_BOVIN,
Q28156,"cGMP-specific 3',5'-cyclic phosphodiesterase",Enzyme,PDE5A_BOVIN,
O89085,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",Enzyme,PDE4A_CAVPO,
P31749,RAC-alpha serine/threonine-protein kinase,Kinase,AKT1_HUMAN,
P34896,"Serine hydroxymethyltransferase, cytosolic",Enzyme,GLYC_HUMAN,
P08543,Ribonucleoside-diphosphate reductase large subunit,Enzyme,RIR1_HHV11,
Q9Z7H2,30S ribosomal protein S4,Unclassified,RS4_CHLPN,
Q9Z8T8,30S ribosomal protein S9,Unclassified,RS9_CHLPN,
P48048,ATP-sensitive inward rectifier potassium channel 1,Ion channel,KCNJ1_HUMAN,
O60706|Q14654,"Sulfonylurea receptor 2, Kir6.2",Ion channel,ABCC9_HUMAN|KCJ11_HUMAN,OPENER
P10109,"Adrenodoxin, mitochondrial",Unclassified,ADX_HUMAN,
P08922,Proto-oncogene tyrosine-protein kinase ROS,Kinase,ROS1_HUMAN,
Q63470,Dual specificity tyrosine-phosphorylation-regulated kinase 1A,Kinase,DYR1A_RAT,
P21398,Amine oxidase [flavin-containing] A,Enzyme,AOFA_BOVIN,
P14679,Tyrosinase,Enzyme,TYRO_HUMAN,INHIBITOR
Q9NS75,Cysteinyl leukotriene receptor 2,GPCR,CLTR2_HUMAN,
Q13304,Uracil nucleotide/cysteinyl leukotriene receptor,GPCR,GPR17_HUMAN,
Q6NS65,Uracil nucleotide/cysteinyl leukotriene receptor,GPCR,GPR17_MOUSE,ANTAGONIST
P79350,Mu-type opioid receptor,GPCR,OPRM_BOVIN,
P47748,Nociceptin receptor,GPCR,OPRX_CAVPO,
Q98UH1,Mu opioid receptor-like OR2,GPCR,Q98UH1_DANRE,
B3DH72,"Opioid receptor, delta 1b",GPCR,B3DH72_DANRE,
O57585,Opioid receptor homologue,GPCR,O57585_DANRE,
Q9Y2I1,Nischarin,Membrane receptor,NISCH_HUMAN,AGONIST
P00956,Isoleucine--tRNA ligase,Enzyme,SYI_ECOLI,
P41252,"Isoleucine--tRNA ligase, cytoplasmic",Enzyme,SYIC_HUMAN,
P41972,Isoleucine--tRNA ligase,Enzyme,SYI1_STAAU,INHIBITOR
Q99YW3,Isoleucine--tRNA ligase,Enzyme,SYI_STRP1,INHIBITOR
P56690,Isoleucine--tRNA ligase,Enzyme,SYI_THET8,
P20839,Inosine-5'-monophosphate dehydrogenase 1,Enzyme,IMDH1_HUMAN,INHIBITOR
P12268,Inosine-5'-monophosphate dehydrogenase 2,Enzyme,IMDH2_HUMAN,INHIBITOR
P20839,Inosine-5'-monophosphate dehydrogenase 1,Enzyme,IMDH1_HUMAN,
P12268,Inosine-5'-monophosphate dehydrogenase 2,Enzyme,IMDH2_HUMAN,
P12268|P20839,Inosine-5'-monophosphate dehydrogenase (IMPDH),Enzyme,IMDH2_HUMAN|IMDH1_HUMAN,INHIBITOR
Q5KP44,Inosine-5'-monophosphate dehydrogenase,Unclassified,IMDH_CRYNJ,
P20272,Cannabinoid receptor 1,GPCR,CNR1_RAT,
P47936,Cannabinoid receptor 2,GPCR,CNR2_MOUSE,
Q9Y5Y6,Suppressor of tumorigenicity 14 protein,Enzyme,ST14_HUMAN,
P00736,Complement C1r subcomponent,Enzyme,C1R_HUMAN,INHIBITOR
P09871,Complement C1s subcomponent,Enzyme,C1S_HUMAN,
Q15661,Tryptase alpha/beta-1,Enzyme,TRYB1_HUMAN,INHIBITOR
O07855,Dehydrosqualene desaturase,Enzyme,CRTN_STAAE,
P33534,Kappa-type opioid receptor,GPCR,OPRK_MOUSE,AGONIST
P42866,Mu-type opioid receptor,GPCR,OPRM_MOUSE,ANTAGONIST
P33534,Kappa-type opioid receptor,GPCR,OPRK_MOUSE,ANTAGONIST
Q8NER1,Transient receptor potential cation channel subfamily V member 1,Ion channel,TRPV1_HUMAN,
P0A7S3,30S ribosomal protein S12,Cytosolic other,RS12_ECOLI,
P08312,Phenylalanine--tRNA ligase alpha subunit,Enzyme,SYFA_ECOLI,
P07395,Phenylalanine--tRNA ligase beta subunit,Enzyme,SYFB_ECOLI,
O95237,Lecithin retinol acyltransferase,Enzyme,LRAT_HUMAN,
P48442,Extracellular calcium-sensing receptor,GPCR,CASR_RAT,AGONIST
P16066,Atrial natriuretic peptide receptor 1,Enzyme,ANPRA_HUMAN,AGONIST
P40261,Nicotinamide N-methyltransferase,Enzyme,NNMT_HUMAN,
Q15274,Nicotinate-nucleotide pyrophosphorylase [carboxylating],Enzyme,NADC_HUMAN,
Q96EB6,NAD-dependent protein deacetylase sirtuin-1,Enzyme,SIR1_HUMAN,
Q8IXJ6,NAD-dependent protein deacetylase sirtuin-2,Enzyme,SIR2_HUMAN,
P53686,NAD-dependent deacetylase HST2,Enzyme,HST2_YEAST,
Q9NTG7,NAD-dependent deacetylase sirtuin 3,Enzyme,SIR3_HUMAN,
Q8I6E4,Putative silent information regulator 2,Unclassified,Q8I6E4_LEIIN,
Q6SZW1,Sterile alpha and TIR motif-containing protein 1,Unclassified,SARM1_HUMAN,
O54698,Equilibrative nucleoside transporter 1,Transporter,S29A1_RAT,
P15385,Potassium voltage-gated channel subfamily A member 4,Ion channel,KCNA4_RAT,BLOCKER
P11509,Cytochrome P450 2A6,Enzyme,CP2A6_HUMAN,
P49582,Neuronal acetylcholine receptor subunit alpha-7,Ion channel,ACHA7_MOUSE,
P43144,Neuronal acetylcholine receptor subunit alpha-9,Ion channel,ACHA9_RAT,
P12392,Neuronal acetylcholine receptor subunit beta-4,Ion channel,ACHB4_RAT,
P04757,Neuronal acetylcholine receptor subunit alpha-3,Ion channel,ACHA3_RAT,
P12389,Neuronal acetylcholine receptor subunit alpha-2,Ion channel,ACHA2_RAT,
P21687,Lycopene cyclase,Enzyme,CRTY_PANAN,
P25162,Acetylcholine receptor subunit beta-like 2,Ion channel,ACH4_DROME,
P09482,Neuronal acetylcholine receptor subunit alpha-4,Ion channel,ACHA4_CHICK,
O70174,Neuronal acetylcholine receptor subunit alpha-4,Ion channel,ACHA4_MOUSE,
P04757|P09483|P12389|P12390|P12391|P12392|P20420|P25108|P25109|P43143|P43144|Q05941|Q9JLB5,Neuronal acetylcholine receptor,Ion channel,ACHA3_RAT|ACHA4_RAT|ACHA2_RAT|ACHB2_RAT|ACHB3_RAT|ACHB4_RAT|ACHA5_RAT|ACHA_RAT|ACHB_RAT|ACHA6_RAT|ACHA9_RAT|ACHA7_RAT|ACH10_RAT,
P17787|P43681,Neuronal acetylcholine receptor; alpha4/beta2,Ion channel,ACHB2_HUMAN|ACHA4_HUMAN,AGONIST
P02708|P07510|P11230|Q07001,Acetylcholine receptor; alpha1/beta1/delta/gamma,Ion channel,ACHA_HUMAN|ACHG_HUMAN|ACHB_HUMAN|ACHD_HUMAN,
P12389|P12392,Neuronal acetylcholine receptor; alpha2/beta4,Ion channel,ACHA2_RAT|ACHB4_RAT,
P02708,Acetylcholine receptor subunit alpha,Ion channel,ACHA_HUMAN,
Q8BLA8,Transient receptor potential cation channel subfamily A member 1,Ion channel,TRPA1_MOUSE,
Q62897,Potassium voltage-gated channel subfamily D member 3,Ion channel,KCND3_RAT,BLOCKER
Q13698,Voltage-dependent L-type calcium channel subunit alpha-1S,Ion channel,CAC1S_HUMAN,INHIBITOR
P48167,Glycine receptor subunit beta,Ion channel,GLRB_HUMAN,ANTAGONIST
P16389,Potassium voltage-gated channel subfamily A member 2,Ion channel,KCNA2_HUMAN,
O75311,Glycine receptor subunit alpha-3,Ion channel,GLRA3_HUMAN,ANTAGONIST
O35505,Voltage-dependent L-type calcium channel subunit alpha-1C,Ion channel,CAC1C_CAVPO,
P16388,Potassium voltage-gated channel subfamily A member 1,Ion channel,KCNA1_MOUSE,BLOCKER
P63142,Potassium voltage-gated channel subfamily A member 2,Ion channel,KCNA2_RAT,BLOCKER
P51800,Chloride channel protein ClC-Ka,Ion channel,CLCKA_HUMAN,ACTIVATOR
P51801,Chloride channel protein ClC-Kb,Ion channel,CLCKB_HUMAN,ACTIVATOR
P29317,Ephrin type-A receptor 2,Kinase,EPHA2_HUMAN,
P06213,Insulin receptor,Kinase,INSR_HUMAN,
Q16620,BDNF/NT-3 growth factors receptor,Kinase,NTRK2_HUMAN,
Q16288,NT-3 growth factor receptor,Kinase,NTRK3_HUMAN,
Q7L7X3,Serine/threonine-protein kinase TAO1,Kinase,TAOK1_HUMAN,
Q01668,Voltage-dependent L-type calcium channel subunit alpha-1D,Ion channel,CAC1D_HUMAN,
Q2A865,Sodium-dependent neutral amino acid transporter B(0)AT1,Transporter,S6A19_RAT,INHIBITOR
L8I2E6,Dipeptidyl peptidase 3,Enzyme,L8I2E6_9CETA,
Q13698,Voltage-dependent L-type calcium channel subunit alpha-1S,Ion channel,CAC1S_HUMAN,GATING INHIBITOR
P27732,Voltage-dependent L-type calcium channel subunit alpha-1D,Ion channel,CAC1D_RAT,GATING INHIBITOR
Q99246,Voltage-dependent L-type calcium channel subunit alpha-1D,Ion channel,CAC1D_MOUSE,GATING INHIBITOR
Q968X7,Pyruvate dehydrogenase [NADP(+)],Enzyme,PNO_CRYPV,INHIBITOR
Q24982,Pyruvate:ferredoxin oxidoreductase,Enzyme,Q24982_GIAIN,INHIBITOR
Q0P8E1,Pyruvate-flavodoxin oxidoreductase,Enzyme,Q0P8E1_CAMJE,
P32754,4-hydroxyphenylpyruvate dioxygenase,Enzyme,HPPD_HUMAN,INHIBITOR
Q02110,4-hydroxyphenylpyruvate dioxygenase,Enzyme,HPPD_PIG,
P32755,4-hydroxyphenylpyruvate dioxygenase,Unclassified,HPPD_RAT,
P21556,Platelet-activating factor receptor,GPCR,PTAFR_CAVPO,
P83512,Snake venom metalloproteinase Bap1,Enzyme,VM1B1_BOTAS,
P07858,Cathepsin B,Enzyme,CATB_HUMAN,
P68871|P69905,Hemoglobin HbA,Enzyme,HBB_HUMAN|HBA_HUMAN,
P18841,Alpha-1B adrenergic receptor,GPCR,ADA1B_MESAU,
P15823|P19328|P22086|P22909|P23944|P43140,Adrenergic receptor alpha,GPCR,ADA1B_RAT|ADA2B_RAT|ADA2C_RAT|ADA2A_RAT|ADA1D_RAT|ADA1A_RAT,
Q01337,Alpha-2C adrenergic receptor,GPCR,ADA2C_MOUSE,
Q01338,Alpha-2A adrenergic receptor,GPCR,ADA2A_MOUSE,
P0AFI2,DNA topoisomerase 4 subunit A,Enzyme,PARC_ECOLI,INHIBITOR
P48169,Gamma-aminobutyric acid receptor subunit alpha-4,Ion channel,GBRA4_HUMAN,
Q16445,Gamma-aminobutyric acid receptor subunit alpha-6,Ion channel,GBRA6_HUMAN,
P78508,ATP-sensitive inward rectifier potassium channel 10,Ion channel,KCJ10_HUMAN,BLOCKER
P0AES6,DNA gyrase subunit B,Enzyme,GYRB_ECOLI,
P0A4L9,DNA gyrase subunit B,Enzyme,GYRB_STRPN,
Q7X1P7,ParE,Enzyme,Q7X1P7_STREE,
C3SLN2,DNA gyrase subunit B,Enzyme,C3SLN2_ECOLX,
Q5HK03|Q5HK04,DNA gyrase,Enzyme,GYRB_STAEQ|GYRA_STAEQ,INHIBITOR
P0C559,DNA gyrase subunit B,Enzyme,GYRB_MYCSM,
P0A0K8,DNA gyrase subunit B,Enzyme,GYRB_STAAU,
A0QNE0,DNULL gyrase subunit B,Enzyme,GYRB_MYCS2,
C3SLN3,DNULL gyrase subunit B,Enzyme,C3SLN3_ECOLX,
P30875,Somatostatin receptor type 2,GPCR,SSR2_MOUSE,
P30935,Somatostatin receptor type 3,GPCR,SSR3_MOUSE,
P31391,Somatostatin receptor type 4,GPCR,SSR4_HUMAN,AGONIST
P30938,Somatostatin receptor type 5,GPCR,SSR5_RAT,
P30872,Somatostatin receptor type 1,GPCR,SSR1_HUMAN,AGONIST
O08858,Somatostatin receptor type 5,GPCR,SSR5_MOUSE,AGONIST
P03362,Gag-Pro-Pol polyprotein,Polyprotein,POL_HTL1A,
P23219|P35354,Cyclooxygenase,Enzyme,PGH1_HUMAN|PGH2_HUMAN,INHIBITOR
P08473,Neprilysin,Enzyme,NEP_HUMAN,
P18434|P19156,Potassium-transporting ATPase,Enzyme,ATP4B_PIG|ATP4A_PIG,
P18597|P27112,Potassium-transporting ATPase,Enzyme,ATP4B_RABIT|ATP4A_RABIT,
P30553,Gastrin/cholecystokinin type B receptor,GPCR,GASR_RAT,
P35563,5-hydroxytryptamine receptor 3A,Ion channel,5HT3A_RAT,
P28565,5-hydroxytryptamine receptor 1D,GPCR,5HT1D_RAT,
Q9Y4D2,Sn1-specific diacylglycerol lipase alpha,Enzyme,DGLA_HUMAN,
Q8NCG7,Sn1-specific diacylglycerol lipase beta,Enzyme,DGLB_HUMAN,
O95870,Abhydrolase domain-containing protein 16A,Enzyme,ABHGA_HUMAN,
Q8N2K0,Monoacylglycerol lipase ABHD12,Enzyme,ABD12_HUMAN,
Q13093,Platelet-activating factor acetylhydrolase,Enzyme,PAFA_HUMAN,
P00591,Pancreatic triacylglycerol lipase,Enzyme,LIPP_PIG,
Q9BV23,Monoacylglycerol lipase ABHD6,Enzyme,ABHD6_HUMAN,
Q6WQJ1,Sn1-specific diacylglycerol lipase alpha,Enzyme,DGLA_MOUSE,
P11150,Hepatic triacylglycerol lipase,Enzyme,LIPC_HUMAN,
Q9Y5X9,Endothelial lipase,Enzyme,LIPE_HUMAN,
P16233,Pancreatic triacylglycerol lipase,Enzyme,LIPP_HUMAN,INHIBITOR
P07098,Gastric triacylglycerol lipase,Enzyme,LIPG_HUMAN,INHIBITOR
P06818,Neuraminidase,Enzyme,NRAM_I79A0,
P16207,Neuraminidase,Enzyme,NRAM_INBVI,
P03468,Neuraminidase,Enzyme,NRAM_I34A1,INHIBITOR
P03474,Neuraminidase,Enzyme,NRAM_INBLE,INHIBITOR
B4URF0,Neuraminidase,Enzyme,B4URF0_9INFA,
P10481,Sialidase,Enzyme,NANH_CLOPF,
Q75VQ4,Neuraminidase,Enzyme,NRAM_I68A0,
Q6Q793,Neuraminidase,Enzyme,Q6Q793_9INFA,
A5Z252,Neuraminidase,Enzyme,A5Z252_9INFA,
Q2LFS1,Neuraminidase,Enzyme,Q2LFS1_9INFA,
C4LRQ6,Neuraminidase,Enzyme,C4LRQ6_9INFA,
Q20MD3,Neuraminidase,Enzyme,Q20MD3_9INFA,
P03470,Neuraminidase,Enzyme,NRAM_I33A0,
Q194T1,Neuraminidase,Enzyme,Q194T1_9INFA,
P03469,Neuraminidase,Enzyme,NRAM_I77AB,
Q07599,Neuraminidase,Enzyme,NRAM_I63A3,
P03471,Neuraminidase,Enzyme,NRAM_I71A1,
Q6XV28,Neuraminidase,Enzyme,NRAM_I77AG,
P11172,Uridine 5'-monophosphate synthase,Enzyme,UMPS_HUMAN,INHIBITOR
P21462,fMet-Leu-Phe receptor,GPCR,FPR1_HUMAN,
P34913,Bifunctional epoxide hydrolase 2,Enzyme,HYES_HUMAN,INHIBITOR
P18871,Alpha-2A adrenergic receptor,GPCR,ADA2A_PIG,
P30545|Q01337|Q01338,Alpha-2 adrenergic receptor,GPCR,ADA2B_MOUSE|ADA2C_MOUSE|ADA2A_MOUSE,
Q16647,Prostacyclin synthase,Enzyme,PTGIS_HUMAN,
P01178,Oxytocin-neurophysin 1,Secreted,NEU1_HUMAN,
P30560,Vasopressin V1a receptor,GPCR,V1AR_RAT,AGONIST
P49430,Thromboxane-A synthase,Enzyme,THAS_RAT,
Q13509,Tubulin beta-3 chain,Structural,TBB3_HUMAN,
Q9Y2T6,G-protein coupled receptor 55,GPCR,GPR55_HUMAN,AGONIST
O95264|P46098,Serotonin 3 receptor (5HT3),Ion channel,5HT3B_HUMAN|5HT3A_HUMAN,
Q07010,Hypoxanthine-guanine phosphoribosyltransferase,Enzyme,HPRT_TRYBB,
Q81VW8,Dihydropteroate synthase,Enzyme,Q81VW8_BACAN,
P9WNC6,2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase,Kinase,HPPK_MYCTO,
Q9Y233,"cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A",Enzyme,PDE10_HUMAN,
Q9QYJ6,"cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A",Enzyme,PDE10_RAT,
P54750|Q01064|Q14123,Phosphodiesterase 1,Enzyme,PDE1A_HUMAN|PDE1B_HUMAN|PDE1C_HUMAN,
P14100|Q01061,Phosphodiesterase 1,Enzyme,PDE1A_BOVIN|PDE1B_BOVIN,
Q01066|Q63421|Q9EPR9,Phosphodiesterase 1,Enzyme,PDE1B_RAT|PDE1C_RAT|Q9EPR9_RAT,
Q99571,P2X purinoceptor 4,Ion channel,P2RX4_HUMAN,
P51577,P2X purinoceptor 4,Unclassified,P2RX4_RAT,
P21146,Beta-adrenergic receptor kinase 1,Kinase,ARBK1_BOVIN,
P0A884,Thymidylate synthase,Enzyme,TYSY_ECOLI,
P45352,Thymidylate synthase,Enzyme,TYSY_RAT,
E2QDN0,Thymidylate synthase (EC 2.1.1.45) (TS) (TSase),Enzyme,E2QDN0_ECOLX,
Q64737,Trifunctional purine biosynthetic protein adenosine-3,Enzyme,PUR2_MOUSE,INHIBITOR
P22102,Trifunctional purine biosynthetic protein adenosine-3,Enzyme,PUR2_HUMAN,INHIBITOR
P02763,Alpha-1-acid glycoprotein 1,Secreted,A1AG1_HUMAN,
P32239,Gastrin/cholecystokinin type B receptor,GPCR,GASR_HUMAN,
P07477,Trypsin-1,Enzyme,TRY1_HUMAN,
P04271,Protein S100-B,Cytosolic other,S100B_HUMAN,
P19801,Amiloride-sensitive amine oxidase [copper-containing],Enzyme,AOC1_HUMAN,
Q05586|Q12879,Glutamate NMDA receptor; GRIN1/GRIN2A,Ion channel,NMDZ1_HUMAN|NMDE1_HUMAN,
P21673,Spermidine/spermine N(1)-acetyltransferase 1,Enzyme,SAT1_HUMAN,
O75365,Protein-tyrosine phosphatase 4A3,Enzyme,TP4A3_HUMAN,
P08001,Acrosin,Enzyme,ACRO_PIG,
P04631,Protein S100-B,Unclassified,S100B_RAT,
Q12974,Protein tyrosine phosphatase type IVA 2,Enzyme,TP4A2_HUMAN,
Q93096,Protein tyrosine phosphatase type IVA 1,Enzyme,TP4A1_HUMAN,
P28472,Gamma-aminobutyric acid receptor subunit beta-3,Ion channel,GBRB3_HUMAN,POSITIVE ALLOSTERIC MODULATOR
P30926|P32297,Neuronal acetylcholine receptor; alpha3/beta4,Ion channel,ACHB4_HUMAN|ACHA3_HUMAN,ANTAGONIST
P00813,Adenosine deaminase,Enzyme,ADA_HUMAN,INHIBITOR
P56658,Adenosine deaminase,Enzyme,ADA_BOVIN,
P23786,"Carnitine O-palmitoyltransferase 2, mitochondrial",Enzyme,CPT2_HUMAN,
P32198,Carnitine palmitoyltransferase 1A,Enzyme,CPT1A_RAT,
P10632,Cytochrome P450 2C8,Enzyme,CP2C8_HUMAN,INHIBITOR
Q16853,Membrane primary amine oxidase,Enzyme,AOC3_HUMAN,
Q834R3,Thymidylate synthase,Enzyme,TYSY_ENTFA,
Q6TEK4,Vitamin K epoxide reductase complex subunit 1,Unclassified,VKOR1_RAT,
P19111,Intestinal alkaline phosphatase,Enzyme,PPBI_BOVIN,
Q6DWJ6,Probable G-protein coupled receptor 139,GPCR,GP139_HUMAN,AGONIST
P98170,E3 ubiquitin-protein ligase XIAP,Unclassified,XIAP_HUMAN,
P36196,Acetylcholinesterase,Enzyme,ACES_CHICK,
P23415,Glycine receptor subunit alpha-1,Ion channel,GLRA1_HUMAN,BLOCKER
P23416,Glycine receptor subunit alpha-2,Ion channel,GLRA2_HUMAN,BLOCKER
P48167,Glycine receptor subunit beta,Ion channel,GLRB_HUMAN,BLOCKER
O75311,Glycine receptor subunit alpha-3,Ion channel,GLRA3_HUMAN,
P16395,Muscarinic acetylcholine receptor DM1,GPCR,ACM1_DROME,
P08912,Muscarinic acetylcholine receptor M5,GPCR,ACM5_HUMAN,AGONIST
P60568,Interleukin-2,Cytokine,IL2_HUMAN,
P48454,Serine/threonine-protein phosphatase 2B catalytic subunit gamma isoform,Enzyme,PP2BC_HUMAN,
Q62658,Peptidyl-prolyl cis-trans isomerase FKBP1A,Enzyme,FKB1A_RAT,INHIBITOR
O94782,Ubiquitin carboxyl-terminal hydrolase 1,Enzyme,UBP1_HUMAN,
Q9EQ60,Voltage-dependent T-type calcium channel subunit alpha-1H,Ion channel,CAC1H_RAT,BLOCKER
O60706,ATP-binding cassette sub-family C member 9,Ion channel,ABCC9_HUMAN,
P08588,Beta-1 adrenergic receptor,GPCR,ADRB1_HUMAN,PARTIAL AGONIST
P07550,Beta-2 adrenergic receptor,GPCR,ADRB2_HUMAN,PARTIAL AGONIST
P37238,Peroxisome proliferator-activated receptor gamma,Transcription factor,PPARG_MOUSE,
O88275,Peroxisome proliferator-activated receptor gamma,Transcription factor,PPARG_RAT,
B0K020,CDGSH iron-sulfur domain-containing protein 1,Unclassified,CISD1_RAT,
P23204,Peroxisome proliferator-activated receptor alpha,Nuclear hormone receptor,PPARA_MOUSE,
Q8N5K1,CDGSH iron-sulfur domain-containing protein 2,Unclassified,CISD2_HUMAN,
O18276,Gamma-aminobutyric acid receptor subunit beta,Ion channel,GBRB_CAEEL,
P28347,Transcriptional enhancer factor TEF-1,Transcription factor,TEAD1_HUMAN,
Q15562,Transcriptional enhancer factor TEF-4,Transcription factor,TEAD2_HUMAN,
Q99594,Transcriptional enhancer factor TEF-5,Transcription factor,TEAD3_HUMAN,
P22303,Acetylcholinesterase,Enzyme,ACES_HUMAN,ACTIVATOR
O08725,Growth hormone secretagogue receptor type 1,GPCR,GHSR_RAT,AGONIST
Q92847,Growth hormone secretagogue receptor type 1,GPCR,GHSR_HUMAN,AGONIST
P30988|O60895,Amylin receptor AMY2,GPCR,CALCR_HUMAN|RAMP2_HUMAN,AGONIST
P30988|O60894,Amylin receptor AMY1,GPCR,CALCR_HUMAN|RAMP1_HUMAN,AGONIST
P30988|O60896,Amylin receptor AMY3,GPCR,CALCR_HUMAN|RAMP3_HUMAN,AGONIST
Q9NS75,Cysteinyl leukotriene receptor 2,GPCR,CLTR2_HUMAN,ANTAGONIST
Q96RI1,Bile acid receptor,Nuclear other,NR1H4_HUMAN,
P08515,Glutathione S-transferase class-mu 26 kDa isozyme,Enzyme,GST26_SCHJA,
Q95US7,High voltage-activated calcium channel beta subunit CavB1,Ion channel,Q95US7_SCHMA,BLOCKER
Q962H3,High voltage-activated calcium channel beta subunit CavB2,Ion channel,Q962H3_SCHMA,BLOCKER
P05231,Interleukin-6,Cytokine,IL6_HUMAN,
Q8TDU6,G-protein coupled bile acid receptor 1,GPCR,GPBAR_HUMAN,
P15104,Glutamine synthetase,Enzyme,GLNA_HUMAN,
P78536,Disintegrin and metalloproteinase domain-containing protein 17,Unclassified,ADA17_HUMAN,
P35869,Aryl hydrocarbon receptor,Transcription factor,AHR_HUMAN,
Q9WKE8,Reverse transcriptase,Unclassified,Q9WKE8_9HIV1,
Q4U2R8,Solute carrier family 22 member 6,Transporter,S22A6_HUMAN,INHIBITOR
Q9WUD2,Transient receptor potential cation channel subfamily V member 2,Ion channel,TRPV2_RAT,ACTIVATOR
O95477,ATP-binding cassette sub-family A member 1,Transporter,ABCA1_HUMAN,INHIBITOR
P35610,Sterol O-acyltransferase 1,Enzyme,SOAT1_HUMAN,
P25102,Histamine H2 receptor,GPCR,HRH2_RAT,
P32239,Gastrin/cholecystokinin type B receptor,GPCR,GASR_HUMAN,ANTAGONIST
Q0IJY2,Bifunctional dihydrofolate reductase-thymidylate synthase,Enzyme,Q0IJY2_PLAMA,
O02604,Bifunctional dihydrofolate reductase-thymidylate synthase,Enzyme,DRTS_PLAVI,
O60706|Q14654,"Sulfonylurea receptor 2, Kir6.2",Ion channel,ABCC9_HUMAN|KCJ11_HUMAN,
P49895,Type I iodothyronine deiodinase,Enzyme,IOD1_HUMAN,INHIBITOR
P34981,Thyrotropin-releasing hormone receptor,GPCR,TRFR_HUMAN,AGONIST
Q01717,Thyrotropin-releasing hormone receptor,GPCR,TRFR_RAT,
Q9R297,Protein Trhr2; Thyrotropin releasing hormone receptor 2; Thyrotropin-releasing hormone receptor 2,GPCR,Q9R297_RAT,
P21761,Thyrotropin-releasing hormone receptor,GPCR,TRFR_MOUSE,
Q9ERT1,Thyrotropin-releasing hormone receptor 2,GPCR,Q9ERT1_MOUSE,
P9WPB6,Cyclopropane mycolic acid synthase 1,Enzyme,CMAS1_MYCTO,
Q50575,Amidase; Nicotinamidase; Nicotinamidase/pyrazinamidase; Pyrazinamidase; Pyrazinamidase/nicotinamidase; Pyrazinamidase/nicotinamidase PncA,Enzyme,Q50575_MYCTX,
P95029,3-oxoacyl-ACP synthase; Fatty acid synthase Fas; Probable fatty acid synthase Fas (Fatty acid synthetase),Enzyme,P95029_MYCTU,INHIBITOR
P22906,Dihydrofolate reductase,Enzyme,DYR_CANAX,
Q27793,Bifunctional dihydrofolate reductase-thymidylate synthase,Enzyme,DRTS_TRYCR,
Q96FL8,Multidrug and toxin extrusion protein 1,Transporter,S47A1_HUMAN,INHIBITOR
Q27783,Bifunctional dihydrofolate reductase-thymidylate synthase,Enzyme,DRTS_TRYBB,
O08966,Solute carrier family 22 member 1,Transporter,S22A1_MOUSE,
Q8K0H1,Multidrug and toxin extrusion protein 1,Unclassified,S47A1_MOUSE,
P06865,Beta-hexosaminidase subunit alpha,Enzyme,HEXA_HUMAN,
P07686,Beta-hexosaminidase subunit beta,Enzyme,HEXB_HUMAN,
Q3V050,Multidrug and toxin extrusion protein 2,Unclassified,S47A2_MOUSE,INHIBITOR
Q8I1R6,Bifunctional dihydrofolate reductase-thymidylate synthase,Enzyme,Q8I1R6_PLAF7,
F1KRD8,Fumarate reductase,Unclassified,F1KRD8_ASCSU,
O43426,Synaptojanin-1,Enzyme,SYNJ1_HUMAN,
P14867|P18505|P18507,GABA A receptor alpha-1/beta-1/gamma-2,Ion channel,GBRA1_HUMAN|GBRB1_HUMAN|GBRG2_HUMAN,POSITIVE ALLOSTERIC MODULATOR
P18505|P18507|P34903,GABA A receptor alpha-3/beta-1/gamma-2,Ion channel,GBRB1_HUMAN|GBRG2_HUMAN|GBRA3_HUMAN,POSITIVE ALLOSTERIC MODULATOR
P18505|P18507|P47869,GABA A receptor alpha-2/beta-1/gamma-2,Ion channel,GBRB1_HUMAN|GBRG2_HUMAN|GBRA2_HUMAN,POSITIVE ALLOSTERIC MODULATOR
P0A7Z4|P0A800|P0A8T7|P0A8V2,Bacterial DNA-directed RNA polymerase,Enzyme,RPOA_ECOLI|RPOZ_ECOLI|RPOC_ECOLI|RPOB_ECOLI,
P00592,Phospholipase A2 group 1B,Enzyme,PA21B_PIG,
P04055,Phospholipase A2 group 1B,Enzyme,PA21B_RAT,
Q9Z258,Potassium channel subfamily T member 1,Ion channel,KCNT1_RAT,BLOCKER
P10635,Cytochrome P450 2D6,Enzyme,CP2D6_HUMAN,INHIBITOR
Q13393,Phospholipase D1,Enzyme,PLD1_HUMAN,
O14939,Phospholipase D2,Enzyme,PLD2_HUMAN,
P03367,Gag-Pol polyprotein,Polyprotein,POL_HV1BR,INHIBITOR
Q7ZJM1,Integrase,Enzyme,Q7ZJM1_9HIV1,INHIBITOR
P32246,C-C chemokine receptor type 1,GPCR,CCR1_HUMAN,
Q76353,Integrase,Enzyme,Q76353_9HIV1,
P21731,Thromboxane A2 receptor,GPCR,TA2R_HUMAN,INVERSE AGONIST
Q6XKD3,Prostaglandin D2 receptor 2,GPCR,PD2R2_RAT,ANTAGONIST
Q9Z2J6,Prostaglandin D2 receptor 2,GPCR,PD2R2_MOUSE,ANTAGONIST
Q5YLN7,Voltage-gated sodium channel Nav1.5 cardiac isoform,Unclassified,Q5YLN7_CANLF,
P30551,Cholecystokinin receptor type A,GPCR,CCKAR_RAT,AGONIST
Q09428,ATP-binding cassette sub-family C member 8,Ion channel,ABCC8_HUMAN,
Q27963,Synaptic vesicular amine transporter,Transporter,VMAT2_BOVIN,
P02753,Retinol-binding protein 4,Secreted,RET4_HUMAN,
P02754,Beta-lactoglobulin,Unclassified,LACB_BOVIN,
P22413,Ectonucleotide pyrophosphatase/phosphodiesterase family member 1,Enzyme,ENPP1_HUMAN,
P49902,Cytosolic purine 5'-nucleotidase,Enzyme,5NTC_HUMAN,
Q8JXU8,NS5B protein,Enzyme,Q8JXU8_9HEPC,INHIBITOR
P9WGY9,DNA-directed RNA polymerase subunit beta,Enzyme,RPOB_MYCTU,
P0A7Z4|P0A800|P0A8T7|P0A8V2,Bacterial DNA-directed RNA polymerase,Enzyme,RPOA_ECOLI|RPOZ_ECOLI|RPOC_ECOLI|RPOB_ECOLI,INHIBITOR
P9WGR1,Enoyl-[acyl-carrier-protein] reductase [NADH],Enzyme,INHA_MYCTU,
P0A8V2,DNA-directed RNA polymerase subunit beta,Enzyme,RPOB_ECOLI,INHIBITOR
P46721,Solute carrier organic anion transporter family member 1A2,Transporter,SO1A2_HUMAN,INHIBITOR
Q9UGI6,Small conductance calcium-activated potassium channel protein 3,Ion channel,KCNN3_HUMAN,ACTIVATOR
Q92952,Small conductance calcium-activated potassium channel protein 1,Ion channel,KCNN1_HUMAN,ACTIVATOR
P21430,Matrix protein 2,Ion channel,M2_I60A0,
P03433,Polymerase acidic protein,Unclassified,PA_I34A1,
Q197X6,Farnesyl diphosphate synthase,Enzyme,Q197X6_TOXGO,
Q8WS26,Farnesyl diphosphate synthase,Enzyme,Q8WS26_TRYCR,
P20815,Cytochrome P450 3A5,Enzyme,CP3A5_HUMAN,INHIBITOR
P22309,UDP-glucuronosyltransferase 1-1,Enzyme,UD11_HUMAN,INHIBITOR
P79400,5-hydroxytryptamine receptor 1D,GPCR,5HT1D_PIG,
O14842,Free fatty acid receptor 1,GPCR,FFAR1_HUMAN,AGONIST
O43924,Phosphodiesterase 6D,Enzyme,PDE6D_HUMAN,
P17708,S-adenosylmethionine decarboxylase proenzyme,Enzyme,DCAM_RAT,
C3SIU2,Met repressor,Unclassified,C3SIU2_ECOLX,
P11086,Phenylethanolamine N-methyltransferase,Enzyme,PNMT_HUMAN,
P22061,Protein-beta-aspartate methyltransferase,Enzyme,PIMT_HUMAN,
Q6RYA0,Salicylic acid-binding protein 2,Enzyme,SABP2_TOBAC,
P56560,Amine oxidase [flavin-containing] B,Enzyme,AOFB_BOVIN,
P19643|P21396,Monoamine oxidase,Enzyme,AOFB_RAT|AOFA_RAT,
P21731,Thromboxane A2 receptor,GPCR,TA2R_HUMAN,
Q02643,Growth hormone-releasing hormone receptor,GPCR,GHRHR_HUMAN,AGONIST
P28335,5-hydroxytryptamine receptor 2C,GPCR,5HT2C_HUMAN,INVERSE AGONIST
P20813,Cytochrome P450 2B6,Enzyme,CP2B6_HUMAN,INHIBITOR
P16499,"Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha",Enzyme,PDE6A_HUMAN,
Q13946,"High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A",Enzyme,PDE7A_HUMAN,
P51160,"Cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha'",Enzyme,PDE6C_HUMAN,
O76083,"High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A",Enzyme,PDE9A_HUMAN,
O60658,"High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A",Enzyme,PDE8A_HUMAN,
O54735,"cGMP-specific 3',5'-cyclic phosphodiesterase",Enzyme,PDE5A_RAT,
P16586,"Cone cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha'",Enzyme,PDE6C_BOVIN,
P11541,"Rod cGMP-specific 3',5'-cyclic phosphodiesterase subunit alpha",Enzyme,PDE6A_BOVIN,
O77746,"cGMP-specific 3',5'-cyclic phosphodiesterase",Enzyme,PDE5A_CANFA,
P14270|P14644|P14646|P54748,Phosphodiesterase 4,Enzyme,PDE4D_RAT|PDE4C_RAT|PDE4B_RAT|PDE4A_RAT,
P04972|P11541|P16586|P22571|P23439|Q95142,Phosphodiesterase 6,Enzyme,CNRG_BOVIN|PDE6A_BOVIN|PDE6C_BOVIN|CNCG_BOVIN|PDE6B_BOVIN|PDE6D_BOVIN,
P14099,Phosphodiesterase 2A,Enzyme,PDE2A_BOVIN,
P14142,"Solute carrier family 2, facilitated glucose transporter member 4",Transporter,GLUT4_MOUSE,
Q10283,3-hydroxy-3-methylglutaryl-coenzyme A reductase,Enzyme,HMDH_SCHPO,
Q00688,Peptidyl-prolyl cis-trans isomerase FKBP3,Enzyme,FKBP3_HUMAN,
Q13451,Peptidyl-prolyl cis-trans isomerase FKBP5,Enzyme,FKBP5_HUMAN,
Q53EL6,Programmed cell death protein 4,Nuclear other,PDCD4_HUMAN,
P06730,Eukaryotic translation initiation factor 4E,Nuclear other,IF4E_HUMAN,
P26883,Peptidyl-prolyl cis-trans isomerase FKBP1A,Enzyme,FKB1A_MOUSE,
P14740,Dipeptidyl peptidase 4,Enzyme,DPP4_RAT,
P27487,Dipeptidyl peptidase 4,Enzyme,DPP4_HUMAN,INHIBITOR
P28843,Dipeptidyl peptidase 4,Enzyme,DPP4_MOUSE,
Q12884,Prolyl endopeptidase FAP,Enzyme,SEPR_HUMAN,
Q6V1X1,Dipeptidyl peptidase 8,Enzyme,DPP8_HUMAN,
Q86TI2,Dipeptidyl peptidase 9,Enzyme,DPP9_HUMAN,
Q9UHL4,Dipeptidyl peptidase 2,Enzyme,DPP2_HUMAN,
O31048,Dipeptidyl peptidase IV,Unclassified,O31048_PORGN,
P72525,DNA topoisomerase 4 subunit A,Enzyme,PARC_STRPN,
P24158,Myeloblastin,Enzyme,PRTN3_HUMAN,
Q3UP87,Neutrophil elastase,Enzyme,ELNE_MOUSE,
P04049,RAF proto-oncogene serine/threonine-protein kinase,Kinase,RAF1_HUMAN,INHIBITOR
P15056,Serine/threonine-protein kinase B-raf,Kinase,BRAF_HUMAN,INHIBITOR
P36888,Receptor-type tyrosine-protein kinase FLT3,Kinase,FLT3_HUMAN,INHIBITOR
P07949,Proto-oncogene tyrosine-protein kinase receptor Ret,Kinase,RET_HUMAN,INHIBITOR
P17948,Vascular endothelial growth factor receptor 1,Kinase,VGFR1_HUMAN,INHIBITOR
P35968,Vascular endothelial growth factor receptor 2,Kinase,VGFR2_HUMAN,INHIBITOR
P35916,Vascular endothelial growth factor receptor 3,Kinase,VGFR3_HUMAN,INHIBITOR
Q00535,Cyclin-dependent-like kinase 5,Kinase,CDK5_HUMAN,
P53778,Mitogen-activated protein kinase 12,Kinase,MK12_HUMAN,
Q96Q40,Cyclin-dependent kinase 15,Kinase,CDK15_HUMAN,
Q9UK32,Ribosomal protein S6 kinase alpha-6,Kinase,KS6A6_HUMAN,
O15264,Mitogen-activated protein kinase 13,Kinase,MK13_HUMAN,
Q00537,Cyclin-dependent kinase 17,Kinase,CDK17_HUMAN,
O94921,Cyclin-dependent kinase 14,Kinase,CDK14_HUMAN,
Q9BYT3,Serine/threonine-protein kinase 33,Kinase,STK33_HUMAN,
P49336,Cyclin-dependent kinase 8,Kinase,CDK8_HUMAN,
O15146,"Muscle, skeletal receptor tyrosine-protein kinase",Kinase,MUSK_HUMAN,
Q8WXR4,Myosin-IIIb,Kinase,MYO3B_HUMAN,
Q00526,Cyclin-dependent kinase 3,Kinase,CDK3_HUMAN,
Q9H3Y6,Tyrosine-protein kinase Srms,Kinase,SRMS_HUMAN,
Q8TD08,Mitogen-activated protein kinase 15,Kinase,MK15_HUMAN,
Q13546,Receptor-interacting serine/threonine-protein kinase 1,Kinase,RIPK1_HUMAN,
P48729,Casein kinase I isoform alpha,Kinase,KC1A_HUMAN,
Q92772,Cyclin-dependent kinase-like 2,Kinase,CDKL2_HUMAN,
Q8IVW4,Cyclin-dependent kinase-like 3,Kinase,CDKL3_HUMAN,
Q9H2X6,Homeodomain-interacting protein kinase 2,Kinase,HIPK2_HUMAN,
Q9H422,Homeodomain-interacting protein kinase 3,Kinase,HIPK3_HUMAN,
Q86Z02,Homeodomain-interacting protein kinase 1,Kinase,HIPK1_HUMAN,
Q32MK0,Myosin light chain kinase 3,Kinase,MYLK3_HUMAN,
P35918,Vascular endothelial growth factor receptor 2,Kinase,VGFR2_MOUSE,
Q5GIT4,Vascular endothelial growth factor receptor 2,Kinase,VGFR2_DANRE,
P10398,Serine/threonine-protein kinase A-Raf,Kinase,ARAF_HUMAN,
Q8T9Z7,Purine nucleoside phosphorylase,Enzyme,Q8T9Z7_PLAFA,
P35917,Vascular endothelial growth factor receptor 3,Kinase,VGFR3_MOUSE,INHIBITOR
P05622,Platelet-derived growth factor receptor beta,Kinase,PGFRB_MOUSE,INHIBITOR
Q9Y572,Receptor-interacting serine/threonine-protein kinase 3,Kinase,RIPK3_HUMAN,
Q9XZT6,Deoxynucleoside kinase,Kinase,DNK_DROME,
O00142,"Thymidine kinase, mitochondrial",Kinase,KITM_HUMAN,
P32304,5-hydroxytryptamine receptor 7,GPCR,5HT7R_MOUSE,
P30728|P51436|P61168|Q61616|Q8BLD9,Dopamine receptor,GPCR,DRD3_MOUSE|DRD4_MOUSE|DRD2_MOUSE|DRD1_MOUSE|DRD5_MOUSE,
P02665,Beta-casein,Unclassified,CASB_RAT,
P9WH62,30S ribosomal protein S12,Ribosomal protein,RS12_MYCTO,
P08173,Muscarinic acetylcholine receptor M4,GPCR,ACM4_HUMAN,ALLOSTERIC MODULATOR
P07727,Glycine receptor subunit alpha-1,Ion channel,GLRA1_RAT,
P59540,Taste receptor type 2 member 46,GPCR,T2R46_HUMAN,AGONIST
Q9GZT9,Egl nine homolog 1,Enzyme,EGLN1_HUMAN,
Q9BXA5,Succinate receptor 1,GPCR,SUCR1_HUMAN,AGONIST
P02708|P07510|P11230|Q04844|Q07001,Muscle-type nicotinic acetylcholine receptor,Ion channel,ACHA_HUMAN|ACHG_HUMAN|ACHB_HUMAN|ACHE_HUMAN|ACHD_HUMAN,AGONIST
Q7X575,Beta-lactamase,Enzyme,Q7X575_ECOLX,
Q0VTR6,Beta-lactamase,Enzyme,Q0VTR6_ACIPI,
Q0VTR8,Beta-lactamase,Enzyme,Q0VTR8_ACIPI,
D5HSX5,Beta-lactamase,Enzyme,D5HSX5_9GAMM,
P83111,"Serine beta-lactamase-like protein LACTB, mitochondrial",Enzyme,LACTB_HUMAN,
Q0VTS0,ADC-18 protein,Enzyme,Q0VTS0_ACIPI,
P00809,Beta-lactamase 1,Enzyme,BLAC_BACCE,
Q25704,"7,8-dihydro-6-hydroxymethylpterin pyrophosphokinase-dihydropteroate synthase; Dihydropteroate synthetase",Kinase,Q25704_PLAFA,INHIBITOR
Q08210,"Dihydroorotate dehydrogenase (quinone), mitochondrial",Enzyme,PYRD_PLAF7,
Q9GZV3,High affinity choline transporter 1,Transporter,SC5A7_HUMAN,
Q8IAU3,"6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase",Unclassified,Q8IAU3_PLAF7,
P08192,Bifunctional protein FolC,Enzyme,FOLC_ECOLI,
Q49184,Dihydropteroate synthase type-1,Enzyme,DHP1_MYCFO,
P24752,"Acetyl-CoA acetyltransferase, mitochondrial",Enzyme,THIL_HUMAN,
Q96NT5,Proton-coupled folate transporter,Transporter,PCFT_HUMAN,INHIBITOR
P25084,Transcriptional activator protein LasR,Unclassified,LASR_PSEAE,
P24530,Endothelin B receptor,GPCR,EDNRB_HUMAN,
O60760,Hematopoietic prostaglandin D synthase,Enzyme,HPGDS_HUMAN,
Q9GJU1,D(2) dopamine receptor,GPCR,DRD2_CANFA,
Q9N2B7,5-hydroxytryptamine receptor 1B,GPCR,5HT1B_GORGO,
Q8MI13,5-hydroxytryptamine 1D receptor,Unclassified,Q8MI13_BOVIN,
P30966,5-hydroxytryptamine receptor 5A,GPCR,5HT5A_MOUSE,AGONIST
P07333,Macrophage colony-stimulating factor 1 receptor,Kinase,CSF1R_HUMAN,INHIBITOR
P51812,Ribosomal protein S6 kinase alpha-3,Kinase,KS6A3_HUMAN,
Q14012,Calcium/calmodulin-dependent protein kinase type 1,Kinase,KCC1A_HUMAN,
Q13464,Rho-associated protein kinase 1,Kinase,ROCK1_HUMAN,
P23458,Tyrosine-protein kinase JAK1,Kinase,JAK1_HUMAN,
Q9UIK4,Death-associated protein kinase 2,Kinase,DAPK2_HUMAN,
O75116,Rho-associated protein kinase 2,Kinase,ROCK2_HUMAN,
P17252,Protein kinase C alpha type,Kinase,KPCA_HUMAN,
Q13555,Calcium/calmodulin-dependent protein kinase type II subunit gamma,Kinase,KCC2G_HUMAN,
Q7KZI7,Serine/threonine-protein kinase MARK2,Kinase,MARK2_HUMAN,
Q15349,Ribosomal protein S6 kinase alpha-2,Kinase,KS6A2_HUMAN,
Q13131,5'-AMP-activated protein kinase catalytic subunit alpha-1,Kinase,AAPK1_HUMAN,
Q13554,Calcium/calmodulin-dependent protein kinase type II subunit beta,Kinase,KCC2B_HUMAN,
Q9UQM7,Calcium/calmodulin-dependent protein kinase type II subunit alpha,Kinase,KCC2A_HUMAN,
P16591,Tyrosine-protein kinase Fer,Kinase,FER_HUMAN,
O75716,Serine/threonine-protein kinase 16,Kinase,STK16_HUMAN,
Q04759,Protein kinase C theta type,Kinase,KPCT_HUMAN,
Q9P1W9,Serine/threonine-protein kinase pim-2,Kinase,PIM2_HUMAN,
P49760,Dual specificity protein kinase CLK2,Kinase,CLK2_HUMAN,
Q9Y2H1,Serine/threonine-protein kinase 38-like,Kinase,ST38L_HUMAN,
Q8IU85,Calcium/calmodulin-dependent protein kinase type 1D,Kinase,KCC1D_HUMAN,
Q00536,Cyclin-dependent kinase 16,Kinase,CDK16_HUMAN,
Q96RR4,Calcium/calmodulin-dependent protein kinase kinase 2,Kinase,KKCC2_HUMAN,
P27448,MAP/microtubule affinity-regulating kinase 3,Kinase,MARK3_HUMAN,
Q8N5S9,Calcium/calmodulin-dependent protein kinase kinase 1,Kinase,KKCC1_HUMAN,
Q96NX5,Calcium/calmodulin-dependent protein kinase type 1G,Kinase,KCC1G_HUMAN,
Q9BXA7,Testis-specific serine/threonine-protein kinase 1,Kinase,TSSK1_HUMAN,
Q9JI10,Serine/threonine-protein kinase 3,Kinase,STK3_MOUSE,
P23443,Ribosomal protein S6 kinase beta-1,Kinase,KS6B1_HUMAN,
P31751,RAC-beta serine/threonine-protein kinase,Kinase,AKT2_HUMAN,
Q13188,Serine/threonine-protein kinase 3,Kinase,STK3_HUMAN,
O14757,Serine/threonine-protein kinase Chk1,Kinase,CHK1_HUMAN,
O75914,Serine/threonine-protein kinase PAK 3,Kinase,PAK3_HUMAN,
Q07002,Cyclin-dependent kinase 18,Kinase,CDK18_HUMAN,
Q99755,Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha,Kinase,PI51A_HUMAN,
P78356,Phosphatidylinositol 5-phosphate 4-kinase type-2 beta,Kinase,PI42B_HUMAN,
Q86YV6,Myosin light chain kinase family member 4,Kinase,MYLK4_HUMAN,
Q14289,Protein-tyrosine kinase 2-beta,Kinase,FAK2_HUMAN,
Q9BRS2,Serine/threonine-protein kinase RIO1,Kinase,RIOK1_HUMAN,
Q8N752,Casein kinase I isoform alpha-like,Kinase,KC1AL_HUMAN,
P78368,Casein kinase I isoform gamma-2,Kinase,KC1G2_HUMAN,
Q9Y6M4,Casein kinase I isoform gamma-3,Kinase,KC1G3_HUMAN,
Q9UKI8,Serine/threonine-protein kinase tousled-like 1,Kinase,TLK1_HUMAN,
Q86UE8,Serine/threonine-protein kinase tousled-like 2,Kinase,TLK2_HUMAN,
P68400,Casein kinase II subunit alpha,Kinase,CSK21_HUMAN,
P19784,Casein kinase II subunit alpha',Kinase,CSK22_HUMAN,
Q9Y463,Dual specificity tyrosine-phosphorylation-regulated kinase 1B,Kinase,DYR1B_HUMAN,
Q14164,Inhibitor of nuclear factor kappa-B kinase subunit epsilon,Kinase,IKKE_HUMAN,
Q15831,Serine/threonine-protein kinase STK11,Kinase,STK11_HUMAN,
P46734,Dual specificity mitogen-activated protein kinase kinase 3,Kinase,MP2K3_HUMAN,
Q8TDX7,Serine/threonine-protein kinase Nek7,Kinase,NEK7_HUMAN,
P14616,Insulin receptor-related protein,Kinase,INSRR_HUMAN,
O14730,Serine/threonine-protein kinase RIO3,Kinase,RIOK3_HUMAN,
Q96SB4,SRSF protein kinase 1,Kinase,SRPK1_HUMAN,
P78362,SRSF protein kinase 2,Kinase,SRPK2_HUMAN,
P54646,5'-AMP-activated protein kinase catalytic subunit alpha-2,Kinase,AAPK2_HUMAN,
Q8NFD2,Ankyrin repeat and protein kinase domain-containing protein 1,Kinase,ANKK1_HUMAN,
O95835,Serine/threonine-protein kinase LATS1,Kinase,LATS1_HUMAN,
Q9NRM7,Serine/threonine-protein kinase LATS2,Kinase,LATS2_HUMAN,
Q9NQU5,Serine/threonine-protein kinase PAK 6,Kinase,PAK6_HUMAN,
Q9P286,Serine/threonine-protein kinase PAK 7,Kinase,PAK5_HUMAN,
O60285,NUAK family SNF1-like kinase 1,Kinase,NUAK1_HUMAN,
Q13873,Bone morphogenetic protein receptor type-2,Kinase,BMPR2_HUMAN,
Q8TDC3,Serine/threonine-protein kinase BRSK1,Kinase,BRSK1_HUMAN,
Q9P0L2,Serine/threonine-protein kinase MARK1,Kinase,MARK1_HUMAN,
Q96L34,MAP/microtubule affinity-regulating kinase 4,Kinase,MARK4_HUMAN,
P45985,Dual specificity mitogen-activated protein kinase kinase 4,Kinase,MP2K4_HUMAN,
P52564,Dual specificity mitogen-activated protein kinase kinase 6,Kinase,MP2K6_HUMAN,
Q16566,Calcium/calmodulin-dependent protein kinase type IV,Kinase,KCC4_HUMAN,
P11799,"Myosin light chain kinase, smooth muscle",Kinase,MYLK_CHICK,
P80192,Mitogen-activated protein kinase kinase kinase 9,Kinase,M3K9_HUMAN,
Q16584,Mitogen-activated protein kinase kinase kinase 11,Kinase,M3K11_HUMAN,
Q9Y6E0,Serine/threonine-protein kinase 24,Kinase,STK24_HUMAN,
Q9HCP0,Casein kinase I isoform gamma-1,Kinase,KC1G1_HUMAN,
P53355,Death-associated protein kinase 1,Kinase,DAPK1_HUMAN,
O15075,Serine/threonine-protein kinase DCLK1,Kinase,DCLK1_HUMAN,
Q8N568,Serine/threonine-protein kinase DCLK2,Kinase,DCLK2_HUMAN,
Q8NEV4,Myosin-IIIa,Kinase,MYO3A_HUMAN,
O96013,Serine/threonine-protein kinase PAK 4,Kinase,PAK4_HUMAN,
Q8IWQ3,Serine/threonine-protein kinase BRSK2,Kinase,BRSK2_HUMAN,
Q13164,Mitogen-activated protein kinase 7,Kinase,MK07_HUMAN,
Q9BZL6,Serine/threonine-protein kinase D2,Kinase,KPCD2_HUMAN,
O94806,Serine/threonine-protein kinase D3,Kinase,KPCD3_HUMAN,
P07332,Tyrosine-protein kinase Fes/Fps,Kinase,FES_HUMAN,
P22455,Fibroblast growth factor receptor 4,Kinase,FGFR4_HUMAN,
Q15418,Ribosomal protein S6 kinase alpha-1,Kinase,KS6A1_HUMAN,
P48736,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",Kinase,PK3CG_HUMAN,
P11802,Cyclin-dependent kinase 4,Kinase,CDK4_HUMAN,
P80370,Protein delta homolog 1,Unclassified,DLK1_HUMAN,
Q13627,Dual specificity tyrosine-phosphorylation-regulated kinase 1A,Kinase,DYR1A_HUMAN,
O75460,Serine/threonine-protein kinase/endoribonuclease IRE1,Kinase,ERN1_HUMAN,
Q15835,Rhodopsin kinase,Kinase,RK_HUMAN,
Q8WTQ7,G protein-coupled receptor kinase 7,Kinase,GRK7_HUMAN,
P57058,Hormonally up-regulated neu tumor-associated kinase,Kinase,HUNK_HUMAN,
Q9UPZ9,Serine/threonine-protein kinase ICK,Kinase,ICK_HUMAN,
O15111,Inhibitor of nuclear factor kappa-B kinase subunit alpha,Kinase,IKKA_HUMAN,
Q9Y2H9,Microtubule-associated serine/threonine-protein kinase 1,Kinase,MAST1_HUMAN,
Q15208,Serine/threonine-protein kinase 38,Kinase,STK38_HUMAN,
Q8IY84,Serine/threonine-protein kinase NIM1,Kinase,NIM1_HUMAN,
O95747,Serine/threonine-protein kinase OSR1,Kinase,OXSR1_HUMAN,
O43172,U4/U6 small nuclear ribonucleoprotein Prp4,Nuclear other,PRP4_HUMAN,
Q9BVS4,Serine/threonine-protein kinase RIO2,Kinase,RIOK2_HUMAN,
Q9UEW8,STE20/SPS1-related proline-alanine-rich protein kinase,Kinase,STK39_HUMAN,
O75385,Serine/threonine-protein kinase ULK1,Kinase,ULK1_HUMAN,
Q8IYT8,Serine/threonine-protein kinase ULK2,Kinase,ULK2_HUMAN,
Q6ZN16,Mitogen-activated protein kinase kinase kinase 15,Kinase,M3K15_HUMAN,
Q9NYY3,Serine/threonine-protein kinase PLK2,Kinase,PLK2_HUMAN,
P0C264,Uncharacterized serine/threonine-protein kinase SBK3,Kinase,SBK3_HUMAN,
Q9H2K2,Tankyrase-2,Enzyme,TNKS2_HUMAN,
P42679,Megakaryocyte-associated tyrosine-protein kinase,Kinase,MATK_HUMAN,
Q13523,Serine/threonine-protein kinase PRP4 homolog,Kinase,PRP4B_HUMAN,
Q12852,Mitogen-activated protein kinase kinase kinase 12,Kinase,M3K12_HUMAN,
Q96BR1,Serine/threonine-protein kinase Sgk3,Kinase,SGK3_HUMAN,
Q9NRH2,SNF-related serine/threonine-protein kinase,Kinase,SNRK_HUMAN,
Q6XUX3,Dual serine/threonine and tyrosine protein kinase,Kinase,DUSTY_HUMAN,
P9WI81,Serine/threonine-protein kinase PknB,Kinase,PKNB_MYCTU,
Q9H8M2,Bromodomain-containing protein 9,Unclassified,BRD9_HUMAN,
P16234,Platelet-derived growth factor receptor alpha,Kinase,PGFRA_HUMAN,INHIBITOR
P47872,Secretin receptor,GPCR,SCTR_HUMAN,AGONIST
Q04844,Acetylcholine receptor subunit epsilon,Ion channel,ACHE_HUMAN,
Q01984,Histamine N-methyltransferase,Enzyme,HNMT_RAT,
Q15393,Splicing factor 3B subunit 3,Nuclear other,SF3B3_HUMAN,
Q96AY3,Peptidyl-prolyl cis-trans isomerase FKBP10,Enzyme,FKB10_HUMAN,
O43924|P16499|P18545|P35913|P51160|Q13956,Phosphodiesterase 6,Enzyme,PDE6D_HUMAN|PDE6A_HUMAN|CNRG_HUMAN|PDE6B_HUMAN|PDE6C_HUMAN|CNCG_HUMAN,
P62508,Estrogen-related receptor gamma,Nuclear hormone receptor,ERR3_HUMAN,
Q9BY08,Emopamil-binding protein-like,Enzyme,EBPL_HUMAN,
Q15125|Q9UBM7,Anti-estrogen binding site (AEBS),Enzyme,EBP_HUMAN|DHCR7_HUMAN,
P10424,Beta-lactamase 1,Enzyme,BLA1_BACCE,
Q46991,IMI-1; IMI-1 carbapenemase,Enzyme,Q46991_ENTCL,
Q6W9J1,Beta-lactamase,Enzyme,Q6W9J1_ENTCL,
P94958,Beta-lactamase,Enzyme,AMPC_MORMO,
P05193,Beta-lactamase,Enzyme,AMPC_CITFR,
B8R6A5,Beta-lactamase,Enzyme,B8R6A5_9BURK,
Q13639,5-hydroxytryptamine receptor 4,GPCR,5HT4R_HUMAN,PARTIAL AGONIST
P07711,Cathepsin L1,Enzyme,CATL1_HUMAN,INHIBITOR
P12822,Angiotensin-converting enzyme,Enzyme,ACE_RABIT,INHIBITOR
P52020,Squalene monooxygenase,Enzyme,ERG1_RAT,
P51589,Cytochrome P450 2J2,Enzyme,CP2J2_HUMAN,
O35627,Constitutive androstane receptor,Nuclear hormone receptor,NR1I3_MOUSE,
Q9UQD0,Sodium channel protein type 8 subunit alpha,Ion channel,SCN8A_HUMAN,
Q00194,cGMP-gated cation channel alpha-1,Ion channel,CNGA1_BOVIN,
P00439,Phenylalanine-4-hydroxylase,Enzyme,PH4H_HUMAN,ACTIVATOR
A4TVL0,Cereblon isoform 4,Unclassified,A4TVL0_9PROT,
Q96SW2,Protein cereblon,Cytosolic other,CRBN_HUMAN,MODULATOR
E1BN64|P14100|Q01061,Heart phosphodiesterase,Enzyme,E1BN64_BOVIN|PDE1A_BOVIN|PDE1B_BOVIN,
P0DMS9,Transmembrane domain-containing protein TMIGD3,Unclassified,TMIG3_HUMAN,
Q09508,"Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial",Enzyme,SDHA_CAEEL,
P0AE18,Methionine aminopeptidase,Enzyme,MAP1_ECOLI,
P26281,2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase,Kinase,HPPK_ECOLI,
Q63734,Potassium voltage-gated channel subfamily C member 4,Ion channel,KCNC4_RAT,GATING INHIBITOR
P40926,"Malate dehydrogenase, mitochondrial",Enzyme,MDHM_HUMAN,
P30531,Sodium- and chloride-dependent GABA transporter 1,Transporter,SC6A1_HUMAN,INHIBITOR
P31651,Sodium- and chloride-dependent betaine transporter,Transporter,S6A12_MOUSE,
Q13488,V-type proton ATPase 116 kDa subunit a isoform 3,Enzyme,VPP3_HUMAN,
P50281,Matrix metalloproteinase-14,Enzyme,MMP14_HUMAN,
P22894,Neutrophil collagenase,Enzyme,MMP8_HUMAN,
O69638,"Epoxide hydrolase EphE; Hydrolase, alpha/beta hydrolase fold family",Enzyme,O69638_MYCTO,
F1PT23,Muscarinic acetylcholine receptor,GPCR,F1PT23_CANFA,
F1PWR7,Muscarinic acetylcholine receptor,GPCR,F1PWR7_CANFA,
F1PGZ2,Muscarinic acetylcholine receptor,GPCR,F1PGZ2_CANFA,
P70634,SMR1-alpha3,Unclassified,P70634_RAT,
P70635,BetaB2-crystallin,Unclassified,P70635_RAT,
P80276,Aldose reductase,Enzyme,ALDR_PIG,
Q91WR5,Aldo-keto reductase family 1 member C21,Enzyme,AK1CL_MOUSE,
P27139,Carbonic anhydrase 2,Enzyme,CAH2_RAT,
P39086|Q13002|Q13003|Q16099|Q16478,Glutamate receptor ionotropic kainate,Ion channel,GRIK1_HUMAN|GRIK2_HUMAN|GRIK3_HUMAN|GRIK4_HUMAN|GRIK5_HUMAN,ANTAGONIST
P42261|P42262|P42263|P48058,Glutamate receptor ionotropic AMPA,Ion channel,GRIA1_HUMAN|GRIA2_HUMAN|GRIA3_HUMAN|GRIA4_HUMAN,ANTAGONIST
Q969P6,"DNA topoisomerase I, mitochondrial",Enzyme,TOP1M_HUMAN,INHIBITOR
Q04750,DNA topoisomerase I,Enzyme,TOP1_MOUSE,
Q05320,Envelope glycoprotein,Unclassified,VGP_EBOZM,
Q8NB78,Lysine-specific histone demethylase 1B,Enzyme,KDM1B_HUMAN,
P28702,Retinoic acid receptor RXR-beta,Nuclear hormone receptor,RXRB_HUMAN,
P48443,Retinoic acid receptor RXR-gamma,Nuclear hormone receptor,RXRG_HUMAN,
Q03181,Peroxisome proliferator-activated receptor delta,Nuclear hormone receptor,PPARD_HUMAN,AGONIST
Q92753,Nuclear receptor ROR-beta,Nuclear hormone receptor,RORB_HUMAN,ANTAGONIST
P62965,Cellular retinoic acid-binding protein 1,Cytosolic other,RABP1_MOUSE,
P22935,Cellular retinoic acid-binding protein 2,Cytosolic other,RABP2_MOUSE,
P11416,Retinoic acid receptor alpha,Transcription factor,RARA_MOUSE,
P22605,Retinoic acid receptor beta,Transcription factor,RARB_MOUSE,
P18911,Retinoic acid receptor gamma,Transcription factor,RARG_MOUSE,
Q9Y466,Nuclear receptor subfamily 2 group E member 1,Nuclear hormone receptor,NR2E1_HUMAN,AGONIST
P49116,Nuclear receptor subfamily 2 group C member 2,Nuclear other,NR2C2_HUMAN,AGONIST
Q13526,Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1,Unclassified,PIN1_HUMAN,
Q9Y466,Nuclear receptor subfamily 2 group E member 1,Nuclear other,NR2E1_HUMAN,AGONIST
P07550|P08588|P13945,Adrenergic receptor beta,GPCR,ADRB2_HUMAN|ADRB1_HUMAN|ADRB3_HUMAN,
P78527,DNA-dependent protein kinase catalytic subunit,Kinase,PRKDC_HUMAN,
P06760,Beta-glucuronidase,Enzyme,BGLR_RAT,
P00697,Lysozyme C-1,Enzyme,LYSC1_RAT,
P9WKE1,Thymidylate kinase,Kinase,KTHY_MYCTU,
P26439,3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 2,Enzyme,3BHS2_HUMAN,INHIBITOR
Q27713,Bifunctional dihydrofolate reductase-thymidylate synthase,Enzyme,DRTS_PLABA,
P0ABQ4,Dihydrofolate reductase,Enzyme,DYR_ECOLI,INHIBITOR
P07807,Dihydrofolate reductase,Enzyme,DYR_YEAST,
O30463,Dihydrofolate reductase,Enzyme,O30463_MYCAV,
P04174,Dihydrofolate reductase,Enzyme,DYR_NEIGO,
Q59487,Dihydrofolate reductase,Enzyme,DYR_LACLA,
Q27552,Bifunctional dihydrofolate reductase-thymidylate synthase,Enzyme,Q27552_CRYPV,
P00382,Dihydrofolate reductase type 1,Enzyme,DYR1_ECOLX,
Q54801,Dihydrofolate reductase,Enzyme,DYR_STRPN,
Q9UUP5,Dihydrofolate reductase,Enzyme,Q9UUP5_PNEJI,
P16184,Dihydrofolate reductase,Enzyme,DYR_PNECA,INHIBITOR
P54840,"Glycogen [starch] synthase, liver",Enzyme,GYS2_HUMAN,
P39654,Polyunsaturated fatty acid lipoxygenase ALOX15,Enzyme,LOX15_MOUSE,
P23415,Glycine receptor subunit alpha-1,Ion channel,GLRA1_HUMAN,ANTAGONIST
P23416,Glycine receptor subunit alpha-2,Ion channel,GLRA2_HUMAN,ANTAGONIST
Q13639,5-hydroxytryptamine receptor 4,GPCR,5HT4R_HUMAN,
O70212,5-hydroxytryptamine receptor 3A,Ion channel,5HT3A_CAVPO,
P97288,5-hydroxytryptamine receptor 4,GPCR,5HT4R_MOUSE,ANTAGONIST
P41180,Extracellular calcium-sensing receptor,GPCR,CASR_HUMAN,ALLOSTERIC MODULATOR
Q9UGI6,Small conductance calcium-activated potassium channel protein 3,Ion channel,KCNN3_HUMAN,BLOCKER
Q9H2S1,Small conductance calcium-activated potassium channel protein 2,Ion channel,KCNN2_HUMAN,BLOCKER
Q401N2,Zinc-activated ligand-gated ion channel,Ion channel,ZACN_HUMAN,
P23979,5-hydroxytryptamine receptor 3A,Ion channel,5HT3A_MOUSE,ANTAGONIST
Q92952,Small conductance calcium-activated potassium channel protein 1,Ion channel,KCNN1_HUMAN,BLOCKER
P70604,Small conductance calcium-activated potassium channel protein 2,Ion channel,KCNN2_RAT,BLOCKER
Q923Y9,Trace amine-associated receptor 1,GPCR,TAAR1_RAT,AGONIST
Q923Y8,Trace amine-associated receptor 1,GPCR,TAAR1_MOUSE,AGONIST
H9TVJ1,TyR1,GPCR,H9TVJ1_9NEOP,
P15144,Aminopeptidase N,Enzyme,AMPN_HUMAN,
P28838,Cytosol aminopeptidase,Enzyme,AMPL_HUMAN,
P15145,Aminopeptidase N,Enzyme,AMPN_PIG,
O96935,M1 family aminopeptidase,Enzyme,AMP1_PLAFQ,
Q8VCT3,Aminopeptidase B,Enzyme,AMPB_MOUSE,
P97629,Leucyl-cystinyl aminopeptidase,Enzyme,LCAP_RAT,
O09175,Aminopeptidase B,Enzyme,AMPB_RAT,
P00727,Cytosol aminopeptidase,Enzyme,AMPL_BOVIN,
P97449,Aminopeptidase N,Enzyme,AMPN_MOUSE,
Q01693,Bacterial leucyl aminopeptidase,Enzyme,AMPX_VIBPR,
P28839,Cytosol aminopeptidase,Enzyme,AMPL_PIG,
P15684,Aminopeptidase N,Enzyme,AMPN_RAT,
P55786,Puromycin-sensitive aminopeptidase,Enzyme,PSA_HUMAN,
Q9NZ08,Endoplasmic reticulum aminopeptidase 1,Enzyme,ERAP1_HUMAN,
Q96RI1,Bile acid receptor,Nuclear hormone receptor,NR1H4_HUMAN,AGONIST
P51649,"Succinate-semialdehyde dehydrogenase, mitochondrial",Enzyme,SSDH_HUMAN,INHIBITOR
Q13547,Histone deacetylase 1,Enzyme,HDAC1_HUMAN,INHIBITOR
P35504,UDP-glucuronosyltransferase 1-5,Enzyme,UD15_HUMAN,
Q5RJP0,Aldose reductase-related protein 1,Enzyme,ALD1_RAT,
Q06241,D-alanyl-D-alanine dipeptidase,Enzyme,VANX_ENTFC,
P17443,UDP-N-acetylglucosamine--N-acetylmuramyl-(pentapeptide) pyrophosphoryl-undecaprenol N-acetylglucosamine transferase,Enzyme,MURG_ECOLI,
P54750,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A",Enzyme,PDE1A_HUMAN,
P37288,Vasopressin V1a receptor,GPCR,V1AR_HUMAN,AGONIST
P47901,Vasopressin V1b receptor,GPCR,V1BR_HUMAN,AGONIST
P30559,Oxytocin receptor,GPCR,OXYR_HUMAN,
P32307,Vasopressin V2 receptor,GPCR,V2R_PIG,
P48044,Vasopressin V2 receptor,GPCR,V2R_BOVIN,
P30560|P48974,Vasopressin V1 receptor,GPCR,V1AR_RAT|V1BR_RAT,
Q13698,Voltage-dependent L-type calcium channel subunit alpha-1S,Ion channel,CAC1S_HUMAN,BLOCKER
Q96PR1,Potassium voltage-gated channel subfamily C member 2,Ion channel,KCNC2_HUMAN,
Q02485,Voltage-dependent L-type calcium channel subunit alpha-1S,Ion channel,CAC1S_RAT,
P22462,Potassium voltage-gated channel subfamily C member 2,Ion channel,KCNC2_RAT,BLOCKER
Q9ULQ1,Two pore calcium channel protein 1,Ion channel,TPC1_HUMAN,BLOCKER
Q8NHX9,Two pore calcium channel protein 2,Ion channel,TPC2_HUMAN,BLOCKER
P09884,DNA polymerase alpha catalytic subunit,Enzyme,DPOLA_HUMAN,
P23921,Ribonucleoside-diphosphate reductase large subunit,Enzyme,RIR1_HUMAN,
P31350,Ribonucleoside-diphosphate reductase subunit M2,Enzyme,RIR2_HUMAN,
Q16854,"Deoxyguanosine kinase, mitochondrial",Kinase,DGUOK_HUMAN,
Q04400,Adenylate cyclase type V,Enzyme,ADCY5_RAT,
P50247,Adenosylhomocysteinase ,Enzyme,SAHH_MOUSE,
P80404,"4-aminobutyrate aminotransferase, mitochondrial",Enzyme,GABT_HUMAN,INHIBITOR
P50554,Gamma-amino-N-butyrate transaminase,Enzyme,GABT_RAT,
P23975,Sodium-dependent noradrenaline transporter,Transporter,SC6A2_HUMAN,ANTAGONIST
Q14123,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",Enzyme,PDE1C_HUMAN,INHIBITOR
Q96NR8,Retinol dehydrogenase 12,Enzyme,RDH12_HUMAN,
Q8NBN7,Retinol dehydrogenase 13,Enzyme,RDH13_HUMAN,
P10745,Retinol-binding protein 3,Surface antigen,RET3_HUMAN,
P82980,Retinol-binding protein 5,Cytosolic other,RET5_HUMAN,
Q96R05,Retinoid-binding protein 7,Cytosolic other,RET7_HUMAN,
P50120,Retinol-binding protein 2,Cytosolic other,RET2_HUMAN,
O94788,Retinal dehydrogenase 2,Enzyme,AL1A2_HUMAN,
P00352,Retinal dehydrogenase 1,Enzyme,AL1A1_HUMAN,
P12271,Retinaldehyde-binding protein 1,Transporter,RLBP1_HUMAN,
P09455,Retinol-binding protein 1,Cytosolic other,RET1_HUMAN,
O60779,Thiamine transporter 1,Transporter,S19A2_HUMAN,
P29401,Transketolase,Enzyme,TKT_HUMAN,
Q9H3S4,Thiamin pyrophosphokinase 1,Kinase,TPK1_HUMAN,
Q9BU02,Thiamine-triphosphatase,Enzyme,THTPA_HUMAN,
P51854,Transketolase-like protein 1,Enzyme,TKTL1_HUMAN,
A2RI47,Thiamine transporter ThiT,Transporter,THIT_LACLM,
P30043,Flavin reductase (NADPH),Enzyme,BLVRB_HUMAN,
Q969G6,Riboflavin kinase,Kinase,RIFK_HUMAN,
P49019,Hydroxycarboxylic acid receptor 3,GPCR,HCAR3_HUMAN,AGONIST
Q80Z39,Hydroxycarboxylic acid receptor 2,GPCR,HCAR2_RAT,
Q9EP66,Hydroxycarboxylic acid receptor 2,GPCR,HCAR2_MOUSE,
Q9NVS9,Pyridoxine-5'-phosphate oxidase,Enzyme,PNPO_HUMAN,
Q96GD0,Pyridoxal phosphate phosphatase,Enzyme,PLPP_HUMAN,
O00764,Pyridoxal kinase,Kinase,PDXK_HUMAN,
P35520,Cystathionine beta-synthase,Enzyme,CBS_HUMAN,
Q9Y617,Phosphoserine aminotransferase,Enzyme,SERC_HUMAN,
Q02318,"Sterol 26-hydroxylase, mitochondrial",Enzyme,CP27A_HUMAN,
P00189,"Cholesterol side-chain cleavage enzyme, mitochondrial",Enzyme,CP11A_BOVIN,
Q9Y6A2,Cholesterol 24-hydroxylase,Enzyme,CP46A_HUMAN,
Q8N0U8,Vitamin K epoxide reductase complex subunit 1-like protein 1,Enzyme,VKORL_HUMAN,
P08709,Coagulation factor VII,Enzyme,FA7_HUMAN,
P03951,Coagulation factor XI,Enzyme,FA11_HUMAN,
Q9UQ49,Sialidase 3,Enzyme,NEUR3_HUMAN,
Q9Y3R4,Sialidase 2,Enzyme,NEUR2_HUMAN,
Q3S340,Neuraminidase,Enzyme,Q3S340_9INFB,
Q8WWR8,Sialidase-4,Enzyme,NEUR4_HUMAN,
D5F1R0,Neuraminidase,Enzyme,D5F1R0_9INFA,
P23919,Thymidylate kinase,Kinase,KTHY_HUMAN,
Q72549,Reverse transcriptase/RNaseH,Enzyme,Q72549_9HIV1,
Q9PPP5,Thymidine kinase,Kinase,KITH_UREPA,
P22939,Farnesyl diphosphate synthase,Enzyme,ISPA_ECOLI,
Q12051,Geranylgeranyl pyrophosphate synthase,Enzyme,GGPPS_YEAST,
O00481,Butyrophilin subfamily 3 member A1,Unclassified,BT3A1_HUMAN,
Q6NSN2,Amine oxidase [flavin-containing],Enzyme,AOF_DANRE,
P18507|P28472|P31644,GABA-A receptor alpha-5/beta-3/gamma-2,Ion channel,GBRG2_HUMAN|GBRB3_HUMAN|GBRA5_HUMAN,POSITIVE MODULATOR
P14867|P47870|Q99928,GABA-A receptor alpha-1/beta-2/gamma-3,Ion channel,GBRA1_HUMAN|GBRB2_HUMAN|GBRG3_HUMAN,POSITIVE MODULATOR
P18507|P34903|P47870,GABA A receptor alpha-3/beta-2/gamma-2,Ion channel,GBRG2_HUMAN|GBRA3_HUMAN|GBRB2_HUMAN,POSITIVE MODULATOR
P34903|P47870|Q99928,GABA A receptor alpha-3/beta-2/gamma-3,Ion channel,GBRA3_HUMAN|GBRB2_HUMAN|GBRG3_HUMAN,POSITIVE MODULATOR
P28472|P31644|Q99928,GABA A receptor alpha-5/beta-3/gamma-3,Ion channel,GBRB3_HUMAN|GBRA5_HUMAN|GBRG3_HUMAN,POSITIVE MODULATOR
P18507|P31644|P47870,GABA A receptor alpha-5/beta-2/gamma-2,Ion channel,GBRG2_HUMAN|GBRA5_HUMAN|GBRB2_HUMAN,POSITIVE MODULATOR
P31644|P47870|Q99928,GABA A receptor alpha-5/beta-2/gamma-3,Ion channel,GBRA5_HUMAN|GBRB2_HUMAN|GBRG3_HUMAN,POSITIVE MODULATOR
Q00975,Voltage-dependent N-type calcium channel subunit alpha-1B,Ion channel,CAC1B_HUMAN,BLOCKER
P54282,Voltage-dependent P/Q-type calcium channel subunit alpha-1A,Ion channel,CAC1A_RAT,BLOCKER
P25103,Substance-P receptor,GPCR,NK1R_HUMAN,AGONIST
P16235,Lutropin-choriogonadotropic hormone receptor,GPCR,LSHR_RAT,
P30518|P37288|P47901,Vasopressin receptor,GPCR,V2R_HUMAN|V1AR_HUMAN|V1BR_HUMAN,AGONIST
Q9HC29,Nucleotide-binding oligomerization domain-containing protein 2,Cytosolic other,NOD2_HUMAN,ACTIVATOR
Q15077,P2Y purinoceptor 6,GPCR,P2RY6_HUMAN,ANTAGONIST
P47900,P2Y purinoceptor 1,GPCR,P2RY1_HUMAN,ANTAGONIST
P41231,P2Y purinoceptor 2,GPCR,P2RY2_HUMAN,ANTAGONIST
Q96G91,P2Y purinoceptor 11,GPCR,P2Y11_HUMAN,ANTAGONIST
Q9BPV8,P2Y purinoceptor 13,GPCR,P2Y13_HUMAN,ANTAGONIST
Q5VLE3,RmtA,Enzyme,Q5VLE3_EMEND,
O15648,ATP-dependent 6-phosphofructokinase,Kinase,PFKA_TRYBB,
O94806|P05129|P05771|P17252|P24723|P41743|Q02156|Q04759|Q05513|Q05655|Q15139,Protein kinase C (PKC),Kinase,KPCD3_HUMAN|KPCG_HUMAN|KPCB_HUMAN|KPCA_HUMAN|KPCL_HUMAN|KPCI_HUMAN|KPCE_HUMAN|KPCT_HUMAN|KPCZ_HUMAN|KPCD_HUMAN|KPCD1_HUMAN,
Q80Z26,Nucleoside triphosphate diphosphohydrolase 3,Enzyme,Q80Z26_RAT,
O35795,Ectonucleoside triphosphate diphosphohydrolase 2,Enzyme,ENTP2_RAT,
P49654,P2X purinoceptor 3,Unclassified,P2RX3_RAT,ANTAGONIST
P49653,P2X purinoceptor 2,Unclassified,P2RX2_RAT,ANTAGONIST
P47824,P2X purinoceptor 1,Unclassified,P2RX1_RAT,ANTAGONIST
P51578,P2X purinoceptor 5,Unclassified,P2RX5_RAT,ANTAGONIST
P42224,Signal transducer and activator of transcription 1-alpha/beta,Unclassified,STAT1_HUMAN,
P42229,Signal transducer and activator of transcription 5A,Unclassified,STA5A_HUMAN,
P51692,Signal transducer and activator of transcription 5B,Unclassified,STA5B_HUMAN,
P30969,Gonadotropin-releasing hormone receptor,GPCR,GNRHR_RAT,AGONIST
Q4WLT4,"1,3-beta-glucan synthase catalytic subunit FksP",Enzyme,Q4WLT4_ASPFU,INHIBITOR
O13383,"1,3-beta-D-glucan synthase catalytic subunit",Unclassified,O13383_CANAX,
P30988,Calcitonin receptor,GPCR,CALCR_HUMAN,AGONIST
P47871,Glucagon receptor,GPCR,GLR_HUMAN,AGONIST
P30082,Glucagon receptor,GPCR,GLR_RAT,
F8V479,Glucagon-like peptide 1 receptor,GPCR,F8V479_MACFA,
O35659,Glucagon-like peptide 1 receptor,GPCR,GLP1R_MOUSE,
O08858|P30873|P30875|P30935|P49660,Somatostatin receptor,GPCR,SSR5_MOUSE|SSR1_MOUSE|SSR2_MOUSE|SSR3_MOUSE|SSR4_MOUSE,
P28646|P30680|P30936|P30937|P30938,Somatostatin receptor,GPCR,SSR1_RAT|SSR2_RAT|SSR3_RAT|SSR4_RAT|SSR5_RAT,
O96529,Acetylcholinesterase,Enzyme,O96529_MELIC,
P30559,Oxytocin receptor,GPCR,OXYR_HUMAN,ANTAGONIST
Q969F8,KiSS-1 receptor,GPCR,KISSR_HUMAN,
P04798,Cytochrome P450 1A1,Enzyme,CP1A1_HUMAN,
Q9Z258,Potassium channel subfamily T member 1,Ion channel,KCNT1_RAT,ACTIVATOR
Q9UBN7,Histone deacetylase 6,Enzyme,HDAC6_HUMAN,INHIBITOR
Q969S8,Histone deacetylase 10,Enzyme,HDA10_HUMAN,INHIBITOR
P54577,"Tyrosine--tRNA ligase, cytoplasmic",Enzyme,SYYC_HUMAN,
P03887,NADH-ubiquinone oxidoreductase chain 1 ,Unclassified,NU1M_BOVIN,
Q8R4D5,Transient receptor potential cation channel subfamily M member 8,Ion channel,TRPM8_MOUSE,
Q704Y3,Transient receptor potential cation channel subfamily V member 1,Ion channel,TRPV1_MOUSE,ACTIVATOR
Q9NJH6,Ace-orthologous acetylcholinesterase; Acetylcholinesterase,Unclassified,Q9NJH6_NEPCI,
Q7YWJ9,Acetylcholinesterase,Enzyme,Q7YWJ9_MUSDO,
K4JQ36,Acetylcholinesterase,Enzyme,K4JQ36_9HEMI,
P31327,"Carbamoyl-phosphate synthase [ammonia], mitochondrial",Enzyme,CPSM_HUMAN,POSITIVE ALLOSTERIC MODULATOR
Q05193,Dynamin-1,Structural,DYN1_HUMAN,
P42575,Caspase-2,Enzyme,CASP2_HUMAN,
Q8TDU6,G-protein coupled bile acid receptor 1,GPCR,GPBAR_HUMAN,AGONIST
P21731,Thromboxane A2 receptor,GPCR,TA2R_HUMAN,ANTAGONIST
P30987,Thromboxane A2 receptor,GPCR,TA2R_MOUSE,ANTAGONIST
Q8TDS5,Oxoeicosanoid receptor 1,GPCR,OXER1_HUMAN,
P19793,Retinoic acid receptor RXR-alpha,Nuclear other,RXRA_HUMAN,
P24723,Protein kinase C eta type,Kinase,KPCL_HUMAN,
P16232,Corticosteroid 11-beta-dehydrogenase isozyme 1,Enzyme,DHI1_RAT,
P50233,Corticosteroid 11-beta-dehydrogenase isozyme 2,Enzyme,DHI2_RAT,
Q9CPU0,Lactoylglutathione lyase,Enzyme,LGUL_MOUSE,
Q92731,Estrogen receptor beta,Nuclear hormone receptor,ESR2_HUMAN,AGONIST
Q01812,"Glutamate receptor ionotropic, kainate 4",Ion channel,GRIK4_RAT,
Q63273,"Glutamate receptor ionotropic, kainate 5",Ion channel,GRIK5_RAT,
P22756|P42260|P42264|Q01812|Q63273,"Glutamate receptor ionotropic, kainate",Ion channel,GRIK1_RAT|GRIK2_RAT|GRIK3_RAT|GRIK4_RAT|GRIK5_RAT,
P25044,Tyrosine-protein phosphatase 1,Enzyme,PTP1_YEAST,
Q13822,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,Enzyme,ENPP2_HUMAN,
P05121,Plasminogen activator inhibitor 1,Secreted,PAI1_HUMAN,INHIBITOR
P04303,Uracil-DNA glycosylase,Enzyme,UNG_VACCW,
P03372|Q92731,Estrogen receptor,Nuclear hormone receptor,ESR1_HUMAN|ESR2_HUMAN,AGONIST
P03952,Plasma kallikrein,Enzyme,KLKB1_HUMAN,
P19327,5-hydroxytryptamine receptor 1A,GPCR,5HT1A_RAT,ANTAGONIST
O88704,Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1,Ion channel,HCN1_MOUSE,
O88703,Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2,Ion channel,HCN2_MOUSE,
O60741,Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1,Ion channel,HCN1_HUMAN,BLOCKER
Q9UL51,Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2,Ion channel,HCN2_HUMAN,BLOCKER
Q9P1Z3,Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 3,Ion channel,HCN3_HUMAN,BLOCKER
P15090,"Fatty acid-binding protein, adipocyte",Cytosolic other,FABP4_HUMAN,
P05413,"Fatty acid-binding protein, heart",Cytosolic other,FABPH_HUMAN,
Q14721,Potassium voltage-gated channel subfamily B member 1,Ion channel,KCNB1_HUMAN,ACTIVATOR
Q5NUL3,Free fatty acid receptor 4,GPCR,FFAR4_HUMAN,AGONIST
O34667,S-ribosylhomocysteine lyase,Unclassified,LUXS_BACSU,
P36633,Amiloride-sensitive amine oxidase [copper-containing],Enzyme,AOC1_RAT,
P14324,Farnesyl pyrophosphate synthase,Enzyme,FPPS_HUMAN,
Q01705,Neurogenic locus notch homolog protein 1,Unclassified,NOTC1_MOUSE,
Q01469,"Fatty acid-binding protein, epidermal",Cytosolic other,FABP5_HUMAN,
P07148,"Fatty acid-binding protein, liver",Unclassified,FABPL_HUMAN,
Q99720,Sigma non-opioid intracellular receptor 1,Membrane receptor,SGMR1_HUMAN,MODULATOR
P04015,Regulatory protein E2,Unclassified,VE2_HPV11,
P03118,Regulatory protein E2,Unclassified,VE2_HPV1A,
P04350|P07437|P68363|P68366|P68371|Q13509|Q13748|Q13885|Q3ZCM7|Q6PEY2|Q71U36|Q9BQE3|Q9BUF5|Q9BVA1|Q9H4B7,Tubulin,Structural,TBB4A_HUMAN|TBB5_HUMAN|TBA1B_HUMAN|TBA4A_HUMAN|TBB4B_HUMAN|TBB3_HUMAN|TBA3C_HUMAN|TBB2A_HUMAN|TBB8_HUMAN|TBA3E_HUMAN|TBA1A_HUMAN|TBA1C_HUMAN|TBB6_HUMAN|TBB2B_HUMAN|TBB1_HUMAN,
P03120,Human papillomavirus regulatory protein E2,Unclassified,VE2_HPV16,
P18762,Beta-2 adrenergic receptor,GPCR,ADRB2_MOUSE,
P51575,P2X purinoceptor 1,Ion channel,P2RX1_HUMAN,
P06493,Cyclin-dependent kinase 1,Kinase,CDK1_HUMAN,
P53350,Serine/threonine-protein kinase PLK1,Kinase,PLK1_HUMAN,
P48147,Prolyl endopeptidase,Enzyme,PPCE_HUMAN,
P04054,Phospholipase A2,Enzyme,PA21B_HUMAN,
P39900,Macrophage metalloelastase,Enzyme,MMP12_HUMAN,
P45452,Collagenase 3,Enzyme,MMP13_HUMAN,
P06737,"Glycogen phosphorylase, liver form",Enzyme,PYGL_HUMAN,
Q00534,Cyclin-dependent kinase 6,Kinase,CDK6_HUMAN,
P0AEK4,Enoyl-[acyl-carrier-protein] reductase [NADH] FabI,Enzyme,FABI_ECOLI,
Q965D5,Enoyl-acyl-carrier protein reductase,Enzyme,Q965D5_PLAFA,
P28074,Proteasome subunit beta type-5,Enzyme,PSB5_HUMAN,
P10584,Malate dehydrogenase,Enzyme,MDH_THETH,
P21588,5'-nucleotidase,Enzyme,5NTD_RAT,
Q965D6,3-oxoacyl-acyl-carrier protein reductase,Enzyme,Q965D6_PLAFA,
Q965D7,Beta-hydroxyacyl-ACP dehydratase; Fatty acid synthesis protein,Enzyme,Q965D7_PLAFA,
P27986,Phosphatidylinositol 3-kinase regulatory subunit alpha,Kinase,P85A_HUMAN,
Q9NPH5,NADPH oxidase 4,Enzyme,NOX4_HUMAN,
Q1CTD3,D-alanine--D-alanine ligase,Enzyme,DDL_HELPH,
Q9HC98,Serine/threonine-protein kinase Nek6,Kinase,NEK6_HUMAN,
P06493|P14635,Cyclin-dependent kinase 1/cyclin B1,Kinase,CDK1_HUMAN|CCNB1_HUMAN,
Q00535|Q15078,Cyclin-dependent kinase 5/CDK5 activator 1,Kinase,CDK5_HUMAN|CD5R1_HUMAN,
O95067|P06493|P14635|Q8WWL7,Cyclin-dependent kinase 1/cyclin B,Kinase,CCNB2_HUMAN|CDK1_HUMAN|CCNB1_HUMAN|CCNB3_HUMAN,
P11802|P24385,Cyclin-dependent kinase 4/cyclin D1,Kinase,CDK4_HUMAN|CCND1_HUMAN,
P49840|P49841,Glycogen synthase kinase-3,Kinase,GSK3A_HUMAN|GSK3B_HUMAN,
Q9UL62,Short transient receptor potential channel 5,Ion channel,TRPC5_HUMAN,
Q99895,Chymotrypsin C,Enzyme,CTRC_HUMAN,
Q03114,Cell division protein kinase 5,Kinase,CDK5_RAT,
Q9NWT6,Hypoxia-inducible factor 1-alpha inhibitor,Enzyme,HIF1N_HUMAN,
P07862,D-alanylalanine synthetase,Enzyme,DDLB_ECOLI,
P28907,Lymphocyte differentiation antigen CD38,Tumour-associated antigen,CD38_HUMAN,
Q01062,Phosphodiesterase 2A,Enzyme,PDE2A_RAT,
P41921,Glutathione reductase,Enzyme,GSHR_YEAST,
P11168,"Solute carrier family 2, facilitated glucose transporter member 2",Transporter,GTR2_HUMAN,
Q14576,ELAV-like protein 3,Unclassified,ELAV3_HUMAN,
Q15717,ELAV-like protein 1,Unclassified,ELAV1_HUMAN,
P19357,"Solute carrier family 2, facilitated glucose transporter member 4",Transporter,GLUT4_RAT,
Q8NFU5,Inositol polyphosphate multikinase,Kinase,IPMK_HUMAN,
Q9UHH9,Inositol hexakisphosphate kinase 2,Kinase,IP6K2_HUMAN,
P02708|P07510|P11230|Q04844|Q07001,Muscle-type nicotinic acetylcholine receptor,Ion channel,ACHA_HUMAN|ACHG_HUMAN|ACHB_HUMAN|ACHE_HUMAN|ACHD_HUMAN,ANTAGONIST
Q8WQX9,Phosphodiesterase,Enzyme,Q8WQX9_9TRYP,
P05771,Protein kinase C beta type,Kinase,KPCB_HUMAN,
Q05655,Protein kinase C delta type,Kinase,KPCD_HUMAN,
P22694,cAMP-dependent protein kinase catalytic subunit beta,Kinase,KAPCB_HUMAN,
P05129,Protein kinase C gamma type,Kinase,KPCG_HUMAN,
Q9Y243,RAC-gamma serine/threonine-protein kinase,Kinase,AKT3_HUMAN,
Q13237,cGMP-dependent protein kinase 2,Kinase,KGP2_HUMAN,
O76039,Cyclin-dependent kinase-like 5,Kinase,CDKL5_HUMAN,
P41743,Protein kinase C iota type,Kinase,KPCI_HUMAN,
O60331,Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma,Kinase,PI51C_HUMAN,
P05696|P09215|P09216|P09217|P63319|P68403|Q64617|Q9WTQ0,Protein kinase C (PKC),Kinase,KPCA_RAT|KPCD_RAT|KPCE_RAT|KPCZ_RAT|KPCG_RAT|KPCB_RAT|KPCL_RAT|KPCT_RAT,
Q13554|Q13555|Q13557|Q9UQM7,CaM kinase II,Kinase,KCC2B_HUMAN|KCC2G_HUMAN|KCC2D_HUMAN|KCC2A_HUMAN,
Q9GZQ4,Neuromedin-U receptor 2,GPCR,NMUR2_HUMAN,
P35351,Type-2 angiotensin II receptor,GPCR,AGTR2_RAT,ANTAGONIST
P26684,Endothelin-1 receptor,GPCR,EDNRA_RAT,ANTAGONIST
P01112,GTPase HRas,Cytosolic other,RASH_HUMAN,
P08913|P18089|P18825|P25100|P35348|P35368,Adrenergic receptor alpha,GPCR,ADA2A_HUMAN|ADA2B_HUMAN|ADA2C_HUMAN|ADA1D_HUMAN|ADA1A_HUMAN|ADA1B_HUMAN,AGONIST
O75936,Gamma-butyrobetaine dioxygenase,Enzyme,BODG_HUMAN,
P0DJD9,Pepsin A-5,Enzyme,PEPA5_HUMAN,
P49638,Alpha-tocopherol transfer protein,Transporter,TTPA_HUMAN,
P95276,Epoxide hydrolase; Epoxide hydrolase EphB,Enzyme,P95276_MYCTO,
P07099,Epoxide hydrolase 1,Enzyme,HYEP_HUMAN,
Q9D379,Epoxide hydrolase 1,Enzyme,HYEP_MOUSE,
P16152,Carbonyl reductase [NADPH] 1,Enzyme,CBR1_HUMAN,
Q6GI75,Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI,Enzyme,FABI_STAAR,
P54616,Enoyl-[acyl-carrier-protein] reductase [NADH] FabI,Enzyme,FABI_BACSU,
Q6UCJ9,Enoyl-acyl carrier reductase; Enoyl-acyl carrier reductase ENR,Enzyme,Q6UCJ9_TOXGO,
Q9BJJ9,Enoyl-ACP reductase,Enzyme,Q9BJJ9_PLAFA,
Q9RMI3,Enoyl-[acyl-carrier-protein] reductase [NADPH],Enzyme,Q9RMI3_STAAU,
M9TGV3,Enoyl-[acyl-carrier-protein] reductase [NULLDH],Enzyme,M9TGV3_MYCTX,
P51582,P2Y purinoceptor 4,GPCR,P2RY4_HUMAN,AGONIST
Q15077,P2Y purinoceptor 6,GPCR,P2RY6_HUMAN,AGONIST
Q96G91,P2Y purinoceptor 11,GPCR,P2Y11_HUMAN,AGONIST
P97321,Prolyl endopeptidase FAP,Enzyme,SEPR_MOUSE,
E1BI31,Dipeptidyl peptidase 9,Unclassified,E1BI31_BOVIN,
P34969,5-hydroxytryptamine receptor 7,GPCR,5HT7R_HUMAN,AGONIST
P30994,5-hydroxytryptamine receptor 2B,GPCR,5HT2B_RAT,ANTAGONIST
P09874,Poly [ADP-ribose] polymerase 1,Enzyme,PARP1_HUMAN,
P35372,Mu-type opioid receptor,GPCR,OPRM_HUMAN,MODULATOR
P22736,Nuclear receptor subfamily 4 group A member 1,Nuclear other,NR4A1_HUMAN,
O75343|P33402|Q02108|Q02153,Soluble guanylate cyclase,Enzyme,GCYB2_HUMAN|GCYA2_HUMAN|GCYA3_HUMAN|GCYB1_HUMAN,
P36544,Neuronal acetylcholine receptor subunit alpha-7,Ion channel,ACHA7_HUMAN,ALLOSTERIC MODULATOR
P23415|P23416|O75311|P48167,Glycine Receptor,Ion channel,GLRA1_HUMAN|GLRA2_HUMAN|GLRA3_HUMAN|GLRB_HUMAN,AGONIST
P91730,Glutamate-gated chloride channel,Ion channel,GLUCB_HAECO,MODULATOR
Q25634,Glutamate-gated chloride channel,Ion channel,Q25634_ONCVO,MODULATOR
P11507,Sarcoplasmic/endoplasmic reticulum calcium ATPase 2,Enzyme,AT2A2_RAT,
P06685,Sodium/potassium-transporting ATPase subunit alpha-1,Enzyme,AT1A1_RAT,
Q64578,Sarcoplasmic/endoplasmic reticulum calcium ATPase 1,Enzyme,AT2A1_RAT,
P51577,P2X purinoceptor 4,Unclassified,P2RX4_RAT,ALLOSTERIC MODULATOR
P00371,D-amino-acid oxidase,Unclassified,OXDA_PIG,
P11344,Tyrosinase,Enzyme,TYRO_MOUSE,
B2ZB02,Tyrosinase,Unclassified,B2ZB02_BACME,
Q00024,Polyphenol oxidase 1,Enzyme,PPO1_AGABI,
Q9NQS5,G-protein coupled receptor 84,GPCR,GPR84_HUMAN,
P47901,Vasopressin V1b receptor,GPCR,V1BR_HUMAN,ANTAGONIST
P13674,Prolyl 4-hydroxylase subunit alpha-1,Enzyme,P4HA1_HUMAN,
Q02809,"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1",Enzyme,PLOD1_HUMAN,
Q9UGH3,Solute carrier family 23 member 2,Transporter,S23A2_HUMAN,
Q9UHI7,Solute carrier family 23 member 1,Transporter,S23A1_HUMAN,
P00689,Pancreatic alpha-amylase,Enzyme,AMYP_RAT,
P0DJD9,Pepsin A-5,Enzyme,PEPA5_HUMAN,INHIBITOR
P23416,Glycine receptor subunit alpha-2,Ion channel,GLRA2_HUMAN,ALLOSTERIC MODULATOR
O75311,Glycine receptor subunit alpha-3,Ion channel,GLRA3_HUMAN,ALLOSTERIC MODULATOR
Q14330,N-arachidonyl glycine receptor,GPCR,GPR18_HUMAN,
P47746,Cannabinoid receptor 1,GPCR,CNR1_MOUSE,
Q9Y2T6,G-protein coupled receptor 55,GPCR,GPR55_HUMAN,
P21554|P34972,Cannabinoid receptor,GPCR,CNR1_HUMAN|CNR2_HUMAN,
P20272|Q9QZN9,Cannabinoid receptor,GPCR,CNR1_RAT|CNR2_RAT,
Q00788,Vasopressin V2 receptor,GPCR,V2R_RAT,ANTAGONIST
P30560,Vasopressin V1a receptor,GPCR,V1AR_RAT,ANTAGONIST
O43526,Potassium voltage-gated channel subfamily KQT member 2,Ion channel,KCNQ2_HUMAN,BLOCKER
Q9Y3Q4,Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4,Ion channel,HCN4_HUMAN,BLOCKER
P22607,Fibroblast growth factor receptor 3,Kinase,FGFR3_HUMAN,INHIBITOR
P11362,Fibroblast growth factor receptor 1,Kinase,FGFR1_HUMAN,INHIBITOR
Q08881,Tyrosine-protein kinase ITK/TSK,Kinase,ITK_HUMAN,INHIBITOR
P21127,Cyclin-dependent kinase 11B,Kinase,CD11B_HUMAN,
Q9UQ88,Cyclin-dependent kinase 11A,Kinase,CD11A_HUMAN,
Q02779,Mitogen-activated protein kinase kinase kinase 10,Kinase,M3K10_HUMAN,
Q6P3R8,Serine/threonine-protein kinase Nek5,Kinase,NEK5_HUMAN,
Q13233,Mitogen-activated protein kinase kinase kinase 1,Kinase,M3K1_HUMAN,
Q9UQL6,Histone deacetylase 5,Enzyme,HDAC5_HUMAN,INHIBITOR
Q8WUI4,Histone deacetylase 7,Enzyme,HDAC7_HUMAN,INHIBITOR
Q9BY41,Histone deacetylase 8,Enzyme,HDAC8_HUMAN,INHIBITOR
P56524,Histone deacetylase 4,Enzyme,HDAC4_HUMAN,
Q9UKV0,Histone deacetylase 9,Enzyme,HDAC9_HUMAN,INHIBITOR
O15379|Q9Y618,Histone deacetylase 3/Nuclear receptor corepressor 2 (HDAC3/NCoR2),Transcription factor,HDAC3_HUMAN|NCOR2_HUMAN,
O15379|O75376,Histone deacetylase 3/NCoR1,Transcription factor,HDAC3_HUMAN|NCOR1_HUMAN,
Q9Z2V5,Histone deacetylase 6,Enzyme,HDAC6_MOUSE,
O15379|P56524|Q13547|Q8WUI4|Q92769|Q969S8|Q96DB2|Q9BY41|Q9UBN7|Q9UKV0|Q9UQL6,Histone deacetylase,Enzyme,HDAC3_HUMAN|HDAC4_HUMAN|HDAC1_HUMAN|HDAC7_HUMAN|HDAC2_HUMAN|HDA10_HUMAN|HDA11_HUMAN|HDAC8_HUMAN|HDAC6_HUMAN|HDAC9_HUMAN|HDAC5_HUMAN,INHIBITOR
Q14831,Metabotropic glutamate receptor 7,GPCR,GRM7_HUMAN,AGONIST
O15303,Metabotropic glutamate receptor 6,GPCR,GRM6_HUMAN,AGONIST
P51788,Chloride channel protein 2,Ion channel,CLCN2_HUMAN,OPENER
Q9UQL6,Histone deacetylase 5,Enzyme,HDAC5_HUMAN,
Q92769,Histone deacetylase 2,Enzyme,HDAC2_HUMAN,INHIBITOR
O15379,Histone deacetylase 3,Enzyme,HDAC3_HUMAN,INHIBITOR
Q8WUI4,Histone deacetylase 7,Enzyme,HDAC7_HUMAN,
Q9UKV0,Histone deacetylase 9,Enzyme,HDAC9_HUMAN,
Q94F81,HD2 type histone deacetylase HDA106; Histone deacetylase 2b; Uncharacterized protein,Enzyme,Q94F81_MAIZE,
O09106,Histone deacetylase 1,Enzyme,HDAC1_MOUSE,
Q9ZTP8,Histone deacetylase,Enzyme,Q9ZTP8_MAIZE,
Q9XYC7,Histone deacetylase,Enzyme,Q9XYC7_PLAFA,
Q70I53,Histone deacetylase-like amidohydrolase,Enzyme,HDAH_ALCSD,
Q96DB2,Histone deacetylase 11,Enzyme,HDA11_HUMAN,
Q7K6A1,Histone deacetylase,Enzyme,Q7K6A1_PLAF7,
O15379|P56524|Q13547|Q8WUI4|Q92769|Q969S8|Q96DB2|Q9BY41|Q9UBN7|Q9UKV0|Q9UQL6,Histone deacetylase,Enzyme,HDAC3_HUMAN|HDAC4_HUMAN|HDAC1_HUMAN|HDAC7_HUMAN|HDAC2_HUMAN|HDA10_HUMAN|HDA11_HUMAN|HDAC8_HUMAN|HDAC6_HUMAN|HDAC9_HUMAN|HDAC5_HUMAN,
O15379|Q13547|Q9BY41|Q9UQL6,Histone deacetylase 1/3/5/8,Enzyme,HDAC3_HUMAN|HDAC1_HUMAN|HDAC8_HUMAN|HDAC5_HUMAN,
Q13547|Q92769,Histone deacetylase (HDAC1 and HDAC2),Enzyme,HDAC1_HUMAN|HDAC2_HUMAN,
B1WBY8|Q4QQW4|Q5RJZ2|Q6P6W3|Q99P96|Q99P97|Q99P99,Histone deacetylase,Enzyme,B1WBY8_RAT|HDAC1_RAT|Q5RJZ2_RAT|HDAC3_RAT|HDAC7_RAT|Q99P97_RAT|HDAC4_RAT,
A5H660,Histone deacetylase 8,Unclassified,A5H660_SCHMA,
P24527,Leukotriene A-4 hydrolase,Enzyme,LKHA4_MOUSE,
P07314,Gamma-glutamyltranspeptidase 1,Enzyme,GGT1_RAT,
P63116,Asc-type amino acid transporter 1,Unclassified,AAA1_RAT,
P21554,Cannabinoid receptor 1,GPCR,CNR1_HUMAN,ANTAGONIST
Q2VKV7,Sodium channel protein,Ion channel,Q2VKV7_SARSC,BLOCKER
O95470,Sphingosine-1-phosphate lyase 1,Enzyme,SGPL1_HUMAN,
P21453,Sphingosine 1-phosphate receptor 1,GPCR,S1PR1_HUMAN,AGONIST
Q9H228,Sphingosine 1-phosphate receptor 5,GPCR,S1PR5_HUMAN,AGONIST
O95977,Sphingosine 1-phosphate receptor 4,GPCR,S1PR4_HUMAN,AGONIST
Q99500,Sphingosine 1-phosphate receptor 3,GPCR,S1PR3_HUMAN,AGONIST
Q923J1,Transient receptor potential cation channel subfamily M member 7,Ion channel,TRPM7_MOUSE,BLOCKER
P61169,D(2) dopamine receptor,GPCR,DRD2_RAT,ANTAGONIST
P19327,5-hydroxytryptamine receptor 1A,GPCR,5HT1A_RAT,AGONIST
P07711,Cathepsin L1,Enzyme,CATL1_HUMAN,
P10619,Lysosomal protective protein,Enzyme,PPGB_HUMAN,INHIBITOR
O60911,Cathepsin L2,Enzyme,CATL2_HUMAN,
P43235,Cathepsin K,Enzyme,CATK_HUMAN,
P25774,Cathepsin S,Enzyme,CATS_HUMAN,
Q9UBX1,Cathepsin F,Enzyme,CATF_HUMAN,
A3EZI9|D2K2A8,"Hepatitis C virus serine protease, NS3/NS4A",Enzyme,A3EZI9_9HEPC|D2K2A8_9HEPC,INHIBITOR
A0A0K1CY61,Nonstructural protein NS3-4A,Unclassified,A0A0K1CY61_9HEPC,
Q9UNI1,Chymotrypsin-like elastase family member 1,Enzyme,CELA1_HUMAN,
C1KIQ2,NS3 protease,Unclassified,C1KIQ2_9HEPC,
Q0ZMF1,NS3 protease,Unclassified,Q0ZMF1_9HEPC,
Q91RS4,NS3 protease,Unclassified,Q91RS4_9HEPC,
Q04912,Macrophage-stimulating protein receptor,Kinase,RON_HUMAN,
Q15303,Receptor tyrosine-protein kinase erbB-4,Kinase,ERBB4_HUMAN,INHIBITOR
Q02763,Angiopoietin-1 receptor,Kinase,TIE2_HUMAN,INHIBITOR
P29322,Ephrin type-A receptor 8,Kinase,EPHA8_HUMAN,INHIBITOR
P54756,Ephrin type-A receptor 5,Kinase,EPHA5_HUMAN,INHIBITOR
P54764,Ephrin type-A receptor 4,Kinase,EPHA4_HUMAN,INHIBITOR
Q9UF33,Ephrin type-A receptor 6,Kinase,EPHA6_HUMAN,INHIBITOR
P29320,Ephrin type-A receptor 3,Kinase,EPHA3_HUMAN,INHIBITOR
P54762,Ephrin type-B receptor 1,Kinase,EPHB1_HUMAN,INHIBITOR
Q15375,Ephrin type-A receptor 7,Kinase,EPHA7_HUMAN,INHIBITOR
P54760,Ephrin type-B receptor 4,Kinase,EPHB4_HUMAN,INHIBITOR
Q13882,Protein-tyrosine kinase 6,Kinase,PTK6_HUMAN,INHIBITOR
P29323,Ephrin type-B receptor 2,Kinase,EPHB2_HUMAN,INHIBITOR
P21709,Ephrin type-A receptor 1,Kinase,EPHA1_HUMAN,INHIBITOR
O15197,Ephrin type-B receptor 6,Kinase,EPHB6_HUMAN,INHIBITOR
P21860,Receptor tyrosine-protein kinase erbB-3,Kinase,ERBB3_HUMAN,INHIBITOR
Q8WU08,Serine/threonine-protein kinase 32A,Kinase,ST32A_HUMAN,
Q182S6|Q18CF1|Q18CF3|Q18CI5,DNA-directed RNA polymerase,Enzyme,RPOZ_PEPD6|RPOB_PEPD6|RPOC_PEPD6|RPOA_PEPD6,INHIBITOR
P56696,Potassium voltage-gated channel subfamily KQT member 4,Ion channel,KCNQ4_HUMAN,ACTIVATOR
Q9Z351,Potassium voltage-gated channel subfamily KQT member 2,Ion channel,KCNQ2_MOUSE,
P00742,Coagulation factor X,Enzyme,FA10_HUMAN,INHIBITOR
O19045,Coagulation factor X,Enzyme,FA10_RABIT,
Q9H244,P2Y purinoceptor 12,GPCR,P2Y12_HUMAN,NEGATIVE ALLOSTERIC MODULATOR
Q9EPX4,P2Y purinoceptor 12,GPCR,P2Y12_RAT,
P01116,GTPase KRas,Enzyme,RASK_HUMAN,
P22830,"Ferrochelatase, mitochondrial",Enzyme,HEMH_HUMAN,
P30411,B2 bradykinin receptor,GPCR,BKRB2_HUMAN,ANTAGONIST
P25023,B2 bradykinin receptor,GPCR,BKRB2_RAT,
O70526,B2 bradykinin receptor,GPCR,BKRB2_CAVPO,
P46663,B1 bradykinin receptor,GPCR,BKRB1_HUMAN,ANTAGONIST
P32299,B2 bradykinin receptor,GPCR,BKRB2_MOUSE,ANTAGONIST
P97583,B1 bradykinin receptor,GPCR,BKRB1_RAT,ANTAGONIST
P08581,Hepatocyte growth factor receptor,Kinase,MET_HUMAN,INHIBITOR
Q9UM73,ALK tyrosine kinase receptor,Kinase,ALK_HUMAN,INHIBITOR
O14920,Inhibitor of nuclear factor kappa-B kinase subunit beta,Kinase,IKKB_HUMAN,
P43403,Tyrosine-protein kinase ZAP-70,Kinase,ZAP70_HUMAN,
Q8TD19,Serine/threonine-protein kinase Nek9,Kinase,NEK9_HUMAN,
Q62190,Macrophage-stimulating protein receptor,Kinase,RON_MOUSE,
Q02858,Angiopoietin-1 receptor,Kinase,TIE2_MOUSE,
O14936,Peripheral plasma membrane protein CASK,Kinase,CSKP_HUMAN,
P06748|Q9UM73,NPM/ALK (Nucleophosmin/ALK tyrosine kinase receptor),Kinase,NPM_HUMAN|ALK_HUMAN,
O15357,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",Enzyme,SHIP2_HUMAN,
Q8NB16,Mixed lineage kinase domain-like protein,Kinase,MLKL_HUMAN,
P23458,Tyrosine-protein kinase JAK1,Kinase,JAK1_HUMAN,INHIBITOR
O60674,Tyrosine-protein kinase JAK2,Kinase,JAK2_HUMAN,INHIBITOR
Q9H4B4,Serine/threonine-protein kinase PLK3,Kinase,PLK3_HUMAN,
P51956,Serine/threonine-protein kinase Nek3,Kinase,NEK3_HUMAN,
Q62120,Tyrosine-protein kinase JAK2,Kinase,JAK2_MOUSE,
O60674|P23458,JAK2/JAK1,Kinase,JAK2_HUMAN|JAK1_HUMAN,
P23458|P52333,JAK3/JAK1,Kinase,JAK1_HUMAN|JAK3_HUMAN,
P23458|P29597,JAK1/TYK2,Kinase,JAK1_HUMAN|TYK2_HUMAN,
O60674|P23458|P29597,JAK1/JAK2/TYK2,Kinase,JAK2_HUMAN|JAK1_HUMAN|TYK2_HUMAN,
O60674|P29597,JAK2/TYK2,Kinase,JAK2_HUMAN|TYK2_HUMAN,
Q9UNQ0,ATP-binding cassette sub-family G member 2,Transporter,ABCG2_HUMAN,INHIBITOR
P02766,Transthyretin,Secreted,TTHY_HUMAN,BINDING AGENT
Q99707,Methionine synthase,Enzyme,METH_HUMAN,
Q9UBK8,Methionine synthase reductase,Enzyme,MTRR_HUMAN,
Q9BXJ7,Protein amnionless,Unclassified,AMNLS_HUMAN,
Q96EY8,"Cob(I)yrinic acid a,c-diamide adenosyltransferase, mitochondrial",Enzyme,MMAB_HUMAN,
Q8IVH4,"Methylmalonic aciduria type A protein, mitochondrial",Enzyme,MMAA_HUMAN,
P20062,Transcobalamin-2,Secreted,TCO2_HUMAN,
P20061,Transcobalamin-1,Secreted,TCO1_HUMAN,
P49840|P49841,Glycogen synthase kinase-3,Kinase,GSK3A_HUMAN|GSK3B_HUMAN,INHIBITOR
P29218,Inositol-1(or 4)-monophosphatase 1,Enzyme,IMPA1_HUMAN,INHIBITOR
P35348,Alpha-1A adrenergic receptor,GPCR,ADA1A_HUMAN,INVERSE AGONIST
P25100,Alpha-1D adrenergic receptor,GPCR,ADA1D_HUMAN,INVERSE AGONIST
P35368,Alpha-1B adrenergic receptor,GPCR,ADA1B_HUMAN,INVERSE AGONIST
O15552,Free fatty acid receptor 2,GPCR,FFAR2_HUMAN,AGONIST
O14843,Free fatty acid receptor 3,GPCR,FFAR3_HUMAN,
P08913|P18089|P18825,Adrenergic receptor alpha-2,GPCR,ADA2A_HUMAN|ADA2B_HUMAN|ADA2C_HUMAN,AGONIST
P31388,5-hydroxytryptamine receptor 6,GPCR,5HT6R_RAT,
P05129,Protein kinase C gamma type,Kinase,KPCG_HUMAN,ACTIVATOR
Q05655,Protein kinase C delta type,Kinase,KPCD_HUMAN,ACTIVATOR
Q62226,Sonic hedgehog protein,Enzyme,SHH_MOUSE,
Q15465,Sonic hedgehog protein,Enzyme,SHH_HUMAN,
Q99835,Smoothened homolog,GPCR,SMO_HUMAN,INHIBITOR
P56726,Smoothened homolog,GPCR,SMO_MOUSE,
P13569,Cystic fibrosis transmembrane conductance regulator,Ion channel,CFTR_HUMAN,POSITIVE MODULATOR
P19235,Erythropoietin receptor,Membrane receptor,EPOR_HUMAN,AGONIST
P51787,Potassium voltage-gated channel subfamily KQT member 1,Ion channel,KCNQ1_HUMAN,ACTIVATOR
Q8R455,Transient receptor potential cation channel subfamily M member 8,Ion channel,TRPM8_RAT,
Q4QYD9,Heat sensitive channel TRPV3,Unclassified,Q4QYD9_RAT,
P00720,Endolysin,Enzyme,ENLYS_BPT4,
E0V9R7|E0VAD1|E0VBK5|E0VCA5|E0VCW8|E0VCW9|E0VDM3|E0VDR0|E0VED4|E0VGV6|E0VHL8|E0VHZ1|E0VJJ0|E0VM29|E0VMV6|E0VMV7|E0VMW9|E0VQ45|E0VQ46|E0VQ47|E0VRD2|E0VSD4|E0VSD5|E0VUR0|E0VUR1|E0VV39|E0VV52|E0VV70|E0VV72|E0VXT9|E0VZW4|E0W115|E0W2B1|E0W389|E0W4F7,Cytochrome P450,Enzyme,E0V9R7_PEDHC|E0VAD1_PEDHC|E0VBK5_PEDHC|E0VCA5_PEDHC|E0VCW8_PEDHC|E0VCW9_PEDHC|E0VDM3_PEDHC|E0VDR0_PEDHC|E0VED4_PEDHC|E0VGV6_PEDHC|E0VHL8_PEDHC|E0VHZ1_PEDHC|E0VJJ0_PEDHC|E0VM29_PEDHC|E0VMV6_PEDHC|E0VMV7_PEDHC|E0VMW9_PEDHC|E0VQ45_PEDHC|E0VQ46_PEDHC|E0VQ47_PEDHC|E0VRD2_PEDHC|E0VSD4_PEDHC|E0VSD5_PEDHC|E0VUR0_PEDHC|E0VUR1_PEDHC|E0VV39_PEDHC|E0VV52_PEDHC|E0VV70_PEDHC|E0VV72_PEDHC|E0VXT9_PEDHC|E0VZW4_PEDHC|E0W115_PEDHC|E0W2B1_PEDHC|E0W389_PEDHC|E0W4F7_PEDHC,INHIBITOR
Q6RI86,Transient receptor potential cation channel subfamily A member 1,Ion channel,TRPA1_RAT,ACTIVATOR
P08684|P20815|P24462|Q9HB55,Cytochrome P450 3A,Enzyme,CP3A4_HUMAN|CP3A5_HUMAN|CP3A7_HUMAN|CP343_HUMAN,INHIBITOR
P31639,Sodium/glucose cotransporter 2,Transporter,SC5A2_HUMAN,INHIBITOR
P13866,Sodium/glucose cotransporter 1,Transporter,SC5A1_HUMAN,
P53792,Sodium/glucose cotransporter 2,Transporter,SC5A2_RAT,
Q8WWX8,Sodium/myo-inositol cotransporter 2,Transporter,SC5AB_HUMAN,
Q9NY91,Low affinity sodium-glucose cotransporter,Transporter,SC5A4_HUMAN,
P08104,Sodium channel protein type 3 subunit alpha,Ion channel,SCN3A_RAT,
Q16555,Dihydropyrimidinase-related protein 2,Enzyme,DPYL2_HUMAN,
Q13258,Prostaglandin D2 receptor,GPCR,PD2R_HUMAN,ANTAGONIST
O43194,G-protein coupled receptor 39,GPCR,GPR39_HUMAN,
A6QR73,G protein-coupled receptor 39-1b,GPCR,A6QR73_RAT,
Q9NPD8,Ubiquitin-conjugating enzyme E2 T,Unclassified,UBE2T_HUMAN,
P49761,Dual specificity protein kinase CLK3,Kinase,CLK3_HUMAN,
Q13177,Serine/threonine-protein kinase PAK 2,Kinase,PAK2_HUMAN,
Q9BQI3,Eukaryotic translation initiation factor 2-alpha kinase 1,Kinase,E2AK1_HUMAN,
Q9NZV8,Potassium voltage-gated channel subfamily D member 2,Ion channel,KCND2_HUMAN,
P62937,Peptidyl-prolyl cis-trans isomerase A,Enzyme,PPIA_HUMAN,INHIBITOR
Q9UGI6,Small conductance calcium-activated potassium channel protein 3,Ion channel,KCNN3_HUMAN,
P29973,cGMP-gated cation channel alpha-1,Ion channel,CNGA1_HUMAN,BLOCKER
Q16280,Cyclic nucleotide-gated olfactory channel,Ion channel,CNGA2_HUMAN,BLOCKER
P29274|P29275,Adenosine A2 receptor,GPCR,AA2AR_HUMAN|AA2BR_HUMAN,ANTAGONIST
P40238,Thrombopoietin receptor,Membrane receptor,TPOR_HUMAN,AGONIST
Q7DHH4,MecA,Enzyme,Q7DHH4_STAAU,
P61073,C-X-C chemokine receptor type 4,GPCR,CXCR4_HUMAN,PARTIAL AGONIST
P48061,Stromal cell-derived factor 1,Cytokine,SDF1_HUMAN,
P51679,C-C chemokine receptor type 4,GPCR,CCR4_HUMAN,ANTAGONIST
O08565,C-X-C chemokine receptor type 4,GPCR,CXCR4_RAT,
P25106,Atypical chemokine receptor 3,GPCR,ACKR3_HUMAN,AGONIST
P35439|Q00959|Q00960|Q00961|Q62645|Q8VHN2|Q9R1M7,Glutamate NMDA receptor,Ion channel,NMDZ1_RAT|NMDE1_RAT|NMDE2_RAT|NMDE3_RAT|NMDE4_RAT|NMD3B_RAT|NMD3A_RAT,ANTAGONIST
P28062,Proteasome subunit beta type-8,Enzyme,PSB8_HUMAN,
P20618,Proteasome subunit beta type-1,Enzyme,PSB1_HUMAN,
P49721,Proteasome subunit beta type-2,Enzyme,PSB2_HUMAN,
Q03431,Parathyroid hormone/parathyroid hormone-related peptide receptor,GPCR,PTH1R_HUMAN,AGONIST
P49190,Parathyroid hormone 2 receptor,GPCR,PTH2R_HUMAN,AGONIST
P70555,Parathyroid hormone 2 receptor,GPCR,PTH2R_RAT,AGONIST
P25961,Parathyroid hormone/parathyroid hormone-related peptide receptor,GPCR,PTH1R_RAT,AGONIST
Q01718,Adrenocorticotropic hormone receptor,GPCR,ACTHR_HUMAN,AGONIST
Q92953,Potassium voltage-gated channel subfamily B member 2,Ion channel,KCNB2_HUMAN,BLOCKER
Q6RY99,Gamma-hydroxybutyrate receptor,Unclassified,Q6RY99_RAT,
Q9NR82,Potassium voltage-gated channel subfamily KQT member 5,Ion channel,KCNQ5_HUMAN,BLOCKER
O88944,Potassium voltage-gated channel subfamily KQT member 3,Ion channel,KCNQ3_RAT,INHIBITOR
P97414,Potassium voltage-gated channel subfamily KQT member 1,Ion channel,KCNQ1_MOUSE,INHIBITOR
P27471,Killer cell lectin-like receptor subfamily B member 1A,Unclassified,KLRBA_RAT,
P23897,Heat-stable enterotoxin receptor,Enzyme,GUC2C_RAT,AGONIST
P25092,Heat-stable enterotoxin receptor,Enzyme,GUC2C_HUMAN,AGONIST
E0VB18|E0VB20|E0VDF4|E0VDF5|E0VDF7|E0VP62,Nicotinic acetylcholine receptor,Ion channel,E0VB18_PEDHC|E0VB20_PEDHC|E0VDF4_PEDHC|E0VDF5_PEDHC|E0VDF7_PEDHC|E0VP62_PEDHC,AGONIST
Q63931,Cholecystokinin receptor type A,GPCR,CCKAR_CAVPO,
O08786|P56481,Cholecystokinin receptor,GPCR,CCKAR_MOUSE|GASR_MOUSE,
O54915,Nuclear receptor subfamily 1 group I member 2,Nuclear hormone receptor,NR1I2_MOUSE,ANTAGONIST
P16278,Beta-galactosidase,Enzyme,BGAL_HUMAN,
O06446,Protein translocase subunit SecA 1,Unclassified,SECA1_STAA8,
Q2FUW6,Protein translocase subunit SecA 2,Unclassified,SECA2_STAA8,
Q9NQS5,G-protein coupled receptor 84,GPCR,GPR84_HUMAN,AGONIST
P35917,Vascular endothelial growth factor receptor 3,Kinase,VGFR3_MOUSE,
O43613,Orexin receptor type 1,GPCR,OX1R_HUMAN,
P56524,Histone deacetylase 4,Enzyme,HDAC4_HUMAN,INHIBITOR
Q96DB2,Histone deacetylase 11,Enzyme,HDA11_HUMAN,INHIBITOR
O35678,Monoglyceride lipase,Enzyme,MGLL_MOUSE,
O08914,Fatty-acid amide hydrolase 1,Enzyme,FAAH1_MOUSE,
Q7T664,Genome polyprotein,Unclassified,Q7T664_HRV1A,
P32241,Vasoactive intestinal polypeptide receptor 1,GPCR,VIPR1_HUMAN,AGONIST
P52333,Tyrosine-protein kinase JAK3,Kinase,JAK3_HUMAN,INHIBITOR
P29597,Non-receptor tyrosine-protein kinase TYK2,Kinase,TYK2_HUMAN,INHIBITOR
Q62137,Tyrosine-protein kinase JAK3,Kinase,JAK3_MOUSE,
P23458|P29597,JAK1/TYK2,Kinase,JAK1_HUMAN|TYK2_HUMAN,INHIBITOR
O60674|P23458|P29597,JAK1/JAK2/TYK2,Kinase,JAK2_HUMAN|JAK1_HUMAN|TYK2_HUMAN,INHIBITOR
O60674|P29597,JAK2/TYK2,Kinase,JAK2_HUMAN|TYK2_HUMAN,INHIBITOR
Q63272,Tyrosine-protein kinase JAK3,Kinase,JAK3_RAT,
O60674|P23458,JAK2/JAK1,Kinase,JAK2_HUMAN|JAK1_HUMAN,INHIBITOR
P23458|P52333,JAK3/JAK1,Kinase,JAK1_HUMAN|JAK3_HUMAN,INHIBITOR
Q04912,Macrophage-stimulating protein receptor,Kinase,RON_HUMAN,INHIBITOR
P11274,Breakpoint cluster region protein,Kinase,BCR_HUMAN,INHIBITOR
P41240,Tyrosine-protein kinase CSK,Kinase,CSK_HUMAN,INHIBITOR
Q9BWU1,Cyclin-dependent kinase 19,Kinase,CDK19_HUMAN,INHIBITOR
P49336,Cyclin-dependent kinase 8,Kinase,CDK8_HUMAN,INHIBITOR
Q13546,Receptor-interacting serine/threonine-protein kinase 1,Kinase,RIPK1_HUMAN,INHIBITOR
Q9Y572,Receptor-interacting serine/threonine-protein kinase 3,Kinase,RIPK3_HUMAN,INHIBITOR
O95838,Glucagon-like peptide 2 receptor,GPCR,GLP2R_HUMAN,AGONIST
Q9Z0W0,Glucagon-like peptide 2 receptor,GPCR,GLP2R_RAT,
P55157,Microsomal triglyceride transfer protein large subunit,Cytosolic other,MTP_HUMAN,INHIBITOR
Q96SW2,Protein cereblon,Cytosolic other,CRBN_HUMAN,
O97554,Prostaglandin G/H synthase 1,Enzyme,PGH1_RABIT,
O02768,Prostaglandin G/H synthase 2,Enzyme,PGH2_RABIT,
P48050,Inward rectifier potassium channel 4,Ion channel,KCNJ4_HUMAN,ACTIVATOR
P14867|P18507|P47870,GABA-A receptor alpha-1/beta-2/gamma-2,Ion channel,GBRA1_HUMAN|GBRG2_HUMAN|GBRB2_HUMAN,NEGATIVE MODULATOR
P18507|P47869|P47870,GABA A receptor alpha-2/beta-2/gamma-2,Ion channel,GBRG2_HUMAN|GBRA2_HUMAN|GBRB2_HUMAN,NEGATIVE MODULATOR
P14867|P18505|P18507,GABA A receptor alpha-1/beta-1/gamma-2,Ion channel,GBRA1_HUMAN|GBRB1_HUMAN|GBRG2_HUMAN,NEGATIVE MODULATOR
P9WPS1|P9WPU5|P9WPU7|P9WPU9|P9WPV1|P9WPV3|P9WPV5|P9WPV7,ATP synthase,Enzyme,ATPL_MYCTU|ATPB_MYCTU|ATPA_MYCTU|ATPG_MYCTU|ATPE_MYCTU|ATPFD_MYCTU|ATPF_MYCTU|ATP6_MYCTU,INHIBITOR
Q5TIX5,ATP synthase subunit c,Enzyme,Q5TIX5_MYCSM,
P00845,ATP synthase subunit c,Enzyme,ATPL_BACP3,
P13569,Cystic fibrosis transmembrane conductance regulator,Ion channel,CFTR_HUMAN,INHIBITOR
Q5XXA6,Anoctamin-1,Ion channel,ANO1_HUMAN,INHIBITOR
Q14145,Kelch-like ECH-associated protein 1,Cytosolic other,KEAP1_HUMAN,INHIBITOR
B2GV46,Free fatty acid receptor 3,GPCR,FFAR3_RAT,
Q02750,Dual specificity mitogen-activated protein kinase kinase 1,Kinase,MP2K1_HUMAN,INHIBITOR
P36507,Dual specificity mitogen-activated protein kinase kinase 2,Kinase,MP2K2_HUMAN,INHIBITOR
P21802,Fibroblast growth factor receptor 2,Kinase,FGFR2_HUMAN,AGONIST
P28565,5-hydroxytryptamine receptor 1D,GPCR,5HT1D_RAT,ANTAGONIST
Q9NP56,"cAMP-specific 3',5'-cyclic phosphodiesterase 7B",Enzyme,PDE7B_HUMAN,
Q02153,Guanylate cyclase soluble subunit beta-1,Enzyme,GCYB1_HUMAN,POSITIVE ALLOSTERIC MODULATOR
Q9BRX8,Redox-regulatory protein FAM213A,Unclassified,F213A_HUMAN,
P42680,Tyrosine-protein kinase Tec,Kinase,TEC_HUMAN,INHIBITOR
P42681,Tyrosine-protein kinase TXK,Kinase,TXK_HUMAN,INHIBITOR
Q06187,Tyrosine-protein kinase BTK,Kinase,BTK_HUMAN,INHIBITOR
P27958,Genome polyprotein,Polyprotein,POLG_HCVH,INHIBITOR
Q6GYR8,Polyprotein,Polyprotein,Q6GYR8_9HEPC,INHIBITOR
Q9IGQ6,Neuraminidase,Enzyme,NRAM_I18A0,INHIBITOR
P48357,Leptin receptor,Membrane receptor,LEPR_HUMAN,AGONIST
Q08493,"cAMP-specific 3',5'-cyclic phosphodiesterase 4C",Enzyme,PDE4C_HUMAN,INHIBITOR
Q08499,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",Enzyme,PDE4D_HUMAN,INHIBITOR
Q2M3M2,Sodium/glucose cotransporter 4,Transporter,SC5A9_HUMAN,
A0PJK1,Sodium/glucose cotransporter 5,Transporter,SC5AA_HUMAN,
P32245,Melanocortin receptor 4,GPCR,MC4R_HUMAN,AGONIST
P33032,Melanocortin receptor 5,GPCR,MC5R_HUMAN,AGONIST
P41968,Melanocortin receptor 3,GPCR,MC3R_HUMAN,AGONIST
P33033,Melanocortin receptor 3,GPCR,MC3R_MOUSE,
P41149,Melanocortin receptor 5,GPCR,MC5R_MOUSE,
P56450,Melanocortin receptor 4,GPCR,MC4R_MOUSE,
Q01727,Melanocyte-stimulating hormone receptor,GPCR,MSHR_MOUSE,
Q01726,Melanocyte-stimulating hormone receptor,GPCR,MSHR_HUMAN,AGONIST
P03952,Plasma kallikrein,Enzyme,KLKB1_HUMAN,INHIBITOR
P10912,Growth hormone receptor,GPCR,GHR_HUMAN,AGONIST
Q3TBT3,Stimulator of interferon genes protein,Unclassified,STING_MOUSE,
Q60748,Corticotropin-releasing factor receptor 2,GPCR,CRFR2_MOUSE,AGONIST
P47866,Corticotropin-releasing factor receptor 2,GPCR,CRFR2_RAT,AGONIST
Q13324,Corticotropin-releasing factor receptor 2,GPCR,CRFR2_HUMAN,AGONIST
P34998,Corticotropin-releasing factor receptor 1,GPCR,CRFR1_HUMAN,AGONIST
P41212,Transcription factor ETV6,Transcription factor,ETV6_HUMAN,
P25116,Proteinase-activated receptor 1,GPCR,PAR1_HUMAN,ANTAGONIST
F2SHH3,Lanosterol 14-alpha demethylase,Enzyme,F2SHH3_TRIRC,INHIBITOR
Q5L478,Nonstructural protein 5A,Unclassified,Q5L478_9HEPC,
P26663,Genome polyprotein,Polyprotein,POLG_HCVBK,INHIBITOR
P26637,"Leucine--tRNA ligase, cytoplasmic",Enzyme,SYLC_YEAST,
F2SF18,Leucine-tRNA ligase,Enzyme,F2SF18_TRIRC,INHIBITOR
Q8NEB9,Phosphatidylinositol 3-kinase catalytic subunit type 3,Kinase,PK3C3_HUMAN,
P42338,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform",Kinase,PK3CB_HUMAN,
O00329,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform",Kinase,PK3CD_HUMAN,INHIBITOR
P58308,Orexin receptor type 2,GPCR,OX2R_MOUSE,
P58307,Orexin receptor type 1,GPCR,OX1R_MOUSE,
O43613,Orexin receptor type 1,GPCR,OX1R_HUMAN,ANTAGONIST
O43614,Orexin receptor type 2,GPCR,OX2R_HUMAN,ANTAGONIST
P53792,Sodium/glucose cotransporter 2,Transporter,SC5A2_RAT,INHIBITOR
Q8C3K6,Sodium/glucose cotransporter 1,Transporter,SC5A1_MOUSE,INHIBITOR
P53790,Sodium/glucose cotransporter 1,Transporter,SC5A1_RAT,INHIBITOR
Q923I7,Sodium/glucose cotransporter 2,Transporter,SC5A2_MOUSE,INHIBITOR
P07650,Thymidine phosphorylase,Enzyme,TYPH_ECOLI,
P19971,Thymidine phosphorylase,Enzyme,TYPH_HUMAN,INHIBITOR
P21802,Fibroblast growth factor receptor 2,Kinase,FGFR2_HUMAN,INHIBITOR
P49840,Glycogen synthase kinase-3 alpha,Kinase,GSK3A_HUMAN,
P22455,Fibroblast growth factor receptor 4,Kinase,FGFR4_HUMAN,INHIBITOR
Q13976,cGMP-dependent protein kinase 1,Kinase,KGP1_HUMAN,
P01375,Tumor necrosis factor,Cytokine,TNFA_HUMAN,ANTIBODY BINDING
P15692,Vascular endothelial growth factor A,Secreted,VEGFA_HUMAN,ANTAGONIST
Q9UKK3,Poly [ADP-ribose] polymerase 4,Enzyme,PARP4_HUMAN,
Q53GL7,Poly [ADP-ribose] polymerase 10,Enzyme,PAR10_HUMAN,
Q9H0J9,Poly [ADP-ribose] polymerase 12,Enzyme,PAR12_HUMAN,
Q460N3,Poly [ADP-ribose] polymerase 15,Enzyme,PAR15_HUMAN,
Q2NL67,Poly [ADP-ribose] polymerase 6,Unclassified,PARP6_HUMAN,
Q8N5Y8,Mono [ADP-ribose] polymerase PARP16,Unclassified,PAR16_HUMAN,
O95271,Tankyrase-1,Enzyme,TNKS1_HUMAN,
Q9UGN5,Poly [ADP-ribose] polymerase 2,Enzyme,PARP2_HUMAN,INHIBITOR
Q9Y6F1,Poly [ADP-ribose] polymerase 3,Enzyme,PARP3_HUMAN,INHIBITOR
P31358,CAMPATH-1 antigen,Surface antigen,CD52_HUMAN,ANTIBODY BINDING
Q9WMX2,Genome polyprotein [Cleaved into: Core protein p21,Unclassified,POLG_HCVCO,
Q8JXU8,NS5B protein,Enzyme,Q8JXU8_9HEPC,
Q8JXU8,NS5B protein,Unclassified,Q8JXU8_9HEPC,
P15391,B-lymphocyte antigen CD19,Surface antigen,CD19_HUMAN,ANTIBODY BINDING
P07766|P09693|P04234,T-cell surface glycoprotein CD3,Surface antigen,CD3E_HUMAN|CD3G_HUMAN|CD3D_HUMAN,ANTIBODY BINDING
P15692,Vascular endothelial growth factor A,Secreted,VEGFA_HUMAN,INHIBITOR
P49763,Placenta growth factor,Secreted,PLGF_HUMAN,INHIBITOR
P49765,Vascular endothelial growth factor B,Secreted,VEGFB_HUMAN,INHIBITOR
P35968,Vascular endothelial growth factor receptor 2,Kinase,VGFR2_HUMAN,ANTIBODY BINDING
Q15116,Programmed cell death protein 1,Membrane receptor,PDCD1_HUMAN,ANTIBODY BINDING
P09619|P16234,Platelet-derived growth factor receptor,Kinase,PGFRB_HUMAN|PGFRA_HUMAN,AGONIST
P32301,Glucagon-like peptide 1 receptor,GPCR,GLP1R_RAT,AGONIST
P23945,Follicle-stimulating hormone receptor,GPCR,FSHR_HUMAN,AGONIST
P22888,Lutropin-choriogonadotropic hormone receptor,GPCR,LSHR_HUMAN,AGONIST
P16473,Thyrotropin receptor,GPCR,TSHR_HUMAN,AGONIST
Q64326,Adrenocorticotropic hormone receptor,GPCR,ACTHR_MOUSE,AGONIST
P08887|P40189,Interleukin-6 receptor,Membrane receptor,IL6RA_HUMAN|IL6RB_HUMAN,ANTIBODY BINDING
Q16552,Interleukin-17A,Cytokine,IL17_HUMAN,ANTIBODY BINDING
P03420,Fusion glycoprotein F0,Surface antigen,FUS_HRSVA,ANTIBODY BINDING
P17612,cAMP-dependent protein kinase catalytic subunit alpha,Kinase,KAPCA_HUMAN,INHIBITOR
K7XJL6,Genome polyprotein,Unclassified,K7XJL6_9HEPC,
Q99IB8,Genome polyprotein,Polyprotein,POLG_HCVJF,INHIBITOR
P01589,Interleukin-2 receptor subunit alpha,Membrane receptor,IL2RA_HUMAN,ANTIBODY BINDING
P50750,Cyclin-dependent kinase 9,Kinase,CDK9_HUMAN,
P20248|P24941,CDK2/Cyclin A,Kinase,CCNA2_HUMAN|CDK2_HUMAN,
P24385|Q00534,CDK6/cyclin D1,Kinase,CCND1_HUMAN|CDK6_HUMAN,
Q15418,Ribosomal protein S6 kinase alpha-1,Kinase,KS6A1_HUMAN,INHIBITOR
Q13627,Dual specificity tyrosine-phosphorylation-regulated kinase 1A,Kinase,DYR1A_HUMAN,INHIBITOR
Q00534,Cyclin-dependent kinase 6,Kinase,CDK6_HUMAN,INHIBITOR
P11802,Cyclin-dependent kinase 4,Kinase,CDK4_HUMAN,INHIBITOR
P32239,Gastrin/cholecystokinin type B receptor,GPCR,GASR_HUMAN,AGONIST
P0AD65,Penicillin-binding protein 2,Enzyme,PBP2_ECOLI,
P05364,Beta-lactamase,Enzyme,AMPC_ENTCL,INHIBITOR
P24735,Beta-lactamase,Enzyme,AMPC_PSEAE,INHIBITOR
Q9EXV5,Beta-lactamase,Enzyme,Q9EXV5_ECOLX,INHIBITOR
Q9Y275,Tumor necrosis factor ligand superfamily member 13B,Cytokine,TN13B_HUMAN,ANTIBODY BINDING
P05106|P08514,Integrin alpha-IIb/beta-3,Adhesion,ITB3_HUMAN|ITA2B_HUMAN,ANTIBODY BINDING
P11836,B-lymphocyte antigen CD20,Surface antigen,CD20_HUMAN,ANTIBODY BINDING
P01584,Interleukin-1 beta,Cytokine,IL1B_HUMAN,ANTIBODY BINDING
P01589|P14784|P31785,Interleukin-2 receptor,Membrane receptor,IL2RA_HUMAN|IL2RB_HUMAN|IL2RG_HUMAN,ANTIBODY BINDING
P00533,Epidermal growth factor receptor,Kinase,EGFR_HUMAN,ANTIBODY BINDING
P00533,Epidermal growth factor receptor,Kinase,EGFR_HUMAN,AGONIST
P15692,Vascular endothelial growth factor A,Secreted,VEGFA_HUMAN,ANTIBODY BINDING
P04626,Receptor tyrosine-protein kinase erbB-2,Kinase,ERBB2_HUMAN,ANTIBODY BINDING
P16410,Cytotoxic T-lymphocyte protein 4,Surface antigen,CTLA4_HUMAN,ANTIBODY BINDING
P20701,Leukocyte adhesion glycoprotein LFA-1 alpha,Adhesion,ITAL_HUMAN,ANTIBODY BINDING
P13423,Protective antigen,Secreted,PAG_BACAN,ANTIBODY BINDING
P28908,Tumor necrosis factor receptor superfamily member 8,Membrane receptor,TNR8_HUMAN,BINDING AGENT
O14788,Tumor necrosis factor ligand superfamily member 11,Cytokine,TNF11_HUMAN,ANTIBODY BINDING
P29459|P29460,Interleukin-12,Cytokine,IL12A_HUMAN|IL12B_HUMAN,ANTIBODY BINDING
P29460|Q9NPF7,Interleukin-23,Cytokine,IL12B_HUMAN|IL23A_HUMAN,ANTIBODY BINDING
P01031,Complement C5,Secreted,CO5_HUMAN,ANTIBODY BINDING
P13612|P05556,Integrin alpha-4/beta-1,Adhesion,ITA4_HUMAN|ITB1_HUMAN,ANTIBODY BINDING
P13612|P26010,Integrin alpha-4/beta-7,Adhesion,ITA4_HUMAN|ITB7_HUMAN,ANTIBODY BINDING
P01854,Ig epsilon chain C region,Antibody,IGHE_HUMAN,ANTIBODY BINDING
P43490,Nicotinamide phosphoribosyltransferase,Cytokine,NAMPT_HUMAN,
P05231,Interleukin-6,Cytokine,IL6_HUMAN,ANTIBODY BINDING
P01375,Tumor necrosis factor,Cytokine,TNFA_HUMAN,INHIBITOR
P20138,Myeloid cell surface antigen CD33,Surface antigen,CD33_HUMAN,ANTIBODY BINDING
Q99062,Granulocyte colony-stimulating factor receptor,Membrane receptor,CSF3R_HUMAN,ACTIVATOR
P07445,Steroid Delta-isomerase,Unclassified,SDIS_PSEPU,
Q8NBP7,Proprotein convertase subtilisin/kexin type 9,Enzyme,PCSK9_HUMAN,INHIBITOR
P41144,Kappa-type opioid receptor,GPCR,OPRK_CAVPO,AGONIST
P15127,Insulin receptor,Kinase,INSR_RAT,
Q99835,Smoothened homolog,GPCR,SMO_HUMAN,ANTAGONIST
P08069,Insulin-like growth factor 1 receptor,Kinase,IGF1R_HUMAN,AGONIST
P13569,Cystic fibrosis transmembrane conductance regulator,Ion channel,CFTR_HUMAN,PHARMACOLOGICAL CHAPERONE
P01589|P14784|P31785,Interleukin-2 receptor,Membrane receptor,IL2RA_HUMAN|IL2RB_HUMAN|IL2RG_HUMAN,AGONIST
P10912,Growth hormone receptor,GPCR,GHR_HUMAN,ANTAGONIST
P14778|Q9NPH3,"Interleukin-1 receptor, type I",Membrane receptor,IL1R1_HUMAN|IL1AP_HUMAN,ANTAGONIST
P15509|P32927,Granulocyte macrophage colony-stimulating factor receptor,Membrane receptor,CSF2R_HUMAN|IL3RB_HUMAN,AGONIST
Q14626|P40189,Interleukin-11 receptor,Membrane receptor,I11RA_HUMAN|IL6RB_HUMAN,AGONIST
P51679,C-C chemokine receptor type 4,GPCR,CCR4_HUMAN,ANTIBODY BINDING
P35462,D(3) dopamine receptor,GPCR,DRD3_HUMAN,PARTIAL AGONIST
A6XA80,Leukotriene C4 synthase,Unclassified,LTC4S_CAVPO,
P00747,Plasminogen,Enzyme,PLMN_HUMAN,ACTIVATOR
P36507,Dual specificity mitogen-activated protein kinase kinase 2,Kinase,MP2K2_HUMAN,ALLOSTERIC MODULATOR
P61169,D(2) dopamine receptor,GPCR,DRD2_RAT,AGONIST
P05113,Interleukin-5,Cytokine,IL5_HUMAN,ANTIBODY BINDING
P53634,Dipeptidyl peptidase 1,Enzyme,CATC_HUMAN,
P28907,Lymphocyte differentiation antigen CD38,Tumour-associated antigen,CD38_HUMAN,ANTIBODY BINDING
Q9NQ25,SLAM family member 7,Membrane receptor,SLAF7_HUMAN,ANTIBODY BINDING
O39929,Genome polyprotein,Polyprotein,POLG_HCVED,INHIBITOR
P06729,T-cell surface antigen CD2,Surface antigen,CD2_HUMAN,INHIBITOR
P33681,T-lymphocyte activation antigen CD80,Surface antigen,CD80_HUMAN,INHIBITOR
P42081,T-lymphocyte activation antigen CD86,Surface antigen,CD86_HUMAN,INHIBITOR
P01583,Interleukin-1 alpha,Cytokine,IL1A_HUMAN,INHIBITOR
P18510,Interleukin-1 receptor antagonist protein,Unclassified,IL1RA_HUMAN,INHIBITOR
P01584,Interleukin-1 beta,Cytokine,IL1B_HUMAN,INHIBITOR
Q59750,Beta-galactosidase,Enzyme,BGAL_RHIML,
Q02401,Lactase-phlorizin hydrolase,Enzyme,LPH_RAT,
Q9UUZ4,Alpha-galactosidase C,Enzyme,AGALC_ASPNG,
Q42656,Alpha-galactosidase,Enzyme,AGAL_COFAR,
D3ZUM4,Beta-galactosidase,Enzyme,D3ZUM4_RAT,
Q8VNN2,Beta-galactosidase,Enzyme,BGAL_ECOLX,
P06280,Alpha-galactosidase A,Enzyme,AGAL_HUMAN,PHARMACOLOGICAL CHAPERONE
Q07817,Bcl-2-like protein 1,Cytosolic other,B2CL1_HUMAN,INHIBITOR
Q92843,Apoptosis regulator Bcl-W,Cytosolic other,B2CL2_HUMAN,INHIBITOR
P10415,Apoptosis regulator Bcl-2,Cytosolic other,BCL2_HUMAN,INHIBITOR
P17181|P48551,Interferon alpha/beta receptor,Membrane receptor,INAR1_HUMAN|INAR2_HUMAN,AGONIST
P28223,5-hydroxytryptamine receptor 2A,GPCR,5HT2A_HUMAN,INVERSE AGONIST
P22734,Catechol O-methyltransferase,Enzyme,COMT_RAT,INHIBITOR
O88587,Catechol O-methyltransferase,Enzyme,COMT_MOUSE,INHIBITOR
Q9NZQ7,Programmed cell death 1 ligand 1,CD molecules,PD1L1_HUMAN,ANTIBODY BINDING
Q81495,Genome polyprotein,Polyprotein,POLG_HCVK3,INHIBITOR
Q9DHD6,Genome polyprotein,Polyprotein,POLG_HCVJP,INHIBITOR
O91936,Genome polyprotein,Polyprotein,POLG_HCVSA,INHIBITOR
Q5I2N3,Genome polyprotein,Polyprotein,POLG_HCV6A,INHIBITOR
P05362,Intercellular adhesion molecule 1,Unclassified,ICAM1_HUMAN,
P20701|P05107,Integrin alpha-L/beta-2,Adhesion,ITAL_HUMAN|ITB2_HUMAN,ANTAGONIST
Q96F46|Q8NAC3,Interleukin-17 receptor,Membrane receptor,I17RA_HUMAN|I17RC_HUMAN,ANTIBODY BINDING
P41180,Extracellular calcium-sensing receptor,GPCR,CASR_HUMAN,AGONIST
P11532,exon 51 of dystrophin pre-mRNA,RNA,DMD_HUMAN,BINDING AGENT
P16234,Platelet-derived growth factor receptor alpha,Kinase,PGFRA_HUMAN,ANTIBODY BINDING
P30874,Somatostatin receptor type 2,GPCR,SSR2_HUMAN,ANTAGONIST
P18177,Toxin B,Enzyme,TOXB_CLODI,ANTIBODY BINDING
Q2M2I8,AP2-associated protein kinase 1,Kinase,AAK1_HUMAN,INHIBITOR
Q9NSY1,BMP-2-inducible protein kinase,Kinase,BMP2K_HUMAN,INHIBITOR
O14976,Cyclin-G-associated kinase,Kinase,GAK_HUMAN,INHIBITOR
Q9H2K2,Tankyrase-2,Enzyme,TNKS2_HUMAN,INHIBITOR
O95271,Tankyrase-1,Enzyme,TNKS1_HUMAN,INHIBITOR
Q9UKK3,Poly [ADP-ribose] polymerase 4,Enzyme,PARP4_HUMAN,INHIBITOR
Q53GL7,Poly [ADP-ribose] polymerase 10,Enzyme,PAR10_HUMAN,INHIBITOR
Q9H0J9,Poly [ADP-ribose] polymerase 12,Enzyme,PAR12_HUMAN,INHIBITOR
Q460N5,Poly [ADP-ribose] polymerase 14,Enzyme,PAR14_HUMAN,INHIBITOR
Q460N3,Poly [ADP-ribose] polymerase 15,Enzyme,PAR15_HUMAN,INHIBITOR
P19438,Tumor necrosis factor receptor superfamily member 1A,Unclassified,TNR1A_HUMAN,
P17752,Tryptophan 5-hydroxylase 1,Enzyme,TPH1_HUMAN,INHIBITOR
O39930,RNA-directed RNA polymerase,Unclassified,O39930_9HEPC,
Q9Y6F1,Poly [ADP-ribose] polymerase 3,Enzyme,PARP3_HUMAN,
Q460N5,Poly [ADP-ribose] polymerase 14,Enzyme,PAR14_HUMAN,
P24394,Interleukin-4 receptor subunit alpha,Membrane receptor,IL4RA_HUMAN,ANTIBODY BINDING
Q01827,Synaptic vesicular amine transporter,Transporter,VMAT2_RAT,INHIBITOR
P55859,Purine nucleoside phosphorylase,Enzyme,PNPH_BOVIN,
P00491,Purine nucleoside phosphorylase,Enzyme,PNPH_HUMAN,INHIBITOR
P51817,cAMP-dependent protein kinase catalytic subunit PRKX,Kinase,PRKX_HUMAN,
P08069,Insulin-like growth factor 1 receptor,Kinase,IGF1R_HUMAN,INHIBITOR
P06213,Insulin receptor,Kinase,INSR_HUMAN,INHIBITOR
P08922,Proto-oncogene tyrosine-protein kinase ROS,Kinase,ROS1_HUMAN,INHIBITOR
P04629,High affinity nerve growth factor receptor,Kinase,NTRK1_HUMAN,AGONIST
P08138,Tumor necrosis factor receptor superfamily member 16,Membrane receptor,TNR16_HUMAN,AGONIST
P20273,B-cell receptor CD22,Membrane receptor,CD22_HUMAN,ANTIBODY BINDING
O75874,Isocitrate dehydrogenase [NADP] cytoplasmic,Enzyme,IDHC_HUMAN,
P48735,"Isocitrate dehydrogenase [NADP], mitochondrial",Enzyme,IDHP_HUMAN,INHIBITOR
Q9NY57,Serine/threonine-protein kinase 32B,Kinase,ST32B_HUMAN,
P42338,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform",Kinase,PK3CB_HUMAN,INHIBITOR
P48736,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",Kinase,PK3CG_HUMAN,INHIBITOR
P42336,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform",Kinase,PK3CA_HUMAN,INHIBITOR
O95069,Potassium channel subfamily K member 2,Ion channel,KCNK2_HUMAN,BLOCKER
P51813,Cytoplasmic tyrosine-protein kinase BMX,Kinase,BMX_HUMAN,INHIBITOR
F5HC79|F5HGI9|F5HCU8,DNA terminase complex,Enzyme,TRM1_HCMVM|TRM2_HCMVM|TRM3_HCMVM,INHIBITOR
Q01344,Interleukin-5 receptor subunit alpha,Membrane receptor,IL5RA_HUMAN,ANTIBODY BINDING
P00742,Coagulation factor X,Enzyme,FA10_HUMAN,ANTIBODY BINDING
P00740,Coagulation factor IX,Enzyme,FA9_HUMAN,ANTIBODY BINDING
P13866,Sodium/glucose cotransporter 1,Transporter,SC5A1_HUMAN,INHIBITOR
P50052,Type-2 angiotensin II receptor,GPCR,AGTR2_HUMAN,AGONIST
P30556,Type-1 angiotensin II receptor,GPCR,AGTR1_HUMAN,AGONIST
Q76353,Integrase,Unclassified,Q76353_9HIV1,
Q12908,Ileal sodium/bile acid cotransporter,Transporter,NTCP2_HUMAN,INHIBITOR
P15207,Androgen receptor,Transcription factor,ANDR_RAT,ANTAGONIST
P10275,Androgen receptor,Nuclear hormone receptor,ANDR_HUMAN,INHIBITOR
P01730,T-cell surface glycoprotein CD4,Membrane receptor,CD4_HUMAN,ANTIBODY BINDING
P0DMS8,Adenosine receptor A3,GPCR,AA3R_HUMAN,INHIBITOR
P43405,Tyrosine-protein kinase SYK,Kinase,KSYK_HUMAN,INHIBITOR
Q9GZV9,Fibroblast growth factor 23,Secreted,FGF23_HUMAN,ANTIBODY BINDING
O60894|Q16602,Calcitonin-gene-related peptide receptor,GPCR,RAMP1_HUMAN|CALRL_HUMAN,ANTIBODY BINDING
Q25634,Glutamate-gated chloride channel,Ion channel,Q25634_ONCVO,INHIBITOR
Q14330,N-arachidonyl glycine receptor,GPCR,GPR18_HUMAN,AGONIST
Q9Y5S1,Transient receptor potential cation channel subfamily V member 2,Ion channel,TRPV2_HUMAN,ACTIVATOR
Q8NER1,Transient receptor potential cation channel subfamily V member 1,Ion channel,TRPV1_HUMAN,INHIBITOR
Q9Y2T6,G-protein coupled receptor 55,GPCR,GPR55_HUMAN,ANTAGONIST
P33815,Envelope protein F13,Viral envelope protein,F13_VAR67,INHIBITOR
O75874,Isocitrate dehydrogenase [NADP] cytoplasmic,Enzyme,IDHC_HUMAN,INHIBITOR
Q8SPZ1,Gonadotropin-releasing hormone receptor,GPCR,GNRHR_MACMU,
P03433,Polymerase acidic protein,Enzyme,PA_I34A1,INHIBITOR
Q05397,Focal adhesion kinase 1,Kinase,FAK1_HUMAN,INHIBITOR
P04629,High affinity nerve growth factor receptor,Kinase,NTRK1_HUMAN,INHIBITOR
P16591,Tyrosine-protein kinase Fer,Kinase,FER_HUMAN,INHIBITOR
Q07912,Activated CDC42 kinase 1,Kinase,ACK1_HUMAN,INHIBITOR
Q16620,BDNF/NT-3 growth factors receptor,Kinase,NTRK2_HUMAN,INHIBITOR
Q14289,Protein-tyrosine kinase 2-beta,Kinase,FAK2_HUMAN,INHIBITOR
Q16288,NT-3 growth factor receptor,Kinase,NTRK3_HUMAN,INHIBITOR
P29376,Leukocyte tyrosine kinase receptor,Kinase,LTK_HUMAN,INHIBITOR
P07332,Tyrosine-protein kinase Fes/Fps,Kinase,FES_HUMAN,INHIBITOR
P30530,Tyrosine-protein kinase receptor UFO,Kinase,UFO_HUMAN,INHIBITOR
Q12866,Tyrosine-protein kinase Mer,Kinase,MERTK_HUMAN,INHIBITOR
P04275,von Willebrand factor,Unclassified,VWF_HUMAN,ANTIBODY BINDING
P03952,Plasma kallikrein,Enzyme,KLKB1_HUMAN,ANTIBODY BINDING
P26255,Beta-3 adrenergic receptor,GPCR,ADRB3_RAT,
O02662,Beta-3 adrenergic receptor,GPCR,ADRB3_CANLF,
Q28524,Beta-3 adrenergic receptor,GPCR,ADRB3_MACMU,
P02766,transthyretin (TTR) mRNA,RNA,TTHY_HUMAN,ANTISENSE INHIBITOR
P20273,B-cell receptor CD22,Membrane receptor,CD22_HUMAN,BINDING AGENT
P06881,Calcitonin gene-related peptide 1,GPCR,CALCA_HUMAN,ANTIBODY BINDING
P01579,Interferon gamma,Cytokine,IFNG_HUMAN,ANTIBODY BINDING
P26951|P32927,Interleukin-3 receptor,Membrane receptor,IL3RA_HUMAN|IL3RB_HUMAN,BINDING AGENT
P48169|P28472|O14764,GABA A receptor alpha-4/beta-3/delta,Ion channel,GBRA4_HUMAN|GBRB3_HUMAN|GBRD_HUMAN,POSITIVE ALLOSTERIC MODULATOR
Q16445|P28472|O14764,GABA-A receptor alpha-6/beta-3/delta,Ion channel,GBRA6_HUMAN|GBRB3_HUMAN|GBRD_HUMAN,POSITIVE ALLOSTERIC MODULATOR
O95977,Sphingosine 1-phosphate receptor 4,GPCR,S1PR4_HUMAN,MODULATOR
Q99500,Sphingosine 1-phosphate receptor 3,GPCR,S1PR3_HUMAN,MODULATOR
O95136,Sphingosine 1-phosphate receptor 2,GPCR,S1PR2_HUMAN,MODULATOR
P21453,Sphingosine 1-phosphate receptor 1,GPCR,S1PR1_HUMAN,MODULATOR
Q9H228,Sphingosine 1-phosphate receptor 5,GPCR,S1PR5_HUMAN,MODULATOR
Q9Z1L0,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform",Kinase,PK3CB_RAT,
O14980,Exportin-1,Nuclear other,XPO1_HUMAN,INHIBITOR
P60880,Synaptosomal-associated protein 25,Cytosolic other,SNP25_HUMAN,BLOCKER
P07437|Q9H4B7|Q13885|Q9BVA1|Q13509|P04350|P68371|Q9BUF5|Q3ZCM7,Tubulin beta,Tumour-associated antigen,TBB5_HUMAN|TBB1_HUMAN|TBB2A_HUMAN|TBB2B_HUMAN|TBB3_HUMAN|TBB4A_HUMAN|TBB4B_HUMAN|TBB6_HUMAN|TBB8_HUMAN,BINDING AGENT
P40259,B-cell antigen receptor complex-associated protein beta chain,Tumour-associated antigen,CD79B_HUMAN,ANTIBODY BINDING
P02656,apolipoprotein C-III (apoC-III) mRNA,RNA,APOC3_HUMAN,ANTISENSE INHIBITOR
Q9NPF7,Interleukin-23 subunit alpha,Cytokine,IL23A_HUMAN,INHIBITOR
P17181|P48551,Interferon alpha/beta receptor,Membrane receptor,INAR1_HUMAN|INAR2_HUMAN,BINDING AGENT
Q8RL90,Beta-lactamase,Enzyme,Q8RL90_PSEAI,
Q2PUH3,Beta-lactamase,Enzyme,Q2PUH3_KLEPN,INHIBITOR
Q9X5A7,Beta-lactamase,Enzyme,Q9X5A7_STEMA,INHIBITOR
Q93LQ9,Beta-lactamase,Enzyme,Q93LQ9_KLEPN,INHIBITOR
Q93DC4,Beta-lactamase,Enzyme,Q93DC4_KLEPN,INHIBITOR
B1PL86,Beta-lactamase,Enzyme,B1PL86_KLEPN,INHIBITOR
P51957,Serine/threonine-protein kinase Nek4,Kinase,NEK4_HUMAN,
Q58F21,Bromodomain testis-specific protein,Unclassified,BRDT_HUMAN,
Q96PY6,Serine/threonine-protein kinase Nek1,Kinase,NEK1_HUMAN,
P26433,Sodium/hydrogen exchanger 3,Transporter,SL9A3_RAT,
P48764,Sodium/hydrogen exchanger 3,Transporter,SL9A3_HUMAN,INHIBITOR
Q07806,Penicillin-binding protein 1A,Enzyme,PBPA_PSEAE,INHIBITOR
G1C775,Penicillin-binding protein 1A,Enzyme,G1C775_ACIBA,INHIBITOR
A6T4V3,Penicillin-binding protein 1B,Enzyme,A6T4V3_KLEP7,INHIBITOR
H4I819,"Peptidoglycan D,D-transpeptidase MrdA",Enzyme,H4I819_ECOLX,INHIBITOR
A0A0W8ASI8,"Peptidoglycan D,D-transpeptidase MrdA",Enzyme,A0A0W8ASI8_KLEPN,INHIBITOR
A6T4M7,"Peptidoglycan D,D-transpeptidase FtsI",Enzyme,A6T4M7_KLEP7,INHIBITOR
G3XD46,"Peptidoglycan D,D-transpeptidase FtsI",Enzyme,FTSI_PSEAE,INHIBITOR
D0CCM7,"Peptidoglycan D,D-transpeptidase FtsI",Enzyme,D0CCM7_ACIB2,INHIBITOR
A0A5E6DR09,Penicillin-binding protein 4,Enzyme,A0A5E6DR09_KLEPN,INHIBITOR
P13196,aminolevulinate synthase1 (ALAS1) mRNA,RNA,HEM1_HUMAN,ANTISENSE INHIBITOR
P48169,Gamma-aminobutyric acid receptor subunit alpha-4,Ion channel,GBRA4_HUMAN,ALLOSTERIC MODULATOR
Q16445,Gamma-aminobutyric acid receptor subunit alpha-6,Ion channel,GBRA6_HUMAN,ALLOSTERIC MODULATOR
P69905,hemoglobin subunit alpha,Transporter,HBA_HUMAN,INHIBITOR
P11532,exon 53 of dystrophin pre-mRNA,RNA,DMD_HUMAN,ANTISENSE INHIBITOR
Q99572,P2X purinoceptor 7,Ion channel,P2RX7_HUMAN,ANTAGONIST
P37840,Alpha-synuclein,Transporter,SYUA_HUMAN,
Q16602,Calcitonin gene-related peptide type 1 receptor,GPCR,CALRL_HUMAN,ANTAGONIST
Q9BQB4,Sclerostin,Glycoprotein,SOST_HUMAN,BINDING AGENT
O95390,Growth/differentiation factor 11,Cytokine,GDF11_HUMAN,BINDING AGENT
O14793,Growth/differentiation factor 8,Cytokine,GDF8_HUMAN,BINDING AGENT
P16109,P-selectin,Adhesion,LYAM3_HUMAN,INHIBITOR
Q96NY8,Nectin-4,Tumour-associated antigen,NECT4_HUMAN,BINDING AGENT
P04626,Receptor tyrosine-protein kinase erbB-2,Kinase,ERBB2_HUMAN,BINDING AGENT
Q9GZT9,Egl nine homolog 1,Enzyme,EGLN1_HUMAN,INHIBITOR
Q96KS0,Egl nine homolog 2,Enzyme,EGLN2_HUMAN,INHIBITOR
Q9H6Z9,Egl nine homolog 3,Enzyme,EGLN3_HUMAN,INHIBITOR
P13569,Cystic fibrosis transmembrane conductance regulator,Ion channel,CFTR_HUMAN,
Q13131,5'-AMP-activated protein kinase catalytic subunit alpha-1,Kinase,AAPK1_HUMAN,INHIBITOR
P19838,Nuclear factor NF-kappa-B p105 subunit,Cytosolic other,NFKB1_HUMAN,INHIBITOR
P05532,Mast/stem cell growth factor receptor Kit,Kinase,KIT_MOUSE,INHIBITOR
Q92800,Histone-lysine N-methyltransferase EZH1,Enzyme,EZH1_HUMAN,INHIBITOR
Q15910,Histone-lysine N-methyltransferase EZH2,Enzyme,EZH2_HUMAN,INHIBITOR
P53396,ATP-citrate synthase,Enzyme,ACLY_HUMAN,INHIBITOR
O95977,Sphingosine 1-phosphate receptor 4,GPCR,S1PR4_HUMAN,
Q99500,Sphingosine 1-phosphate receptor 3,GPCR,S1PR3_HUMAN,
O95136,Sphingosine 1-phosphate receptor 2,GPCR,S1PR2_HUMAN,
P30099,"Cytochrome P450 11B2, mitochondrial",Enzyme,C11B2_RAT,
P28907,Lymphocyte differentiation antigen CD38,Tumour-associated antigen,CD38_HUMAN,BINDING AGENT
P06881,Calcitonin gene-related peptide 1,GPCR,CALCA_HUMAN,BINDING AGENT
P10092,Calcitonin gene-related peptide 2,GPCR,CALCB_HUMAN,BINDING AGENT
P08069,Insulin-like growth factor 1 receptor,Kinase,IGF1R_HUMAN,ANTAGONIST
P04626|P21860,ERBB2/ERBB3,Kinase,ERBB2_HUMAN|ERBB3_HUMAN,INHIBITOR
P55899,IgG receptor FcRn large subunit p51,Membrane receptor,FCGRN_HUMAN,ANTIBODY BINDING
P11387,DNA topoisomerase 1,Enzyme,TOP1_HUMAN,BINDING AGENT
P09758,Tumor-associated calcium signal transducer 2,Tumour-associated antigen,TACD2_HUMAN,ANTIBODY BINDING
Q96GD4,Aurora kinase B,Kinase,AURKB_HUMAN,INHIBITOR
P03372,Estrogen receptor,Nuclear hormone receptor,ESR1_HUMAN,BINDING AGENT
P10636,Microtubule-associated protein tau,Structural,TAU_HUMAN,BINDING AGENT
P08637,Low affinity immunoglobulin gamma Fc region receptor III-A,Membrane receptor,FCG3A_HUMAN,ANTIBODY BINDING
P18508|P20236|P63138,GABA A receptor alpha-3/beta-2/gamma-2,Ion channel,GBRG2_RAT|GBRA3_RAT|GBRB2_RAT,MODULATOR
P18508|P62813|P63138,GABA-A receptor; alpha-1/beta-2/gamma-2,Ion channel,GBRG2_RAT|GBRA1_RAT|GBRB2_RAT,MODULATOR
P18508|P23576|P63138,GABA A receptor alpha-2/beta-2/gamma-2,Ion channel,GBRG2_RAT|GBRA2_RAT|GBRB2_RAT,MODULATOR
P19969|P63138|P18508,GABA A receptor alpha-5/beta-2/gamma-2,Ion channel,GBRA5_RAT|GBRB2_RAT|GBRG2_RAT,MODULATOR
P14867|P47869|P34903|P31644|Q8N1C3|P18507|Q99928,GABA-A receptor; benzodiazepine binding site,Ion channel,GBRA1_HUMAN|GBRA2_HUMAN|GBRA3_HUMAN|GBRA5_HUMAN|GBRG1_HUMAN|GBRG2_HUMAN|GBRG3_HUMAN,MODULATOR
Q75760,Envelope glycoprotein gp160,Viral envelope protein,Q75760_9HIV1,INHIBITOR
P32320,Cytidine deaminase,Enzyme,CDD_HUMAN,INHIBITOR
P51685,C-C chemokine receptor type 8,GPCR,CCR8_HUMAN,
P55899,IgG receptor FcRn large subunit p51,Membrane receptor,FCGRN_HUMAN,BINDING AGENT
P12314,High affinity immunoglobulin gamma Fc receptor I,Membrane receptor,FCGR1_HUMAN,BINDING AGENT
P08637,Low affinity immunoglobulin gamma Fc region receptor III-A,Membrane receptor,FCG3A_HUMAN,BINDING AGENT
Q02223,Tumor necrosis factor receptor superfamily member 17,Tumour-associated antigen,TNR17_HUMAN,BINDING AGENT
P41146,Nociceptin receptor,GPCR,OPRX_HUMAN,AGONIST
P11532,exon 53 of dystrophin pre-mRNA,RNA,DMD_HUMAN,BINDING AGENT
P08887|P40189,Interleukin-6 receptor,Membrane receptor,IL6RA_HUMAN|IL6RB_HUMAN,ANTAGONIST
P30874,Somatostatin receptor type 2,GPCR,SSR2_HUMAN,BINDING AGENT
Q08345,Epithelial discoidin domain-containing receptor 1,Kinase,DDR1_HUMAN,INHIBITOR
P10912,Growth hormone receptor,GPCR,GHR_HUMAN,
P01112,GTPase HRas,Cytosolic other,RASH_HUMAN,INHIBITOR
P01116,GTPase KRas,Enzyme,RASK_HUMAN,INHIBITOR
P01111,GTPase NRas,Enzyme,RASN_HUMAN,INHIBITOR
P01112,GTPase HRas,Enzyme,RASH_HUMAN,INHIBITOR
P49354|P49356,Protein farnesyltransferase,Enzyme,FNTA_HUMAN|FNTB_HUMAN,INHIBITOR
Q9UJM8,Hydroxyacid oxidase 1 (HAO1) mRNA,RNA,HAOX1_HUMAN,ANTISENSE INHIBITOR
P01857|P01859|P01860|P01861,"Immunoglobulin gamma (IgG), heavy chain",Antibody,IGHG1_HUMAN|IGHG2_HUMAN|IGHG3_HUMAN|IGHG4_HUMAN,INHIBITOR
P15692,Vascular endothelial growth factor A,Unclassified,VEGFA_HUMAN,
Q8N543,Prolyl 3-hydroxylase OGFOD1,Unclassified,OGFD1_HUMAN,
Q9NWT6,Hypoxia-inducible factor 1-alpha inhibitor,Unclassified,HIF1N_HUMAN,
Q63016,L-type amino acid transporter 1,Transporter,LAT1_RAT,SUBSTRATE
Q9NWZ3,Interleukin-1 receptor-associated kinase 4,Kinase,IRAK4_HUMAN,INHIBITOR
P20309,Muscarinic acetylcholine receptor M3,GPCR,ACM3_HUMAN,INHIBITOR
P07288,Prostate-specific antigen,Surface antigen,KLK3_HUMAN,BINDING AGENT
P30969,Gonadotropin-releasing hormone receptor,GPCR,GNRHR_RAT,ANTAGONIST
P87666,Envelope glycoprotein,Glycoprotein,VGP_EBOZ5,ANTIBODY BINDING
P04626,Receptor tyrosine-protein kinase erbB-2,Kinase,ERBB2_HUMAN,ANTAGONIST
P08637,Low affinity immunoglobulin gamma Fc region receptor III-A,Membrane receptor,FCG3A_HUMAN,ANTAGONIST
P20595,Guanylate cyclase soluble subunit beta-1,Enzyme,GCYB1_RAT,ACTIVATOR
Q02153,Guanylate cyclase soluble subunit beta-1,Enzyme,GCYB1_HUMAN,ACTIVATOR
P49674,Casein kinase I isoform epsilon,Kinase,KC1E_HUMAN,INHIBITOR
P06493,Cyclin-dependent kinase 1,Kinase,CDK1_HUMAN,INHIBITOR
P24941,Cyclin-dependent kinase 2,Kinase,CDK2_HUMAN,INHIBITOR
Q00535,Cyclin-dependent-like kinase 5,Kinase,CDK5_HUMAN,INHIBITOR
P50750,Cyclin-dependent kinase 9,Kinase,CDK9_HUMAN,INHIBITOR
P50613,Cyclin-dependent kinase 7,Kinase,CDK7_HUMAN,INHIBITOR
Q9H093,NUAK family SNF1-like kinase 2,Kinase,NUAK2_HUMAN,INHIBITOR
Q6ZWH5,Serine/threonine-protein kinase Nek10,Kinase,NEK10_HUMAN,INHIBITOR
Q9NZB8,Molybdenum cofactor biosynthesis protein 1,Enzyme,MOCS1_HUMAN,
Q9Y5C1,Angiopoietin-related protein 3,Secreted,ANGL3_HUMAN,INHIBITOR
P01024,Complement C3,Unclassified,CO3_HUMAN,INHIBITOR
Q04609,Glutamate carboxypeptidase 2,Enzyme,FOLH1_HUMAN,BINDING AGENT
Q99835,Smoothened homolog,GPCR,SMO_HUMAN,
P41143,Delta-type opioid receptor,GPCR,OPRD_HUMAN,PARTIAL AGONIST
Q6FTN8,"1,3-Beta-D-glucan-UDP glucosyltransferase",Enzyme,Q6FTN8_CANGA,INHIBITOR
P87204,"1,3-Beta-D-glucan-UDP glucosyltransferase",Enzyme,P87204_ASPFM,INHIBITOR
